WorldWideScience

Sample records for iodine-131 dosimetria biologica

  1. Biological dosimetry of patients with differenced carcinoma of thyroid treated with Iodine-131; Dosimetria biologica de pacientes con carcinoma diferenciado de tiroides tratados con Iodo-131

    Energy Technology Data Exchange (ETDEWEB)

    Vallerga, M. B.; Rojo, A.M.; Taja, M.R.; Deluca, G.; Di Giorgio, M. [Autoridad Regulatoria Nuclear Av. Del Libertador 8250 (C1429BNP). Buenos Aires (Argentina); Fadel, A. [Hospital General de Agudos Dr. Carlos Durand Av. Diaz Velez 5044. Buenos Aires (Argentina); Cabrejas, M.; Valdivieso, C. [Hospital de Clfnicas Jose de San Martin Av. Cordoba 2351 (CP1120). Buenos Aires (Argentina)]. e-mail: mvallerg@cae.arn.gov.ar

    2006-07-01

    The administration of I-131 to patient with Differentiated Thyroid Carcinoma (CaDiT) it is used inside the therapeutic outline as later step to the thyroidectomy. However, the good activity to give is of difficult determination due to factors such as, the variability in the capacity of tumoral reception of the I-131, distribution of the pharmaceutical, physiologic status, other associate pathologies, grade of advance of the illness, and previous treatments. Additionally, the activity to administer is dependent of the dose of tolerance in the healthy tissues; superior dose to 2 Gy in bone marrow, its could drive to myelotoxicity. At the moment, the form more extended of administration it is the empiric prescription that considers clinical parameters and of laboratory for their determination. Presently work, the protocol of applied treatment incorporates the evaluation for internal dosimetry and biological dosimetry to estimate absorbed dose in bone marrow. The biological estimate of the dose of these patients is based on the quantification of chromosomal aberrations whose frequency is referred to a curve-dose response in which the lymphocytes is irradiated in vitro with I-131, allowing to determine the in vivo dose to the patient's circulating lymphocytes. The objective of the present work is to determine the applicability of different cytogenetic essays in the estimate of the absorbed dose to the whole body or specific organs. Three patients were evaluated with CaDiT. Their treatment protocol consisted on a tracer administration of radioactive iodine of 74 - 111 MBq (2 - 3 mCi) and a therapy 7,4 - 11,1 GBq (200 - 300 mCi). Previous to the tracer administration and 8 days post-therapeutic administration took samples of veined blood that were evaluated by biological dosimetry by means of the application of the techniques: conventional cytogenetic Micronucleus and FISH (Hybridization in situ by Fluorescence). Starting from the frequencies of observed chromosomal aberrations it was considered absorbed dose to whole body. The obtained doses were compared by the different biological methods used. The evaluation by internal dosimetry of the data obtained tracer post-activity allowed to personalize the activity of I-131 to administer, starting from physical-mathematical models that consider the particular biokinetics of each patient (MIRD methodology). The doses estimated by the used biological dosemeters were consistent among them. It was discussed its scopes and limitations to be applied in the validation of the dosimetric estimation based on models, in order to administer a therapeutic dose protecting the patient of the adverse effects of the internal radiotherapy in organs that are not target of the same one. The acquired experience is considered of utility to give answer in cases of radioiodine incorporation in occupationally exposed personnel. (Author)

  2. Iodine 131 and 133 as Fission Indicators

    Energy Technology Data Exchange (ETDEWEB)

    Broda, E.

    1944-07-01

    This report was written by E. Broda at the Cavendish Laboratory (Cambridge) in September 1944 and is about the possible use of Iodine 131 and 133 as fission indicators. Additionally, the description of the chemical procedure for I 131 and I 133 and the corresponding results can be found in this report. (nowak)

  3. Radiosensitizers action on Iodine 131 therapeutical effect

    International Nuclear Information System (INIS)

    Agote, Marcos; Kreimann, Erica L.; Bocanera, Laura V.; Dagrosa, Maria A.; Juvenal, Guillermo J.; Pisarev, Mario A.

    1999-01-01

    Present studies were aimed to research the possible application of a radiosensitizer, nicotinamide, to increase the therapeutical effect of radioiodine. There were used goitrous and normal rats with growing dose of Iodine 131, with and without simultaneous treatment with nicotinamide. The obtained results show that the nicotinamide treatment importantly increases the thyroid radio destructive effect induced by radioiodine. Under these experimental conditions, nicotinamide induces to a significant increase of thyroid vascularisation, without changes in the proteins ADP-ribosylation activity. These results show, for the first time, the radiosensitizer effect of nicotinamide in front of Iodine 131 and give the possibility of using it in the treatment of hyperthyroid or thyroid difference cancer patients. (author)

  4. Iodine-131 monitoring in sewage plant outflow

    International Nuclear Information System (INIS)

    McGowan, D R; Crawley, M T; Pratt, B E; Hinton, P J; Peet, D J

    2014-01-01

    Three different hospital sites (Oxford, Sutton and Guildford) have performed sampling of their local sewage plant outflow to determine levels of radioactivity resulting from iodine-131 patients undergoing radionuclide therapies. It was found that a maximum of 20% of activity discharged from the hospitals was present in the sewage plant final effluent channel. This is significantly below the level predicted by mathematical models in current use. The results further show that abatement systems to reduce public exposure are unlikely to be warranted at hospital sites. (paper)

  5. Malignant disease after iodine-131 therapy

    International Nuclear Information System (INIS)

    Holm, L.E.; Hall, P.; Lundell, G.

    1991-01-01

    Iodine-131 therapy is one of the most common treatments for hyperthyroidism and thyroid cancer. Data on man exposed to 131-I are still scarce, and there is concern as to its possible genetic and carcinogenic effects. No overall increased cancer risk has been observed in patients receiving 131-I therapy for hyperthyroidism. Two studies have reported increased risks for leukemia after 131-I therapy for throid cancer. Different sites have been demonstrated to be at increased cancer risk in different record-linkage studies of thyroid cancer patients, e.g. bone-marrow, breast and kidney, nervous tissue, and connective tissue. However, the findings are not consistent. This article presents results from a Swedish multicenter cohort study analyzing risks of second primary tumors in patients treated with 131-I for hyperthyroidism or thyroid cancer. 10 refs

  6. Chapter 5: Measurements of iodine-131 in milk supplies

    International Nuclear Information System (INIS)

    Duggleby, J.C.; Kotler, L.H.; Wilks, M.J.; Wise, K.N.

    1974-01-01

    As with previous series of French nuclear tests in Polynesia, a program was instituted to monitor major milk supplies for iodine-131. This program extended from 25 July to 23 October 1973, and was terminated only after there was no further possibility of iodine-131 reaching the milk supplies. The program covered the nine major population centres and effectively monitored the milk consumed by 80 per cent of the entire Australian population. The method employed for iodine-131 assay of milk supplies is described, and the final results obtained are presented. (author)

  7. Nursing of patients with hyperthyroidism treated by using iodine-131

    International Nuclear Information System (INIS)

    Chen Dongju; Cao Guoxiang

    2002-01-01

    Hyperthyroidism was a common endocrine disease, its clinic treatment mainly include anti thyroid drug treatment, surgical operation and iodine-131 therapy. The latter have unique superiority, which was adapted by clinic doctors. The nursing method was distinguished from that of others because the principle of iodine-131 therapy was different from other therapy in course of the treatment of hyperthyroidism. Combining the nursing experiences with related documents, this article was about to sum up briefly the nursing and matters needing attention in course of treatment of iodine-131 in patients with hyperthyroidism

  8. Source of Iodine-131 in Europe Identified

    International Nuclear Information System (INIS)

    2011-01-01

    Full text: The IAEA has received information from the Hungarian Atomic Energy Authority (HAEA) that the source of the iodine-131 (I-131) detected in Europe was most probably a release to the atmosphere from the Institute of Isotopes Ltd., Budapest. The Institute of Isotopes Ltd. produces radioisotopes for healthcare, research and industrial applications. According to the HAEA, the release occurred from September 8 to November 16, 2011. The cause of the release is under investigation. As previously mentioned, the levels of I-131 that have been detected in Europe are extremely low. There is no health concern to the population. If any member of the public were to breathe iodine for a whole year at the levels measured in European countries, then they would receive a dose in the range of 0.01 microsieverts for the year. To put this into perspective, the average annual background is 2 400 microsieverts per year. The IAEA was first notified of the presence of trace levels of I-131 by authorities from the Czech Republic on 11 November. Since this notification, the IAEA contacted several member states throughout the region to determine the cause and origin. The IAEA also worked with the World Meteorological Organization (WMO) to conduct air dispersion modelling, as part of efforts to determine the source. (IAEA)

  9. Genetic effects of iodine 131 incorporation in mammals

    International Nuclear Information System (INIS)

    Bajrakova, A.

    1988-01-01

    The translocation yield after single treatment of male mice with iodine 131 (55,5 - 222,0 kBq/g b.w.) was investigated. The results of the cytogenetic analysis of the gonad cells revealed the effectiveness only of the highest activity, distroying the thyroid gland. The so-called direct method was also used for determination of the risk coefficients for the expected new carriers of balanced and unbalanced translocations in the first generation - the genetic effects which could be expected from the use of iodine-131-diagnostics in a hypothetic population

  10. Merkel cell carcinoma and iodine-131 metaiodobenzylguanidine scan

    International Nuclear Information System (INIS)

    Castagnoli, A.; Biti, G.; De Cristofaro, M.T.R.; Papi, M.G.; Ferri, P.; Magrini, S.M.; Bianchi, S.

    1992-01-01

    Two cases of Merkel cell carcinoma, a neuroendocrine neoplasia of the skin, investigated with iodine, 131 metaiodobenzylguanidine ( 131 I-mIBG) scintigraphy, are reported. Uptake in the tumor was evident only in 1 case. The possible diagnostic and therapeutic role of 131 I-mIBG in patients with this rare neoplasm is discussed. (orig.)

  11. Iodine-131 releases from the Hanford Site, 1944--1947

    International Nuclear Information System (INIS)

    Heeb, C.M.

    1992-10-01

    Detailed results of the Hanford Environmental Dose Reconstruction (HEDR) iodine-131 release reconstruction are presented in this volume. Included are daily data on B, D, and F Plant, reactor operations from the P-Department Daily Reports (General Electric Company 1947). Tables of B and T Plant material processed from the three principal sources on separations plant operations: The Jaech report (Jaech undated), the 200 Area Report (Acken and Bird 1945; Bird and Donihee 1945), and the Metal History Reports (General Electric Company 1946). A transcription of the Jaech report is also provided because it is computer-generated and is not readily readable in its original format. The iodine-131 release data are from the STRM model. Cut-by-cut release estimates are provided, along with daily, monthly, and yearly summations. These summations are based on the hourly release estimates. The hourly data are contained in a 28 megabyte electronic file. Interested individuals may request a copy

  12. Radiation doses by therapeutical practices with iodine 131

    International Nuclear Information System (INIS)

    Di Trano, J.L.; Rojo, A.M.; Gomez Parada, I.M.; Grassi, E.; Gatica, N.; Kunst, J.J.; Gonzalez, M.

    1998-01-01

    The aim of this document is to estimate the doses to workers and public due to therapeutical practices with iodine 131. Environmental and personal doses by external irradiation were determined using thermoluminescent dosimeters (TLD). The environmental dosimetry resulted in an equivalent dose H * (10) of approximately 0,1 mSv. The calculated personal equivalent dose Hp (10) was of the order of 0,1 mSv. The exposition rate was measured, being the values obtained in the range of 0,20 and 0,35 mSv/h. (1m from the abdominal wall). Concentrations of iodine 131 were determinate in the air of the room, during the first day in the hospital. Values obtained were between 0,04 Bq/l and 0,20 Bq/l. Surface samples were taken in the service, obtaining levels of contamination in the range of 0,001 and 0,4 Bq/cm 2 . The surface samples obtained in the hospital room were about 0,15 Bq/cm 2 . Urine samples were collected resulting in an eliminated activity of iodine 131, during the first 24 hours, of about 60 % of the administered activity. Samples of sweat of different cutaneous regions were obtained, the maximum values of the activity measured reached 200 Bq/cm 2 . According to the obtained results it is important to elaborate guides to be given to patients as an instrument to reduce the external exposure and to avoid internal contamination. (author)

  13. Some methods of detection of atmospheric contamination by iodine 131

    International Nuclear Information System (INIS)

    Billard, Francois; Chevalier, Gerard; Gaillard, Pierre; Pradel, Jacques

    1964-01-01

    Due to the extensive use of iodine, risks of contamination by iodine 131 are increasing. Moreover, the increase of reactor power requires venting installations equipped with efficient safety filters which must be tested. The authors thus report the study of iodine trapping in filters, and its atmospheric detection and measurement. They report studies and achievements in the field of measurement of atmospheric pollution, and tests performed on iodine trapping by activated coals. After having outlined key qualities of an apparatus for atmospheric control, the authors indicate the various sampling methods. They discuss the method and calibration for the measurement of radioactivity of filters and coal which have trapped iodine 131. They discuss measurement sensitivity. They report how the efficiency of coals has been checked. They describe the experimental installation, and report the tests of some detectors of atmospheric contamination: sampling cartridges full of activated coal, gas mask cartridge, continuous control apparatus ('coffee machine' type), and detector of gaseous iodine. Appendices indicate the calculation of error on a cartridge counting rate, iodine generation methods (discontinuous method, continuous method) [fr

  14. Chemical treatment of wastewaters produced during separation of iodine 131

    International Nuclear Information System (INIS)

    Cohen, P.; Marcaillou, J.; Amavis, R.

    1959-01-01

    The authors report the development and assessment of a chemical treatment of radioactive wastewaters by co-precipitation. This treatment is aimed at replacing a treatment based on the use of calcium phosphate which proved to be insufficient for wastewaters resulting from the production of iodine 131. After a presentation of the characteristics of the effluents to be processed, the authors report co-precipitation tests performed on effluents before release in the storage vessel (by using barium hydroxide, lead acetate or lead sulfate) and on effluents diluted on the storage vessel. They show that a co-precipitation method based on the use of lead sulfate in alkaline medium gives the best results

  15. Guidelines on the management of patients treated with iodine-131

    International Nuclear Information System (INIS)

    1993-03-01

    The purpose of these guidelines is to assist health care institutions establish protocols for the management of patients treated with iodine-131. These guidelines are written primarily for the use of Na 131 I in the treatment of benign and malignant thyroid disease. The principles have some application for the use of complex 131 I-labelled radiopharmaceuticals in that the treated patient will become a temporary radiation source and since contamination with body fluids of treated patients must be guarded against. The document outlines radiation protection and logistical concerns associated with the management of 131 I patients before, during and after therapy. These concerns include the safety of health care personnel, visitors, and any other persons who are at risk; and protection of the environment. (L.L.) 23 refs., 2 tabs

  16. Activity concentrations of iodine-131 and radiocesium in milk

    International Nuclear Information System (INIS)

    Rabitsch, H.; Kahr, G.; Oswald, K.

    1991-12-01

    We have measured the activity concentrations of iodine-131 and radiocesium in pasteurized fresh milk following the Chernobyl accident. Average monthly concentrations of radiocesium are given until December 1991. Samples originated from the local dairy (Milchhof Graz, Austria) and the measured activities in milk represent a large part of the total intake in the population of Graz. Observed activities are also compared with the activity levels obtained after the earlier nuclear contaminations. From the data of our measurements for radiocesium we have estimated the internal effective dose equivalent due to the intake of contaminated milk during the first year after the fallout. Results indicate that the averaged consumer rates for milk, usually used for predictions of dose, were too high. We have also observed great differences in the activity levels of raw milk and the activities in milk consumed by the population. (authors)

  17. Immunotoxic effects of iodine-131 in prenatally exposed rats

    International Nuclear Information System (INIS)

    Cole, D.A.; Stevens, R.H.; Lindholm, P.A.; Cheng, H.F.

    1985-01-01

    Present results suggest that offspring exposed in utero to radioactive iodine-131 develop a measureable cell-mediated immune (CMI) response. Regnant Fischer F344 inbred rats were exposed to 370 kBg to 3.7 MBg (10 to 100 μCi) Na 131I on 16 to 18 days of gestation and evaluated for CMI responsiveness 2 to 3 months post exposure using an 125I radiolabeled membrane release assay. Current data suggest that not only the F1, but also the F2 pups develop a measureable CMI response. In order to determine whether other immune functions are altered studies have been initiated to evaluate the immunotoxic effect of prenatal exposure to 131I. These studies include the evaluation of the delayed hypersensitivity response and the blastogenic responses to phytoheemagglutinin, concanavalin A, and lipopolysaccharide

  18. Treatment of hyperthyroidism with fixed dose form Iodine 131

    International Nuclear Information System (INIS)

    Pacheco Torres, P.; Cerquera, A.M.; Acosta, F.; Sierra, M.

    2007-01-01

    Full text: Objective: Evaluation of the response to therapy with fixed dose of Iodine-131 in patients with hyperthyroidism. One hundred seventeen patients with hyperthyroidism were tested and sent for treatment with Iodine-131. The dose of the therapy was calculated according to the pathology (Diffuser goiter (DG): Multinodular goiter (MNG) and Single toxic nodule (NST). Values of TSH confirmed hyperthyroidism by laboratory methods. The thyroid-blocking agents were discontinued: methimazole for five days and propylthiouracil two days prior to therapy. The pregnancy tests were routinely conducted in females of reproductive age group. Patients reported fasting for therapy. The doses were administered in capsule form after obtaining informed consent from the patients. The patients were normally instructed to eat only after two hours after administration of iodine to promote gastric absorption of the radionuclide. Normally a post therapy thyroid scan is performed four days after treatment. Patients are usually followed up by the endocrinologists. A three- month post therapy evaluation is done by the nuclear medicine physician by telephone. The demographic data of our patients treated are as follows: Total number of patients: 117 Female: 88 (75.21%) Male: 29 (24.79%) Age average: 45 years. Diffuse Goiter= 94 (80.34%), Multinodular Goiter= 17 (14.52%) and Toxic Adenoma (NST) = 6 (5.12%). The average administered dose was 22.5 mCi to DG, 41.8 mCi to MNG and 37.5 mCi to NST. 102 (87.14%) patients at the control at 2 years after treatment presented stable response to therapy, 15 (12.86%) required a second therapy, 11 (11.70%) with BD and 4 (23.52%) with BMN; and any patient with NST required a second therapy. 83 (88.29%) of the patients with BD; 13 (76.48%) with BMN and 6 (100%) with NST the therapy was successful. Conclusion: Fixed dose of I-131 in hyperthyroidism is useful in patients with DG (11.70%). In patients with MNG whom a fixed dose is supplied, 23.52% require a

  19. [Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice].

    Science.gov (United States)

    Guiraud-Vitaux, Françoise; Elbast, Mouhamad; Colas-Linhart, Nicole; Hindie, Elif

    2008-02-01

    The large increase in the incidence of thyroid cancer among children who were mainly less than five years old at the time of the Chernobyl accident is still a major preoccupation for endocrinologists and nuclear physicians. Epidemiological studies have focused solely on iodine 131. However, past knowledge on thyroid irradiation (medical use of iodine 131, radioactive fallout on Marshall islands and the Nevada, and Hanford site releases) as well as number of recent works (about low-dose irradiation), raise question on the role of other factors. It is here shown that post-Chernobyl thyroid irradiation is complex and that all factors (iodine 131, but also short lived isotopes of iodine and external irradiation) should be considered. Finally, one need to think about some of the present medical uses of iodine 131, and especially to the treatment of hyperthyroidism in young subjects.

  20. Radiation safety considerations for post-iodine-131 hyperthyroid therapy

    International Nuclear Information System (INIS)

    Culver, C.M.; Dworkin, H.J.

    1991-01-01

    The purpose of this study was to develop guidelines based on patient measurements as to when iodine-131- (131I) treated hyperthyroid patients may resume close personal contact. External exposure rates were measured on 59 patients using an ionization survey meter in the upright position. The initial measurement was recorded within 20 min post-dose administration at one meter. Exposure rates were measured 2-11 days post-dose administration at 1, 0.6, and 0.3 meters from the patient's thyroid. In the administered dose range of 3 to less than 12 mCi of 131I, all 40 patients measured less than or equal to 2.0 mR/hr at one meter on Day 0, and 25 patients (25/29) were less than or equal to 2.0 mR/hr at 0.6 meter on Days 2-4. Guidelines can be prepared based on the administered dose that are rational and in conformity with existing radiologic health standards

  1. Iodine-131: optimal therapy for hyperthyrodism in children and adolescents

    International Nuclear Information System (INIS)

    Freitas, J.E.; Swanson, D.P.; Gross, M.D.; Sisson, J.C.

    1979-01-01

    To assess the medium- to long-term effects of I-131 therapy of hyperthyroidism in children and adolescents, we studied 51 patients (age range 6 to 18; 8 boys, 43 girls) treated with I-131 for Graves' disease with hyperthyroidism at the University of Michigan Medical Center (1951 to 1972). Patients received total doses ranging from 3 to 81.6 mCi. The mean followup period was 14.6 +- 7.9 yr. Hyperthyroidism was effectively treated in 49 within 1 to 12 months. One patient failed to respond to three treatment doses, and hyperthyroidism recurred in two patients: 2 and 11 yr after initial therapy. Of these three patients, two were treated by thyroidectomy and was retreated successfully with I-131. There were no cases of thyroid cancer, other malignancies or leukemia. The patients' reproductive histories and the health of their offspring were as in the general population. At the time of study, the prevalence of hypothyroidism was 92%, with no recurrent goiters or thyroid nodules. Iodine-131 is found to be safe and effective treatment of hyperthyroidism in children and adolescents and should be the preferred mode of therapy

  2. Radiation protection data sheets for the use of iodine 131 in unsealed sources

    International Nuclear Information System (INIS)

    Anon.

    1993-01-01

    This radiation protection data sheet is intended for supervisors and staff in the different medical, hospital, pharmaceutical, university and industrial laboratories and departments where Iodine 131 is handled, and also for all those involved in risk prevention in this field. It provides essential data on radiation protection measures during the use of Iodine 131 in unsealed sources: physical characteristics, risk assessment, administrative procedures, recommendations, regulations and bibliography

  3. Hyperthyroidism treatment by iodine 131: about a study on 270 patients

    International Nuclear Information System (INIS)

    Leroux, M.A.

    2005-01-01

    This study constitutes a starting point for a thought about the use of iodine 131 in the treatment of hyperthyroidism. The therapies are different depending on the teams, for the iodine 131 activities to deliver and their calculation modes; The use of synthesis anti-thyroid drugs before therapy is discussed. The radiation protection is an important factor in the decision of a metabolic radiotherapy. The indications of the treatment by radioactive iodine are different in Europe and in Usa. (N.C.)

  4. Experimental results concerning the metabolism of ingested iodine-131 in adult sheep under lactation

    International Nuclear Information System (INIS)

    Daburon, F.; Capelle, A.; Tricaud, Y.; Nizza, P.

    1967-01-01

    The authors give the results of a series of experiments on metabolism of ingested iodine-131 in adult sheep under lactation; the measurement were carried out over a number of years from 1961 to 1966. The work was concerned initially with the fixation of iodine 131 in the thyroid gland, with the calculation of radiation doses absorbed and with ways of showing up any possible radiation damage in the gland. The modes of absorption of iodine 131 and its elimination through milk, urine and the faeces were then considered. Finally, a last chapter is devoted to changes in the radioactivity of the blood and of the milk, to variations of the PBI level of the blood serum as to different methods for measuring this level. (authors) [fr

  5. Putting to point the production process of iodine-131 by dry distillation (Preoperational tests)

    International Nuclear Information System (INIS)

    Alanis M, J.

    2002-12-01

    With the purpose of putting to point the process of production of 131 I, one of the objectives of carrying out the realization of operational tests of the production process of iodine-131, it was of verifying the operation of each one of the following components: heating systems, vacuum system, mechanical system and peripheral equipment that are part of the production process of iodine-131, another of the objectives, was settling down the optimal parameters that were applied in each process during the obtaining of iodine-131, it is necessary to point out that this objective is very important, since the components of the equipment are new and its behavior during the process is different to the equipment where its were carried out the experimental studies. (Author)

  6. Uptake of Iodine-131 in mussel (Mytilus smaragdinns) and algae (caulerpa racemosa)

    International Nuclear Information System (INIS)

    Sombrito, E.Z.; Banzon, R.B.; de la Mines, A.S.; Bautista, E.Rb.

    1982-01-01

    The behavior of radionuclides in the environment has been the subject of research. Iodine-131, a beta emitter as one of the radionuclides has been studied. This study describes Iodine-131 uptake in mussel and algae. The bioaccumulation factor C was determined which gave the relationship between the concentration of radioactivity in biota relative to the water environment. Results of the experiments showed that the mussels steadily accumulated I-131 from radioactive medium. Much higher bioaccumulation factor was obtained in algae than in mussel. No attempt was made to measure activity in the soft parts. (ELC)

  7. Comparison of short-term effects between interventional embolization treatment and iodine-131 therapy for graves'hyperthyroidism

    International Nuclear Information System (INIS)

    Zhu Gaohong; Zhao Wei; Yuan Weihong; Wang Bailing; Yi Gengfa; Yang Shumin

    2010-01-01

    Objective: To compare the short-term effects between interventional arterial embolization and iodine-131 therapy in treating Graves' disease. Methods: A total of 84 patients with Graves' disease (GD), confirmed by clinical data and laboratory tests, were divided into two groups: interventional group (n = 42) receiving arterial embolization and iodine-131 group (n = 42)receiving iodine-131 therapy. Before and after the treatment thyroid angiography and SPECT / CT imaging were performed to determine the shape and size of the thyroid, and radioimmunoassay method was used to measure serum levels of FT3, FT4, TSH and TRAb at 3, 6 and 12 months after the therapy. The results were compared and statistically analyzed. The occurrence of complications was observed. Results: No statistically significant difference in short-term therapeutic effects was found between interventional group and iodine-131 group. The occurrence of early severe complication was much higher in interventional group than that in iodine-131 group, while the occurrence of hypothyroidism was obviously higher in iodine-131 group than that in interventional group. Conclusion: Both interventional embolization and iodine-131 therapy have reliable effect for the treatment of Graves' disease. Iodine-131 therapy may be used in patients who plan to receive initial treatment or in patients who failed to effectively respond to other kinds of therapies, while interventional embolization may be employed in patients who are not able to receive surgery or in patients who have failed to respond to anti-thyroid drug treatment, or in patients whose iodine-131 intake rate is too low to undergo iodine-131 therapy, especially in patients with refractory and intractable hyperthyroidism. Interventional embolization can be regarded as an alternative treatment for Graves' disease. (authors)

  8. A review of best practice in relation to iodine-131 ablation discharges to sewer

    International Nuclear Information System (INIS)

    Punt, A.; Kruse, P.; Smith, K

    2010-03-01

    This report was produced by Enviros Consulting Ltd under contract to the RPII. It presents a review of best practice in relation to the management of iodine-131 ablation discharges to sewer and recommends a waste management strategy that could be adopted in the Republic of Ireland

  9. Production of fusion radionuclides: Molybdenum-99/ Iodine - 131 and Xenon-133

    International Nuclear Information System (INIS)

    Barrachina, M.; Carrillo, D.

    1982-01-01

    This report presents a new radiochemical method for industrial production of the radionuclides: molybdenum-99, iodine-131 and xenon-133. The above mentioned method based on the alkaline metathesis reaction of irradiated uranium (IV) fluoride, presents the best characteristics for the proposed objective. The study deals with the analysis of that reaction and the separation and purification processes. (Author) 71 refs

  10. Incidence of thyroid carcinoma in patients who had diagnostic iodine-131 tests during childhood and adolescence

    International Nuclear Information System (INIS)

    Hahn, K.; Schnell-Inderst, P.; Haenseler, G.J.; Kandziora, C.; Meyer, G.

    1999-01-01

    To determine the carcinogenic effects of diagnostic amounts of radioactive iodine-131 on the infantile thyroid gland a multi-center retrospective cohort study was conducted which included data of 4973 subjects who had either been referred to diagnostic iodine-131 uptake tests (2262 subjects) or had had a diagnostic procedure of the thyroid without 131-iodine (2711 subjects) until the age of 18 years. Follow-up examinations of 35 percent of the subjects in the iodine-131 group and 41 percent of the subjects in the control group took place after a mean time period of 20 years after the first examination. Dosimetry of the thyroid burden of iodine-131 was carried out according to ICRP 53. The median of the thyroid organ dose was 1012 mGy. The report compares prevalences or incidences of thyroid disorders resp. occurring in both groups and gives a stratified analysis of primary diagnosis, age at exposure, and organ dose. A total number of five carcinomas of the thyroid was found. In the radioiodine group two carcinomas were assessed in a period of 16500 person-years. The control group yielded three carcinomas over 21000 person-years (Relative rate: 0,89, 95% confidence interval: 0,14-5,13). (orig.) [de

  11. Manual on therapeutic uses of iodine-131. Incorporating: Applications guide, procedures guide, basics guide

    International Nuclear Information System (INIS)

    1992-01-01

    This booklet contains information about procedures to protect hospital staff and visitors and families of patients treated with iodine 131 from exposure to radiation from I-131. It also includes a basic guide to the principles of the production of ionizing radiation and to methods of radiation protection and dosimetry

  12. Chromosomal damage after Iodine-131 treatment for differentiated thyroid cancer: in vivo dose-effect relationship

    International Nuclear Information System (INIS)

    Nguyen, V.K.; Nguyen, X.P.; Truong, Q.X.

    2007-01-01

    Full text: Although it is well known that radiation induces chromosomal aberrations, there is a lack of information on the in- vivo dose-effect relationship in patients receiving Iodine-131 treatment and the results of previous studies are controversial. In this study, the dicentric chromosomal aberrations (DCA) analysis method was employed to investigate acute and late chromosomal damage (CD) in the peripheral lymphocytes of 58 differentiated thyroid cancer patients who received dose 1,1 GBq of Iodine-131 (group A), and 34 patients who received dose 3,7 GBq of Iodine- 131 (group B). The mean 100 metaphase spreads were scored for each subject. The DCA frequencies in cultured peripheral lymphocytes were determined before treatment to assess basal DCA frequencies, on the 3rd day to assess acute DCA frequencies and 6 months later to assess late DCA frequencies. The basal, acute and late DCA frequencies were divided into two groups: 0,18%, 2,14% and 0,53% (group A) and 0,18%, 2,12 % and 0,89% (group B), respectively, and these values differed significantly at various time after treatment (p 2 = 0,987), and group B as Y= 32,71 + 0,189 X. (r = 0,9381, R 2 = 0,880). However, there was an interesting difference in comparison with in- vitro studies, in that we found the coefficient β to have a negative value, suggesting the disappearance of damaged lymphocytes from peripheral circulation in a dose- dependent manner following Iodine-131 treatment. Further studies are therefore needed to clarify the effect of the negative β value on biological dosimetry approach in continuous internal low LET radiation, as in the case of Iodine-131 treatment. (author)

  13. Evaluation of radiation exposure from patients with thyroid disease by iodine-131 therapy

    International Nuclear Information System (INIS)

    Li Xianfeng; Lu Keyi; Duan Lian

    2004-01-01

    Purpose: To evaluate the radiation exposure to the individuals other than patients with thyroid disease, who had received radioiodine (iodine-131) therapy and had turned into a specific 'radiant point'. Methods: 107 outpatients or inpatients, with iodine-131 therapy had been investigated and followed up by telephone and outpatients. There were 117 times treatment (68 females, 49 males, mean age 41 years old), including the patients with hyperthyroidism (39 females, 40 males), thyroid cancer (27 females, 8 males), toxic thyroid adenoma (1 female and 1 male) and nontoxic nodular goiter(1 female). According to the personal condition of the patients, we attained the percentage of thyroid iodine-131 uptake (U), the iodine-131 dose (Q), the duration of constrained social activity, and the occupancy factor (OF) for the 3 periods (the preequilibrium, OFp; the constrained, OFc; and the unconstrained, OFuc), and the time of exposure to individuals other than patients, and to calculate the exposure dose (mSv) to the individuals. The formula is E (mSv) = Q[OFP(0.0173)+ OFC(0.537)U(1-e-0.095C)+0.023(1-U)(1-e-2.08C ) +OFUC (0.537) Ue-0.095C +0.0236(1-U)e-2.08C]. In accordance with the new recommendations of the national criteria from GB18871-2002, we evaluated the radiation safety to the individuals other than patients Results: Based on the national criteria the total effective dose equivalent to the individuals other than patients may not exceed 5 mSv. For all patients, including 79 hyperthyroidism, 2 toxic thyroid adenoma and 16 times treatment of thyroid cancer, the exposure doses to the individuals were not likely to exceed 5 mSv, but the others, including 19 times treatment of thyroid cancer and 1 nontoxic nodular goiter, the exposure doses were higher than 5 mSv. There were no difference between the part of hyperthyroidism and thyroid cancer of inpatients were compared with outpatients (P>0.05, respectively). we found that occupancy factor during the preequilibrium period

  14. Scintigraphic disagreement in the study of thyroid nodules using technetium 99m and iodine 131

    International Nuclear Information System (INIS)

    Planchon, C.A.

    1977-01-01

    116 patients with thyroid nodules, iso or hyperfixing, heterogeneous or scintigraphically indistinct after administration of pertechnetate 99mTc, were systematically re-examined with iodine 131. The results of this study are as follows: 1) 99mTc, while its advantages justify its extensive application, is an imperfect tracer and cannot replace iodine 131 altogether. In fact in 12% of the cases the results were conflicting. 2) The technological conditions may sometimes be to blame but the hypothesis of a special metabolic behavior of the nodule examined seems plausible in certain cases of disagreement (blocking of hormone synthesis and escape of non-hormonal iodine). 3) These observations correspond to no particular anatomo-clinical factors. The legitimate conclusion therefore is that the exclusive use of 99mTc could result in failure to recognise a non-functional nodule (1 case in about 10), a possibility not to be neglected because of the risk of cancer [fr

  15. Treatment by iodine 131 and thyroid pathologies 14 Nfs iatrogenic 'Around France of that particular medical treatment'

    International Nuclear Information System (INIS)

    Baldet, L.

    2000-01-01

    In the case of hyperthyroidism bound to amiodarone, the iodine 131 prescription appears able to cure this disease in 84% of cases; the use of iodine 131 before amiodarone to prevent a hyperthyroidism, in case of goiter or thyroid nodules is little used (17% of practitioners) when it is more used in case of past history of induced hyperthyroidism (34% of physicians). This prescription is nevertheless efficient in the both cases. The use of iodine 131 is little used in the case of hyperthyroidism appeared during the use of cytokines (22% of physicians). The induction of hypothyroidism by iodine 131 in the case of severe cardiopathies is becoming little frequent (9% of physicians). (N.C.)

  16. Manual on therapeutic uses of iodine-131. Incorporating: Applications guide, procedures guide, basics guide

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1996-03-01

    This publication is part of practical radiation safety manual series for different fields of application aimed primarily at persons handling radiation sources on a daily routine basis, which could at same time be used by the competent authorities, supporting their efforts in the radiation protection training of workers or medical assistance personnel or helping on-site management to set up local radiation protection rules. It is dedicated to therapeutic uses of Iodine-131: its application and procedures guides.

  17. Implementation of the protocol on treatment of outpatients and hospitalized patients with iodine 131r

    International Nuclear Information System (INIS)

    Mildred De Mendoza, L.

    1996-01-01

    In Nuclear medicine different working protocols are used which are adequate for the treatment of patients with radioactive materials and which at the same time prevent the contamination of the occupationally exposed workers In Guatemala (the implementation of these protocols aims at keeping a records all the personal and centers that make use of iodine 131, improving the quality of diagnostic information; utilizing the necessary amount of radionuclide activity so as to ensure a good diagnosis and effectively utilizing economic resources

  18. The method of obtaining of sodium orthoiodohippurate labelled with iodine-131

    International Nuclear Information System (INIS)

    Aripov, D.; Abdukayumov, M.; Shukurov, A.Sh.

    1994-01-01

    The method of labelling of sodium orthoiodohippurate was elaborated with the purpose of increasing the preparation quality. Method includes the reaction of isotopic exchange between orthoiodhippur acid and sodium iodide solution labelled with iodine-131 with volume activity 150-200 mCu/mL and pH=6,5-7,0. Reaction occurs at temperature 120-130 C during 1,1-1,3 hours and the compound obtained is dissolved in 1% sodium bicarbonate solution. (author)

  19. Manual on therapeutic uses of iodine-131. Incorporating: Applications guide, procedures guide, basics guide

    International Nuclear Information System (INIS)

    1996-01-01

    This publication is part of practical radiation safety manual series for different fields of application aimed primarily at persons handling radiation sources on a daily routine basis, which could at same time be used by the competent authorities, supporting their efforts in the radiation protection training of workers or medical assistance personnel or helping on-site management to set up local radiation protection rules. It is dedicated to therapeutic uses of Iodine-131: its application and procedures guides

  20. Internal contamination of nurses as a result of the therapeutic use of iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Termorshuizen, W; Gerritsen, A J.M.

    1988-02-01

    The internal contamination of nurses with sodium iodide-131 is studied in two different housing situations. Before moving, the therapy unit was an unventilated double room with a lock. In the new building, the unit consists of three single rooms and one double room with a lock and air conditioning. Also the concentration of iodine-131 in the air is measured. 2 figs.; 1 table.

  1. Iodine-125 and Iodine-131 in the Thames Valley and other areas

    International Nuclear Information System (INIS)

    Howe, J.R.; Lloyd, M.K.; Bowlt, C.

    1985-01-01

    Part of the Iodine-125 and Iodine-131 waste from hospitals and research centres is discarded down drains and passes through sewage and water reclamation works into the river system. Relatively high concentration of radioiodine occur in outfalls that discharge into the river Thames, lower levels are found in the mainstream river and less still in the reservoirs and tap water supplies abstracted from the river. The pathway from waste to drinking water could account for the low levels of Iodine-125 found in the thyroid glands of some farm animals and human beings in the Thames valley

  2. Evaluation of radiation safety from patients with thyroid disease undergoing iodine-131 therapy

    International Nuclear Information System (INIS)

    Lu, K.-Y.; Li, X.F.; Liu, J.-Z.; Li, S.-J.; Hu, G.

    2007-01-01

    Full text: Objective: By calculating the dose equivalent of patients with thyroid disease who had received iodine-131 therapy, based on the China national criteria, we evaluate the radiation safety of the individuals other than the patients who had turned into a specific 'radiant source'. Methods: 152 outpatients and inpatients, with iodine-131 therapy had been investigated and followed-up. There were 162 treatments which included patients with hyperthyroidism (HT)-124, 35 thyroid cancers (TC), 2 toxic thyroid adenomas and 1 nontoxic nodular goiter. In addition, we had achieved the practical measures and contact instance with household members and the general public, including 37 HT (contact with 37 adults and 8 infants) and 3 TC. According to the personal condition of the patients and the time of exposure to individuals other than patients, and to calculate the exposure dose (mSv) to the individuals with formulae. Results: Based on the national criteria the total dose equivalent to the individuals other than patients may not exceed 5 mSv. For most patients, including 124 HT, 2 toxic thyroid adenomas and 16 times treatment of TC, the exposure doses to the individuals were not likely to exceed 5 mSv, but the others, including 19 treatments of TC and 1 nontoxic nodular goiter, the exposure doses were higher than 5 mSv. There was no difference between the part of HT and TC of inpatients when compared with outpatients (P>0.05, respectively). We found that occupancy factor during the preequilibrium period play an important role on the exposure doses to the individuals, especially TC patients. With the dose equivalent to the same HT patient, practical measures for accumulating doses is higher and more practical than the simplistic formula calculating ones (P 0.05). Conclusions: Most of the outpatients with iodine- 131 therapy were safe to the individuals surrounding them within 1 meter, but the part of TC patients needed to be treated in the hospital and took a dose

  3. Introduction of iodine 131 and bromine 82 in antibiotics of tetracycline group

    International Nuclear Information System (INIS)

    Mironov, V.P.; Kudryashov, V.P.; Grushevich, L.E.; Kuz'mina, T.S.

    1983-01-01

    Chloline- and oxytetracycline reactions with iodide-131-and bromide-82-ions in methanol and acetone are studied. It is established that labelled compounds reveal tetracycline (TC) properties in pharmacokinetic experiments on laboratory animals for 20-25 hours after synthesis; the yield of purposeful preparations for radioactive isotopes is 90-95%. Kinetic dependences of iodine-131 and bromine-82-TC yield on acidity and temperature of medium are presented. TC radiation resistance in solutions and in solid state at different temperatures in the range of absorbed doses of 1-10 Mrad is investigated. The possibility of TC radiation sterilization is shown

  4. Test of irradiation of tellurium oxide for obtaining iodine-131 by dry distillation

    International Nuclear Information System (INIS)

    Alanis M, J.

    2003-07-01

    With the purpose of optimizing to the maximum independently the work of the reactor of those mathematical calculations of irradiation that are already optimized, now it corresponds to carry out irradiation tests in the different positions with their respective neutron fluxes that it counts the reactor for samples irradiation. Then, it is necessary to carry out the irradiation of the tellurium dioxide through cycles, with the purpose of observing the activity that it goes accumulating in each cycle and this way to obtain an activity of the Iodine-131 obtained when finishing the last cycle. (Author)

  5. Considerations of food hygiene in the case of mussels accidentally contaminated by iodine 131

    International Nuclear Information System (INIS)

    Battani, N.; Chambost, Marie-Daniel; Leandri, Marcel

    1969-09-01

    As the transfer to mankind of radioactive pollution by food chains is a matter of concern, the authors report the study of the use of mussels contaminated by iodine 131 in a food preparation in order to follow the evolution of this radionuclide. After their contamination in seawater, mussels are prepared either with or without their shell. Counting is performed after cooking. Results are discussed in terms of presence of the radionuclide in the different parts of the crude or cooked mussels (shell, body, liquid) [fr

  6. Iodine-131 distribution on the territory of the Republic of Belarus during the first period of the Chernobyl NPP catastrophe

    International Nuclear Information System (INIS)

    Germenchuk, M.G.; Zhukova, O.M.; Shagalova, E.D.; Matveenko, I.I.

    1998-01-01

    To reconstruct space distribution of iodine-131 on the territory of Belarus we used the following data: (i) contents of iodine-131 in soil measured by gamma spectrometry method in May-July, 1986; (ii) contents of iodine-131 in samples of radioactive atmospheric fall-outs measured by gamma spectrometry method in May, 1986; (iii) daily measurements of exposure dose power levels on the territory of Belarus obtained in April-July, 1986; (iv) results of aerial gamma radiation mapping, obtained in May, 1986; (v) daily measurements of radioactive contamination of milk on the territory of Belarus obtained in May-July, 1986; (vi) measurements of iodine-131 content in links of biological chain 'soil-grass-milk' sampled from 15 reference farms; (vii) maps of specific activity of natural hayfields grass on the territory of Belarus (for every district) obtained on June 2 and 5, on July 3, 1986. Dose commitments on thyroid gland caused by iodine isotopes were formed mainly during the first 2.5 months after the accident. Local irradiation of this organ was stipulated by high accumulation factor of iodine isotopes in thyroid gland that caused increasing of malignant thyroid tumors incidences, including children, on all over the territory of Belarus. Comparison of iodine-131 distribution map and malignant thyroid gland tumor incidences among children on the territory of Belarus map shows that the more level of iodine contamination the more malignant thyroid gland tumor incidence

  7. Scoping calculation for components of the cow-milk dose pathway for evaluating the dose contribution from iodine-131

    International Nuclear Information System (INIS)

    Ikenberry, T.A.; Napier, B.A.

    1992-12-01

    A series of scoping calculations have been undertaken to evaluate The absolute and relative contribution of different exposure pathways to doses that may have been received by individuals living in the vicinity of the Hanford site. This scoping calculation (Calculation 001) examined the contributions of the various exposure pathways associated with environmental transport and accumulation of iodine-131 in the pasture-cow-milk pathway. Addressed in this calculation were the contributions to thyroid dose of infants and adult from (1) the ingestion by dairy cattle of various feedstuffs (pasturage, silage, alfalfa hay, and grass hay) in four different feeding regimes; (2) ingestion of soil by dairy cattle; (3) ingestion of stared feed on which airborne iodine-131 had been deposited; and (4) inhalation of airborne iodine-131 by dairy cows

  8. Conversion and correction factors for historical measurements of iodine-131 in Hanford-area vegetation 1948--1951

    International Nuclear Information System (INIS)

    Denham, D.H.; Mart, E.I.; Thiede, M.E.

    1993-09-01

    This report is a part of the Hanford Environmental Dose Reconstruction (HEDR) Project, whose goal is to estimate the radiation dose that individuals could have received from emissions since 1944 at the US Department of Energy's (DOE) Hanford Site near Richland, Washington. The key radionuclide emitted that would affect the radiation dose was iodine-131 (Napier 1992). Because the early methods of measuring iodine-131 were not comparable to later techniques, conversion and correction factors are needed to convert the historical measurement data into concentration values that would be determined using today's knowledge and technologies. This report describes the conversion and correction factors developed for reconstructing historical measurements of iodine-131 in Hanford-area vegetation, which was collected from 1948 through the end of December 1951

  9. Labeling of Salmonella typhimurium with iodine-131 to study phagocytic function in rats

    International Nuclear Information System (INIS)

    Sato, M.K.; Rodrigues Junior, A.J.; Camargo, E.E.

    1989-01-01

    The present study descibes a method for labeling Salmonella tyhymurium with iodine-131 to evaluate both the morphological and the functional characteristics of the reticulo-endothelial system. A suspension containing 2 x 10 9 bacteria per ml was labeled with carrier-free Na 131 I without reductor, with a labeling yield of 46.5 +- 3% and 3.5 +- 1.3% of free Iodine-131. The biodistribution of the labeled bacteria in rats was studied with a large-field-of-view scintillation camera equiped with a pinhole collimator. Whole body images were obtained 15 and 30 minutes after intravenous injection of the labeled microorganisms. Images showed accumulation of bacteria in the liver and both normal and transplanted spleens of the animals. Autoradiographs of liver and spleen demonstrated labeled bacteria within the cells of the reticulo-endothelial system. The method described is easy to perform, has a good labeling yield and allows the function of the reticulo-monophagocytic system, including transplanted spleens. (author) [pt

  10. Iodine-131 induced hepatotoxicity in previously healthy patients with Grave's disease.

    Science.gov (United States)

    Jhummon, Navina Priya; Tohooloo, Bhavna; Qu, Shen

    2013-01-01

    To describe the association of the rare and serious complication of liver toxicity in previously healthy Grave's disease (GD) patients after the treatment with radioactive iodine (131)I (RAI). We report the clinical, laboratory and pathologic findings of 2 cases of severe liver toxicity associated with the treatment with RAI in previously healthy patients with GD. Clinical examination and laboratory investigations excluded viral hepatitis, autoimmune hepatitis, granulomatous disease, primary biliary disease, extrahepatic biliary obstruction, and heart failure. Case 1: A previously healthy 52-years old man reportedly having a typical GD but following RAI treatment, concomitantly developed severe liver toxicity that required 1 week of treatment in hospital. Case 2: A previously healthy 34-years old woman is reported as having a typical GD but developed jaundice following RAI treatment that required several weeks of in hospital treatment in the hepato-biliary department. In both cases, the liver dysfunction resolved after intensive treatment with hepato-protective agents. In this report the therapeutic considerations as well as the pathogenetic possibilities are reviewed. To the best of our knowledge, this is the first description of the association observed, which is rare but may be severe and should be considered in any case of thyrotoxicosis where a liver dysfunction develops after the treatment with radioactive iodine (131)I.

  11. Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease

    Science.gov (United States)

    2013-01-01

    Objective To describe the association of the rare and serious complication of liver toxicity in previously healthy Grave’s disease (GD) patients after the treatment with radioactive iodine 131I (RAI). Case presentation We report the clinical, laboratory and pathologic findings of 2 cases of severe liver toxicity associated with the treatment with RAI in previously healthy patients with GD. Clinical examination and laboratory investigations excluded viral hepatitis, autoimmune hepatitis, granulomatous disease, primary biliary disease, extrahepatic biliary obstruction, and heart failure. Case 1: A previously healthy 52-years old man reportedly having a typical GD but following RAI treatment, concomitantly developed severe liver toxicity that required 1 week of treatment in hospital. Case 2: A previously healthy 34-years old woman is reported as having a typical GD but developed jaundice following RAI treatment that required several weeks of in hospital treatment in the hepato-biliary department. In both cases, the liver dysfunction resolved after intensive treatment with hepato-protective agents. In this report the therapeutic considerations as well as the pathogenetic possibilities are reviewed. Conclusion To the best of our knowledge, this is the first description of the association observed, which is rare but may be severe and should be considered in any case of thyrotoxicosis where a liver dysfunction develops after the treatment with radioactive iodine 131I. PMID:23497434

  12. Conversion and correction factors for historical measurements of iodine-131 in Hanford-area vegetation, 1945--1947

    International Nuclear Information System (INIS)

    Mart, E.I.; Denham, D.H.; Thiede, M.E.

    1993-12-01

    This report is a result of the Hanford Environmental Dose Reconstruction (HEDR) Project whose goal is to estimate the radiation dose that individuals could have received from emissions since 1944 at the U.S. Department of Energy's (DOE) Hanford Site near Richland, Washington. The HEDR Project is conducted by Battelle, Pacific Northwest Laboratories (BNW). One of the radionuclides emitted that would affect the radiation dose was iodine-131. This report describes in detail the reconstructed conversion and correction factors for historical measurements of iodine-131 in Hanford-area vegetation which was collected from the beginning of October 1945 through the end of December 1947

  13. Guide-line of the radio-iodine (131I) therapy in Graves' disease and thyroid cancer

    International Nuclear Information System (INIS)

    Mori, Yutaka; Ikekubo, Katsuji

    2005-01-01

    Radio-iodine ( 131 I) therapy has been using in Graves' disease and well differentiated thyroid cancer. The rules of control in the discharge from radio-isotope hospital were notified in 1999 in Japan. Guideline of the 131 I therapy in Graves' disease and thyroid cancer were prepared by sub-group of Japanese Society of Nuclear Medicine. (author)

  14. Long-term follow-up study of the therapeutic effect after iodine-131 therapy for hyperthyroidism

    International Nuclear Information System (INIS)

    Liu Changjiang; Li Long; Gao Jianqing; Xu Sumei; Chen Linna; Zhou Jianming

    2006-01-01

    To investigate the therapeutic effect through long-term visit and analyze the affecting factors of cure rate after iodine-131 therapy for hyperthyroidism, a long-term follow-up has been undertaken for the patients with hyperthyroidism after iodine-131 treatment. The following results have been obtained. (1) The cure rate of iodine-131 therapy for hyperthyroidism is 74.4%, and the incidence of permanent hypothyroidism is 7.5%. (2) There is no significant difference in the cure rate and incidence of hypothyroidism between the groups of male and female or 'not take ATD' and 'ATD withdrawn longer than 2 weeks' (P>0.05). (3) The difference of the cure rate among the groups of the courses of disease 3 a are significant (P 55 g are significant (P 0.05). The course of disease, age and thyroid mass are the major factors which influence the cure rate. Meanwhile, age and thyroid mass are the major factors which influence the incidence of hypothyroidism. To get high cure rate, the patients with hyperthyroidism should be treated with iodine-131 as early as possible. In the meantime, the incidence of permanent hypothyroidism must be paid attention to. (authors)

  15. Retrospective reconstruction of Iodine-131 distribution through the analysis of Iodine-129

    Science.gov (United States)

    Matsuzaki, Hiroyuki; Muramatsu, Yasuyuki; Ohno, Takeshi; Mao, Wei

    2017-09-01

    Iodine-131 distribution released from the Fukushima Dai-ichi Nuclear Power Plant accident was reconstructed through the iodine-129 measurements. From nearly 1,000 surface soil samples iodine was extracted by the pyro hydrolysis method. Extracted iodine was then mixed with carrier, purified and finally collected as silver iodide. Silver iodide sample was pressed into the cathode holder and set at the ion source of the MALT facility, The University of Tokyo. The isotopic ratio 129I/127I was measured by means of Accelerator Mass Spectrometry. From 129I data obtained, 131I deposition map was constructed. There observed various fine structures in the map which could not estimated neither by the simulation nor 137Cs distribution.

  16. [Iodine 131 joint radio frequency ablation treatment for child with hyperthyroidism goiter: one case report].

    Science.gov (United States)

    Chen, Yonghua; Liang, Li; Fang, Yanlan; Wang, Chunlin; Li, Linfa; Jiang, Tian'an

    2017-01-25

    A 12-year-old girl presented with a history of cervical mass, and one week of throat discomfort and dyspnea. Five years ago, the patient was diagnosed as Hashimoto's thyroiditis and hyperthyroidism; she received antithyroid drug treatment, but the result was not satisfactory. B-ultrasonic showed that the size of thyroid gland was 8.1 cm×3.2 cm in the left and 8.2 cm×4.8 cm in the right. After iodine 131 combined with radiofrequency ablation (RFA) treatment, throat discomfort and recumbent breathing difficulties disappeared, and B-ultrasonic showed that the size of thyroid reduced to 2.3 cm×1.7 cm (left) and 2.8 cm×2.0 cm (right). No recurrence was observed during the two and a half years of follow-up.

  17. Gold-198 and rose bengal marked with iodine-131 in the diagnostic of hepatic vesicular affections

    International Nuclear Information System (INIS)

    Manambelona Razafimalaza, J.

    1961-06-01

    Colloidal gold-198 makes it possible to obtain clear images of hepatic parenchyma; the examination can be repeated from different angles thus demonstrating the presence of pathologically inert regions, whether they be hydatic cysts, abscesses or neoplasia. The study of the disappearance curve for the colloid, together with a measurement of the blood volume, makes it possible also to calculate the hepatic flow. Using Rose Bengal marked with iodine-131, it is possible to obtain images of the liver and of the bile ducts, and to follow the elimination of the dye in the intestines. The simultaneous recording of the disappearance curves for the blood and of the appearance of the dye in the intestines constitutes an useful working test which is particularly sensible for evaluating the permeability of the bile ducts and, to a certain degree, the site of an obstruction. (author) [fr

  18. Iodine-131 MIBG scintigraphy of the extremities in metastatic pheochromocytoma and neuroblastoma

    International Nuclear Information System (INIS)

    Shulkin, B.L.; Shen, S.W.; Sisson, J.C.; Shapiro, B.

    1987-01-01

    Iodine-131 MIBG scintigraphy may be used to determine the presence or absence of metastases to the appendicular skeleton in malignant pheochromocytoma and neuroblastoma. Normal bones show no uptake of [ 131 I]MIBG and the joints are seen as photon-deficient areas surrounded by background muscle activity. Discrete concentrations of radioactivity in bone are often seen in patients with malignant pheochromocytoma and neuroblastoma. Bone marrow involvement in neuroblastoma may be indicated by diffuse uptake of [ 131 I]MIBG or focal accumulation at the metaphyses. Uncommonly, bone involvement may not be displayed by the [ 131 I]MIBG images. Since conventional bone scanning agents may also fail to detect these tumors, skeletal scintigraphy with both [ 131 I]MIBG and [/sup 99m/Tc]MDP is necessary to reliably stage malignant pheochromocytoma and neuroblastoma

  19. Biological dosimetry, scopes and limitations; Dosimetria biologica, alcances y limitaciones

    Energy Technology Data Exchange (ETDEWEB)

    Guerrero C, C.; Brena V, M. [Departamento de Biologia, Instituto Nacional de Investigaciones Nucleares, C.P. 52045 Salazar, Estado de Mexico (Mexico)

    1999-07-01

    The analysis of the aberrations in chromosomes is an alternative to establish the exposure dose to the radiation, when the information provided by the traditional physical methods is insufficient. There are diverse causes by which it can reached to apply an alternative system, such is the case of exposures of another persons to the management of radiation sources, which not carry physical dosemeter. Contrary case is to the occupational exposure personnel (OEP), what must to utilize some system for determining the exposure dose, even so can be needed the case for more information. In any case, the cells from the affected person are the alternative without the biological system be overlap to the physical, it is complementary. (Author)

  20. Identifying best practice in relation to Iodine-131 ablation discharges to sewers in Ireland

    International Nuclear Information System (INIS)

    Ryan, Thomas P.; Fennell, Stepehn; McGarry, Ann; Punt, Adrian

    2008-01-01

    Full text: In line with a commitment in Ireland's strategy on the implementation of the Oslo-Paris Convention (OSPAR) as well as recent developments in the provision of national oncology services, best practice in relation to Iodine-131 (I-131) ablation discharges to sewers in Ireland is under review. Preparatory to this review the Radiological Protection Institute of Ireland (RPII) commissioned a study of current practices in Ireland and associated doses as well as a review of international best practice and advice. Currently, there are three hospitals in Ireland at which thyroid ablation therapy procedures (large therapeutic administrations of I-131 for thyroid cancer treatment) are carried out. Only one facility has a limited capacity for delay and decay storage prior to discharge. Based on current administrations and discharges, the potentially most exposed workers comprises hospital plumbers dealing with specific incidents with estimated doses in the order of 50 to 70 μSv per incident. Doses to sewage workers and fishing communities are estimated at less than 4 μSv y -1 and 0.4 μSv y -1 respectively. Based on anticipated future service requirements in Ireland, a marginal increase in doses to some of these groups is estimated. Iodine-131 discharges to the environment and associated doses to workers and members of the public may be significantly reduced by the introduction of state-of-the-art delay and decay tanks using multi-tank vacuum systems. The justification for the introduction of a regulatory requirement to install such systems is examined taking account of: discharges to the environment, concentrations in the environment, doses to workers and members of the public, best available techniques (BAT), international best practice and advice as well as the financial implications for medical facilities. The case for retrofitting delay and decay tanks to existing medical facilities is also examined as well as the option of including such tanks in the

  1. The influence of physical parameters on the adsorption of iodine 131 by activated charcoals

    International Nuclear Information System (INIS)

    Billard, F.; Chevalier, G.; Caron, J.; Van Der Meersch, J.

    1966-01-01

    Following an outline of the means of generating iodine 131 in the gas phase and a brief description of the apparatus used, the authors analyse the experimental results obtained on the trapping of iodine 131 by activated charcoal. The efficiency depends concurrently on the relative humidity and the iodine concentration of the air. While it is independent of this concentration in dry air, it does not exceed 50 in moist air, whatever the bed depth, when the concentration is less than 1 mCi/m 3 , then it increases with the concentrations to reach values close to those obtained in dry air for concentrations of around 1000 Ci/m 3 . At the same time the efficiency of a dust filter with respect to iodine remains very low in dry air whatever the iodine concentration; in moist air this efficiency, which is high at low concentrations, decreases when the latter increases. In addition if a charcoal bed is divided into several beds, separated by an amount corresponding to a passage time of about a second, it is found that the efficiency of the whole is appreciably higher than that of the initial bed. These results appear to establish the existence of at least two forms of iodine, one molecular form and one particulate form probably formed by clusters, the forms equilibrium being functions of the relative concentrations of iodine and water vapour in the air. The third form evidence, a gaseous form compound, remains hypothetical; the experimental curves can be explained either by the molecular and particular forms reversibility or by the increase of clusters size with the relative humidity of the air. (authors) [fr

  2. Radiochemical studies on the separation of iodine-131 and radioiodination of some organic compounds

    International Nuclear Information System (INIS)

    Mohamed, M.A.I.

    2010-01-01

    This thesis is constituted of three chapters:Chapter I: It deals with the theoretical consideration of the subject. The chapter deals with the importance of radioisotopes in medical applications, and the physical and biological properties of these isotopes. Also, this part deals with the chemical and physical properties of both tellurium and iodine and the methods of the production of radioiodine from tellurium targets especially dry distillation method and ion exchange method. It deals with general methods of labeling, chemistry of iodine especially the most frequently used in nuclear medicine, their methods of production and applications. It includes also the techniques used for the preparation of the radioiodinated compounds, especially the electrophilic technique or the oxidative radioiodination technique. In this technique, oxidizing agents are used to oxidize iodide ions to iodonium ions capable of electrophilic attack on the aryl group of the organic compound. This chapter deals also with the receptor tracers, their types and the effects that can occur due to the binding of these receptors to the cell membrane. Since these radiopharmaceuticals are used for diagnosis and therapeutic treatment of human diseases, quality control tests such as chemical purity, radionuclidic purity, radiochemical purity, sterility, apyrogenicity and biodistribution are performed to ensure the purity, the safety and efficiency of these products for the intended nuclear medicine application.Chapter II:It contains detailed information concerning the chemicals, reagents, the radionuclides, the equipment and the counting systems used in the study. It describes production technique of iodine-131 using dry distillation method. It describes also the electrophilic radioiodination for each of Y-indole and epidepride. Analysis of the labeled products was performed using two chromatographic techniques. The first technique is thin layer chromatography in which the compound was identified by

  3. Iodine-131 in sewage sludge from a small water pollution control plant serving a thyroid cancer treatment facility.

    Science.gov (United States)

    Rose, Paula S; Swanson, R Lawrence

    2013-08-01

    Iodine-131 (half-life = 8.04 d) is the most widely used radionuclide in medicine for therapeutic purposes. It is excreted by patients and is discharged directly to sewer systems. Despite considerable dilution in waste water and the relatively short half-life of I, it is readily measured in sewage. This work presents I concentrations in sewage sludge from three water pollution control plants (WPCPs) on Long Island, NY. Iodine-131 concentrations ranged from 0.027 ± 0.002 to 148 ± 4 Bq g dry weight. The highest concentrations were measured in the Stony Brook WPCP, a relatively small plant (average flow = 6.8 × 10 L d) serving a regional thyroid cancer treatment facility in Stony Brook, NY. Preliminary radiation dose calculations suggested further evaluation of dose to treatment plant workers in the Stony Brook WPCP based on the recommendations of the Interagency Steering Committee on Radiation Standards.

  4. The evaluation of functioning thyroid nodules using sodium pertechnetate TC-99m scan in comparison with iodine-131

    Directory of Open Access Journals (Sweden)

    Saghari M

    1993-04-01

    Full Text Available Thyroid scintigraphy has been helpful in detecting and evaluation of thyroid nodules. Sodium pertechnetate Tc-99m is the most commonly used radionuclide for thyroid imaging because of its general availability, favorable dosimetric characteristics and low cost. But, there are reports of occasional disparity in isotope uptake in lesions compared with radioiodide. In order to determine percentage and clinical significance of this disparity, we screened 101 patients with solitary functioning nodules using sodium pertechnetate TC-99m in comparison with subsequent Iodine-131 scan in research institute for nuclear medicine. We conclude that sodium pertechnetate TC-99m is a reliable radiotracer for the detection and evaluation of thyroid nodules and there is no need for the subsequent Iodine-131 scan.

  5. Impact of iodine 131 release from an anti cancerous center on the activity present in the channel of waste water treatment

    International Nuclear Information System (INIS)

    Desjardins, E.; Laugle, S.; Houy, J.C.

    2002-01-01

    Iodine 131 has been detected in the incineration waste. This iodine 131 would come from the muds of the water treatment by plant of Beaurade. This plant treats the waste water of Rennes. This radioactivity is caused by iodine 131 used in the medical medium for the diagnosis and the treatment of liver and thyroid neoplasms. The urines are stocked in tanks until a decrease of activity to 7 Bq/l and the waste waters used to wash the clothes are at delayed evacuation. The iodine comes from the patients feces. This study consists in defining the activity levels of iodine 131 in the channel of waste water treatment, from the purification station of Beaurade to the incinerator of Villejean. (N.C.)

  6. Destruction of post-surgery thyroid remnants by 19 mCi (703 MBq) of iodine 131

    International Nuclear Information System (INIS)

    Tassy, D.; Lonchampt, M.F.; Minebois, A.; Antigny, J.F.

    1997-01-01

    The adjuvant treatment by iodine 131 in good prognostic forms of differentiated thyroid cancers (DTC) makes not the object of a general consensus. There is no study demonstrating the benefit from such a treatment. Administration of an elevated iodine 131 activity and the constraint of a supplementary hospitalization are in these conditions questionable. In 6 patients, presenting the criteria of good prognostic and in post-operation, ambulatory conditions, administration of 19 mCi (703 MBc) of iodine 131 was done without previous administration of tracing dosage, followed after 72 hours by a whole-body scintigraphy, in the usual pause conditions. This administration was repeated 6 to 12 months later and followed by a new scintigraphic examination. The cervical fixation of iodine 131 was established qualitatively and quantitatively (as compared with a control zone). Five/six patients presented initially a cervical intense fixation with the star-like usual image and 1/6 patient a moderated fixation. Beginning with the second administration no cervical fixation was noted in 4/6 patients and a very low fixation in 2/6 patients. The concomitantly measured thyroglobulin, under simulation by TSH endogenous, was 131 I after quasi-total thyroidectomy in good-prognostic forms of DTC, without administration of previous tracing dosage to avoid possible phenomena of thyroid tissue blocking, allows probably, in overwhelming majority of cases, both a full or quasi-full destruction of the thyroid remnants and a severe reduction in the thyroglobulin rate measured in the conditions of pause of hormone-therapy

  7. Lymphocyte proliferative responses to mitogens in rats having an ancestry of a perinatal iodine-131 insult

    International Nuclear Information System (INIS)

    Stevens, R.H.; Cheng, H.F.

    1987-01-01

    The possible existence of a genealogical memory consisting of altered lymphocyte proliferative responses to a perinatal iodine-131 insult has been investigated in two generations of inbred Fischer F344 rat offspring. The studies which involved exposure to the radioiodine during late pregnancy with concentrations ranging from 1.85 MBq (50 μCi) to 7.4 MBq (200 μCi) revealed that only the peripheral blood T lymphocytes of the first generation male animals were significantly affected. These animals were found to possess T lymphocytes which exhibited increased proliferative responses expressed toward the mitogens concanavalin A and phytohemagglutin; however, no significant changes were noticeable in their B cell population following exposure to lipopolysaccharide. Neither the first generation females nor the male and female offspring of the second generation developed through sibling interbreeding seemed to be affected, this was unlike the cellular, humoral, and natural immunity which had previously been observed to be changed in both the second and third generation animals. These observations suggest that the effects of the radiation insult upon immunocompetency as measured by lymphocyte proliferation do not appear to be inherited

  8. Iodine-131 Therapy and Nasolacrimal Duct Obstructions: What We Know and What We Need to Know.

    Science.gov (United States)

    Ali, Mohammad Javed

    2016-01-01

    The aims of the current review are to summarize the etiopathogenesis, symptomatology, management, complications, and outcomes of iodine-131-induced nasolacrimal duct obstructions, to propose a screening protocol and elucidate the potential avenues of future research. The authors performed an electronic database (PubMed, MEDLINE, EMBASE, and Cochrane Library) search of all articles published in English on nasolacrimal duct obstructions following radioiodine therapy. These articles were reviewed along with their relevant cross references. Data reviewed included demographics, presentations, investigations, management, complications, and outcomes. In addition, based on relevant unanswered questions and current lacunae in literature, potential avenues for further research have been elucidated. The frequency of nasolacrimal duct obstruction is reported to range from 2.2% to 18% following I-131 therapy. They are mostly bilateral and noted in patients who receive more than 150 mCi radioiodine. Exact etiopathogenesis is unknown but radiotoxicity to lacrimal sac and nasolacrimal duct is believed to be mediated through a sodium-iodine symporter protein. Although uncommon, it is important to increase awareness among treating physicians and patients receiving radioiodine therapy about the potential side effect of nasolacrimal duct obstruction. Imaging modalities are useful adjuncts in the diagnosis. Dacryocystorhinostomy is the most common modality of management with good outcomes. Nasolacrimal duct obstruction following radioiodine treatment is a distinct clinical entity. Increased awareness would facilitate timely diagnosis, management, and an enhanced quality of life for the patients.

  9. Using ion-selective electrode for determining iodine-131 preparation specific activity

    International Nuclear Information System (INIS)

    Melnik, M.I.; Nazirova, T.E.

    2002-01-01

    A pilot facility was developed in 2000 for the production of iodine-131. The parameters of the preparation are as follows: chemical form: sodium iodide solution (NaI-131) in a carbonate-bicarbonate buffer (or in 0.001M NaOH); specific activity: carrier free (> 5 Ci/mg); solution pH: 7-10; radionuclide purity: > 99.9%; radiochemical purity: > 97%; bulk activity: 0.15 Ci/ml. The experimental results of investigation aimed at the determination of the specific activity of the I-131 preparation using a iodine-selective electrode are described. The method enables the analytical concentration of iodide ions in the carbonate-bicarbonate buffer (pH = 8-11) and NaOH solution (0.01 mol/l, pH = 8-11) to be determined. A micro-cell has been developed for the analysis of the I-131 solution allowing the sample volume to be reduced to below 0.3 ml. The relative error of determination of the analytical concentration of iodide (10 -6 to 10 -1 mol/l) does not exceed 1%

  10. Management of fear of radiation exposure in carers of outpatients treated with iodine-131

    International Nuclear Information System (INIS)

    Calais, P.J.; Turner, J.H.

    2012-01-01

    The objective of this study was to characterise potential fear of radiation exposure in a normal population of individuals who have volunteered to care for a radioactive family member or friend after outpatient radioimmunotherapy (RIT) treatment for cancer, and obtain their knowing and willing acceptance of the risk. Over 750 carers of 300 patients confined to their homes for 1 week following outpatient iodine-131 rituximab RIT of lymphoma were interviewed by a nuclear medicine physicist according to a multi-visit integrated protocol designed to minimise radiation exposure, define risk and gain informed consent. Median radiation exposure of carers was 0.49 mSv (range 0.01-3.7 mSv) which is below the Western Australian regulatory limit of 5 mSv for consenting adult carers of radioactive patients. After signing a declaration of consent, only 2 carers of 750 abrogated their responsibility and none of those who carried out their duties expressed residual concerns at the end of the exit interview with respect to their radiation exposure. Fear of radiation exposure in a normal population may be characterised as a normal emotional response. In the special case of carers of radioactive patients, this fear may be successfully managed by rational, authoritative and empathic explanation to define the risk and gain willing acceptance within the context of domiciliary patient care. (author)

  11. Effect of decicurie doses of radioactive iodine 131 on parathyroid function

    International Nuclear Information System (INIS)

    Glazebrook, G.A.

    1987-01-01

    Although parathyroid deficiency has been reported after administration of relatively small doses of iodine 131, reports of such deficiency after the much larger doses given in the management of thyroid cancer are notable by their absence in the literature. We observed one such patient, then instituted a prospective study. We observed a 58 percent incidence of apparently diminished parathyroid reserve among 53 patients given high doses of I 131. Susceptibility does not appear to be related to age, sex, extent of thyroid operation, operative technique, the amount of thyroidal I 131 uptake, the use of external radiation to the neck, or to the presence of parathyroid glands or of Hashimoto's disease in the operative specimen; however, susceptibility may be related to the anatomic location of the parathyroid glands in relation to the thyroid gland. The administered dose of I 131 almost reached significant levels (p = 0.1) in the present study. The initial pretreatment serum calcium levels were consistently lower among affected patients (p = 0.01), suggesting the presence of a preexisting latent impairment of parathyroid reserve which was subsequently unmasked after the administration of I 131. Thyroid cancer is compatible with very long-term survival, and therefore, there is a considerable risk of delayed chronic hypocalcemia among patients who have received large doses of I 131, particularly female patients in the premenopausal age group. These patients deserve special management surveillance

  12. [Metabolic therapy with iodine 131 in patients with chronic renal failure. Clinical case].

    Science.gov (United States)

    Vázquez-Rodríguez Barbero, Inmaculada; Espadas-Maeso, María José; Muñoz-Morales, Ana; Flores-Gómez, Pilar; Serrano-Carretero, María Belén; Castedo-Sal, Juan José; Sánchez Rey-Castro, Elena; Zamorano-Córdoba, Antonio

    2015-01-01

    62 year-old male with CKD stage 5 in dialysis program since 2012 who underwent surgery for papillary thyroid carcinoma with lymph node metastasis. Subsequently, the patient was admitted to the Unit of Metabolic Therapy at his reference hospital, where he is administered 80 millicuries of iodine-131 as a treatment associated with the surgery, unable to have his conventional dialysis, nursing interventions required in various stages of implementation of the continuous extrarenal clearance techniques (TCDE) were performed. The following care values were addressed targeted to patients undergoing treatment with I(131): specific equipment, personal protective measures and major diagnoses and nursing interventions. TCDE, despite being attributed to very critical patients, they can be extrapolated to other patients in a given time. TCDE allowed these patients to undergo dialysis in a safe environment for staff, ensuring proper disposal of contaminated liquids. TCDE were an effective treatment for the removal of I131, a single ssesion being necessary to normalize the levels of radioactivity. Coordination between services allewed ensure proper and effective treatment for the patient. Copyright © 2015 Elsevier España, S.L.U. All rights reserved.

  13. Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis

    International Nuclear Information System (INIS)

    Hawkins, P.N.; Pepys, M.B.; Aprile, C.; Capri, G.; Vigano, L.; Munzone, E.; Gianni, L.; Merlini, G.

    1998-01-01

    Radiolabelled serum amyloid P component (SAP) is a specific tracer for amyloid. Iodine-123 has ideal physical characteristics for scintigraphy but is expensive and not widely available. Here we report serial imaging and turnover studies in which we labelled SAP with iodine-131, a cheap alternative isotope which would be expected to yield poorer images but permit more prolonged turnover measurements. Imaging and plasma clearance and whole body retention (WBR) of tracer were studied for up to 7 days in ten patients with proven systemic AL amyloidosis and two patients in whom the diagnosis was suspected, after i.v. administration of about 37 MBq of 131 I-SAP. Normal blood pool images were obtained in the latter two subjects and amyloidosis was subsequently refuted histologically. WBR at 48 h was 65% of the injected dose (i.d.). Among the other ten patients, amyloid deposits were identified in the spleen in eight cases, liver in five and kidneys in four; other sites that gave positive results included bone, joints and soft tissues, and the myocardium in one case. Up to 95% of the tracer localised into amyloid within 6-h, and the values for WBR became progressively more discriminating during the study period, exceeding the normal reference value ( 131 I-SAP produced diagnostic scans in every patient in this series and, coupled with the detailed turnover information, is adequate for monitoring disease progress. (orig.)

  14. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy

    International Nuclear Information System (INIS)

    Pujol, P.; Bringer, J.; Faurous, P.; Jaffiol, C.

    1995-01-01

    Iodine-131 metaiodobenzylguanidine ([ 131 I] MIBG), a radiopharmaceutical agent, is used for treating malignant phaeochromocytoma. [ 131 I]MIBG therapy results in a hormone response rate of approximately 50%, but generally it yields only a partial or no tumour response. We present a case of a 46-year-old woman with a familial history of von Hippel-Lindau disease, who was treated with [ 131 I]MIBG for a metastatic phaeochromocytoma involving the lungs, liver and bones. The patient received a cumulative dose of 33.3 GBq (900 mCi) and a complete hormone response was observed, as evaluated on the basis of catecholamine and metanephrine levels. Conventional radiography, computerized tomography and [ 131 I]MIBG scintigraphy indicated that a near-complete tumour regression was achieved, with no evidence of relapse during a 4-year follow-up period. This case thus demonstrates that treatment with [ 131 I]MIBG may lead to a dramatic tumour response in malignant phaeochromocytoma presenting both soft tissue and bone metastases. (orig.)

  15. Colon transit scintiraphy in health and constipation using oral iodine-131-cellulose

    International Nuclear Information System (INIS)

    McLean, R.G.; Smart, R.C.; Gaston-Parry, D.; Barbagallo, S.; Baker, J.; Lyons, N.R.; Bruck, C.E.; King, D.W.; Lubowski, D.Z.; Talley, N.A.

    1990-01-01

    The purpose of the study was to assess if a new scintigraphic method for noninvasive assessment of colonic transit could differentiate between subjects with normal bowel transit and those with constipation. Eleven normal subjects and 29 constipated patients were given 4 MBq iodine-131-cellulose ( 131 I-cellulose) orally and sequential abdominal scans were performed at 6, 24, 48, 72, and 96 hr from which total and segmental percent retentions were calculated. There were clear differences between the normal subjects and the constipated patients for the total percent retention at all time intervals, on a segmental basis in the right colon at 24 hr, and in all segments at 48 and 72 hr. Three-day urinary excretion of radioiodine was minimal; 2.4% +/- 1.2% (mean +/- s.d.) in constipated patients and 3.1% +/- 0.8% in normals, with approximately 75% occurring in the first day. The use of oral radiotracers in the investigation of constipation appears promising

  16. Radiation exposure and radiation protection of the physician in iodine-131 Lipiodol therapy of liver tumours

    International Nuclear Information System (INIS)

    Risse, J.H.; Ponath, C.; Palmedo, H.; Biersack, H.J.; Menzel, C.; Gruenwald, F.

    2001-01-01

    Intra-arterial iodine-131 labelled Lipiodol therapy for liver cancer has been investigated for safety and efficacy over a number of years, but data on radiation exposure of personnel have remained unavailable to date. The aim of this study was to assess the radiation exposure of the physician during intra-arterial 131 I-Lipiodol therapy for liver malignancies and to develop appropriate radiation protection measures and equipment. During 20 intra-arterial administrations of 131 I-Lipiodol (1110-1924 MBq), radiation dose equivalents (RDE) to the whole body, fingers and eyes of the physician were determined for (a) conventional manual administration through a shielded syringe, (b) administration with an automatic injector and (c) administration with a lead container developed in-house. Administration by syringe resulted in a finger RDE of 19.5 mSv, an eye RDE of 130-140 μSv, and a whole-body RDE of 108-119 μSv. The injector reduced the finger RDE to 5 mSv. With both technique (a) and technique (b), contamination of angiography materials was observed. The container allowed safe transport and administration of the radiopharmaceutical from 4 m distance and reduced the finger RDE to 131 I-Lipiodol was administered by syringe or injector, but was significantly reduced with the lead container. (orig.)

  17. Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective

    Directory of Open Access Journals (Sweden)

    Daiki Kayano

    2015-01-01

    Full Text Available Neuroblastoma, which derives from neural crest, is the most common extracranial solid cancer in childhood. The tumors express the norepinephrine (NE transporters on their cell membrane and take in metaiodobenzylguanidine (MIBG via a NE transporter. Since iodine-131 (I-131 MIBG therapy was firstly reported, many trails of MIBG therapy in patients with neuroblastoma were performed. Though monotherapy with a low dose of I-131 MIBG could achieve high-probability pain reduction, the objective response was poor. In contrast, more than 12 mCi/kg I-131 MIBG administrations with or without hematopoietic cell transplantation (HCT obtain relatively good responses in patients with refractory or relapsed neuroblastoma. The combination therapy with I-131 MIBG and other modalities such as nonmyeloablative chemotherapy and myeloablative chemotherapy with HCT improved the therapeutic response in patients with refractory or relapsed neuroblastoma. In addition, I-131 MIBG therapy incorporated in the induction therapy was proved to be feasible in patients with newly diagnosed neuroblastoma. To expand more the use of MIBG therapy for neuroblastoma, further studies will be needed especially in the use at an earlier stage from diagnosis, in the use with other radionuclide formations of MIBG, and in combined use with other therapeutic agents.

  18. Management of fear of radiation exposure in carers of outpatients treated with iodine-131.

    Science.gov (United States)

    Calais, Phillipe J; Page, Andrew C; Turner, J Harvey

    2012-07-01

    To characterise potential fear of radiation exposure in a normal population of individuals who have volunteered to care for a radioactive family member or friend after outpatient radioimmunotherapy (RIT) treatment for cancer, and obtain their knowing and willing acceptance of the risk. Over 750 carers of 300 patients confined to their homes for 1 week following outpatient iodine-131 rituximab RIT of lymphoma were interviewed by a nuclear medicine physicist according to a multi-visit integrated protocol designed to minimise radiation exposure, define risk and gain informed consent. Median radiation exposure of carers was 0.49 mSv (range 0.01-3.7 mSv) which is below the Western Australian regulatory limit of 5 mSv for consenting adult carers of radioactive patients. After signing a declaration of consent, only 2 carers of 750 abrogated their responsibility and none of those who carried out their duties expressed residual concerns at the end of the exit interview with respect to their radiation exposure. Fear of radiation exposure in a normal population may be characterised as a normal emotional response. In the special case of carers of radioactive patients, this fear may be successfully managed by rational, authoritative and empathic explanation to define the risk and gain willing acceptance within the context of domiciliary patient care.

  19. Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?

    Energy Technology Data Exchange (ETDEWEB)

    Rodrigues, M.; Havlik, E.; Sinzinger, H. [Univ. Hospital of Vienna (Austria). Dept. of Nuclear Medicine; Peskar, B. [Graz Univ. (Austria). Abt. Pharmakologie

    1998-03-01

    Because salivary glands, as well as thyroid tissue, are able to concentrate radioiodine, the treatment of thyroid diseases with iodine-131 may have secondary effects on salivary gland function which seriously impair the quality of life. Such effects include sialoadenitis and xerostomia. Salivary secretion is stimulated by prostaglandins (PGs). In this study we evaluate whether {sup 131}I therapy influences the levels of PGs in saliva. Patients who had previously received {sup 131}I for treatment of hyperthyroidism or differentiated thyroid cancer and healthy volunters were studied. Levels of PGs [6-oxo-PGF{sub 1{alpha}}, bicyclo-PGEm, thromboxane B{sub 2} (TXB{sub 2}), PGF{sub 2{alpha}}], in unstimulated saliva were measured using enzyme immunoassay. Significantly lower levels of 6-oxo-PGF{sub 1} {sub {alpha}}, bicyclo-PGEm and PGF{sub 2{alpha}} and higher levels of TXB{sub 2} were found in the group of patients in comparison with the controls. Differences between patients and controls were more pronounced in smokers. This study demonstrates that salivary gland uptake of {sup 131}I significantly affects PG levels in saliva. (orig.)

  20. Alteration of radioactive iodine uptake after treatment of hyperthyroidism with iodine 131

    International Nuclear Information System (INIS)

    Heath, R.C.; Gossain, V.V.; Rovner, D.R.

    1988-01-01

    To determine whether a therapeutic dose of iodine 131 affects the results of 24-hour radioactive iodine uptake (RAIU) testing, we reviewed records of hyperthyroid patients previously treated with 131 I at Michigan State University and its affiliated hospitals. We identified 26 patients who had had clinical evaluation and determination of the serum thyroxine (T4) level, triiodothyronine resin uptake (T3RU), and RAIU (using 131 I) within two weeks before and several months after the therapeutic dose of 131 I. Before treatment, all patients had clinical hyperthyroidism, with an elevated T4 level and increased T3RU and RAIU. After treatment with 131 I, eight patients (31%) had an RAIU that was discordant with their clinical and biochemical (T4 and T3RU) assessment. In six patients (23%) of the RAIU was inappropriately high, and in two patients (8%) it was inappropriately low. Since we did not identify any other factors known to interfere with the results of RAIU testing, we conclude that a therapeutic dose of 131 I, may by itself increase or decrease a subsequent RAIU determination; therefore, after treatment with 131 I, RAIU is not a good diagnostic index of thyroid activity

  1. Prostaglandins as biochemical markers of radiation injury to the salivary glands after iodine-131 therapy?

    International Nuclear Information System (INIS)

    Rodrigues, M.; Havlik, E.; Sinzinger, H.; Peskar, B.

    1998-01-01

    Because salivary glands, as well as thyroid tissue, are able to concentrate radioiodine, the treatment of thyroid diseases with iodine-131 may have secondary effects on salivary gland function which seriously impair the quality of life. Such effects include sialoadenitis and xerostomia. Salivary secretion is stimulated by prostaglandins (PGs). In this study we evaluate whether 131 I therapy influences the levels of PGs in saliva. Patients who had previously received 131 I for treatment of hyperthyroidism or differentiated thyroid cancer and healthy volunters were studied. Levels of PGs [6-oxo-PGF 1α , bicyclo-PGEm, thromboxane B 2 (TXB 2 ), PGF 2α ], in unstimulated saliva were measured using enzyme immunoassay. Significantly lower levels of 6-oxo-PGF 1 α , bicyclo-PGEm and PGF 2α and higher levels of TXB 2 were found in the group of patients in comparison with the controls. Differences between patients and controls were more pronounced in smokers. This study demonstrates that salivary gland uptake of 131 I significantly affects PG levels in saliva. (orig.)

  2. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship.

    Science.gov (United States)

    Erselcan, Taner; Sungu, Selma; Ozdemir, Semra; Turgut, Bulent; Dogan, Derya; Ozdemir, Ozturk

    2004-05-01

    Although it is well known that radiation induces chromosomal aberrations, there is a lack of information on the in vivo dose-effect relationship in patients receiving iodine-131 treatment, and the results of previous studies are controversial. In this study, the sister chromatid exchange (SCE) method was employed to investigate acute and late chromosomal damage (CD) in the peripheral lymphocytes of 15 patients who received various doses of (131)I (259-3,700 MBq), either for thyrotoxicosis (TTX) or for ablation treatment in differentiated thyroid cancer (DTC). The SCE frequencies in cultured peripheral lymphocytes were determined before treatment (to assess basal SCE frequencies), on the 3rd day (to assess acute SCE frequencies) and 6 months later (to assess late SCE frequencies). The basal, acute and late SCE frequencies (mean+/-SD) were 3.19+/-0.93, 10.83+/-1.72 and 5.75+/-2.06, respectively, in the whole group, and these values differed significantly from each other ( Pdisappearance of damaged lymphocytes from the peripheral circulation in a dose-dependent manner following (131)I treatment. Further studies are therefore needed to clarify the effect of the negative beta value on the biological dosimetry approach in continuous internal low LET radiation, as in the case of (131)I treatment.

  3. Practical recommendations for outpatients after differentiated thyroid carcinoma treatment with iodine-131

    International Nuclear Information System (INIS)

    Carlier, T.; Kraeber-Bodere, F.; Ansquer, C.; Couturier, O.; Lisbona, A.; Kraeber-Bodere, F.; Couturier, O.

    2004-01-01

    Few studies on radiation protection recommendation for patients leaving hospitalization area after thyroid carcinoma treatment with iodine-131 are based on experimental determination of effective half life. The aim of this work was to calculate times of adhesion to restrictions for patients using one dose rate measurement at 30 cm the last day, just before leaving hospital. Dose rate measurements were achieved every day at two localizations (abdomen mid trunk and neck) during hospitalization. Data were fitted by a monoexponential or a biexponential model in order to derive the effective half life. We considered 7 exposure states between patient and neighboring. We showed, according to our realistic scatter state, a dose rate variation inversely proportional to the distance from patient. Effective half life is equal to 16 ± 6 h whatever the measurement localization. Thus the times of adhesion to restrictions is never greater than 2 days after 3 days of hospitalization. A simple table is given to allow the computation of restrictions times according to the dose rate measurement before the patient is discharged. This protocol is applied in our institution and gives whole satisfaction as far as the ALARA principle and the patient information are concerned. (author)

  4. A Study on Labelling of Linolenic Acid as A Model of Isolated Benalu Teh for Cancer Diagnosis with Iodine-131

    International Nuclear Information System (INIS)

    Isti Daruwati; Eva Maria Widyasari; Nanny Kartini Oekar

    2009-01-01

    A study on active fraction of benalu teh has been carried out at Center for Application of Isotope and Radiation Technology - BATAN. This benalu teh active fraction has inhibition capability about 99% to the cancer cell. The isolated fraction is octadeca-8,10,12-triyonic acid compound which have long chain unsaturated fatty acid compound with three triple bonds. The Benalu teh active fraction has similar structure with linolenic acid which is a long chain unsaturated fatty acid with three triple bonds. Based on this similarity, the study of labelling of linolenic acid with iodine-131 has been conducted. The research was focused on optimum conditions for labelling of linolenic acid using Iodine-131 radionuclide. Labelling with iodine-131 was conducted using KIO 3 as an oxidizing agent, which can additionated linolenic acid and sodium metabisulfite for ending the reaction. Labelling efficiency determination was conducted using paper chromatography technique. The result showed that the optimum condition achieved by using KIO 3 as an oxidizing agent that gave radiochemical purity of 99,44% in virgin coconut oil, and labelling efficiency of about 69,9%. The labelled compound has high radiochemical purity i.e 96,85% in chloroform and 98,33% virgin coconut oil that was stable until 10 days in refrigerator. (author)

  5. Iodine-131 treatment strategy in papillary and follicular thyroid cancers at Centre Antoine Lacassagne (Nice)

    International Nuclear Information System (INIS)

    Bussiere, F.

    2003-01-01

    We report on iodine-131 treatment strategy in 1207 papillary and 250 follicular thyroid cancers admitted at our institution between 1976 and 2001. At the time of diagnosis, 51 patients (3.5%) had already metastases. The rest were 155 (11 %) pT4, 619 (44.6 %) pT1 588 (42,6 %) pT2, 26 pT3, 5 pT0 and 4 pTx. All patients underwent quasi-total thyroidectomy. Lymph node dissection was performed in most patients except in 49.7 %n of pT1 and 33% of pT2. Lastly, multifocal thyroid lesions were found in 28.5% of pT1 and 27,6 % of pT2. 80 patients did not receive radio-iodine (among them 60 were pT1 pN0 or pNx). 1114 patients received one therapeutic dose of 3.7 GBq of 131-iodine 6 to 8 weeks post surgery. 181 patients were treated twice (89 for remnants and 92 for disease progression). 82 patients received at least 3 doses and 5 up to 7 doses. 116 deaths were recorded, 59 (4 %) were related to thyroid cancer. The relatively poor prognosis of the follicular form is confirmed with 15.2 % deaths. This study needs to be further analysed focusing oil the follow-up of pT1 patients in order to redefine the indications of iodine therapy in that group. (author)

  6. Evaluation of the uncertainties associated to the in vivo monitoring of iodine-131 in the thyroid

    Energy Technology Data Exchange (ETDEWEB)

    Gontijo, Rodrigo Modesto Gadelha; Lucena, Eder Augusto; Dantas, Ana Leticia A.; Dantas, Bernardo Maranhao [Instituto de Radioprotecao e Dosimetria (IRD/CNEN-RJ), Rio de Janeiro, RJ (Brazil)

    2011-07-01

    The internal dose from the incorporation of radionuclides by humans can be estimated by in vivo direct measurements in the human body and in vitro analysis of biological indicators. In vivo techniques consist on the identification and quantification of radionuclides present in the whole body and in specific organs and tissues. The results obtained in measurements may present small uncertainties which are within pre-set limits in monitoring programs for occupationally exposed individuals. This study aims to evaluate the sources of uncertainty associated with the results of in vivo monitoring of iodine 131 in the thyroid. The benchmarks adopted in this study are based on the criteria suggested by the General Guide for Estimating Effective Doses from Monitoring Data (Project IDEAS/European Community). The reference values used were the ones for high-energy photons (>100 keV). Besides the parameters suggested by the IDEAS Guide, it has also been evaluated the fluctuation of the counting due to the phantom repositioning, which represents the reproducibility of the counting geometry. Measurements were performed at the Whole Body Counter Unit of the IRD using a scintillation detector NaI (Tl) 3'' x 3'' and a neck-thyroid phantom developed at the In Vivo Monitoring Laboratory of IRD. This phantom contains a standard source of barium-133 added to a piece of filter paper with the dimension and shape of a thyroid gland. Scattering factors were calculated and compared in different counting geometries. The results show that the technique studied presents reproducibility equivalent to the values suggested in the IDEAS Guide and measurement uncertainties compatible to international quality standards for this type of in vivo monitoring. (author)

  7. Phaeochromocytoma and functioning paraganglioma in childhood and adolescence: Role of iodine 131 metaiodobenzylguanidine

    International Nuclear Information System (INIS)

    Khafagi, F.A.; Shapiro, B.; Fischer, M.; Sisson, J.C.; Beierwaltes, W.H.; Hutchinson, R.

    1991-01-01

    Phaeochromocytomas and functioning paragangliomas are rare tumours in childhood and adolescence. We review our experience of 43 cases (24 men, 19 women) who were first diagnosed at the age of ≤ 18 years. All patients were evaluated at some point in their illness, with iodine 131 metaiodobenzylguanidine ( 131 I-mIBG) scintigraphy. Eight patients (19%) had bilateral adrenal tumours, 12 (28%) had solitary extraadrenal tumours, and 8 (19%) had multiple tumours. In 10 patients (23%), the tumours were associated with a familial neurocristopathic syndrome. Thirteen of 24 (54%) unifocal tumours which were initially considered to be benign ultimately proved to be multi-focal and/or malignant. The final prevalence of malignancy was 60% - 26 patients, of whom only 15 (57%) had obviously malignant tumours at the time of diagnosis. Primary tumour size ≥ 5 cm was more commonly associated with a malignant course in adrenal but not extra-adrenal tumours. No other clinical, biochemical or morphological characteristic was significantly associated with malignancy. Although the high prevalence of malignancy in this series at least partly reflects referral bias, the need for lifelong follow-up of these patients is underscored. 131 I-mIBG scintigraphy was positive in 36 patients (84%), with a somewhat lower false-negative rate (12%) than X-ray computed tomography (20%). Eight patients with malignant tumours received therapeutic doses of 131 I-mIBG, with partial tumour responses in 3. Thus, 131 I-mIBG is an efficacious, non-invasive, localising agent and may be considered as a palliative therapeutic agent when alternatives have failed. (orig.)

  8. Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves’ Disease

    International Nuclear Information System (INIS)

    Manohar, Kuruva; Mittal, Bhagwant Rai; Bhoil, Amit; Bhattacharya, Anish; Dutta, Pinaki; Bhansali, Anil

    2013-01-01

    Treatment of Graves' disease with iodine-131 ( 131 I) is well-known; however, all patients do not respond to a single dose of 131 I and may require higher and repeated doses. This study was carried out to identify the factors, which can predict treatment failure to a single dose of 131 I treatment in these patients. Data of 150 patients with Graves' disease treated with 259-370 MBq of 131 I followed-up for at least 1-year were retrospectively analyzed. Logistic regression analysis was used to predict factors which can predict treatment failure, such as age, sex, duration of disease, grade of goiter, duration of treatment with anti-thyroid drugs, mean dosage of anti-thyroid drugs used, 99m Tc-pertechnetate ( 99m TcO 4 - ) uptake at 20 min, dose of 131 I administered, total triiodothyronine and thyroxine levels. Of the 150 patients, 25 patients required retreatment within 1 year of initial treatment with 131 I. Logistic regression analysis revealed that male sex and 99m TcO 4 - uptake were associated with treatment failure. On receiver operating characteristic (ROC) curve analysis, area under the curve (AUC) was significant for 99m TcO 4 - uptake predicting treatment failure (AUC = 0.623; P = 0.039). Optimum cutoff for 99m TcO 4 - uptake was 17.75 with a sensitivity of 68% and specificity of 66% to predict treatment failure. Patients with >17.75% 99m TcO 4 - uptake had odds ratio of 3.14 (P = 0.014) for treatment failure and male patients had odds ratio of 1.783 for treatment failure. Our results suggest that male patients and patients with high pre-treatment 99m TcO 4 - uptake are more likely to require repeated doses of 131 I to achieve complete remission

  9. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations

    International Nuclear Information System (INIS)

    Casara, D.; Rubello, D.; Saladini, G.; Piotto, A.; Pelizzo, M.R.; Girelli, M.E.; Busnardo, B.

    1993-01-01

    Seventy female patients who had been treated with high doses of iodine-131 for differented thyroid cancer (DTC) and who had a subsequent pregnancy were evaluated. The global 131 I dose ranged from 1.85 to 16.55 GBq (mean±SD=4.39±25.20 GBq). Age at first therapy ranged from 15 to 36 years (mean±SD=24.3±5.0 years) and the interval from 131 I therapy to pregnancy varied from 2 to 10 years (mean±SD=5.3±2.8 years). The estimated radiation dose to the gonads ranged from 10 to 63 cGy (mean±SD=24.0±13.5 cGy). All patients were treated with L-thyroxine at doses capable of suppressing thyroid-stimulating hormone. Seventy-three children were followed-up and seven pregnancies are still in progress. One child was affected by Fallot's trilogy and three had a low birth weight though with subsequent regular growth; the others were healthy with subsequent regular growth. No newborn with clinical or biochemical thyroid dysfunctions was found. Two spontaneous abortions during the second month of pregnancy were recorded. One of two patients in question subsequently had two healthy children. On the basis of these data, previous administration of high 131 I doses does not appear to be a valid reason for dissuading young female DTC patients from considering pregnancy. However, patients should be advised to avoid pregnancy after 131 I administration for a period sufficient to ensure complete elimination of the radionuclide and to permit confirmation of complete disease remission, i.e. at least 1 year in our opinion. (orig.)

  10. Managing Terrorism or Accidental Nuclear Errors, Preparing for Iodine-131 Emergencies: A Comprehensive Review

    Directory of Open Access Journals (Sweden)

    Eric R. Braverman

    2014-04-01

    Full Text Available Chernobyl demonstrated that iodine-131 (131I released in a nuclear accident can cause malignant thyroid nodules to develop in children within a 300 mile radius of the incident. Timely potassium iodide (KI administration can prevent the development of thyroid cancer and the American Thyroid Association (ATA and a number of United States governmental agencies recommend KI prophylaxis. Current pre-distribution of KI by the United States government and other governments with nuclear reactors is probably ineffective. Thus we undertook a thorough scientific review, regarding emergency response to 131I exposures. We propose: (1 pre-distribution of KI to at risk populations; (2 prompt administration, within 2 hours of the incident; (3 utilization of a lowest effective KI dose; (4 distribution extension to at least 300 miles from the epicenter of a potential nuclear incident; (5 education of the public about dietary iodide sources; (6 continued post-hoc analysis of the long-term impact of nuclear accidents; and (7 support for global iodine sufficiency programs. Approximately two billion people are at risk for iodine deficiency disorder (IDD, the world’s leading cause of preventable brain damage. Iodide deficient individuals are at greater risk of developing thyroid cancer after 131I exposure. There are virtually no studies of KI prophylaxis in infants, children and adolescents, our target population. Because of their sensitivity to these side effects, we have suggested that we should extrapolate from the lowest effective adult dose, 15–30 mg or 1–2 mg per 10 pounds for children. We encourage global health agencies (private and governmental to consider these critical recommendations.

  11. Iodine-131 labelled octreotide: not an option for somatostatin receptor therapy

    International Nuclear Information System (INIS)

    Bakker, W.H.; Breeman, W.A.P.; Pluijm, M.E. van der; Jong, M. de; Visser, T.J.; Krenning, E.P.

    1996-01-01

    This study deals with the radioiodination of very small amounts of peptide on a therapeutic scale, the required purification procedures after radioiodination, and the influence of high beta fluxes from 131 I on a peptide during radioiodination and purification. Based on the regularly used therapeutic doses of 131 I in cancer treatment and out previous experience with [ 111 In-DTPA-D-Phe 1 ]-octreotide, it was assumed that a minimal effective therapeutic dose of 3.7 GBq 131 I has to be coupled to a maximum of ∼100 μg peptide, representing only a slight excess of peptide over 131 I. This contrasts with non-peptide radiopharmaceuticals in which high compound to radionuclide ratios are usually used. Labelling at low peptide to radionuclide ratios (low labelling yields) results in the formation of di-iodinated compounds, whereas at high peptide to radionuclide ratios mono-iodinated products of low specific activity are formed. Thus, after radioiodination the desired mono-iodinated peptide has to be separated form unreacted iodide, and from di-iodinated and unreacted peptide, as both compounds compete for the receptors. Possible radiolysis of the peptide during labelling and separation steps were investigated by irradiating 30 μg unlabelled peptide with 370 MBq 131 I in a small volume. The peptide composition of the incubation mixtures was investigated by high-performance liquid chromatography after irradiation for 30 min to 24 h. The results showed that the peptide was degraded with a half-life of less than 1 h. During the preparation of a real therapeutic dose (at much higher β-flux) the peptide will be degraded even faster during the various steps required. In conclusion, intact mono-iodinated 131 I-labelled somatostatin analogues for peptide receptor therapy will be difficult to obtain. (orig./VHE)

  12. Rapid clearance of iodine-131 MIBG from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma

    International Nuclear Information System (INIS)

    Nakajo, M.; Shimabukuro, K.; Miyaji, N.; Shimada, J.; Shirono, K.; Sakata, H.; Yoshimura, H.; Yonekura, R.; Shinohara, S.

    1985-01-01

    Iodine-131 MIBG, a radiolabeled adrenergic neuron-blocking agent, decreased rapidly from the heart and liver of patients with adrenergic dysfunction and pheochromocytoma when compared with eight controls. However, there was no significant difference in the rate of [ 131 I]MIBG decrease in these organs between controls and patients in the intervals subsequent to 4 hr. These findings suggest that adrenergic neuronal uptake of [ 131 I]MIBG in these organs is smaller in the patients than in the controls. Measurements of time-activity relationships of radioiodinated MIBG may be useful for assessment of adrenergic function of these organs and thus of generalized disorders of adrenergic innervation

  13. Intrathoracic stomach mimicking bone metastasis from thyroid cancer in whole-body iodine-131 scan diagnosed by SPECT/CT

    Energy Technology Data Exchange (ETDEWEB)

    Garcia-Gomez, Francisco Javier; Riva-Perez, Pablo Antonio de la; Calvo-Moron, Cinta; Bujan-Lloret, Cristina; Cambil-Molina, Teresa; Castro-Montano, Juan [Dept. of Nuclear Medicine, Virgen Macarena University Hospital, Sevilla (Spain)

    2017-05-15

    The whole-body iodine-131 scintigraphy is an imaging technique in monitoring patients with a history of thyroid cancer. Although the rate of false positives is negligible, it is not nonexistent. We report the case of an intervened and treated patient for thyroid cancer with good clinical and biochemical response. Scintigraphic findings were consistent with unsuspected bone metastasis. Fused SPECT/CT data allowed accurate diagnosis of giant diaphragmatic hernia associated with intrathoracic stomach, a very rare pathology that can lead to false positive results. (author)

  14. Using medically-derived iodine-131 to track sewage effluent in the Laurentian Great Lakes.

    Science.gov (United States)

    Montenero, Michael P; Dilbone, Elizabeth K; Waples, James T

    2017-10-15

    Tracking sewage wastewater in a large lake is difficult. Concentrations of pharmaceuticals that can be used as indicator compounds are quickly diluted and not easy to measure. In this study, we examined the potential of using medically-derived iodine-131 ( 131 I, t ½  = 8.02 d) as a tracer for Milwaukee sewage effluent in Lake Michigan. 131 I activities in sewage effluent from two Milwaukee wastewater treatment plants (WWTPs) were measured in conjunction with 131 I activities in water, sediment and biota in the Milwaukee Outer Harbor and Lake Michigan. 131 I discharge rates from both WWTPS ranged from 34 ± 15 to 1807 ± 24 MBq d -1 , with average and median 131 I discharges of 278 and 129 MBq d -1 . A budget of 131 I in the Milwaukee Outer Harbor - based on measured sediment and water column inventories - showed that ∼11% of the 131 I discharged to the harbor was scavenged to bottom sediments, ∼19% decayed in the harbor water column, and ∼70% was flushed out of the harbor to Lake Michigan. From this budget, we derived a harbor flushing rate of 3.1 days. In Lake Michigan, 131 I activity was found in Cladophora algae (undetected to 91 ± 2 Bq kg -1 ) along ∼40 km of shoreline. Benthic trawl samples showed 131 I activity up to 8 km from shore. Calculated 131 I length scales were 30 km alongshore and 3.4 km offshore and corresponded to sewage effluent dispersion rates of ∼2.6 km d -1 and ∼0.3 km d -1 in along- and offshore directions. Using 131 I as a tracer of sewage effluent from other coastal municipalities to the Laurentian Great Lakes appears feasible, particularly for larger (>10 5 ) population centers. Copyright © 2017 Elsevier Ltd. All rights reserved.

  15. Iodine-131 treatment and chromosomal damage: in vivo dose-effect relationship

    International Nuclear Information System (INIS)

    Erselcan, Taner; Ozdemir, Semra; Turgut, Bulent; Dogan, Derya; Sungu, Selma; Ozdemir, Ozturk

    2004-01-01

    Although it is well known that radiation induces chromosomal aberrations, there is a lack of information on the in vivo dose-effect relationship in patients receiving iodine-131 treatment, and the results of previous studies are controversial. In this study, the sister chromatid exchange (SCE) method was employed to investigate acute and late chromosomal damage (CD) in the peripheral lymphocytes of 15 patients who received various doses of 131 I (259-3,700 MBq), either for thyrotoxicosis (TTX) or for ablation treatment in differentiated thyroid cancer (DTC). The SCE frequencies in cultured peripheral lymphocytes were determined before treatment (to assess basal SCE frequencies), on the 3rd day (to assess acute SCE frequencies) and 6 months later (to assess late SCE frequencies). The basal, acute and late SCE frequencies (mean±SD) were 3.19±0.93, 10.83±1.72 and 5.75±2.06, respectively, in the whole group, and these values differed significantly from each other (P 131 I dose in the whole group, but a negative correlation was found between the 131 I dose and the RR at the 6th month (r=-0.60, P=0.04). The best fit for this relationship was obtained by a linear-quadratic model, as y=104.89x-28.4x 2 +38.1 (R 2 =0.51, P=0.04). On the other hand, comparative analysis with the results of previous studies with comparable sampling times revealed that the best fit for the relationships between the administered dose of 131 I and DR and RR were obtained with a linear-quadratic model (Y=αD+βD 2 ) rather than a linear one. However, there was an interesting difference in comparison with in vitro studies, in that we found the coefficient β to have a negative value, suggesting the disappearance of damaged lymphocytes from the peripheral circulation in a dose-dependent manner following 131 I treatment. Further studies are therefore needed to clarify the effect of the negative β value on the biological dosimetry approach in continuous internal low LET radiation, as in the case

  16. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism

    Energy Technology Data Exchange (ETDEWEB)

    Barrington, S.F.; O`Doherty, M.J.; Seed, P. [Guy`s, King`s and St. Thomas` Schools of Medicine, London (United Kingdom); Kettle, A.G. [Kent and Canterbury NHS Trust, Canterbury (United Kingdom); Thomson, W.H.; Harding, L.K. [City Hospitals NHS Trust, Birmingham (United Kingdom); Mountford, P.J.; Farrell, R.J. [North Staffordshire Hospital NHS Trust, Stoke-on-Trent (United Kingdom); Burrell, D.N. [University Hospital, Birmingham NHS Trust, Birmingham (United Kingdom); Batchelor, S. [Guy`s and St. Thomas` Hospitals NHS Trust, London (United Kingdom)

    1999-07-01

    Patients who receive radioiodine (iodine-131) treatment for hyperthyroidism (195-800 MBq) emit radiation and represent a potential hazard to other individuals. Critical groups amongst the public are fellow travellers on the patient`s journey home from hospital and members of the patient`s family, particularly young children. The dose which members of the public are allowed to receive as a result of a patient`s treatment has been reduced in Europe following recently revised recommendations from ICRP. The annual public dose limit is 1 mSv, though adult members of the patient`s family are allowed to receive higher doses, with the proviso that a limit of 5 mSv should not be exceeded over 5 years. Unless the doses received during out-patient administration of radioiodine can be demonstrated to comply with these new limits, hospitalisation of patients will be necessary. The radiation doses received by family members (35 adults and 87 children) of patients treated with radioiodine at five UK hospitals were measured using thermoluminescent dosimeters mounted in wrist bands. Families were given advice (according to current practice) from their treatment centre about limiting close contact with the patient for a period of time after treatment. Doses measured over 3-6 weeks were adjusted to give an estimate of values which might have been expected if the dosimeters had been worn indefinitely. Thirty-five passengers accompanying patients home after treatment also recorded the dose received during the journey using electronic (digital) personal dosimeters. For the ``adjusted`` doses to infinity, 97% of adults complied with a 5-mSv dose limit (range:0.2-5.8 mSv) and 89% of children with a 1-mSv limit (range: 0.2-7.2 mSv). However 6 of 17 children aged 3 years or less had an adjusted dose which exceeded this 1 mSv limit. The dose received by adults during travel was small in comparison with the total dose received. The median travel dose was 0.03 mSv for 1 h travel (range: 2 {mu

  17. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism

    International Nuclear Information System (INIS)

    Barrington, S.F.; O'Doherty, M.J.; Seed, P.; Kettle, A.G.; Thomson, W.H.; Harding, L.K.; Mountford, P.J.; Farrell, R.J.; Burrell, D.N.; Batchelor, S.

    1999-01-01

    Patients who receive radioiodine (iodine-131) treatment for hyperthyroidism (195-800 MBq) emit radiation and represent a potential hazard to other individuals. Critical groups amongst the public are fellow travellers on the patient's journey home from hospital and members of the patient's family, particularly young children. The dose which members of the public are allowed to receive as a result of a patient's treatment has been reduced in Europe following recently revised recommendations from ICRP. The annual public dose limit is 1 mSv, though adult members of the patient's family are allowed to receive higher doses, with the proviso that a limit of 5 mSv should not be exceeded over 5 years. Unless the doses received during out-patient administration of radioiodine can be demonstrated to comply with these new limits, hospitalisation of patients will be necessary. The radiation doses received by family members (35 adults and 87 children) of patients treated with radioiodine at five UK hospitals were measured using thermoluminescent dosimeters mounted in wrist bands. Families were given advice (according to current practice) from their treatment centre about limiting close contact with the patient for a period of time after treatment. Doses measured over 3-6 weeks were adjusted to give an estimate of values which might have been expected if the dosimeters had been worn indefinitely. Thirty-five passengers accompanying patients home after treatment also recorded the dose received during the journey using electronic (digital) personal dosimeters. For the ''adjusted'' doses to infinity, 97% of adults complied with a 5-mSv dose limit (range:0.2-5.8 mSv) and 89% of children with a 1-mSv limit (range: 0.2-7.2 mSv). However 6 of 17 children aged 3 years or less had an adjusted dose which exceeded this 1 mSv limit. The dose received by adults during travel was small in comparison with the total dose received. The median travel dose was 0.03 mSv for 1 h travel (range: 2

  18. Proposal of a methodology for individualized iodine-131 therapy for Graves' disease in patients with hyperthyroidism

    International Nuclear Information System (INIS)

    Araujo, Francisco de; Melo, Rossana Corbo de; Rebelo, Ana Maria de Oliveira; Dantas, Bernardo Maranhao; Dantas, Ana Leticia A.; Lucena, Eder Augusto de

    2007-01-01

    Objective: Several methods are utilized for determining the radioiodine activity in the treatment of Graves' disease (hyperthyroidism). Some of this methods do not take into consideration the thyroid absorbed dose or the necessary parameters for this estimation. The association between absorbed dose and administered activity depends on effective half-life, iodine uptake and thyroid mass of each patient. The present study was aimed at developing a methodology for individualized 131 I therapy for Graves' disease in patients with hyperthyroidism of the Graves' disease. Materials and methods: A neck-thyroid phantom developed at Instituto de Radioprotecao e Dosimetria, containing a standard solution of 131 I, was utilized for calibrating the scintillation gamma camera and uptake probe installed in the Department of Nuclear Medicine of the Hospital Universitario Clementino Fraga Filho da Universidade Federal do Rio de Janeiro. Results: The view angle of the collimator/detector assembly presented values compatible with the thyroid gland size for distances of 25 cm (uptake probe) and 45.8 cm (scintillation gamma camera). Calibration factors were 39.3 ± 0.78 and 4.3 ± 0.17 cpm/kBq, respectively. The 14-30-hour interval in the retention curve allows the estimation of activity between two points for determining the effective iodine half-life in the thyroid. Conclusion: The utilization of equipment usually available in nuclear medicine clinics is feasible, so this is a simple, effective and low cost methodology. (author)

  19. Radiation protection measures for reduction of incorporations of iodine-131 by the staff of a radionuclide therapy ward

    International Nuclear Information System (INIS)

    Petzold, J.; Meyer, K.; Lincke, T.; Sabri, O.; Alborzi, H.; Lorenz, J.; Schoenmuth, T.; Keller, A.

    2009-01-01

    The air in patient's rooms with thyroid therapies is loaded with iodine 131, which is to be seen as a cause for the incorporation of iodine 131 by the staff. The patients exhale a part of the iodine applied for their intended radionuclide therapy. The activity is concentrated in the saliva and, thereby, the breath air is moistened and iodine reaches the exhaled and compartment air. The detection of iodine in the form of contaminations and/or incorporations with the staff succeeds only after a longer stay in the patient's room. With this, a clear relation between the particular type of work performed in the room and therapy of malignant thyroid disease with high amounts of radioactivity can be found. The measured values of incorporations, obtained with an whole-body counter, are in the range of up to 400Bq. The activity concentration in the compartment air some hours after application of the therapeutic activity reaches a maximum and then decreases with a half-life of about 15 hours. As a protection measure we asked the patients wearing a mask up to 30 hours after application to (orig.)

  20. Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure.

    Science.gov (United States)

    Yeyin, Nami; Cavdar, Iffet; Uslu, Lebriz; Abuqbeitah, Mohammad; Demir, Mustafa

    2016-03-01

    Radioiodine therapy could be challenging in chronic renal failure patients requiring hemodialysis. The aim of this study was to establish the effects of hemodialysis on elimination of radioiodine from the body in thyroid carcinoma patients with end-stage chronic renal failure and to determine its effects on environmental radiation dose. Three end-stage chronic renal failure patients (four cases) diagnosed with differentiated thyroid carcinoma requiring radioiodine therapy were included in our study. Each patient was given 50-75 mCi (1850-2775 MBq) iodine-131 with 50% dose reduction. Dose rate measurement was performed at the 2nd, 24th, and 48th hour (immediately before and after hemodialysis) after radioiodine administration. The Geiger-Müller probe was held at 1 m distance at the level of the midpoint of the thorax for the dose rate measurement. The effective half-life of iodine-131 for three patients was found to be 44 h. In conclusion, the amount of radioiodine excreted per hemodialysis session was calculated to be 51.25%.

  1. Conversion and correction factors for historical measurements of iodine-131 in Hanford-area vegetation, 1945--1947. Hanford Environmental Dose Reconstruction Project

    Energy Technology Data Exchange (ETDEWEB)

    Mart, E.I.; Denham, D.H.; Thiede, M.E.

    1993-12-01

    This report is a result of the Hanford Environmental Dose Reconstruction (HEDR) Project whose goal is to estimate the radiation dose that individuals could have received from emissions since 1944 at the U.S. Department of Energy`s (DOE) Hanford Site near Richland, Washington. The HEDR Project is conducted by Battelle, Pacific Northwest Laboratories (BNW). One of the radionuclides emitted that would affect the radiation dose was iodine-131. This report describes in detail the reconstructed conversion and correction factors for historical measurements of iodine-131 in Hanford-area vegetation which was collected from the beginning of October 1945 through the end of December 1947.

  2. RETROSPECTIVE RECONSTRUCTION OF INTEGRAL IODINE-131 FALLOUT FOR THE SETTLEMENTS OF THE BRYANSK REGION OF RUSSIA ON THE BASIS OF RESULTS OF IODINE-129 CONTENT IN THE SOIL DETERMINATION IN 2008

    Directory of Open Access Journals (Sweden)

    Yu. I. Gavrilin

    2009-01-01

    Full Text Available The article briefly describes the procedure of reconstruction of integral iodine-131 fallouts using fragmentary data on iodine-131 fallouts in May-June 1986, as well as results of determination (in the late period after the accident of iodine-129 concentration in the soil and values of integral fallouts of cesium-137 in the settlements of the Bryansk region of Russia. Results of estimation of integral iodine-131 fallouts (in the area of 32 soil sampling points are presented in the table form. Regularities of ratio (131I/137CsII change in the integral radionuclide fallouts are being determined and values of integral iodine-131 fallouts are being estimatedfor the other settlements of the region with the known values of integral cesium-137 fallouts. It is shown that variability of the average for settlements values of integral iodine-131 fallouts is 70 times less then variability of corresponding integral cesium-137 fallouts.

  3. Use of Iodine-131 to Tellurium-132 Ratios for Assessing the Relationships between Human Inhaled Radioactivity and Environmental Monitoring after the Accident in Fukushima

    Directory of Open Access Journals (Sweden)

    Koji Uchiyama

    2018-03-01

    Full Text Available Significant differences in findings were seen between the intake amounts of iodine-131 that were derived from direct measurements and the estimated intake from environmental monitoring data at the Fukushima accident. To clarify these discrepancies, we have investigated the iodine-131 and tellurium-132 body burdens of five human subjects, who after being exposed to a radioactive plume, underwent 21.5 h whole body counter measurements at Fukui Prefectural Hospital, so clear intake scenario and thyroid counter measurement data were available. To determine the iodine-131 and tellurium-132 body burdens, we introduced a new method of whole body counter calibration composed of a self-consistent approach with the time-dependent correction efficiency factors concept. The ratios of iodine-131 to tellurium-132, ranging from 0.96 ± 0.05 to 2.29 ± 0.38, were consistent with results of the environmental measurements. The 24 h iodine uptake values ranging from 12.1–16.0% were within euthyroid range in Japanese people. These results suggest, even if the relatively low thyroid iodine uptake in the Japanese population was taken into consideration, that there is no doubt about the consistency between direct measurements and environmental monitoring data. Adequate intake scenario is suggested to be principally important to estimate the inhaled radioactivity in areas in or around nuclear accidents.

  4. Production of fusion radionuclides: Molybdenum-99/ Iodine - 131 and Xenon-133; Produccion de los radionucleidos de fision: Molibdeno-99, Yodo-131 y Xenon-133

    Energy Technology Data Exchange (ETDEWEB)

    Barrachina, M; Carrillo, D

    1982-07-01

    This report presents a new radiochemical method for industrial production of the radionuclides: molybdenum-99, iodine-131 and xenon-133. The above mentioned method based on the alkaline metathesis reaction of irradiated uranium (IV) fluoride, presents the best characteristics for the proposed objective. The study deals with the analysis of that reaction and the separation and purification processes. (Author) 71 refs.

  5. Thyroid uptake and imaging with iodine-123 at 4-5 hours: replacement of the 24-hour iodine-131 standard

    International Nuclear Information System (INIS)

    Floyd, J.L.; Rosen, P.R.; Borchert, R.D.; Jackson, D.E.; Weiland, F.L.

    1985-01-01

    A study was carried out to determine the suitability of utilizing a 4 to 5 hr interval from administration of Iodine-123 to imaging and uptake measurement as a replacement for the 24-hr standard originally established with Iodine-131. In 55 patients who underwent scintigraphy at 4 and 24 hr, there was no discrepancy between paired images. In 55 patients who had uptake measured at 4 and 24 hr and in 191 patients who had uptake measured at 5 and 24 hr, the early measurements proved equal or better discriminants of euthyroid from hyperthyroid patients. In our institutions, these findings and the logistical advantages of completing the exam in 4-5 hr led us to abandon the 24-hr study in the majority of patients

  6. Experimental dosimetry and kinetics of radioactive tracers for human applications: example of therapeutic injection of Lipiodol labelled with Iodine 131

    International Nuclear Information System (INIS)

    Ahmed Mahidi, N.

    1992-10-01

    We have evaluated the radiation dose received by the liver and lungs for 10 patients with a hepatic carcinoma after surgical operation followed by a therapeutic dose of Lipiodol labelled with iodine 131. The cumulated activities have been obtained by using a calibrated gamma camera. Fixation and kinetics of the I 131 Lipiodol in normal and cancers livers have been measured with the determination of the effective and biological half-lives. The calculated doses are based on the MIRD method. Results confirm that Lipiodol fixation is important in the liver at J1 (about 74% of the injected activity). Its elimination is essentially urinary, pulmonary fixation remained low, the dose received by the healthy part of liver is acceptable. These values have been compared with those obtained by another method using a thermoluminescent dosimeter (LiF) installed on the skin over the liver. Comparison between results obtained by the 2 methods shows a good correlation

  7. A comparison of physical and cytogenetic estimates of radiation dose in patients treated with iodine-131 for thyroid carcinoma

    International Nuclear Information System (INIS)

    Lloyd, D.C.; Purrott, R.J.; Dolphin, G.W.; Horton, P.W.; Halnan, K.E.; Scott, J.S.; Mair, G.

    1976-01-01

    Physical and cytogenetic estimates of the whole-body radiation doses have been compared in 11 patients receiving large doses of iodine-131 for the treatment of thyroid carcinoma. The physical estimate was based on the measurement of thyroid uptake, of the plasma activity variation, and of urinary activity. The cytogenetic estimate was obtained from the analysis of chromosome aberrations in peripheral blood lymphocytes. Good agreement between the estimates was observed in patients whose thyroid glands had previously be ablated by radioiodine. In patients who had varying degrees of thyroid function, there were considerable differences between the estimates with the cytogenetic value always being higher. It is suggested that these differences might be due in part to non-uniform irradiation of lymphocytes by local sources of activity in the thyroid and in the liver. (author)

  8. Accidental release of iodine 131 by the IRE of the Fleurus site: return on experience by the Belgian safety authority

    International Nuclear Information System (INIS)

    Vandecasteele, C.M.; Sonck, M.; Degueldre, D.

    2010-01-01

    After a presentation of the activities of the IRE, the Belgian National Institute of Radio-elements, i.e. the production of radionuclides used in nuclear medicine, this report describes the process and chemical reaction which caused an accidental release of iodine 131. It analyzes the causes of this incident, and how the incident has been managed by the Belgian safety authority. It discusses the first assessment of radiological consequences, describes how the incident has been managed at the federal level, and how population and media have been informed. It discusses the actual radiological consequences through measurements performed on grass and vegetables (graphs and maps indicate contamination levels and contaminated areas), and through the assessment of exposure of adults and children by different ways. Lessons learned are then discussed

  9. A model for determination of human foetus irradiation during intrauterine development when the mother incorporates iodine 131

    International Nuclear Information System (INIS)

    Vasilev, V.; Doncheva, B.

    1989-01-01

    A model is presented for irradiation calculation of human foetus during weeks 8-15 of the intrauterine development, when the mother chronically incorporates iodine 131. This period is critical for the nervous system of the foetus. Compared to some other author's models, the method proposed eliminates some uncertainties and takes into account the changes in the activity of mother's thyroid in time. The model is built on the base of data from 131 I-kinetics of pregnant women and experimental mice. A formula is proposed for total foetus irradiation calculation including: the internal γ and β irradiation; the external γ and β irradiation from the mother as a whole; and the external γ irradiation from the mother's thyroid

  10. The therapeutic threesome, Iodine 131, Lutetium-111 and Rhenium-188 Radionuclide Trifecta

    International Nuclear Information System (INIS)

    Turner, J.H.

    2007-01-01

    Full text: Affordable, available, cost-effective, safe, efficacious therapeutic radiopharmaceuticals are required for clinical application throughout the world. In-house preparation of non-proprietary therapeutic radiopharmaceuticals at tertiary referral hospitals in all countries following appropriate technology transfer and training at key research and development centres can potentially supply this need. Illustrative examples of novel therapeutic radiopharmaceuticals currently under development in physician sponsored phase II clinical trials and candidates for contemplation of translation to developing countries include: (1) I-131 Rituximab radioimmunotherapy of relapsed/refractory and first-line treatment of non- Hodgkin's lymphoma; (2) Lu-177 octreotate radiopeptide therapy of neuroendocrine malignancy with capecitabine tumour radiosensitization; (3) Re-188 lipiodol intrahepatic arterial therapy of hepatocellular carcinoma. In addition to presentation of preliminary clinical results, the logistics and techniques of preparation, quality control and administration of each of these therapeutic radiopharmaceuticals will be described and the calculation of individual patient dosimetry and issues of radiation safety will also be addressed. 1. Iodine-131 rituximab: I-131 rituximab may be prepared in a hospital department of nuclear medicine equipped with a shielded fume cupboard, using commercially available single-use sterile pyrogen-free labelling kits (Go Medical Industries Pty Ltd, Subiaco, Australia) (1). Individualized prospective dosimetry is performed on each patient by quantitative whole body gamma imaging, to determine the therapeutic administered activity, to provide a maximum safe whole body radiation absorbed dose of 0.75 Gy, which equates to less than 2 Gy to red marrow (2). More than 200 patients with relapsed/refractory non-Hodgkin's lymphoma have been treated at Fremantle Hospital without infection or haemorrhagic incident. Myelosuppression is self

  11. Patient release criteria following radioactive iodine-131 treatment in the light of international practice: where does South Africa fit in?

    Science.gov (United States)

    Mongane, Modisenyane S; Rae, William I D

    2017-10-01

    The release from hospital of patients treated with radioactive iodine-131 (I) remains a controversial issue as a result of the range of guidelines implemented by national regulatory bodies responsible for radiation protection in various countries worldwide. The aim of this study was to review and analyse the literature on patient release criteria (PRC) applied internationally in an attempt to achieve a justifiable approach to setting equivalent criteria in South Africa. In 2016, the South African Department of Health, Directorate: Radiation Control added conditions (numbers 50 and 90), to licences to use radioactive nuclides. These conditions state that patients must be hospitalized when the dose rate at 1 m is above 25 μSv/h, or more than 555 MBq of iodine-131 was administered to the patient. However, these criteria do not consider patients' socioeconomic conditions. A literature survey was carried out of articles detailing PRC from high-income countries as well as those in the middle-income and lower-income groups. Socioeconomic conditions within countries were determined using the International Monetary Fund lists of gross domestic product. The results from the literature have shown that in setting PRC, several countries have considered the socioeconomic conditions prevailing in their countries to achieve harmony between public protection and cost associated with hospitalization. The South African authority conditions must be seen in the context of the approach followed by other countries. Considering the international context, a justifiable, and potentially implementable, guideline or policy for improving individualized and more caring patient management is advocated.

  12. Evaluation of the Basedow disease treatment by a iodine 131 fixed dose; Evaluation du traitement de la maladie de Basedow par une dose fixe d'iode 131

    Energy Technology Data Exchange (ETDEWEB)

    El Ajmi, W.; Slim, I; Rmadi, S.; Yeddes, I.; Krimi, S.; Ltaief, B.; Mhiri, A.; Ben Slimene, M.F. [Service de medecine nucleaire, institut Salah Azeiz, Tunis, (Tunisia)

    2009-05-15

    The treatment of the basedow disease by iodine 131 is more and more used. however, the doses used stay variable. In order to reduce the treatment failure, we chose a protocol with strong fix doses of iodine 131. We give our preliminary results for 63 patients. The treatment by strong fix dose of iodine 131 is simple, safe and efficient for the control of hyperthyroidism in the Basedow disease. This protocol has for advantage to be simpler comparatively to these ones using adjusted doses according the weight of the thyroid and its fixation rate. (N.C.)

  13. Estimation of the activity and doses to personnel which intake Iodine 131 by coffee consumption in a cabinet of Nuclear Medicine

    International Nuclear Information System (INIS)

    Ruiz C, M.A.; Alfaro L, M.; Salinas, J.A.; Molina, G.

    2003-01-01

    Soon after an incident in a cabinet of nuclear medicine, its were carried out in the National Institute of Nuclear Research of Mexico (ININ), a series of bio essays measurements by whole-body counting to six people attributed to this cabinet. Of six people, five are classified as Occupational Exposed Personnel (POE), and the other one that works as secretary, according to the General Regulation of Radiological Safety, is classified as public member. Six people that were involved in this incident, the one which presumably it took place among November 15 and 18, 2002 and that it consisted on the effusion of a vial containing an unknown quantity of Iodine-131 to a coffeepot, they ingested coffee in diverse quantities. The Iodine-131 is used in nuclear medicine, so much for the illnesses diagnostic like in the treatment of thyroid cancer and of hyperthyroidism. (Author)

  14. Place of synthesis anti thyroids in the hyperthyroidism treatment by iodine 131; Place des antithyroidiens de synthese dans le traitement par iode 131 des hyperthyroidies

    Energy Technology Data Exchange (ETDEWEB)

    Clerc, J. [Hopital Necker, 75 - Paris (France)

    2000-01-01

    The prescription of synthesis anti thyroids allows to get a fast control of hyperthyroidism when the average time of curing after iodine 131 varies from 6 to 12 weeks, according to the level of radiation doses. It allows to treat the patients in euthyroidism and to avoid aggravation of thyrotoxicosis in the following of the iodine and is particularly useful for the old patients with a cardio vascular risk.

  15. Image findings of a false positive radioactive iodine-131 uptake mimicking metastasis in pulmonary aspergillosis identified on single photon emission computed tomography-computed tomography

    Directory of Open Access Journals (Sweden)

    Kamaleshwaran Koramadai Karuppusamy

    2015-01-01

    Full Text Available High doses of iodine-131 are commonly used in patients with differentiated thyroid cancer after total or subtotal thyroidectomy, in order to ablate the remaining cancer or normal thyroid tissue. Multiple different false-positive scans can occur in the absence of residual thyroid tissue or metastases. The authors present a case of abnormal uptake of radioactive iodine in the aspergilloma, potentially masquerading as pulmonary metastases.

  16. Skin eruptions following treatment with Iodine-131 for hyperthyroidism. A rare and un-reported early/intermediate side effect

    International Nuclear Information System (INIS)

    Paul, A. K.; AL-Nahhas, A.; Ansari, S. M.; Islam, N.

    2005-01-01

    Iodine-131 ( 131I ) is a well-established method for the treatment of hyperthyroidism. Following such therapy, patients may experience symptoms relating to early or delayed side effects that can be prevented or minimized if necessary measures are taken. We have noticed an unusual side effect of 131I therapy in the form of a skin eruption (iododerma) and aimed at assessing the frequency and severity of this side effect. Retrospective review of 141 patients treated with 131I between January 1994 to December 2000 (86 F, 55 M; mean age 41.35±11.02 years) was performed. The dose of 131I ranged from 250.500 MBq. Post therapy clinical and biochemical evaluation of thyroid function was done at 6 weeks, 3, 6, and 9 months then annually. Of the 141 treated patients, 3 patients (2.1%) presented with iododerma 4.6 weeks after 131I therapy administration. Lesions were observed at both ankles and lower legs in all 3 cases. All lesions disappeared within 6 months with no residual effect. No other skin lesions were seen thereafter during the follow-up period. Iododerma is a rare complication of 131I therapy that has not been reported before. It appears within 4.6 weeks after therapy and is a self-limiting condition. (author)

  17. Effect on thyroid function and serum PTH, BGP, CT of small dose of iodine 131 combined with Methimazole in patients with hyperthyroidism

    Directory of Open Access Journals (Sweden)

    Jia-Yin Qiu

    2016-03-01

    Full Text Available Objective: To observe the effect on thyroid function and serum PTH, BGP, CT of small dose of iodine 131 combined with Methimazole in patients with hyperthyroidism. Methods: A total of 104 patients with hyperthyroidism willing be incorporated into the study were randomly divided into the observation group (54 cases and the control group (50 cases. The control group was treated with Methimazole, and the observation group was given a small dose of iodine 131 the basised on the control group. For 2 months, to observe the changes of thyroid function (TT3, TT4, FT3, FT4 and TSH and bone metabolism related indexes (PTH, BGP and CT of the two groups. Results: (1 After treatment, TT3, FT3, TT4 and FT4 of the two groups decreased with before, and the observation group improved more significantly than the control group, with statistical difference; TSH of the two groups had no significant change. (2 After treatment, BGP and CT of the two groups decreased and PTH increased, the observation group improved more significantly than the control group, with statistical difference. Conclusion: small dose of iodine 131 combined with Methimazole can correct thyroid function and bone metabolism quickly in patients with hyperthyroidism.

  18. Hyperthyroidism treatment by iodine 131: about a study on 270 patients; Traitement de l'hyperthyroidie par l'iode 131: a propos d'une etude sur 270 patients

    Energy Technology Data Exchange (ETDEWEB)

    Leroux, M.A

    2005-07-01

    This study constitutes a starting point for a thought about the use of iodine 131 in the treatment of hyperthyroidism. The therapies are different depending on the teams, for the iodine 131 activities to deliver and their calculation modes; The use of synthesis anti-thyroid drugs before therapy is discussed. The radiation protection is an important factor in the decision of a metabolic radiotherapy. The indications of the treatment by radioactive iodine are different in Europe and in Usa. (N.C.)

  19. Targeting radioimmunotherapy of hepatocellular carcinoma with iodine (131I) metuximab injection: Clinical Phase I/II trials

    International Nuclear Information System (INIS)

    Chen Zhinan; Mi Li; Xu Jing

    2006-01-01

    Purpose: HAb18G/CD147 is a hepatocellular carcinoma (HCC)-associated antigen. We developed iodine ( 131 I) metuximab injection (Licartin), a novel 131 I-labeled HAb18G/CD147-specific monoclonal antibody F(ab') 2 fragment, and evaluated its safety, pharmacokinetics, and clinical efficacy on HCC in Phase I/II trials. Methods and Materials: In a Phase I trial, 28 patients were randomly assigned to receive the injection in 9.25-, 18.5-, 27.75-, or 37-MBq/kg doses by hepatic artery infusion. In a multicenter Phase II trial, 106 patients received the injection (27.75 MBq/kg) on Day 1 of a 28-day cycle. Response rate and survival rate were the endpoints. Results: No life-threatening toxic effects were found. The safe dosage was 27.75 MBq/kg. The blood clearance fitted a biphasic model, and its half-life was 90.56-63.93 h. In the Phase II trial, the injection was found to be targeted and concentrated to tumor tissues. Of the 73 patients completing two cycles, 6 (8.22%) had a partial response, 14 (19.18%) minor response, and 43 (58.90%) stable disease. The 21-month survival rate was 44.54%. The survival rate of progression-free patients was significantly higher than that of patients with progressive disease after either one or two cycles (p 131 I) metuximab injection is safe and active for HCC patients

  20. Exposure rates (versus time after administration), in relation with clinical factors, for thyroid carcinoma patients treated with Iodine-131

    International Nuclear Information System (INIS)

    Papadimitriou, D.; Oros, L.; Manetou, A.; Perris, A.; Molfetas, M.; Kottou, S.

    2002-01-01

    While the therapeutic use of iodine-131 for thyroid carcinoma patients offers enormous benefit to them, it contributes also significantly to the radiation exposure of individuals and population. A critical quantity for decisions relating radiation protection system based on restrictions recommended by authorities is the residual I-131 activity in patient's body. When this value is larger than a threshold level, it may keep the patient hospitalised for a short period of usually 2 to 3 days with an additional period of 7 days at home, where he must sleep separately and avoid close contact with other people. Essential for radiation protection issues is the careful collection of radioactive urine, radioactive waste and avoidance of any contaminations by perspiration and saliva. Longer hospital stay would increase the total cost of the treatment and limit the availability of the isolation room. So the patient has then to return home, having always in mind that in spite of the fast washout of the I-131 from his body, even the second week still contributes significantly to the total radiation burden to relatives and friends. Radiation hazards concerning relatives and friends can be kept to a truly negligible level (a small fraction of the annual dose limit of only 1mSv), only if it is provided that: a) reasonable standards of personal hygiene and cleanliness are followed, b) urine or saliva contaminations are avoided and c) patient's close contact with relatives or friends is kept to a minimum. These measures should be followed for a time period of 2-8 days after hospital discharge, a period that depends on administered and retained I-131 activity. This work tries to estimate the correlation between several clinical factors and the residual activity of I-131 in patient's body and proposes a method for a more simple measurement of the total body activity during patient's stay in the treatment centre - hospital

  1. Synthesis and Bioevaluation of Iodine-131 Directly Labeled Cyclic RGD-PEGylated Gold Nanorods for Tumor-Targeted Imaging

    Directory of Open Access Journals (Sweden)

    Yingying Zhang

    2017-01-01

    Full Text Available Introduction. Radiolabeled gold nanoparticles play an important role in biomedical application. The aim of this study was to prepare iodine-131 (131I-labeled gold nanorods (GNRs conjugated with cyclic RGD and evaluate its biological characteristics for targeted imaging of integrin αvβ3-expressing tumors. Methods. HS-PEG(5000-COOH molecules were applied to replace CTAB covering the surface of bare GNRs for better biocompatibility, and c(RGDfK peptides were conjugated onto the carboxyl terminal of GNR-PEG-COOH via EDC/NHS coupling reactions. The nanoconjugate was characterized, and 131I was directly tagged on the surface of GNRs via AuI bonds for SPECT/CT imaging. We preliminarily studied the characteristics of the probe and its feasibility for tumor-targeting SPECT/CT imaging. Results. The [131I]GNR-PEG-cRGD probe was prepared in a simple and rapid manner and was stable in both PBS and fetal bovine serum. It targeted selectively and could be taken up by tumor cells mainly via integrin αvβ3-receptor-mediated endocytosis. In vivo imaging, biodistribution, and autoradiography results showed evident tumor uptake in integrin αvβ3-expressing tumors. Conclusions. These promising results showed that this smart nanoprobe can be used for angiogenesis-targeted SPECT/CT imaging. Furthermore, the nanoprobe possesses a remarkable capacity for highly efficient photothermal conversion in the near-infrared region, suggesting its potential as a multifunctional theranostic agent.

  2. Evaluation of pancreatic lipase activity by simple urine analysis after oral administration of a new iodine-131-labeled triglyceride

    International Nuclear Information System (INIS)

    Kropp, J.; Knapp, F.F. Jr.; Weyenberg, A.; McPherson, D.W.; Ambrose, K.R.; Callahan, A.P.; Bergmann, K. von; Biersack, H.J.

    1994-01-01

    A new iodine-131-labeled triglyceride analogue called ''MIPAG'' [1,2-dipalmitoyl-3-[(15-p-iodophenyl) pentadecan-1-oyl]rac-glycerol] has been prepared in which 15-(p-iodophenyl)pentadecanoic acid (IPPA) is attached to position-3. MIPAG has been developed for the evaluation of pancreatic exocrine function by simple urine analysis and has been evaluated in rats and humans. After oral administration, IPPA is released from the triglyceride by the action of pancreatic lipases followed by intestinal absorption and the principal IPPA metabolite (p-iodobenzoic acid. IBA) is primarily excreted in the urine. Excretion in the urine and feces was evaluated in rats, as well as the biodistribution in various organs over 21 days. Twenty patients without pancreatic disease (normals) and four patients with pancreatic insufficiency were also investigated. Following oral administration of 30 μCi of MIPAG, urine was collected for two successive 24-h periods. Blood samples were drawn and thin-layer chromatographic (TLC) analysis was performed on the serum lipid extracts. Urine from normals contained 44.9%±7.7% and 61.8%±8.4% of the administered activity after 24 and 48 h, respectively. The patients with pancreatic insufficiency excreted 13.1%±5.6% and 18.9%±6.2%, respectively, which was significantly decreased (P<0.001) compared with normals. The TLC profiles showed an increasing proportion of IBA with time. Urine analysis after oral administration of MIPAG thus appears to be an attractive new technique for the evaluation of pancreatic lipase activity by a simple urine analysis. (orig.)

  3. Three-dimensional noninvasive monitoring iodine-131 uptake in the thyroid using a modified Cerenkov luminescence tomography approach.

    Science.gov (United States)

    Hu, Zhenhua; Ma, Xiaowei; Qu, Xiaochao; Yang, Weidong; Liang, Jimin; Wang, Jing; Tian, Jie

    2012-01-01

    Cerenkov luminescence tomography (CLT) provides the three-dimensional (3D) radiopharmaceutical biodistribution in small living animals, which is vital to biomedical imaging. However, existing single-spectral and multispectral methods are not very efficient and effective at reconstructing the distribution of the radionuclide tracer. In this paper, we present a semi-quantitative Cerenkov radiation spectral characteristic-based source reconstruction method named the hybrid spectral CLT, to efficiently reconstruct the radionuclide tracer with both encouraging reconstruction results and less acquisition and image reconstruction time. We constructed the implantation mouse model implanted with a 400 µCi Na(131)I radioactive source and the physiological mouse model received an intravenous tail injection of 400 µCi radiopharmaceutical Iodine-131 (I-131) to validate the performance of the hybrid spectral CLT and compared the reconstruction results, acquisition, and image reconstruction time with that of single-spectral and multispectral CLT. Furthermore, we performed 3D noninvasive monitoring of I-131 uptake in the thyroid and quantified I-131 uptake in vivo using hybrid spectral CLT. Results showed that the reconstruction based on the hybrid spectral CLT was more accurate in localization and quantification than using single-spectral CLT, and was more efficient in the in vivo experiment compared with multispectral CLT. Additionally, 3D visualization of longitudinal observations suggested that the reconstructed energy of I-131 uptake in the thyroid increased with acquisition time and there was a robust correlation between the reconstructed energy versus the gamma ray counts of I-131 (r(2) = 0.8240). The ex vivo biodistribution experiment further confirmed the I-131 uptake in the thyroid for hybrid spectral CLT. Results indicated that hybrid spectral CLT could be potentially used for thyroid imaging to evaluate its function and monitor its treatment for thyroid cancer.

  4. Iodine-131 dose dependent gene expression in thyroid cancers and corresponding normal tissues following the Chernobyl accident.

    Directory of Open Access Journals (Sweden)

    Michael Abend

    Full Text Available The strong and consistent relationship between irradiation at a young age and subsequent thyroid cancer provides an excellent model for studying radiation carcinogenesis in humans. We thus evaluated differential gene expression in thyroid tissue in relation to iodine-131 (I-131 doses received from the Chernobyl accident. Sixty three of 104 papillary thyroid cancers diagnosed between 1998 and 2008 in the Ukrainian-American cohort with individual I-131 thyroid dose estimates had paired RNA specimens from fresh frozen tumor (T and normal (N tissue provided by the Chernobyl Tissue Bank and satisfied quality control criteria. We first hybridized 32 randomly allocated RNA specimen pairs (T/N on 64 whole genome microarrays (Agilent, 4×44 K. Associations of differential gene expression (log(2(T/N with dose were assessed using Kruskall-Wallis and trend tests in linear mixed regression models. While none of the genes withstood correction for the false discovery rate, we selected 75 genes with a priori evidence or P kruskall/P trend <0.0005 for validation by qRT-PCR on the remaining 31 RNA specimen pairs (T/N. The qRT-PCR data were analyzed using linear mixed regression models that included radiation dose as a categorical or ordinal variable. Eleven of 75 qRT-PCR assayed genes (ACVR2A, AJAP1, CA12, CDK12, FAM38A, GALNT7, LMO3, MTA1, SLC19A1, SLC43A3, ZNF493 were confirmed to have a statistically significant differential dose-expression relationship. Our study is among the first to provide direct human data on long term differential gene expression in relation to individual I-131 doses and to identify a set of genes potentially important in radiation carcinogenesis.

  5. Test of irradiation of tellurium oxide for obtaining iodine-131 by dry distillation; Prueba de irradiacion de dioxido de telurio para obtener yodo-131 por destilacion seca

    Energy Technology Data Exchange (ETDEWEB)

    Alanis M, J. [ININ, Departamento de Materiales Radiactivos, 52045 Ocoyoacac, Estado de Mexico (Mexico)

    2003-07-15

    With the purpose of optimizing to the maximum independently the work of the reactor of those mathematical calculations of irradiation that are already optimized, now it corresponds to carry out irradiation tests in the different positions with their respective neutron fluxes that it counts the reactor for samples irradiation. Then, it is necessary to carry out the irradiation of the tellurium dioxide through cycles, with the purpose of observing the activity that it goes accumulating in each cycle and this way to obtain an activity of the Iodine-131 obtained when finishing the last cycle. (Author)

  6. Evaluation the sources of uncertainty associated to the measurement results of in vivo monitoring of iodine 131 in the thyroid

    International Nuclear Information System (INIS)

    Gontijo, Rodrigo Modesto Gadelha

    2011-01-01

    In vivo monitoring techniques consist of identification and quantification of radionuclides present in the whole body and specific organs and tissues. In Vivo monitoring requires the use of detedors which are sensitive to the radiation emitted by radionuclides present in the monitored individual. The results obtained in measurements may present small uncertainties which are within pre-set limits in monitoring programs for occupationally exposed individuais. However, any device used to determine physical quantities present uncertainties in the measured values. The total uncertainty of a measurement result is estimated from the propagation of the uncertainties associated to each parameter of the calculation. This study aims to evaluate the sources of uncertainty associated to the measurement results of in vivo monitoring of iodine 131 in the thyroid, in comparison to the suggested in the General Guide for Estimating Effective Doses from Monitoring Data (Project IDEAS/European Community). The reference values used were the ones for high-energy photons (>100 keV). The measurement uncertainties were divided into two categories: type A and type B. The component of type A represents the statistical fluctuation in the counting of the standard source. Regarding type B, the following variations were presented: detector positioning over the phantom; variation of background radiation; thickness of the overlay tissue over the monitored organ, distribution of the activity in the organ. Besides the parameters suggested by the IDEAS Guide, it has also been evaluated the fluctuation of the counting due to the phantom repositioning, which represents the reproducibility of the measurement geometry. Measurements were performed at the Whole Body Counter Unit of IRD using a scintillation detector Nal (Tl) 3 x3 and a neck-thyroid phantom developed at LABMIVIRD. Scattering factors were calculated and compared in different counting geometries. The results of this study show that the

  7. Proposal of a methodology for individualized iodine-131 therapy for Graves' disease in patients with hyperthyroidism

    Energy Technology Data Exchange (ETDEWEB)

    Araujo, Francisco de [Instituto de Radioprotecao e Dosimetria (IRD), Rio de Janeiro, RJ (Brazil)]. E-mail: faraujo@ird.gov.br; Melo, Rossana Corbo de [Universidade Federal do Rio de Janeiro (UFRJ), RJ (Brazil); Rebelo, Ana Maria de Oliveira [Universidade Federal, Rio de Janeiro, RJ (Brazil). Coordenacao dos Programas de Pos-graduacao de Engenharia (COPPE); Dantas, Bernardo Maranhao; Dantas, Ana Leticia A.; Lucena, Eder Augusto de [Universidade do Estado do Rio de Janeiro (UERJ), RJ (Brazil)

    2007-11-15

    Objective: Several methods are utilized for determining the radioiodine activity in the treatment of Graves' disease (hyperthyroidism). Some of this methods do not take into consideration the thyroid absorbed dose or the necessary parameters for this estimation. The association between absorbed dose and administered activity depends on effective half-life, iodine uptake and thyroid mass of each patient. The present study was aimed at developing a methodology for individualized {sup 131}I therapy for Graves' disease in patients with hyperthyroidism of the Graves' disease. Materials and methods: A neck-thyroid phantom developed at Instituto de Radioprotecao e Dosimetria, containing a standard solution of {sup 131}I, was utilized for calibrating the scintillation gamma camera and uptake probe installed in the Department of Nuclear Medicine of the Hospital Universitario Clementino Fraga Filho da Universidade Federal do Rio de Janeiro. Results: The view angle of the collimator/detector assembly presented values compatible with the thyroid gland size for distances of 25 cm (uptake probe) and 45.8 cm (scintillation gamma camera). Calibration factors were 39.3 {+-} 0.78 and 4.3 {+-} 0.17 cpm/kBq, respectively. The 14-30-hour interval in the retention curve allows the estimation of activity between two points for determining the effective iodine half-life in the thyroid. Conclusion: The utilization of equipment usually available in nuclear medicine clinics is feasible, so this is a simple, effective and low cost methodology. (author)

  8. Putting to point the production process of iodine-131 by dry distillation (Preoperational tests); Puesta a punto el proceso de produccion de yodo-131 por destilacion seca (Pruebas preoperacionales)

    Energy Technology Data Exchange (ETDEWEB)

    Alanis M, J. [ININ, Departamento de Materiales Radiactivos, 52045 Ocoyoacac, Estado de Mexico (Mexico)

    2002-12-15

    With the purpose of putting to point the process of production of {sup 131}I, one of the objectives of carrying out the realization of operational tests of the production process of iodine-131, it was of verifying the operation of each one of the following components: heating systems, vacuum system, mechanical system and peripheral equipment that are part of the production process of iodine-131, another of the objectives, was settling down the optimal parameters that were applied in each process during the obtaining of iodine-131, it is necessary to point out that this objective is very important, since the components of the equipment are new and its behavior during the process is different to the equipment where its were carried out the experimental studies. (Author)

  9. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours

    International Nuclear Information System (INIS)

    Wafelman, A.R.; Hoefnagel, C.A.; Maessen, H.J.M.; Maes, R.A.A.; Beijnen, J.H.

    1997-01-01

    Iodine-131 labelled meta-iodobenzylguanidine ([ 131 I[MIBG) is used for diagnostic scintigraphy and radionuclide therapy of neural crest-derived tumours. After administration of therapeutic doses of [ 131 I[MIBG (3.1-7.5 GBq) to 17 patients (n=32 courses), aged 2-73 years, 56%±10%, 73%±11%, 80%±10% and 83%±10% of the dose was cumulatively excreted as total radioactivity in urine at t=24 h, 48 h, 72 h and 96 h, respectively. Except for two adult patients, who showed excretion of 14%-18% of [ 131 I[meta-iodohippuric acid ([ 131 I[MIHA), the cumulatively excreted radioactivity consisted of >85% [ 131 I[MIBG, with 6% of the dose excreted as free [ 131 I[iodide, 4% as [ 131 I[MIHA and 2.5% as an unknown iodine-131 labelled metabolite. Cumulative renal excretion rates of total radioactivity and of [ 131 I[MIBG appeared to be higher in neuroblastoma and phaeochromocytoma patients than in carcinoid patients. Based on the excretion of small amounts of [ 131 I[meta-iodobenzoic acid in two patients, a possible metabolic pathway for [ 131 I[MIBG is suggested. The degree of metabolism was not related to the extent of liver uptake of radioactivity. (orig.). With 2 figs., 5 tabs

  10. 18F-FDG SPECT/CT in the diagnosis of differentiated thyroid carcinoma with elevated thyroglobulin and negative iodine-131 scans

    International Nuclear Information System (INIS)

    Ma, C.; Wu, Z.; Wang, H.; Wang, X.; Shao, M.; Zhao, L.; Jiawei, X.

    2015-01-01

    Aim of the present study was to investigate the usefulness of 18 F-FDG SPECT/CT in differentiated thyroid cancer (DTC) with elevated serum thyroglobulin (Tg) but negative iodine-131 scan. This retrospective review of patients with DTC recurrence who had 18 F-FDG SPECT/CT and 18 F-FDG PET/CT for elevated serum Tg but negative iodine-131 scan (March 2007-October 2012). After total thyroidectomy followed by radioiodine ablation, 86 consecutive patients with elevated Tg levels underwent 18 F-FDG SPECT/CT or 18 F-FDG PET/CT. Of these, 45 patients had 18 F-FDG SPECT/CT, the other 41 patients had 18 F-FDG PET/CT 3-4 weeks after thyroid hormone withdrawal. The results of 18 F-FDG PET/CT and SPECT/CT were correlated with patient follow-up information, which included the results from subsequent imaging modalities such as neck ultrasound, MRI and CT, Tg levels, and histologic examination of surgical specimens. The diagnostic accuracy of the two imaging modalities was evaluated. In 18 F-FDG SPECT/CT scans, 24 (24/45) patients had positive findings, 22 true positive in 24 patients, false positive in 2 patients, true-negative and false-negative in 6, 15 patients, respectively. The overall sensitivity, specificity, and accuracy of 18F-FDG SPECT/CT were 59.5%, 75% and 62.2%, respectively. Twenty six patients had positive findings on 18 F-FDG PET/CT scans, 23 true positive in 26 (26/41) patients, false positive in 3 patients, true-negative and false-negative in 9, 6 patients, respectively. The overall sensitivity, specificity, and accuracy of 18F-FDG PET/CT were 79.3%, 81.8% and 78.1%, respectively. Clinical management changed for 13 (29%) of 45 patients by 18 F-FDG SPECT/CT, 14 (34%) of 41 patients by 18F-FDG PET/CT including surgery, radiation therapy, or multi kinase inhibitor. Based on the retrospective analysis of 86 patients, 18F-FDG SPECT/CT has lower sensitivity in the diagnosis of DTC recurrence with elevated Tg and negative iodine-131scan to 18F-FDG PET/CT. The clinical

  11. Calibration curves for biological dosimetry; Curvas de calibracion para dosimetria biologica

    Energy Technology Data Exchange (ETDEWEB)

    Guerrero C, C.; Brena V, M. [ININ, A.P. 18-1027, 11801 Mexico D.F. (Mexico)]. E-mail cgc@nuclear.inin.mx

    2004-07-01

    The generated information by the investigations in different laboratories of the world, included the ININ, in which settles down that certain class of chromosomal leisure it increases in function of the dose and radiation type, has given by result the obtaining of calibrated curves that are applied in the well-known technique as biological dosimetry. In this work is presented a summary of the work made in the laboratory that includes the calibrated curves for gamma radiation of {sup 60} Cobalt and X rays of 250 k Vp, examples of presumed exposure to ionizing radiation, resolved by means of aberration analysis and the corresponding dose estimate through the equations of the respective curves and finally a comparison among the dose calculations in those people affected by the accident of Ciudad Juarez, carried out by the group of Oak Ridge, USA and those obtained in this laboratory. (Author)

  12. A cause of false positive of the whole body scanning with iodine 131: obstructive hydronephrosis; Une cause de faux-positif du balayage corps entier a l'iode 131: l'hydronephrose obstructive

    Energy Technology Data Exchange (ETDEWEB)

    Sellem, A.; Elbez, I.; Rejeb, O.; Elkadri, N.; Hammami, H. [Service de medecine nucleaire, hopital Militaire, Tunis, (Tunisia)

    2009-05-15

    The objective is to report the case of a differentiated carcinoma of the thyroid with a false positive aspect to the whole-body scanning with iodine 131 in relation with an accumulation of the tracer at the level of an obstructive appearance hydronephrosis. (N.C.)

  13. Chemical treatment of wastewaters produced during separation of iodine 131; Traitement chimique des eaux residuaires provenant de la preparation d'iode-131

    Energy Technology Data Exchange (ETDEWEB)

    Cohen, P.; Marcaillou, J.; Amavis, R.

    1959-06-22

    The authors report the development and assessment of a chemical treatment of radioactive wastewaters by co-precipitation. This treatment is aimed at replacing a treatment based on the use of calcium phosphate which proved to be insufficient for wastewaters resulting from the production of iodine 131. After a presentation of the characteristics of the effluents to be processed, the authors report co-precipitation tests performed on effluents before release in the storage vessel (by using barium hydroxide, lead acetate or lead sulfate) and on effluents diluted on the storage vessel. They show that a co-precipitation method based on the use of lead sulfate in alkaline medium gives the best results.

  14. Radioablative therapy with Iodine-131 on a patient with thyroid cancer and chronic renal failure in hemodialysis first experience in Peru

    International Nuclear Information System (INIS)

    Apaza Veliz, D. G.; Herrera Vera, R. D.; Cardenas Abarca, C. A.; Oporto Gonzales, C. A.; Aguilar Ramírez, C.; Urquizo Baldomero, R. M.; Vega Ramírez, J. L.

    2016-01-01

    The Iodine-131 (I-131) is a radioisotope used as a standard treatment for radioablation of thyroid remnants. Among thyroid cancer patients, the ones undergoing hemodialysis represent a specific group. The dose of I-131 is given orally to these patients, part of it is absorbed by the thyroid remnants and the rest of it, largely not incorporated, is excreted primarily by renal excretion. The use of a high dose of radioactivity in the process, and the inability of excretion, represents a high risk of exposure to the patient, medical staff and hemodialysis equipment. This work describes the procedure applied on the radioablation therapy for thyroid cancer while receiving hemodialysis, minimizing the risks for the patient and the staff involved. This clinical procedure will establish the dosimetric measures, a plan on radiation protection and a treatment protocol for this specific type of patients.

  15. Radioablative therapy with Iodine-131 on a patient with thyroid cancer and chronic renal failure in hemodialysis first experience in Peru

    Energy Technology Data Exchange (ETDEWEB)

    Apaza Veliz, D. G., E-mail: dgav02@gmail.com [Hospital Nacional Carlos Alberto Seguin Escobedo, Servicio de Medicina Nuclear, Arequipa, Perú, Universidad Nacional de San Agustín de Arequipa, Escuela de Física, Arequipa (Peru); Herrera Vera, R. D.; Cardenas Abarca, C. A.; Oporto Gonzales, C. A.; Aguilar Ramírez, C.; Urquizo Baldomero, R. M. [Hospital Nacional Carlos Alberto Seguin Escobedo, Servicio de Medicina Nuclear, Arequipa (Peru); Vega Ramírez, J. L. [Universidad Nacional de San Agustín de Arequipa, Escuela de Física, Arequipa (Peru)

    2016-07-07

    The Iodine-131 (I-131) is a radioisotope used as a standard treatment for radioablation of thyroid remnants. Among thyroid cancer patients, the ones undergoing hemodialysis represent a specific group. The dose of I-131 is given orally to these patients, part of it is absorbed by the thyroid remnants and the rest of it, largely not incorporated, is excreted primarily by renal excretion. The use of a high dose of radioactivity in the process, and the inability of excretion, represents a high risk of exposure to the patient, medical staff and hemodialysis equipment. This work describes the procedure applied on the radioablation therapy for thyroid cancer while receiving hemodialysis, minimizing the risks for the patient and the staff involved. This clinical procedure will establish the dosimetric measures, a plan on radiation protection and a treatment protocol for this specific type of patients.

  16. Experience in the patients management which received treatments with radioactive iodine (131I). Measurements and dosimetry pertaining to the personnel related

    International Nuclear Information System (INIS)

    Ruiz J, A.

    1999-01-01

    In the INNSZ there are administering ablative doses of radioactive iodine to patients with problems of the thyroid gland from 40 years ago. Starting from 1992 was initiated the restlessness to inform to the patients verbally and in writing over the measurements of radiological safety that must be followed for the protection of their families. In this work it is commented, the benefits obtained with the patients and the teachings to give to the personnel what attend the patients which receive treatments with iodine-131 and must be hospitalized. It is commented too over the standardization standing of the patients discharged whom received radioactive material and lastly, it was make a dosimetric study of the nurses, radiotherapeutic and control area. (Author)

  17. Radioablative therapy with Iodine-131 on a patient with thyroid cancer and chronic renal failure in hemodialysis first experience in Peru

    Science.gov (United States)

    Apaza Veliz, D. G.; Herrera Vera, R. D.; Cardenas Abarca, C. A.; Oporto Gonzales, C. A.; Aguilar Ramírez, C.; Vega Ramírez, J. L.; Urquizo Baldomero, R. M.

    2016-07-01

    The Iodine-131 (I-131) is a radioisotope used as a standard treatment for radioablation of thyroid remnants. Among thyroid cancer patients, the ones undergoing hemodialysis represent a specific group. The dose of I-131 is given orally to these patients, part of it is absorbed by the thyroid remnants and the rest of it, largely not incorporated, is excreted primarily by renal excretion. The use of a high dose of radioactivity in the process, and the inability of excretion, represents a high risk of exposure to the patient, medical staff and hemodialysis equipment. This work describes the procedure applied on the radioablation therapy for thyroid cancer while receiving hemodialysis, minimizing the risks for the patient and the staff involved. This clinical procedure will establish the dosimetric measures, a plan on radiation protection and a treatment protocol for this specific type of patients.

  18. Preliminary study of the distribution of dose in patients with Graves disease undergoing examination of uptake of iodine-131 using Monte Carlo simulation

    International Nuclear Information System (INIS)

    Schwarcke, Marcelo; Marques, Tatiana; Alva, Mirko; Baffa, Oswaldo; Nicolucci, Patricia

    2009-01-01

    Patients with Graves' disease have a high hormonal disorder, which causes the change of behavior in society. One way to treat this disease is the use of doses of Iodine-131, requiring that the patient carries out the examination of uptake of 131 I estimates for completion of the activity to be administered. Using these data capture and compared with the simulated data using the Monte Carlo code Penelope is possible to determine a distribution of dose to the region surrounding the thyroid. As noted the difference between the simulated values and the experimentally obtained were 10.36%, thus showing the code of simulation for accurate determination of absorbed dose in tissue near the thyroid. (author)

  19. Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131

    Directory of Open Access Journals (Sweden)

    Wu HX

    2016-05-01

    Full Text Available Hong-Xia Wu,1,* Hua Zhong,2,3,* Yue-Dong Xu,1 Cui-Ping Xu,4 Ying Zhang,5 Wei Zhang1 1Department of Endocrinology, Shandong Provincial Qianfoshan Hospital, Shandong University, 2Department of Oncology, Shandong University of Traditional Chinese Medicine, 3Department of Traditional Chinese Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, 4Department of Nursing, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, 5Department of Nursing, Tianjin Chest Hospital, Tianjing, People’s Republic of China *These authors contributed equally to this work Background: We examined the effects of psychological and behavioral intervention on health-related quality of life and mental health among patients suffering from differentiated thyroid cancer (DTC treated with postoperative radioactive iodine-131 (RAI.Methods: Sixty patients with DTC, undergoing RAI, were randomly assigned to receive either conventional nursing (n=30 or a 1-year psychological and behavioral intervention based on conventional nursing (n=30. Health-related quality of life and mental health issues, depression, and anxiety were measured using the Quality of Life Core Questionnaire, Self-rating Depression Scale, and Self-rating Anxiety Score, respectively.Results: After RAI treatment, patients in both groups showed improved functional capacities (ie, physical, role, cognitive, emotional, and social and global quality of life, along with reduced depression and anxiety (P<0.05. At 1-year follow-up, compared with patients in the routine nursing group, those in the psychological and behavioral intervention group demonstrated greater improvements in functional capacities, global quality of life, and depression and anxiety symptoms (P<0.05.Conclusion: Psychological and behavioral interventions for patients with DTC undergoing RAI facilitated positive outcomes, suggesting that nursing care models that include psychological and behavioral interventions

  20. Radioecology application to electronuclear site studies. Experimental data on uptake and desorption of iodine 131 and molybdenum 99 by Cyprinus carpio (L.)

    International Nuclear Information System (INIS)

    Bourdeau, F.; Baudin, J.P.; Foulquier, L.; Lambrechts, A.

    1980-01-01

    The contamination of the carps by the iodine 131 is characterized by a very swift build-up followed by a slight radioactive decay which tends to an equilibrium state; 16 days later, the concentration factor, in terms of the wet weight, is in the order of 6. 37,5% of the fixed radionuclide is concentrated in the muscles and the skeleton and 43% in the viscera. The decontamination study shows a biological half-life of about 33 days and an effective half-life of 6 days. Because of the difficult radioactivity measurements pertaining to the separation of the molybdenum 99, and of its by-product the technetium 99m, the study, then, relates to the mixing of the two elements. The build-up of the two radionuclides essentially takes place in the first hours after introducing the contaminating solution into the medium. 14 days later, the concentration factor, in terms of the wet weight, is about 0,20. The highest 99 Mo+sup(99m)Tc abundance is to be found in the viscera which hold up 50% of the whole radioactivity for fishes. The elimination of the mixing by the carps occurs very fast. The desorption process corresponds to two biological half-lives: Tb 1 approximately 8 hours and Tb 2 approximately 180 hours. The effective half-lives are: Te 1 approximately 8 hours and Te 2 approximately 50 hours. This preliminary data shows a low transfer rate of the iodine 131 and of the mixing molybdenum 99 + technetium 99m between water and fishes. This data must be completed as follows: by knowing the role of the food chain and the influence of the physico-chemical form of these radionuclides [fr

  1. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, nk cells, subsets CD4, CD8 in differentiated thyroid cancer patients treated with iodine-131

    International Nuclear Information System (INIS)

    Luo Quanyong; Yu Yongli; Chen Libo; Lu Hankui; Zhu Ruisen

    2004-01-01

    Objective: To evaluate the changes in the percentage of B (CD19) and T (CD3) lymphocytes, NK cells, subsets CD4, CD8 in patients with differentiated thyroid carcinoma (DTC) who received iodine-131 for therapeutic purposes. Methods: In this study, 102 DTC patients were divided into three groups. Group A, 8 cases received 1850 MBq of iodine-131 for the remnant thyroid ablation. Group B, 43 cases received 3700 MBq of iodine-131 for the treatment of cervical lymph node metastasis. Group C, 51 cases received 7400 MBq of iodine-131 for remote metastasis. All patients were in a hypothyroid state at the time of administration of iodine-131 and resumed L-thyroxine (2μg/Kg/day) 5 days after iodine-131 administration. The percentage of B and T lymphocytes, NK cells, subsets CD4, CD8 in peripheral blood were serially analyzed at baseline and at days 7, 30 and 90 after iodine-131 administration using a Coulter EPICS XL cytometer. Ten healthy individuals were used as a control group for lymphocyte subset values. Results: Comparing the basal lymphocyte subset levels in groups A, B and C with the control group, only NK cells showed significantly higher levels in patients than in controls (P=0.043). In group A, only the percentage of NK cells (P=0.031) and B cells (P =0.024) were reduced at day 7. In group B, a decrease in the percentage of NK cells at days 7(P=0.005), 30 (P=0.021) was observed, while a significant decrease in the percentage of B cells was only observed at day 7(P=0.006). Among T cells, only CD4+ was obviously affected, resulting in a reduction in the CD4+/CD8+ ratio at day 30 (P=0.034). In group C, patients showed a decrease in the percentage of NK cells at days 7 (P=0.023), 30 (P=0.006). A decrease in the percentage of both B and T lymphocytes was observed at days 7(P=0.020, 0.018 respectively), 30(P=0.041, 0.025 respectively). Among T cells, a decrease in the percentage of CD4+ and an increase in the percentage of CD8+ were observed, resulting in a marked

  2. The study of labeling with Iodine-131 of monoclonal antibody anti-CD20 used for the treatment of non-Hodgkin lymphoma

    International Nuclear Information System (INIS)

    Akanji, Akinkunmi Ganiyu

    2006-01-01

    Lymphomas are malignancies of the lymphatic system, described by Thomas Hodgkin in 1932. Traditionally, lymphomas are classified in two basic groups: Hodgkin disease and non-Hodgkin lymphoma (NHL). Patients with NHL were earlier treated with radiotherapy alone or in combination with immunotherapy using monoclonal antibody anti-CD20 (ex., Rituximab-Mabthera, Roche). However, Radioimmunotherapy is a new modality of treatment for patients with NHL, in which cytotoxic radiation from therapeutic radioisotopes is delivered to tumors through monoclonal antibodies. This study focused on labeling conditions of monoclonal antibody anti-CD20 (Rituximab-Mabthera, Roche) with iodine-131, by direct radioiodination method using Chloramine-T as oxidizing agent. Labeling parameters investigated were: Radiochemical purity (RP), method of purification, incubation time, antibody mass, oxidative agent mass, stability in vitro, stability in vivo, immunoreactivity and biological distribution performed in normal Swiss mouse. Product of high radiochemical purity was obtained with no notable difference between the methods applied. No clear evidence of direct influence of incubation time on radiochemical purity of the labeled antibody was observed. Whereas, a clear evidence of direct influence of activity on radiochemical purity of the labeled antibody was observed when antibody mass was varied. After purification, the labeled product presented radiochemical purity of approximately 100 %. Product of superior radiochemical yield was observed when standard condition of labeling was used. The labeled product presented variation in radiochemical purity using five different stabilizer conditions. The condition in which gentisic acid was combined with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with high therapeutic activity of iodine-131. The labeled product presented low immunoreactivity when compared to the literature. Biological distribution in

  3. The study of labeling with iodine-131 of monoclonal antibody anti-CD20 used for the treatment of non-Hodgkin lymphoma

    International Nuclear Information System (INIS)

    Akanji, Akinkunmi Ganiyu

    2006-01-01

    Lymphomas are malignancies of the lymphatic system, described by Thomas Hodgkin in 1932. Traditionally, lymphomas are classified in two basic groups: Hodgkin disease and non-Hodgkin lymphoma (NHL). Patients with NHL were earlier treated with radiotherapy alone or in combination with immunotherapy using monoclonal antibody anti-CD20 (ex., Rituximab-Mabthera, Roche). However, Radioimmunotherapy is a new modality of treatment for patients with NHL, in which cytotoxic radiation from therapeutic radioisotopes is delivered to tumors through monoclonal antibodies. This study focused on labeling conditions of monoclonal anti-CD20 (ex., Rituximab-Mabthera, Roche) with iodine-131, by direct radioiodination method using Chloramine-T as oxidizing agent. Labeling parameters investigated were: Radiochemical purity (RP), method of purification, incubation time, antibody mass, oxidative agent mass, stability in vitro, immunoreactivity and biological distribution performed in normal Swiss mouse. Product of high radiochemical purity was obtained with no notable difference between the methods applied. No clear evidence of direct influence of incubation time on radiochemical purity of the labeled antibody was observed. Whereas, a clear evidence of direct influence of activity on radiochemical purity of the labeled antibody was varied. After purification the labeled product presented radiochemical purity of approximately 100 %. Product of superior radiochemical yield was observed when standard condition of labeling was used. The labeled product presented variation in radiochemical purity using five different stabilizer conditions. The condition in which gentisic acid combined with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with freeze appears more suitable and capable of minimizing autoradiolysis of the antibody labeled with high therapeutic activity of iodine-131. The labeled product presented low immunoreactivity when compared to the

  4. An estimation of Iodine 131 intakes for occupational workers of nuclear medicine group at the Instituto Nacional de Cancerologia, Bogota, Colombia

    International Nuclear Information System (INIS)

    Nino, Nelcy Yasmin; Lagares, Luis Carlos; Veloza, Luz Stella; Martinez, Maria Cristina; Reyes, Amelia de los

    2008-01-01

    Full text: In nuclear medicine, unsealed radioactive substances are administered to patients for diagnosis, treatment or research. The manipulation of these radionuclides, particularly those volatile, like iodine 131 (I-131), generates a risk of internal contamination by ingestion and inhalation. The inhaled radioactive particles are retained in the lungs or uptake by the thyroid tissue and could produce health effects. The IAEA provides regulatory practices in handling radioactive material to reduce internal contamination in the staff, based on the radiation protection principle to achieve occupational doses as low as reasonably achievable (ALARA). A quality assurance program in radioprotection should include the monitoring of occupational intakes. This paper describes a pilot study which determined quantitative methods to monitoring the nuclear medicine staff. The estimates of intakes and doses of I-131 were derived from the review and interpretation of urine monitoring data, using a Ludlum model 203 Shielded Well Scintillator (2 inches diameter x 1.8 inches thick), with a ratemeter model 2200. This study included workers occupationally exposed to I-131: physicians, technicians, radio pharmacists and physicists. The initial tests of the activity levels of I-131 in urine showed an average MPBB (Maximum Permissible Body Burden) of 0.035%, i.e. 0.025 μCi. Comparing with the maximum value of whole body 0.7μCi, the percentages of I-131 MPBB indicate the presence of small activities of I-131 in the urine, suggesting low-level chronic exposures from occupational workers in Nuclear Medicine. The higher values are the medical personnel who perform treatments for thyroid disorders. Conclusion: To do statistically significant the sampling and to protect individuals in each area it should be considered the daily urinary excretion, which is due to implement a protocol for regular assessment of the levels of incorporation of iodine 131 for jobs and activities, personnel in

  5. Quantitative mRNA expression analysis of selected genes in patients with early-stage hypothyroidism induced by treatment with iodine-131.

    Science.gov (United States)

    Guo, Kun; Gao, Rui; Yu, Yan; Zhang, Weixiao; Yang, Yuxuan; Yang, Aimin

    2015-11-01

    The present study aimed to investigate the molecular markers indicative of early-stage hypothyroidism induced by treatment with iodine-131, in order to assist in further investigations of radio iodine‑induced hypothyroidism. A total of 59 patients diagnosed with hyperthyroidism (male/female, 16/43; median age, 46.4 years) and 27 healthy subjects (male/female, 7/21; median age, 44.6 years) were included in the present study. All patients were treated with appropriate doses of iodine‑131 and, three months following treatment, the patients were subdivided into two groups: A group with early‑stage hypothyroidism symptoms, and a group with non‑early‑stage hypothyroidism, including euthyroid patients and patients remaining with hyperthyroidism. Tissue samples from the patients and healthy subjects were collected by fine needle biopsies, and the mRNA expression levels of B-cell lymphoma 2 (Bcl‑2), nuclear factor (NF)‑κB, Ku70, epidermal growth factor receptor (EGFR), early growth response 1 (Egr‑1), TP53 and ataxia telangiectasia mutated were analyzed using reverse transcription‑quantitative polymerase chain reaction prior to iodine‑131 treatment. The association of the variation of target genes with susceptibility to early‑stage hypothyroidism was analyzed. Compared with normal subjects, the mRNA expression levels of Ku70 (0.768, vs. 3.304, respectively; Ptreatment with iodine‑131, 30 of the 59 (50.8%) patients with hyperthyroidism were diagnosed with early‑stage hypothyroidism, and in the early‑stage hypothyroidism group, the mRNA expression levels of Bcl‑2 were significantly decreased (Phypothyroidism group. The association between the changes in the expression levles of Bcl‑2 and Egr‑1 and susceptibility to early‑stage hypothyroidism was supported by multivariate regression analysis. No significant changes in the expression levels of the other target genes were detected. The opposing changes in the mRNA expression levels of Bcl‑2

  6. Prognostication of the radioactive contamination with iodine 131, strontium 90 and cesium 137 of the air and soil after commissioning the ''Kozloduj'' nuclear power plant

    Energy Technology Data Exchange (ETDEWEB)

    Khristova, M; Paskalev, Z [Nauchno-Izsledovatelski Inst. po Radiologiya i Radiatsionna Khigiena, Sofia (Bulgaria)

    1975-01-01

    The content of iodine 131, strontium 90 and cesium 137 in the air (curie/l) and soil (curie/m/sup 2/ sec) in the area of the Kozloduj atomic power station (at a distance from 3 to 75 km from the chimney-stack of the power station) was determined. The concentrations of these radionuclides are determined under different meteorologic conditions: air temperature from -20/sup 0/C to +20/sup 0/C and a wind speed from 2 m/sec to 30 m/sec. The data show that at -20/sup 0/C radionuclide concentrations in the air decrease with increasing distance from the chimney-stack, regardless of the speed of the wind. At +20/sup 0/C radionuclide concentrations in the air increase with the distance from the chimney-stack, peak at a definite distance and then decrease. At 2 m/sec and speed this maximum is at a distance of 50 km from station. As the speed of the air increases, the peak moves nearer and remains about 30 km from the power station. Results on ground surface concentrations show that a trend is observed toward persistent decrease with distance from the power station. In rainy weather they are almost four times higher than in dry weather. The radionuclide concentrations on the ground surface will be comparable to their global deposits.

  7. Real-life radiation burden to relatives of patients treated with iodine-131: a study in eight centres in Flanders (Belgium)

    International Nuclear Information System (INIS)

    Monsieurs, M.; Thierens, H.; Dierckx, R.A.; Casier, K.; Simons, M.; Baere, E. de; Ridder, L. de; Saedeleer, C. de; Winter, H. de; Lippens, M.; Imschoot, S. van; Wulfrank, D.

    1998-01-01

    In view of the EURATOM 96/29 regulations, a prospective multicentre study was performed to evaluate the present guidelines given to relatives of patients treated with iodine-131 for both thyroid carcinoma and thyrotoxicosis, based on the real-life radiation burden. This study comprised 166 measurements carried out on a group of 94 relatives of 65 patients. All relatives wore a thermoluminescent dosemeter (TLD) on the wrist for 7 days. Sixty-one relatives agreed to wear another TLD for an additional 7 days. TLD were placed on nine patients' bedside tables. The eight participating centres were arbitrarily divided into three groups according to the period of time they advised their patients to sleep separately. Groups I, II and III respectively advised their patients to sleep separately for 0, 7-10 and 14-21 days. The median dose received by in-living relatives of thyroid carcinoma patients during the 14 days following hospital discharge was 281 μSv (doses to infinity not calculated); the median dose to infinity received by in-living relatives of ambulatory treated thyrotoxicosis patients was 596 μSv, as compared with 802 μSv for in-living relatives of hospitalised thyrotoxicosis patients. In general the children of patients received a significantly (P 131 I, while still following the ALARA principle. (orig.)

  8. Radioimmunotherapy targeting the extra domain B of fibronectin in C6 rat gliomas: a preliminary study about the therapeutic efficacy of iodine-131-labeled SIP(L19)

    International Nuclear Information System (INIS)

    Spaeth, Nicolas; Wyss, Matthias T.; Pahnke, Jens; Biollaz, Gregoire; Trachsel, Eveline; Drandarov, Konstantin; Treyer, Valerie; Weber, Bruno; Neri, Dario; Buck, Alfred

    2006-01-01

    Despite aggressive treatment protocols, patients suffering from glioblastoma multiforme still experience poor outcome. Therefore, new adjuvant therapeutic options such as radioimmunotherapy (RIT) have been studied and have resulted in significant survival benefit. In this study, we assessed the efficacy of a novel radioimmunotherapeutic approach targeting the extra domain B (EDB) of fibronectin, a marker of angiogenesis, in glioma-bearing rats. Methods: C6 gliomas were induced intracerebrally in Wistar rats. Ten to 11 days later, 220-360 MBq of iodine-131-labeled anti-EDB SIP(L19) ('small immunoprotein') was administered intravenously into nine animals, yielding a radiation dose of 13-21 Gy. Another nine rats served as controls. Then the following parameters were compared: median survival time, tumor size and histology. Results: Histological examination of the tumors revealed typical glioblastoma characteristics. Eleven of 18 rats developed a tumor size bigger than 150 mm 3 . When these animals were used for survival analysis, median survival did significantly differ between groups [22 days (therapy; n=7) vs. 16 days (control; n=4); P 131 I-SIP(L19)-RIT showed promising potential in treating C6 gliomas, warranting further studies. However, larger trials with preferentially higher doses are needed to confirm this finding and, potentially, to further increase the efficacy of this treatment

  9. Iodine metabolism and thyroid functions in various species of domestic animals and poultry birds. II - Distribution of iodine-131 in developing ova in poultry birds

    International Nuclear Information System (INIS)

    Parshad, Omkar; Setia, M.S.; Rattan, P.J.S.; Sodhi, S.P.S.; Varman, P.N.

    1974-01-01

    To study the distribution of iodine in different stages of developing ova in relation to iodine metabolism, twentyfour healthy laying birds were randomly distributed into four groups of 6 birds each. Each bird was injected with 25.26 μCi. of carrier-free iodine-131. Afterwards, birds of group I, II, III and IV were sacrificed at 24, 48, 72 and 96 hours respectively. The results have revealed that : (i) the state of development of ovum may be an important factor in controlling the distribution of iodine in ova; (ii) the iodine may be found distributed in both the lipid as well as non-lipid fractions of the ova; (iii) most of the iodine in the ova may be present in the form of inorganic iodine whereas very minor amount of the iodine may be as butanol-extractable iodine and (iv) the changes in iodine content in different stages of development of ova observed during the present study may be considered to have a direct effect on the overall metabolism of iodine in the poultry birds. (author)

  10. Necrosis targeted radiotherapy with iodine-131-labeled hypericin to improve anticancer efficacy of vascular disrupting treatment in rabbit VX2 tumor models.

    Science.gov (United States)

    Shao, Haibo; Zhang, Jian; Sun, Ziping; Chen, Feng; Dai, Xu; Li, Yaming; Ni, Yicheng; Xu, Ke

    2015-06-10

    A viable rim of tumor cells surrounding central necrosis always exists and leads to tumor recurrence after vascular disrupting treatment (VDT). A novel necrosis targeted radiotherapy (NTRT) using iodine-131-labeled hypericin (131I-Hyp) was specifically designed to treat viable tumor rim and improve tumor control after VDT in rabbit models of multifocal VX2 tumors. NTRT was administered 24 hours after VDT. Tumor growth was significantly slowed down by NTRT with a smaller tumor volume and a prolonged tumor doubling time (14.4 vs. 5.7 days), as followed by in vivo magnetic resonance imaging over 12 days. The viable tumor rims were well inhibited in NTRT group compared with single VDT control group, as showed on tumor cross sections at day 12 (1 vs. 3.7 in area). High targetability of 131I-Hyp to tumor necrosis was demonstrated by in vivo SPECT as high uptake in tumor regions lasting over 9 days with 4.26 to 98 times higher radioactivity for necrosis versus the viable tumor and other organs by gamma counting, and with ratios of 7.7-11.7 and 10.5-13.7 for necrosis over peri-tumor tissue by autoradiography and fluorescence microscopy, respectively. In conclusion, NTRT improved the anticancer efficacy of VDT in rabbits with VX2 tumors.

  11. Evaluation of cardiac adrenergic neuronal damage in rats with doxorubicin-induced cardiomyopathy using iodine-131 MIBG autoradiography and PGP 9.5 immunohistochemistry

    International Nuclear Information System (INIS)

    Jeon, T.J.; Lee, J.D.; Ha, J.-W.; Yang, W.I.; Cho, S.H.

    2000-01-01

    Doxorubicin is one of the most useful anticancer agents, but its repeated administration can induce irreversible cardiomyopathy as a major complication. The purpose of this study was to investigate doxorubicin toxicity on cardiac sympathetic neurons using iodine-131-metaiodobenzylguanidine (MIBG) and protein gene product (PGP) 9.5 immunohistochemistry, which is a marker of cardiac innervation. Wistar rats were treated with doxorubicin (2 mg/kg, i.v.) once a week for 4 (n=5), 6 (n=6) or 8 (n=7) weeks consecutively. Left ventricular ejection fraction (LVEF), calculated by M-mode echocardiography, was used as an indicator of cardiac function. Plasma noradrenaline (NA) concentration was measured by high-performance liquid chromatography (HPLC). 131 I-MIBG uptake of the left ventricular wall (24 ROIs) was measured by autoradiography. 131 I-MIBG uptake pattern was compared with histopathological results, the neuronal population on PGP 9.5 immunohistochemistry and the degree of myocyte damage assessed using a visual scoring system on haematoxylin and eosin and Masson's trichrome staining. LVEF was significantly decreased in the 8-week group (P 131 I-MIBG uptake ratio of subepicardium to subendocardium were significantly increased (P<0.05) in the 8-week group as compared with the control group. It may be concluded that radioiodinated MIBG is a reliable marker for the detection of cardiac adrenergic neuronal damage in doxorubicin-induced cardiomyopathy; it detects such damage earlier than do other clinical parameters and in this study showed a good correlation with the reduction in the neuronal population on PGP 9.5 stain. The subendocardial layer appeared to be more vulnerable to doxorubicin than the subepicardium. (orig.)

  12. Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue

    International Nuclear Information System (INIS)

    Liu, S Y.; Eary, Janet F.; Petersdorf, S H.; Martin, P J.; Maloney, D G.; Applebaum, F. R.; Matthews, D. C.; Bush, S A.; Durack, L. D.; Fisher, Darrell R.; Gooley, T A.; Bernstein, I. D.; Press, O. W.

    1997-01-01

    Radioimmunotherapy (RIT) is a promising treatment approach for B-cell lymphomas. This is our first opportunity to report long-term follow-up data and late toxicities in 29 patients treated with myeloablative doses of iodine-131-anti-CD20 antibody (anti-B1) and autologous stem-cell rescue. PATIENTS AND METHODS: Trace-labeled biodistribution studies first determined the ability to deliver higher absorbed radiation doses to tumor sites than to lung, liver, or kidney at varying amounts of anti-B1 protein (0.35, 1.7, or 7 mg/kg). Twenty- nine patients received therapeutic infusions of single-agent (131)I- anti-B1, given at the protein dose found optimal in the biodistribution study, labeled with amounts of (131)I (280 to 785 mCi[10.4 to 29.0 GBq]) calculated to deliver specific absorbed radiation doses to the normal organs, followed by autologous stem-cell support. RESULTS: Major responses occurred in 25 patients (86%), with 23 complete responses (CRs; 79%). The nonhematopoietic do se-limiting toxicity was reversible cardiopulmonary insufficiency, which occurred in two patients at RIT doses that delivered > or = 27 Gy to the lungs. With a median follow-up time of 42 months, the estimated overall and progression-free survival rates are 68% and 42%, respectively. Currently, 14 of 29 patients remain in unmaintained remissions that range from 27+ to 87+ months after RIT. Late toxicities have been uncommon except for elevated thyroid-stimulating hormone (TSH) levels found in approximately 60% of the subjects. Two patients developed second malignancies, but none have developed myelodysplasia (MDS). CONCLUSION: Myeloablative (131)I-anti- B1 RIT is relatively well tolerated when given with autologous stem- cell support and often results in prolonged remission durations with few late toxicities

  13. [Proposals for the revision of radiation protection measures for doses up to 222 MBq iodine-131 for whole body scintiscan for the detection of metastatic lesions].

    Science.gov (United States)

    Karaveli, Maria; Hatzigiannaki, Anastasia; Dedousi, Eleni

    2006-01-01

    The goal of this study was to estimate the necessary period of time, required for radiation protection instructions to be followed by patients with differentiated thyroid carcinoma (DTC) after total thyroidectomy who are given iodine-131 ((131)I) for a whole body scintiscan (WBS) in relation to the instructions of the European Commission and the ICRP. In order to estimate and evaluate the dose received by the family members and the general public, we have studied 30 patients and were given a dose of 92-222 MBq of (131)I for a diagnostic WBS. The patients studied were four men with mean age+/-standard deviation (M+/-SD)=55+/-6 y and 26 women with: M+/-SD=47+/-14 y. Dose rate measurements were carried out at the Nuclear Medicine Department of the AHEPA University Hospital; 1 h after the patients had received the (131)I dose and 48 h later when they returned to the hospital for the WBS. The calculated doses received by the in-living relatives of the patients and by the general public, assuming that radiation protection measures were applied for 2d, ranged between 76-640 microSv and 22-171 microSv respectively. In conclusion, the results of this study, compared to the dose constraints suggested by the European Commission, indicate that the duration of radiation protection guidelines for patients receiving (131)I for diagnostic purposes could be reduced to only two days without any potential risk to family members or to members of the public. The case of children of the immediate family environment, aged less than 3 y, was not investigated in this study.

  14. Role of single photon emission computed tomography/computed tomography in diagnostic iodine-131 scintigraphy before initial radioiodine ablation in differentiated thyroid cancer

    International Nuclear Information System (INIS)

    Agrawal, Kanhaiyalal; Bhattacharya, Anish; Mittal, Bhagwant Rai

    2005-01-01

    The study was performed to evaluate the incremental value of single photon emission computed tomography/computed tomography (SPECT/CT) over planar radioiodine imaging before radioiodine ablation in the staging, management and stratification of risk of recurrence (ROR) in differentiated thyroid cancer (DTC) patients. Totally, 83 patients (21 male, 62 female) aged 17–75 (mean 39.9) years with DTC were included consecutively in this prospective study. They underwent postthyroidectomy planar and SPECT/CT scans after oral administration of 37–114 MBq iodine-131 (I-131). The scans were interpreted as positive, negative or suspicious for tracer uptake in the thyroid bed, cervical lymph nodes and sites outside the neck. In each case, the findings on planar images were recorded first, without knowledge of SPECT/CT findings. Operative and pathological findings were used for postsurgical tumor–node–metastasis staging. The tumor staging was reassessed after each of these two scans. Single photon emission computed tomography/computed tomography localized radioiodine uptake in the thyroid bed in 9/83 (10.8%) patients, neck nodes in 24/83 (28.9%) patients and distant metastases in 8/83 (9.6%) patients in addition to the planar study. Staging was changed in 8/83 (9.6%), ROR in 11/83 (13.2%) and management in 26/83 (31.3%) patients by the pretherapy SPECT/CT in comparison to planar imaging. SPECT/CT had incremental value in 32/83 patients (38.5%) over the planar scan. Single photon emission computed tomography/computed tomography is feasible during a diagnostic I-131 scan with a low amount of radiotracer. It improved the interpretation of pretherapy I-131 scintigraphy and changed the staging and subsequent patient management

  15. Comparison of computational models for estimation of whole body and organ radiation dose in rainbow trout from uptake of iodine-131 - Comparison of rainbow trout phantoms for estimation of whole body and organ radiation dose rates from uptake of iodine-131 in freshwater systems

    Energy Technology Data Exchange (ETDEWEB)

    Martinez, Nicole E. [Department of Environmental and Engineering Sciences, Clemson University, Clemson, South Carolina, 29634 (United States); Johnson, Thomas E.; Ruedig, Elizabeth; Pinder, John E. III [Department of Environmental and Radiological Health Sciences, Colorado State University, 1681 Campus Delivery, Fort Collins, Colorado, 80523 (United States)

    2014-07-01

    Internal radiation dose rates to biota are typically calculated utilizing dose conversion factors (DCF), which are values for absorbed dose rate per activity concentration (i.e. mGy d{sup -1} per Bq g{sup -1}). The current methodology employed by both the ICRP and within the ERICA Integrated Approach for calculating dose conversion coefficients is to use Monte Carlo modeling of a homogeneously distributed radionuclide within an ellipsoidal phantom chosen to represent a particular organism. It has been shown that for whole-body DCF, homogenous distribution is a reasonable assumption for electrons, and is associated with an uncertainty of less than 30% for photons. However, if a radionuclide has a specific tissue tropism (e.g. iodine-131 in thyroid) a much higher dose will be received by the organ or tissue than by the whole body. Internal organs are modeled generically as spheres within the ellipsoid phantom, due to the complex and variable nature of organ structure and arrangement within different types of organisms. Ratios of whole-body to organ mass offer conservative conversions of whole-body to organ specific DCF (Gomez-Ros et al 2008), but may considerably overestimate the organ dose; more accurate estimates can be made based on specific absorbed fractions and activity concentrations. Establishment of appropriate screening levels in the regulatory paradigm requires incorporation of sufficient knowledge of dose effects; the ICRP currently lists no derived consideration reference levels for organs, meaning that specific risks associated with organ dose rates are unavailable (ICRP 108). Model comparison and refinement is important in the process of determining both dose rates and dose effects, and here we develop and compare three models for rainbow trout (Oncorhynchus mykiss): the simple geometry described above, a more specific geometry employing anatomically relevant organ size and location, and voxel reconstruction of internal anatomy obtained from CT imaging

  16. Experimental results concerning the metabolism of ingested iodine-131 in adult sheep under lactation; Resultats experimentaux relatifs au metabolisme de l'iode 131 ingere chez la brebis adulte en lactation

    Energy Technology Data Exchange (ETDEWEB)

    Daburon, F.; Capelle, A.; Tricaud, Y.; Nizza, P. [Commissariat a l' Energie Atomique, 92 - Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires. Departement de la Protection Sanitaire, Laboratoire-etable de Radiobiologie Appliquee

    1967-07-01

    The authors give the results of a series of experiments on metabolism of ingested iodine-131 in adult sheep under lactation; the measurement were carried out over a number of years from 1961 to 1966. The work was concerned initially with the fixation of iodine 131 in the thyroid gland, with the calculation of radiation doses absorbed and with ways of showing up any possible radiation damage in the gland. The modes of absorption of iodine 131 and its elimination through milk, urine and the faeces were then considered. Finally, a last chapter is devoted to changes in the radioactivity of the blood and of the milk, to variations of the PBI level of the blood serum as to different methods for measuring this level. (authors) [French] Les auteurs rapportent les resultats d'une serie d'experimentations relatives au metabolisme de l'iode 131 ingere chez la brebis adulte en lactation, et qui se sont etalees sur plusieurs annees, de 1961 a 1966. Les etudes ont porte d'abord sur les aspects de la fixation de l'iode 131 dans la thyroide, avec le calcul des doses de rayonnements absorbees et les moyens de mettre en evidence les radiolesions eventuelles de la glande. Ensuite ont ete traitees les modalites de l'absorption de l'iode 131 et de son elimination par le lait, les urines et les feces. Enfin un dernier chapitre a ete consacre a l'evolution de la radioactivite du sang et du lait, aux variations ainsi qu'aux divers moyens d'evaluation du taux de PBI du serum sanguin. (auteurs)

  17. Experimental results concerning the metabolism of ingested iodine-131 in adult sheep under lactation; Resultats experimentaux relatifs au metabolisme de l'iode 131 ingere chez la brebis adulte en lactation

    Energy Technology Data Exchange (ETDEWEB)

    Daburon, F; Capelle, A; Tricaud, Y; Nizza, P [Commissariat a l' Energie Atomique, 92 - Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires. Departement de la Protection Sanitaire, Laboratoire-etable de Radiobiologie Appliquee

    1967-07-01

    The authors give the results of a series of experiments on metabolism of ingested iodine-131 in adult sheep under lactation; the measurement were carried out over a number of years from 1961 to 1966. The work was concerned initially with the fixation of iodine 131 in the thyroid gland, with the calculation of radiation doses absorbed and with ways of showing up any possible radiation damage in the gland. The modes of absorption of iodine 131 and its elimination through milk, urine and the faeces were then considered. Finally, a last chapter is devoted to changes in the radioactivity of the blood and of the milk, to variations of the PBI level of the blood serum as to different methods for measuring this level. (authors) [French] Les auteurs rapportent les resultats d'une serie d'experimentations relatives au metabolisme de l'iode 131 ingere chez la brebis adulte en lactation, et qui se sont etalees sur plusieurs annees, de 1961 a 1966. Les etudes ont porte d'abord sur les aspects de la fixation de l'iode 131 dans la thyroide, avec le calcul des doses de rayonnements absorbees et les moyens de mettre en evidence les radiolesions eventuelles de la glande. Ensuite ont ete traitees les modalites de l'absorption de l'iode 131 et de son elimination par le lait, les urines et les feces. Enfin un dernier chapitre a ete consacre a l'evolution de la radioactivite du sang et du lait, aux variations ainsi qu'aux divers moyens d'evaluation du taux de PBI du serum sanguin. (auteurs)

  18. National intercomparison on in vivo measurement of Iodine-131 in the thyroid within a Brazilian Internal Dosimetry Laboratory Network - IAEA PROJECT BRA9055; Intercomparacao nacional de medicao in vivo de Iodo-131 na tireoide - Projeto TC IAEA BRA 9055

    Energy Technology Data Exchange (ETDEWEB)

    Dantas, B.M.; Dantas, A.L.A.; Lucena, E.A., E-mail: bmdantas@ird.gov.br [Instituto de Radioprotecao e Dosimetria (IRD/CNEN-RJ), Rio de Janeiro (Brazil); Cardoso, J.S. [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil); Ramos, M.A.P.; Sa, M.S. [Eletrobras Eletronuclear, Angra dos Reis, RJ (Brazil); Alonso, T.C.; Silva, T.V.; Oliveira, C.M. [Centro de Desenvolvimento da Tecnologia Nuclear (CDTN/CNEN-MG), Belo Horizonte, MG (Brazil); Lima, F.F.; Oliveira, M.L.; Lacerda, I.V.B. [Centro Regional de Ciencias Nucleares (CRCN-NE/CNEN-PE), Recife, PE (Brazil); Fajgelj, A. [International Atomic Energy Agency (IAEA), Vienna (Austria)

    2013-08-15

    In 2011, in Brazil, a National Intercalibration and Intercomparison exercise on in vivo measurement of iodine-131 in the thyroid was carried out in the scope of the Project IAEABRA9055 'Establishing a National Laboratory Network for Internal Individual Monitoring'. The exercise was conducted by the Institute for Radiation Protection and Dosimetry (IRD) and the Institute for Nuclear and Energetic Research (IPEN), from National Nuclear Energy Commission (CNEN). The objectives of the exercise were to (i) update information on current instrumentation resources available in the in vivo monitoring laboratories in operation in Brazil and to (ii) verify the reliability of the results of measurements of iodine-131 in thyroid provided by those laboratories. The procedure consisted on the measurement of a neck-thyroid anthropomorphic phantom provided by the In Vivo Monitoring Laboratory of IRD, containing two barium-133 standard sources certified by the National Laboratory for Metrology of Ionizing Radiation. Each participant should measure the phantom in a period of five days. The five laboratories are located in the States of Rio de Janeiro, Sao Paulo, Minas Gerais and Pernambuco, in the following Institutions: Institute for Radiation Protection and Dosimetry, Nuclear Power Station Almirante Alvaro Alberto, Center for the Development of Nuclear Technology, Institute for Nuclear and Energetic Research, and Regional Center for Nuclear Sciences. The results reported included: activity measured, minimum detectable activity, accuracy and precision. The performance of the laboratories was evaluated according to the criteria suggested by ANSI 13.30 indicating their capacity to provide reliable results of iodine-131 content in the thyroid. (author)

  19. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma

    International Nuclear Information System (INIS)

    Lin Jen-Der; Weng Hsiao-Fen; Lu Wen-Tsoung; Kao Pan-Fu; Huang Miau-Ju

    1998-01-01

    Radioactive iodine ( 131 I) has been found to be more sensitive and more specific than thallium-201 for the detection of distant metastases and thyroid remnants in the neck in cases of well-differentiated thyroid carcinoma. 201 Tl has been deemed particularly useful in localizing metastases or recurrence in patients with a negative 131 I scan and abnormal levels of serum thyroglobulin (Tg). This study aimed to: (1) determine the value of 201 Tl imaging in localizing metastases or recurrence in patients with well-differentiated thyroid carcinoma, and (2) evaluate the false-positive and false-negative results of 131 I and 201 Tl scintigraphy. Sixty-two thyroid remnant ablated patients who underwent simultaneous postoperative 201 Tl and 131 I scans and and serum Tg determinations were evaluated. Fifty patients had papillary thyroid carcinomas and 12 had follicular thyroid carcinomas. 201 Tl imaging was performed before the 131 I studies. Of the 62 patients who underwent 201 Tl imaging studies, 24 were found to have positive results, with local recurrence or distant metastases. Patients with positive results in the 201 Tl imaging studies tended to be older, were mor often male, had higher Tg levels and had a higher recurrence rate. Of these 24 patients, ten had negative diagnostic or therapeutic 131 I scans. Concurrently, serum Tg levels were less than 5 ng/ml in five of these ten patients. Three patients were deemed false positive by 201 Tl scans; one had a parotid tumour, one a periodontal abscess and one lung metastasis. Among the 38 patients with negative 201 Tl scans, 11 had positive findings on 131 I scans. Three had distant metastases: two with lung metastases and one with bone metastases. Patients with false-positive results on 131 I scans included those with biliary tract stones, ovarian cysts, and breast secretion. Of the 27 patients with negative 201 Tl and 131 I scans, 15 had elevated serum Tg levels. Among these, local recurrence followed by lung

  20. Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine.

    Science.gov (United States)

    Willegaignon, José; Pelissoni, Rogério A; Lima, Beatriz C G D; Sapienza, Marcelo T; Coura-Filho, George B; Buchpiguel, Carlos A

    2016-05-01

    This study aimed to present a comparison of iodine-131 (I) biokinetics and radiation doses to red-marrow (rm) and whole-body (wb), following the administration of tracer and therapeutic activities, as a means of confirming whether I clearance and radiation doses for therapy procedures can be predicted by tracer activities. Eleven differentiated thyroid cancer patients were followed after receiving tracer and therapeutic I activity. Whole-body I clearance was estimated using radiation detectors and OLINDA/EXM software was used to calculate radiation doses to rm and wb. Tracer I activity of 86 (±14) MBq and therapeutic activity of 8.04 (±1.18) GBq were administered to patients, thereby producing an average wb I effective half-time and residence time of, respectively, 13.51 (±4.05) and 23.13 (±5.98) h for tracer activities and 13.32 (±3.38) and 19.63 (±4.77) h for therapy. Radiation doses to rm and wb were, respectively, 0.0467 (±0.0208) and 0.0589 (±0.0207) mGy/MBq in tracer studies and 0.0396 (±0.0169) and 0.0500 (±0.0163) mGy/MBq in therapy. Although the differences were not considered statistically significant between averages, those between the values of effective half-times (P=0.906), residence times (P=0.145), and radiation doses to rm (P=0.393) and to wb (P=0.272), from tracer and therapy procedures, large differences of up to 80% in wb I clearance, and up to 50% in radiation doses were observed when patients were analyzed individually, thus impacting on the total amount of I activity calculated to be safe for application in individual therapy. I biokinetics and radiation doses to rm and wb in therapy procedures are well predicted by diagnostic activities when average values of a group of patients are compared. Nonetheless, when patients are analyzed individually, significant differences may be encountered, thus implying that nuclear medicine therapy-planning requires due consideration of changes in individual patient-body status from

  1. Iodine-131 imaging using 284 keV photons with a small animal CZT-SPECT system dedicated to low-medium-energy photon detection.

    Science.gov (United States)

    Kojima, Akihiro; Gotoh, Kumiko; Shimamoto, Masako; Hasegawa, Koki; Okada, Seiji

    2016-02-01

    Iodine-131 is widely used for radionuclide therapy because of its β-particle and for diagnostic imaging employing its principal gamma ray. Since that principal gamma ray has the relatively high energy of 364 keV, small animal single-photon emission computed tomography (SPECT) imaging systems may be required to possess the ability to image such higher energy photons. The aim of this study was to investigate the possibility of imaging I-131 using its 284 keV photons instead of its 364 keV photons in a small animal SPECT imaging system dedicated to the detection of low-medium-energy photons (below 300 keV). The imaging system used was a commercially available preclinical SPECT instrument with CZT detectors that was equipped with multi-pinhole collimators and was accompanied by a CT imager. An energy window for I-131 imaging was set to a photopeak of 284 keV with a low abundance compared with 364 keV photons. Small line sources and two mice, one of each of two types, that were injected with NaI-131 were scanned. Although higher counts occurred at the peripheral region of the reconstructed images due to the collimator penetration by the 364 keV photons, the shape of the small line sources could be well visualized. The measured spatial resolution was relatively poor (~1.9 mm for full width at half maximum and ~3.9 mm for full width at tenth maximum). However, a good linear correlation between SPECT values and the level of I-131 radioactivity was observed. Furthermore, the uptake of NaI-131 to the thyroid gland for the two mice was clearly identified in the 3D-SPECT image fused with the X-ray CT image. We conclude that the use of an energy window set on the photopeak of 284 keV and the multi-pinhole collimator may permit I-131 imaging for a preclinical CZT-SPECT system that does not have the ability to acquire images using the 364 keV photons.

  2. Biological Dosimetry of X-rays by micronuclei study; Dosimetria Biologica de rayos-X mediante el estudio de micronucleos

    Energy Technology Data Exchange (ETDEWEB)

    Gomez, E.; Silva, A.; Navlet, J.

    1991-07-01

    Biological dosimetry consists of estimating absorbed doses for people exposed to radiation by mean biological methods. Several indicators used are based in haematological, biochemical an cytogenetics data, although nowadays without doubt, the cytogenetic method is considered to be the most reliable, in this case, the study of micronuclei in peripheral blood lymphocytes citokinetics blocked can be related to absorbed dose through an experimental calibration curve. An experimental dose-response curve, using micronuclei assay for X-rays at 250 kVp, 43,79 rads/min and temperature 37 degree centigree has been produced. Experimental data is fitted to model Y=C+ {alpha}D+BD''2 where Y is the number of micronuclei per cell and D the dose. The curve is compared with those produced elsewhere. (Author) 24 refs.

  3. Biological Dosimetry of X-rays by micronuclei study; Dosimetria Biologica de rayos-X mediante el estudio de micronucleos

    Energy Technology Data Exchange (ETDEWEB)

    Gomez, E; Silva, A; Navlet, J

    1991-07-01

    Biological dosimetry consists of estimating absorbed doses for people exposed to radiation by mean biological methods. Several indicators used are based in haematological, biochemical an cytogenetics data, although nowadays without doubt, the cytogenetic method is considered to be the most reliable, in this case, the study of micronuclei in peripheral blood lymphocytes citokinetics blocked can be related to absorbed dose through an experimental calibration curve. An experimental dose-response curve, using micronuclei assay for X-rays at 250 kVp, 43,79 rads/min and temperature 37 degree centigree has been produced. Experimental data is fitted to model Y=C+ {alpha}D+BD''2 where Y is the number of micronuclei per cell and D the dose. The curve is compared with those produced elsewhere. (Author) 24 refs.

  4. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer, Volume 1

    International Nuclear Information System (INIS)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-01-01

    In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest risks of contracting thyroid cancer. Doses from cow's milk are considerably less . Detailed

  5. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer, Volume 1

    Energy Technology Data Exchange (ETDEWEB)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-07-01

    In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest risks of contracting thyroid cancer. Doses from cow

  6. Estimation of the activity and doses to personnel which intake Iodine 131 by coffee consumption in a cabinet of Nuclear Medicine; Estimacion de la actividad y dosis a personal que ingirio Yodo 131 por consumo de cafe en un gabinete de Medicina nuclear

    Energy Technology Data Exchange (ETDEWEB)

    Ruiz C, M.A.; Alfaro L, M.; Salinas, J.A.; Molina, G. [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico)

    2003-07-01

    Soon after an incident in a cabinet of nuclear medicine, its were carried out in the National Institute of Nuclear Research of Mexico (ININ), a series of bio essays measurements by whole-body counting to six people attributed to this cabinet. Of six people, five are classified as Occupational Exposed Personnel (POE), and the other one that works as secretary, according to the General Regulation of Radiological Safety, is classified as public member. Six people that were involved in this incident, the one which presumably it took place among November 15 and 18, 2002 and that it consisted on the effusion of a vial containing an unknown quantity of Iodine-131 to a coffeepot, they ingested coffee in diverse quantities. The Iodine-131 is used in nuclear medicine, so much for the illnesses diagnostic like in the treatment of thyroid cancer and of hyperthyroidism. (Author)

  7. Radioactive pollutions by iodine-131 in France, from November 1, 1961 to February 1, 1962; Les pollutions radioactives par l'iode 131 en France du 1er novembre 1961 au 1er fevrier 1962

    Energy Technology Data Exchange (ETDEWEB)

    Jeanmaire, L; Michon, G

    1962-07-01

    The report gives all the results of iodine-131 measurements on 450 milk samples, on 27 animal thyroids, and on 311 human thyroids between November 1, 1961 and February 1, 1962. All these results and their interpretation show that the iodine concentrations, even if they have not attained a critical level have nevertheless come close to it, and that if the Soviet series of explosions had continued it would perhaps have been necessary to take sanitary precautions. The discussion concerns the determination of the moment when such steps should be taken. (authors) [French] Le rapport fournit l'ensemble des dosages d'iode 131 effectues sur 450 echantillons de lait, sur 27 thyroides animales et sur 311 thyroides humaines entre le 1er novembre 1961 et le 1er fevrier 1962. L'ensemble des resultats et leur interpretation montrent que les teneurs en iode, si elles n'ont pas atteint les niveaux critiques, s'en sont toutefois approchees et que si la serie des explosions sovietiques s'etait poursuivie, la situation aurait pu necessiter la mise en place de mesures sanitaires. La discussion porte sur la determination du moment ou de telles mesures doivent etre prises. (auteurs)

  8. Oak Ridge Reservation Volume 3. Records relating to RaLa, iodine-131, and cesium-137 at the Oak Ridge National Laboratory and the Oak Ridge Operations Office: A guide to record series of the Department of Energy and its contractors

    International Nuclear Information System (INIS)

    1995-01-01

    The purpose of this guide is to describe each of the documents and record series pertaining to the production, release, and disposal of radioactive barium-lanthanum (RaLa), iodine-131, and cesium-137 at the Department of Energy's (DOE) Oak Ridge National Laboratory (ORNL) in Oak Ridge, Tennessee. History Associates Incorporated (HAI) prepared this guide as part of DOE's Epidemiologic Records Inventory Project, which seeks to verify and conduct inventories of epidemiologic and health-related records at various DOE and DOE contractor sites. This introduction briefly describes the Epidemiologic Records Inventory Project and HAI's role. It provides information on the history of the DOE-Oak Ridge Reservation (ORR), particularly ORNL. Specific attention is given to the production of RaLa and the fission products iodine-131 and cesium-137. This introduction also describes the methodologies HAI used in the selection and inventorying of documents and record series pertaining to RaLa, iodine-131, and cesium-137, and in the production of this guide. Concluding paragraphs describe the arrangement of the record series, explain the information contained in the record series descriptions, and indicate restrictions on access to the records

  9. Gold-198 and rose bengal marked with iodine-131 in the diagnostic of hepatic vesicular affections; L'or{sup 198} et le rose bengale marque a l'iode{sup 131} dans le diagnostic des affections hepatovesiculaires

    Energy Technology Data Exchange (ETDEWEB)

    Manambelona Razafimalaza, J [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires

    1961-06-15

    Colloidal gold-198 makes it possible to obtain clear images of hepatic parenchyma; the examination can be repeated from different angles thus demonstrating the presence of pathologically inert regions, whether they be hydatic cysts, abscesses or neoplasia. The study of the disappearance curve for the colloid, together with a measurement of the blood volume, makes it possible also to calculate the hepatic flow. Using Rose Bengal marked with iodine-131, it is possible to obtain images of the liver and of the bile ducts, and to follow the elimination of the dye in the intestines. The simultaneous recording of the disappearance curves for the blood and of the appearance of the dye in the intestines constitutes an useful working test which is particularly sensible for evaluating the permeability of the bile ducts and, to a certain degree, the site of an obstruction. (author) [French] L'or colloidal-198 permet d'obtenir avec nettete des images du parenchyme hepatique; l'examen peut etre repete sous plusieurs incidences mettant ainsi en evidence les zones muettes pathologiques, qu'il s'agisse de kystes hydatiques, d'abces ou de neoplasies. L'etude de la courbe d'epuration du colloide completee par une mesure du volume sanguin offre en outre la possibilite de calculer le debit hepatique. A l'aide du rose bengale marque a l'iode-131, il est possible d'obtenir des images du foie et de la vesicule biliaire, et de suivre l'elimination intestinale du colorant. L'enregistrement simultane des courbes d'epuration sanguine et d'apparition intestinale constitue une epreuve fonctionnelle particulierement sensible pour apprecier la permeabilite des voies biliaires et dans une certaine mesure le site d'une obstruction. (auteur)

  10. Iodine-131 treatment of thyroid cancer cells leads to suppression of cell proliferation followed by induction of cell apoptosis and cell cycle arrest by regulation of B-cell translocation gene 2-mediated JNK/NF-κB pathways

    Energy Technology Data Exchange (ETDEWEB)

    Zhao, L.M.; Pang, A.X., E-mail: zhaoliming515@126.com [Department of Nuclear Medicine, Linyi People' s Hospital, Linyi (China); Department of Urology, Linyi People' s Hospital, Linyi (China)

    2017-10-01

    Iodine-131 ({sup 131}I) is widely used for the treatment of thyroid-related diseases. This study aimed to investigate the expression of p53 and BTG2 genes following {sup 131}I therapy in thyroid cancer cell line SW579 and the possible underlying mechanism. SW579 human thyroid squamous carcinoma cells were cultured and treated with {sup 131}I. They were then assessed for {sup 131}I uptake, cell viability, apoptosis, cell cycle arrest, p53 expression, and BTG2 gene expression. SW579 cells were transfected with BTG2 siRNA, p53 siRNA and siNC and were then examined for the same aforementioned parameters. When treated with a JNK inhibitor of SP600125 and {sup 131}I or with a NF-kB inhibitor of BMS-345541 and {sup 131}I, non-transfected SW579 cells were assessed in JNK/NFkB pathways. It was observed that {sup 131}I significantly inhibited cell proliferation, promoted cell apoptosis and cell cycle arrest. Both BTG2 and p53 expression were enhanced in a dose-dependent manner. An increase in cell viability by up-regulation in Bcl2 gene, a decrease in apoptosis by enhanced CDK2 gene expression and a decrease in cell cycle arrest at G{sub 0}/G{sub 1} phase were also observed in SW579 cell lines transfected with silenced BTG2 gene. When treated with SP600125 and {sup 131}I, the non transfected SW579 cell lines significantly inhibited JNK pathway, NF-kB pathway and the expression of BTG2. However, when treated with BMS-345541 and {sup 131}I, only the NF-kB pathway was suppressed. {sup 131}I suppressed cell proliferation, induced cell apoptosis, and promoted cell cycle arrest of thyroid cancer cells by up-regulating B-cell translocation gene 2-mediated activation of JNK/NF--κB pathways. (author)

  11. Exposure to iodine 131 during the supply of capsules used for ira-therapy: comparative study of three measurement systems; Exposition a l'iode 131 lors de la dispensation des gelules utilisees pour l'iratherapie: etude comparative de trois systemes de mesure

    Energy Technology Data Exchange (ETDEWEB)

    Moubarik, C.; Giraud, F.; Bourrelly, M.; Guillet, B.; Pisano, P. [Service de medecine nucleaire, CHU de la Timone, Marseille, (France)

    2009-05-15

    The objective was to study the efficiency in the field of radiation protection of the new handle elaborated by the Covidien laboratories. In conclusions, this new handle seems to be the most efficient system in term of radiation protection of hands extremities. Indeed, it allows to reduce of 70% the exposure to extremities during the distribution of iodine 131 capsules. This supplementary protection comes from a better ergonomics and from the presence of a lead shield on the new prehension handle of Covidien laboratories. (N.C.)

  12. Phase III Randomized Study of Rituximab/Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) Compared With Iodine-131 Tositumomab/BEAM With Autologous Hematopoietic Cell Transplantation for Relapsed Diffuse Large B-Cell Lymphoma: Results From the BMT CTN 0401 Trial

    Science.gov (United States)

    Vose, Julie M.; Carter, Shelly; Burns, Linda J.; Ayala, Ernesto; Press, Oliver W.; Moskowitz, Craig H.; Stadtmauer, Edward A.; Mineshi, Shin; Ambinder, Richard; Fenske, Timothy; Horowitz, Mary; Fisher, Richard; Tomblyn, Marcie

    2013-01-01

    Purpose This clinical trial evaluated standard-dose radioimmunotherapy with a chemotherapy-based transplantation regimen followed by autologous hematopoietic cell transplantation versus rituximab with the same regimen in patients with relapsed diffuse large B-cell lymphoma (DLBCL). Patients and Methods Patients with chemotherapy-sensitive persistent or relapsed DLBCL were randomly assigned to receive iodine-131 tositumomab (dosimetric dose of 5 mCi on day −19 and therapeutic dose of 0.75 Gy on day −12), carmustine 300 mg/m2 (day −6), etoposide 100 mg/m2 twice daily (days −5 to −2), cytarabine 100 mg/m2 twice daily (days −5 to −2), and melphalan 140 mg/m2 (day −1; B-BEAM) or rituximab 375 mg/m2 on days −19 and −12 and the same chemotherapy regimen (R-BEAM). Results Two hundred twenty-four patients were enrolled, with 113 patients randomly assigned to R-BEAM and 111 patients assigned to B-BEAM. Two-year progression-free survival (PFS) rates, the primary end point, were 48.6% (95% CI, 38.6% to 57.8%) for R-BEAM and 47.9% (95% CI, 38.2% to 57%; P = .94) for B-BEAM, and the 2-year overall survival (OS) rates were 65.6% (95% CI, 55.3% to 74.1%) for R-BEAM and 61% (95% CI, 50.9% to 69.9%; P = .38) for B-BEAM. The 100-day treatment-related mortality rates were 4.1% (95% CI, 0.2% to 8.0%) for R-BEAM and 4.9% (95% CI, 0.8% to 9.0%; P = .97) for B-BEAM. The maximum mucositis score was higher in the B-BEAM arm (0.72) compared with the R-BEAM arm (0.31; P < .001). Conclusion The B-BEAM and R-BEAM regimens produced similar 2-year PFS and OS rates for patients with chemotherapy-sensitive relapsed DLBCL. No differences in toxicities other than mucositis were noted. PMID:23478060

  13. Treatment of Thyrotoxicosis Using Radioactive Iodine 131

    International Nuclear Information System (INIS)

    JAJA, Salvador Bessarione

    1998-01-01

    Throtoxicosis is common in the Sudan, and its management constitute a significant health problem in terms of expenses, in addition to dilemma of best therapy between the physician's choice and the patients' reference. As the role of Radioactive lodine is becoming more acceptable. It is wise to evaluate our experience and compare it to the current literature, aiming to use the treatment more effectively in our setting. The objective is to evaluate the effectively of radioiodine and factors affecting them, and to find out the possible complications, and compare the cost of treatment to that of surgery and antithyroid drugs, as well as to find out the patient attitude and knowledge towards the treatment. 103 thyrotoxic patients referred to Radioisotope center and received Radioiodine therapy in the period between 1986-1997 were considered in the study. Those who received the treatment in 1997 were followed up prospectively for minimum of 12 months. Clinical feature, severity of the disease, size and type of goitre and complications were considered. Patients were treated as out patients and followed up in the referred clinic. 115 patients (88.5%) were female and 15(11.5%) were male. The mean age was (49±)10.7), the majority (43.9%) were fluocortolonum state and the least (1.5%) from Southern states. Most of the patients (58%) were referred from medical units in the hospitals, their mean thyroxine level (212.285±36.753) and mean weight (58.031±8.724)kg. (54.6%) had diffused goitre and 36% multinodular goitre and 9.2% had solitary nodule. 48.5% of the patients had moderate size goitre, 32.3% large size and 19.2% small size goitre. The main indication was replace after medical treatment (40%). Out of the 59 patients interviewed (77.9%) have no knowledge about the therapy, and (48.4%) accepted the treatment without difficulty. 22 patients presented with complications, and most of the complications were cardiac, heart failure with arrhythmia (50%) 15 patients had ophthalmopathy and they had variable response to treatment. (80.7%) of the patients showed clinical response within 6 months. 113 patients gained weight and all had reduction of thyroid size with (100%) disappearance among patients with solitary, and (91.7%) among those with diffused goitre. (23%) of the patients developed early complications. (50%) was transient worsening of the symptoms and (20%) was transient hypothyroidism. Recurrence was mainly seen among patients with diffused gotire (7.04%) and hypothyroidism was in (16.6%) among patients with diffused goitre, which from the highest percentage of hypothyroidism. There was no significant differences in treatment response in relation to initial thyroxine level and size of goitre, but the response was better among diffuse goitre and solitary nodule. Carcinoma of the thyroid and Leukaemia were not seen in our series, genetic effect and infertility were not considered in our study. Radioactive lodine is cheap, effective and safe with exception of hypothyroidism, there was not other significant complication. Excluding children and pregnant women, it can be used in all patients and as a first line in elderly and patients with complications.(Author)

  14. Nodular Hashitoxicosis - treatment with iodine-131

    International Nuclear Information System (INIS)

    Jara Yorg, J.A.; Ruiz Perez, V.; Acosta, N.

    2004-01-01

    Present case presents a patient of 58 years old of feminine sex with records of Tiroiditis of Hashimoto TSH of15 UI/ml (VN 0.5-4.0) who has been treated orally with sodium levotiroxina (100 ucg/dia) on a daily basis during 3 years with antibodies antimicrosomal or antitiroperoxidasa (TPO ab) with a value of 1/1550 UI/ml, with court 50 UI/ml and antitiroglobuliana (ATG ab) with values of 1/320 UI/ml with court 100 positive UI/ml [es

  15. Treatments of hyperthyroidism with iodine-131

    International Nuclear Information System (INIS)

    Kuniyasu, Yoshio

    1978-01-01

    The results of treatment 131 I were reported, and hypothyroidism as a late disturbance was described. The therapeutic results of a standard dose of 6000 rad and the incidence of hypothyroidism were discussed. Of the 117 patients followed up (80% were 21-50 years of age, and 30% were followed up for more than 10 years), 98 (83.8%) were euthyroid (cured), and 19 (16.2%) had hypothyroidism. Hypothyroidism occurred 6 months and 2 years later in one case each, 5 years later in 9, and more than 10 years later in 6; the onset increased with increasing years. Sixty patients (55%) were cured by the first treatment, and 36 were relieved by the second a total of 96 patients (87.2%) were relieved by two irradiations. Of all hypothyroidism was observed in 12 patients (10%). The incidence of hypothyroidism increased among the patients given more than 3 irradiations. There was no significant difference in the incidence of hypothyroidism between single 131 I treatment and 131 I treatment following the internal use of antithyroid drugs. Hypothyroidism did not occur in cases given less than 5000 rad, but occurred in 8.5% of those given 5000-10000 rad and 18.9% of those given 10000-15000 rad. With a standard dose of 6000 rad, 109 (82%) of the 133 patients followed up for less than 4 years were relieved or cured; hypothyroidism appeared in 13 cases (9.8%) including transient one immediately after recovery and this result is less satisfactory than that obtained with 9000 rad previously. (Chiba, M.)

  16. Axillary iodine-131 accumulation due to perspiration

    International Nuclear Information System (INIS)

    Camponovo, E.J.; Goyer, P.F.; Silverman, E.D.; Kistler, A.M.; Yudt, W.M.

    1989-01-01

    A case of spurious axillary uptake of I-131 proven to be caused by perspiration is presented. False-positive localizations of radioiodine, both pathologic and physiologic, are reviewed to avoid confusion of these entities with functioning thyroid carcinoma metastases

  17. Contamination with iodine-131 in metabolic therapy

    International Nuclear Information System (INIS)

    Garcia, R.; Luis, J.; Gomez, A.; Gonzalez, V.; Herrador, M.; Rogriguez, J.R.

    1997-01-01

    High-dose radioactive iodine therapy using 131 I is the treatment of choice for patients with thyroid cancer following thyroidectomy. Because of the large amount of activity which is excreted during hospitalization, contamination harzard from 131 I excretion via perspiration, saliva, breath and urine may arise. In twelve patients treated with doses of 131 I ranging from 1.85-7.4GBq activity levels were measured in room surface, the toilet, patients saliva and skin. Removable activity from skin reached a maximum at 24h post-therapy. Removable activity from room surfaces exceed the level of contamination which requires clean-up in a public area during patient's hospitalization. The relatively high activities present in the saliva and skin of these patients emphasizes the need for all individuals coming in contact with these patients to be made aware of the contamination hazard present. (author)

  18. Thyroid cancer following diagnostic iodine-131 administration

    International Nuclear Information System (INIS)

    Hall, P.; Holm, L.-E.; Boice, J.D.

    1996-01-01

    To provide quantitative data on the risk of thyroid cancer following 131 I exposure, 34104 patients administered 131 I for diagnostic purposes were followed for up to 40 years. Mean thyroid dose was estimated as 1.1 Gy, and 67 thyroid cancers occurred in contrast to 49.7 expected [standardized incidence ratio (SIR)=1.35; 95% confidence interval (CI) 1.05-1.71]. Excess cancers were apparent only among patients referred because of a suspected thyroid tumor and no increased risk was seen among those referred for other reasons. Further, risk was not related to radiation dose to the thyroid gland, time since exposure, or age at exposure. The slight excess of thyroid cancer, then appeared due to the underlying thyroid condition and not radiation exposure. Among those under age 20 years when 131 I was administered, a small excess risk (3 cancers vs 1.8 expected) was about 2-10 times lower than that predicted from A-bomb data. These data suggest that protraction of dose may result in a lower risk than acute x-ray exposure of the same total dose

  19. Uptake of iodine-131 in tropical crops

    International Nuclear Information System (INIS)

    Asprer, G.A.; Lansangan, L.M.

    1986-01-01

    Vegetable crops which include sweet potato tops (Ipomoea batatas), kangkong (Ipomoea repitans) and tomato plants were grown in dark-painted jars containing Hoagland-Arnon modified nutrient solution, utilizing the technique of hydroponics. The experiments for sweet potato tops and kangkong plants were duplicated for replicate studies and steady-state conditions were simulated throughout. Tomato plants were grown in the same manner but growth was observed to be hampered when starting from mature plants. Radioiodine was added to the nutrient medium containing 0.5% non-radioactive NaI solution. The solution in the jar was adjusted daily so as to maintain a constant concentration which would simulate routine releases that are essentially continuous. After incorporating the radioiodine to the solution, 10 ml aliquot was taken and counted for radioactivity by means of a 5'' x 5'' NaI(T1) detector connected to the multichannel gamma analyzer. Both plants and solution were counted for radioactivity at different time intervals using the same geometry. Results indicate that the activity in the plants were relatively higher than that of the solution. The activity tends to level off or decrease after a few days. The concentration factor which is the ratio of the activity in the plant (uCi/gm) over the activity in the medium (uCi/ml) varied for each time interval. 12 references, 2 figures, 3 tables

  20. Iodine-131 therapy for parotid oncocytoma

    Energy Technology Data Exchange (ETDEWEB)

    Kosuda, S.; Ishikawa, M.; Tamura, K.; Mukai, M.; Kubo, A.; Hashimoto, S.

    1988-06-01

    We present a rare case of a patient with coexisting parotid oncocytoma and chronic thyroiditis who received two therapeutic doses of (/sup 131/I)iodide for a recurrent oncocytoma (oxyphilic granular cell adenoma), resulting in a definite reduction in tumor volume. We suggest that radioiodine therapy for a recurrent oncocytoma is an effective form of tumor therapy.

  1. Contamination of pasture by iodine 131

    International Nuclear Information System (INIS)

    Angeletti, Livio

    1980-08-01

    The reassessment of the experimental data on the transfer of iodine to aerial parts of rye-gras leads to the following significant findings: 1 - Water content of herbage depending markedly on time and location, the contamination of the vegetals has to be expressed on a dry weight basis. 2 - The value of the geometrical mean of the deposition velocity of iodine vapour as derived from 19 experiments carried out over 4 years is 0.76 cm/s. This value agrees very well with the value of V(d)=0.80 obtained in the USA during experiments comparable as to the number of tests and their duration. Consequently we propose a value of V(d)=0.76 cm/s for the evaluation of pasture land contamination by iodine resulting from routine releases. For accidental releases, however, we propose a value of V(d)=2 cm/s, which was the upper limit in about 90% of our experimental results. 3 - The analysis of data on wet deposition of iodine on the aerial parts of rye-grass shows that the initial retention when expressed as percent of the total deposit decreases with aspersion intensities. If expressed as retention factor, the initial retention is constant, for all aspersion intensities. The average initial iodine retention being lower by a factor of 2.3 than water retention the value of the latter will therefore be the upper limit for this radionuclide [fr

  2. Accidental release of iodine-131 by IRE at Fleurus: back experience of Belgium safety authority; Rejet accidentel d'iode-131 par l'IRE sur le site de Fleurus: retour d'experience de l'autorite de surete belge

    Energy Technology Data Exchange (ETDEWEB)

    Vandecasteele, C.M.; Sonck, M. [AFCN - Agence federale de controle nucleaire, Bruxelles (Belgium); Degueldre, D. [Bel V, Anderlecht (Belgium)

    2011-04-15

    The IRE (National institute for radioelements) produces radionuclides for nuclear medicine from highly enriched uranium irradiated targets. On 22/08/2008, fresh production wastes were transferred into an almost empty decay tank. The mixing of these liquids led to the release of approximately 47 GBq of molecular iodine-131 into the atmosphere. The first conservative assessments of the radiological consequences did not require taking direct protective actions for the population, such as sheltering or stable iodine intake. However, the estimated iodine-131 deposits could locally reach or exceed the derived reference levels for the contamination of milk (4 kBq/m2) and leafy vegetables (10 kBq/m2). For this reason, and because there was a threat of a further release, the federal emergency plan was activated on 28/08 and the population potentially concerned was recommended to avoid consumption of locally produced fruits, vegetables and fresh milk. These protective actions were lifted on 7/09 and the emergency plan was lifted on 12/09. The main lesson learned from this event concerns the paramount importance of the rapid exchange of information that is as accurate and complete as possible between the different stakeholders: from the operator up to the population, through federal and local authorities. (authors)

  3. Iodine-131 treatment of hyperthyroidism in the elderly. Results in 180 patients. Radioprotection and waste management in 131-iodine therapy; Traitement de l'hyperthyroidie du sujet age par l'iode 131. A propos de 180 patients. Problemes de radioprotection et de gestion des dechets lies au traitement par l'iode 131

    Energy Technology Data Exchange (ETDEWEB)

    Dejax, C.; Freitas, D. de; Leroux, M.A.; Aubert, B. [Centre Jean-Perrin, Medecine Nucleaire, 63 - Clermont-Ferrand (France); Vennat, J.C. [Centre Jean-Perrin, Radiopharmacie, 63 - Clermont-Ferrand (France); Kwiatkowski, F. [Centre Jean-Perrin, Biostatistiques, 63 - Clermont-Ferrand (France)

    2005-09-15

    A retrospective study has been performed in patients treated by iodine-131 for hyperthyroidism between April 1999 and February 2004..Among the 270 patients, 180 were more than 65 years old. After 65 years, hyperthyroidism is most often the consequence of a toxic adenoma or multi-nodular goiter while Graves' disease is most frequent in young patients. Iodine-131 is usually proposed as first line treatment in the elderly, at the opposite of young patients. With a mean follow-up of 12 months, return to euthyroidism is observed in 56.5% of the older patients and in 73.6% of the young patients. We explain this results by the lower incidence of Graves' disease in the elderly. Nuclear medicine physicians are legally obliged to provide patients with a proper information about radioprotection. Recommendations should nevertheless not induce overdue nor illegitimate fear. They should not only be written and standardized, but also given orally and adapted to each patient. Urinary incontinence is not specific to the old patients, but it is more frequent after 65. Collection and storage of contaminated waste is sometimes difficult and has often to be solved on a case by case basis. (author)

  4. Biological dosimetry after criticality accidents. Intercomparison exercise in the Silene Reactor - France; Dosimetria biologica en accidentes de criticidad. Ejercicio de intercomparacion en el Reactor Silene - Francia

    Energy Technology Data Exchange (ETDEWEB)

    Di Giorgio, Marina; Vallerga, Maria B; Taja, Maria R [Autoridad Regulatoria Nuclear, Buenos Aires (Argentina); arn gov ar, E-mail: mdigiorg@cae

    2004-07-01

    The Institute of Radiation Protection and Nuclear Safety Institute (IRSN) organized an international biological dosimetry intercomparison, at the SILENE experimental reactor (Valduc, France), simulating different criticality scenarios: bare source 4 Gy, lead shield source 1 and 2 Gy and gamma pure {sup 60}Co source 2 Gy. Fifteen laboratories were involved in this exercise, including the Argentine Biological Dosimetry Laboratory. The purposes of the intercomparison were: 1) To compare the unstable chromosome aberration (UCA) frequency observed by the different laboratories; and 2) To compare the dose estimation for gamma rays and neutrons. The objects of the present work were: I) To compare the mean frequency of UCA observed by the Argentine laboratory with the mean frequency observed by the participant laboratories as a whole. II) To compare the dose estimates performed by the Argentine lab with those estimated by the other laboratories involved in the second stage of the intercomparison. Overall, the mean frequencies of UCA and the correspondent 95% confidence limits obtained by the Argentine lab were consistent with the results obtained by the laboratories as a whole. For the gamma pure scenario, smaller variations were observed among laboratories in terms of dose (CV=18,2%) than in terms of frequency (CV=30,1%). For the mixed field scenarios, only four laboratories, including the Argentine lab, estimated gamma and neutron components of the total dose and just two (Argentine lab and lab 12) were in agreement with the given physical doses. The 1 Gy experiment presented lesser variations both in terms of frequency and dose than the other two scenarios. For the 4 and 2 Gy experiments, variations in neutron dose were more significant than variations in gamma dose, related to the magnitude of the dose. The results suggest that intercomparison exercises jointly with the accreditation of biological dosimetry by cytogenetic service laboratories, in compliance with ISO/IEC 17025, would allow to unify the protocols applied regarding: techniques, metaphase selection and scoring process. Thus, the dosimetric response in accidental overexposures that would require cooperation among countries, will be improved. (author)

  5. Biological dosimetry of ionizing radiation by chromosomal aberration analysis; Dosimetria biologica de las radiaciones ionizantes mediante el analisis de aberraciones cromosomicas

    Energy Technology Data Exchange (ETDEWEB)

    Gonzalez-Castano, S.; Silva, A.; Navlet, J.

    1990-07-01

    Biological dosimetry consists of estimating absorbed doses for people exposed to radiation by mean biological methods. Several indicators used are based in haematological, biochemical, and cytogenetic data, although nowadays without doubt, the cytogenetic method is considered to be the most reliable. In this case, the study ol chromosomal aberrations, normally dicentric chromosomes, in peripheral lymphocytes can be related to absorbed dose through an experimental calibration curve. An experimental dose-response curve, using dicentric chromosomes analysis, X-rays at 300 kVp, 114 rad/min and temperature 37 degree celsius has been produced. Experimental data is fitted to model Y ={alpha} + {beta}{sub 1}D + {beta}{sub 2}D 2 , where Y is the number of dicentrics per cell and D the dose. The curve is compared with those produced elsewhere. (Author) 14 refs.

  6. Chromosomal analysis and application of biological dosimetry in two cases of apparent over exposure; Analisis cromosomico y aplicacion de la dosimetria biologica en dos casos de aparente sobreexposicion

    Energy Technology Data Exchange (ETDEWEB)

    Guerrero C, C.; Brena V, M. [Departamento de Biologia, ININ A.P. 18-1027, 11801 Mexico D.F. (Mexico)

    2002-07-01

    The gamma radiation calibration curve of {sup 60} Co is used which was generated in the ININ Laboratory of Biology to calculate the exposure dose of two workers whose dosemeters marked values above of the limit allowed. The analysis indicates that in a first case, the aberrations frequency corresponded to the basal value, therefore there is not over exposure. The aberrations frequency of the second case is lightly above to the basal value and therefore the probability favors to what the physical dosimetry indicates. (Author)

  7. Optimization of SPECT calibration for quantification of images applied to dosimetry with iodine-131; Otimização da calibração em SPECT para a quantificação de imagens aplicada à dosimetria com iodo-131

    Energy Technology Data Exchange (ETDEWEB)

    Carvalho, Samira Marques de

    2018-04-01

    SPECT systems calibration plays an essential role in the accuracy of the quantification of images. In this work, in its first stage, an optimized SPECT calibration method was proposed for {sup 131}I studies, considering the partial volume effect (PVE) and the position of the calibration source. In the second stage, the study aimed to investigate the impact of count density and reconstruction parameters on the determination of the calibration factor and the quantification of the image in dosimetry studies, considering the reality of clinical practice in Brazil. In the final step, the study aimed evaluating the influence of several factors in the calibration for absorbed dose calculation using Monte Carlo simulations (MC) GATE code. Calibration was performed by determining a calibration curve (sensitivity versus volume) obtained by applying different thresholds. Then, the calibration factors were determined with an exponential function adjustment. Images were performed with high and low counts densities for several source positions within the simulator. To validate the calibration method, the calibration factors were used for absolute quantification of the total reference activities. The images were reconstructed adopting two approaches of different parameters, usually used in patient images. The methodology developed for the calibration of the tomographic system was easier and faster to implement than other procedures suggested to improve the accuracy of the results. The study also revealed the influence of the location of the calibration source, demonstrating better precision in the absolute quantification considering the location of the target region during the calibration of the system. The study applied in the Brazilian thyroid protocol suggests the revision of the calibration of the SPECT system, including different positions for the reference source, besides acquisitions considering the Signal to Noise Ratio (SNR) of the images. Finally, the doses obtained with the simulations presented significant differences between the doses calculated according to their location and calibration factor used, also showing a tendency to overestimate the dose calculation with the use of standard central calibration. The results obtained will contribute to the optimization and better accuracy of therapeutic procedures in nuclear medicine. (author)

  8. Analysis of the organic horticultural market in Lazio; Analisi della filiera ortofrutticola biologica del Lazio

    Energy Technology Data Exchange (ETDEWEB)

    Letardi, A [ENEA, Divisione Biotecnologie e Agricoltura, Centro Ricerche Casaccia, Rome (Italy); Lumaca, P [Centro Ecologico di Dimostrazione Agraria, Rome (Italy); Grandi, C; Dominicis, L [Centro Ecologico di Dimostrazione Agraria/Associazione Italiana per l' Agricoltura Biologica, Lazio, Rome (Italy)

    2001-07-01

    In 1998 Agriculture and Biotechnology Division of ENEA (BIOAG), Ecological Centre for Extension Service (CEDA), and Italian Association for Biological Agriculture (AIAB) established a research collaboration on the limiting factors that regulate marketing of fresh biological products. Field research was carried out, starting at the end 1998 to 1999, on horticultural production, mainly by means a fellowship in agriculture factors that regulate marketing of fresh biological products. Results and conclusion of the study focuses critical steps regulating productions, transformation and distribution of biological agriculture and could be associated to general situation of this sector in Italy. Moreover attention should be put on the rapid evolution of this sector in the last months, with respect to research time duration, i.e., 1998-1999 years, because of food safety emergencies and legislative innovations issued by European Commission. [Italian] Nel 1998 una lunga collaborazione tra ricercatori della Divisione Biotecnologie ed Agricoltura dell'ENEA, del Ceda (Centro Ecologico di Dimostrazione Agraria) e dell'AIAB (Associazione Italiana per l'Agricoltura Biologica), grazie all'apporto finanziario di un imprenditore privato interessato allo sviluppo del settore, produsse un bando di concorso per una borsa di formazione e studio sperimentale per laureato in agraria con specializzato in materie economiche. Grazie a tale borsa e' stata realizzata, tra la fine del 1998 e il 1999, una indagine sulla filiera agroalimentare biologica del Lazio, finalizzata all'analisi dei punti critici che limitavano i segmenti della commercializzazione e della distribuzione del prodotto fresco. Nella discussione su principali problemi per lo sviluppo dell'agricoltura biologica in Italia, ed in particolare nel Lazio, tra i ricercatori delle strutture sopra menzionate era emersa infatti una carenza di dati sperimentali certi che potessero supportare una serie di considerazioni gia' da noi

  9. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer- APPENDICES Appendices-Volume 1A

    International Nuclear Information System (INIS)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-01-01

    This report consists of all the appendices for the report described below: In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values as appendices. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from I-131 and would have had the highest

  10. Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956)- An Assessment of Quantities released, Off-Site Radiation Doses, and Potential Excess Risks of Thyroid Cancer- APPENDICES Appendices-Volume 1A

    Energy Technology Data Exchange (ETDEWEB)

    Apostoaei, A.I.; Burns, R.E.; Hoffman, F.O.; Ijaz, T.; Lewis, C.J.; Nair, S.K.; Widner, T.E.

    1999-07-01

    This report consists of all the appendices for the report described below: In the early 1990s, concern about the Oak Ridge Reservation's past releases of contaminants to the environment prompted Tennessee's public health officials to pursue an in-depth study of potential off-site health effects at Oak Ridge. This study, the Oak Ridge dose reconstruction, was supported by an agreement between the U.S. Department of Energy (DOE) and the State of Tennessee, and was overseen by a 12-member panel appointed by Tennessee's Commissioner of Health. One of the major contaminants studied in the dose reconstruction was radioactive iodine, which was released to the air by X-10 (now called Oak Ridge National Laboratory) as it processed spent nuclear reactor fuel from 1944 through 1956. The process recovered radioactive lanthanum for use in weapons development. Iodine concentrates in the thyroid gland so health concerns include various diseases of the thyroid, such as thyroid cancer. The large report, ''Iodine-131 Releases from Radioactive Lanthanum Processing at the X-10 Site in Oak Ridge, Tennessee (1944-1956) - An Assessment of Quantities Released, Off-site Radiation Doses, and Potential Excess Risks of Thyroid Cancer,'' is in two volumes. Volume 1 is the main body of the report, and Volume 1A, which has the same title, consists of 22 supporting appendices. Together, these reports serve the following purposes: (1) describe the methodologies used to estimate the amount of iodine-131 (I-131) released; (2) evaluate I-131's pathway from air to vegetation to food to humans; (3) estimate doses received by human thyroids; (4) estimate excess risk of acquiring a thyroid cancer during ones lifetime; and (5) provide equations, examples of historical documents used, and tables of calculated values as appendices. Results indicate that females born in 1952 who consumed milk from a goat pastured a few miles east of X-10 received the highest doses from

  11. Radioiodine therapy of differentiated thyroid cancer: radiologic impact of out-patient treatment with 100 to 150 mCi Iodine-131 activities; Radioiodoterapia do carcinoma diferenciado da tireoide: impacto radiologico da liberacao hospitalar de pacientes com atividades entre 100 e 150 mCi de iodo-131

    Energy Technology Data Exchange (ETDEWEB)

    Sapienza, Marcelo Tatit; Willegaignon, Jose; Ono, Carla Rachel; Watanabe, Tomoco; Guimaraes, Maria Ines Calil Cury; Buchpiguel, Carlos Alberto [Universidade de Sao Paulo (USP), SP (Brazil). Faculdade de Medicina. Servico de Medicina Nuclear; Gutterres, Ricardo Fraga; Marechal, Maria Helena da Hora [Comissao Nacional de Energia Nuclear (CNEN), Rio de Janeiro, RJ (Brazil)

    2009-07-01

    Purpose: To evaluate exposure and dosimetry to family members and environment due to outpatient radioiodine therapy of differentiated thyroid carcinoma. Methods: Twenty patients were treated with 100-150 mCi of iodine-131 on an out-patient basis. Family members dosimetry (n = 27) and potential doses inside the house were measured with thermoluminescent dosimeters. Surface contamination and radioactive wastes were also monitored. Results: Less than 1.0 mSv doses were found in 26 co-habitants and 2.8 mSv in a single case (inferior to the acceptable value of 5.0 mSv/procedure). Potential doses in the houses were inferior to 0.25 mSv, excluding the patients bedroom (mean value = 0.69 mSv). Surface contamination (mean = 4.2 Bq.cm{sup -2}) were below clearance levels. Radioactive wastes generated had a volume of 2.5 liters and a total activity estimated in 90 {mu}Ci, with a calculated exposure close to the background radiation levels. Conclusions: No radiological impact was detected after iodine therapy with 100-150 mCi on an out-patient basis followed by experienced professionals. (author)

  12. Analysis of the organic horticultural market in Lazio; Analisi della filiera ortofrutticola biologica del Lazio

    Energy Technology Data Exchange (ETDEWEB)

    Letardi, A. [ENEA, Divisione Biotecnologie e Agricoltura, Centro Ricerche Casaccia, Rome (Italy); Lumaca, P. [Centro Ecologico di Dimostrazione Agraria, Rome (Italy); Grandi, C.; Dominicis, L. [Centro Ecologico di Dimostrazione Agraria/Associazione Italiana per l' Agricoltura Biologica, Lazio, Rome (Italy)

    2001-07-01

    In 1998 Agriculture and Biotechnology Division of ENEA (BIOAG), Ecological Centre for Extension Service (CEDA), and Italian Association for Biological Agriculture (AIAB) established a research collaboration on the limiting factors that regulate marketing of fresh biological products. Field research was carried out, starting at the end 1998 to 1999, on horticultural production, mainly by means a fellowship in agriculture factors that regulate marketing of fresh biological products. Results and conclusion of the study focuses critical steps regulating productions, transformation and distribution of biological agriculture and could be associated to general situation of this sector in Italy. Moreover attention should be put on the rapid evolution of this sector in the last months, with respect to research time duration, i.e., 1998-1999 years, because of food safety emergencies and legislative innovations issued by European Commission. [Italian] Nel 1998 una lunga collaborazione tra ricercatori della Divisione Biotecnologie ed Agricoltura dell'ENEA, del Ceda (Centro Ecologico di Dimostrazione Agraria) e dell'AIAB (Associazione Italiana per l'Agricoltura Biologica), grazie all'apporto finanziario di un imprenditore privato interessato allo sviluppo del settore, produsse un bando di concorso per una borsa di formazione e studio sperimentale per laureato in agraria con specializzato in materie economiche. Grazie a tale borsa e' stata realizzata, tra la fine del 1998 e il 1999, una indagine sulla filiera agroalimentare biologica del Lazio, finalizzata all'analisi dei punti critici che limitavano i segmenti della commercializzazione e della distribuzione del prodotto fresco. Nella discussione su principali problemi per lo sviluppo dell'agricoltura biologica in Italia, ed in particolare nel Lazio, tra i ricercatori delle strutture sopra menzionate era emersa infatti una carenza di dati sperimentali certi che potessero supportare una serie di

  13. Treatment's results of hyperthyroid patients with Iodine-131

    International Nuclear Information System (INIS)

    Bastan-Hagh, M.H.; Larijani, B.; Rahim-Tabrizi, P.; Khalili-Fard, A.R.; Baradar-Jalili, R.; Saghari, M.

    2004-01-01

    Introduction: radioiodine ( 131 I) is an effective and inexpensive alternative to surgery in the treatment of thyroid hyper function. The debate today concerns the maximum and minimum ablative doses, and factors leading to hypothyroidism. Patients and method: 1035 hyperthyroid patients treated with weight-adjusted ablative doses of 131 I were retrospectively assessed for treatment outcome or correlated with sex, age, underlying pathology, and administrated dose of 131 I . Results: Thyroid hyper function was more common in women. The greatest proportions of patients were in the 31-40 years age group and the smallest proportion over -70. The commonest underlying pathology was Grave's disease. Men had a lower response rate to 131 I therapy, with 2.4-fold greater probability of persistent hyperthyroidism (P 131 I hypothyroidism decreased with increasing age (P 131 I therapy was seen in patients with toxic adenoma, (P=0.0001). The incidence of hypothyroidism did not show a positive correction with increased administered dose of 131 I (P 131 I was effective in reducing thyroid nodule size. There were 18 cases of temporary hyperthyroidism, all of which recovered to euthyroid status within 12 months. Conclusion: one dose of radioiodine was effective in treatment of hyperthyroid patients in 91.2 % of cases. Age, sex and underlying pathology were determining factors. In most cases the average time to hypothyroidism was reasonably short, obviating the need for long time follow up in these patients

  14. Decreased uptake after fractionated ablative doses of iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Wu, Hurng-Sheng [Show Chwan Memorial Hospital, Department of Surgery, Changhua, Taiwan (Taiwan); Hseu, Huey-Herng [Taichung Veterans General Hospital, Department of Medical Education and Research, Taichung (Taiwan); Lin, Wan-Yu; Wang, Shyh-Jen [Taichung Veterans General Hospital, Department of Nuclear Medicine, Taichung, Taiwan (Taiwan); Liu, Yao-Chi [Department of Surgery, General Surgery, National Defense Medical Center, Taipe (Taiwan)

    2005-02-01

    In an attempt to obviate the necessity for hospitalisation, the ablative dose of {sup 131}I in the treatment of thyroid cancer is divided into two or three fractions at weekly intervals in some hospitals with no special bed for {sup 131}I treatment. Thyroid stunning has been observed in patients receiving a {sup 131}I dose between 74 and 370 MBq (2-10 mCi). However, the influence of {sup 131}I uptake after administration of a higher dose, such as 1,110-1,850 MBq of {sup 131}I, has never been reported. In this study, we evaluated the degree of reduction in {sup 131}I uptake after patients received 1,480 MBq of {sup 131}I and evaluated the clinical value of fractionated ablative doses of {sup 131}I. Thirty-five patients with functional thyroid cancer received a total of 4,440 MBq (120 mCi) of {sup 131}I which was divided into three fractions administered at weekly intervals. In all patients two {sup 131}I whole-body scans were performed. The first scan was performed directly prior to the second dose of {sup 131}I (7 days after the first administration of {sup 131}I), and the second scan was performed 7 days after the second administration of {sup 131}I and directly prior to the third administration. Regions of interest including the neck and lungs were drawn to calculate the uptake of {sup 131}I in the thyroid remnant and possible cervical lymph node and lung metastases. The mean uptake of {sup 131}I was 2.73% 7 days after the first administration, and decreased significantly to 0.26% 7 days after the second administration. The mean decrease was as high as 80.7%. The decrease in {sup 131}I uptake was significant in all patients except the two with lung metastases. In the two patients with lung metastases, no definite evidence of decreased uptake was noted; the uptake of {sup 131}I in the lung metastases even increased on the second {sup 131}I image in one of these patients. After administration of 1,480 MBq of {sup 131}I, the decreased uptake was significant in all neck lesions but not in lung metastases. The use of fractionated ablative doses of {sup 131}I is not to be recommended in patients without lung metastases. However, the influence of fractionated ablative doses of {sup 131}I in patients with lung metastases is worthy of further study. (orig.)

  15. Iodine-131 in breast milk following therapy for thyroid carcinoma

    International Nuclear Information System (INIS)

    Robinson, P.S.; Barker, P.; Campbell, A.

    1994-01-01

    This study evaluates breast milk secretion of 131 I following therapeutic adminstration of 4000 MBq of 131 I-iodide during lactation. Breast milk 131 I activity concentration was measured over a 32-day period. Dosimetry calculations were undertaken to estimate the period for discontinuation of breast feeding and the equivalent dose to the breasts. To achieve an infant effective dose 131 I-iodide adminstration is not undertaken during lactation and that breast feeding is discontinued several days prior to administration. 26 refs., 2 figs., 2 tabs

  16. Meta-iodobenzylguanidine synthesis and labelling with iodine-131

    International Nuclear Information System (INIS)

    Miranda, J.; Herrera, J.; Robles, A.; Caballero, J.; Portilla, A.; Ticona, L.

    1997-01-01

    Meta-iodo-benzylguanidine (MIBG) synthesis is carried out through m-iodo benzylamine condensation and subsequent formation of the hemisulfate salt. The synthesized product is characterized and identified by IR spectroscopy and m.p. determination. Acute toxicity tests conducted in mice demonstrated that the synthesized product is not toxic. MIBG hemisulfate labelling methods with I-131 is carried out by nucleophilic isotopic exchange; the reaction is catalyzed with cooper sulfate in the presence of ammonium sulfate at temperatures ranging between 140 and 150 o C . Biological distribution tests in wistar rats present an average value of 1,54% of injected dose/organ gram in suprarenal glands. These values show promise for the application of this radiopharmaceutical in radiodiagnosis of suprarenal tumors and procurement of adrenal medulla, myocardium and salivary gland images

  17. Treatments with radioactive iodine, 131 I. How, when and where?

    International Nuclear Information System (INIS)

    Ruiz J, A.; Gonzalez T, O.

    2006-01-01

    A great variety of approaches exists in the application of the treatments with radioactive materials, as the 131 I, but it is necessary to standardize them for the patient's benefit, because their doctor doesn't always know the principle that it bases this therapy, called metabolic therapy or radioiodine therapy (RYT). In this work the experience that was acquired by more of 50 years of RYT management in the Thyroid and Nuclear Medicine Clinic in patients with thyroid pathologies is informed, so that their management fulfills its function and it was carried out inside the corresponding juridical frame and the physicochemical and endocrinological principles that should take implicit. (Author)

  18. The absorption of iodine-131 on a ceramic matrix

    International Nuclear Information System (INIS)

    Han, H.S.; Park, U.J.; Dash, A.

    2004-01-01

    The retention of 131 I on ceramic rod coated with silver nitrate followed by coating with a polyurethane membrane to be applied in brachytherapy was studied. The concentration of silver nitrate (20 g/l), the volume of 131 I as a sodium iodide solution (100 μl), the pH of the reaction mixture (pH 9) etc., were optimized to get a maximum uptake on the ceramic rod. The concentration of coating solution (5%, polyurethane in tetrahydrofuran) was also optimized to obtain a minimum leaching of 131 I activity in normal saline solution. After coating with a polyurethane membrane, the 131 I absorbed on the ceramic rod exhibited low leachability (0.03%). This method can be applied for the preparation of 125 I interstitial sources to be used in eye and prostate cancer therapy. (author)

  19. Thyroid cancer from occupational exposures to iodine-131

    International Nuclear Information System (INIS)

    Shore, R.E.

    1983-01-01

    Studies of external irradiation, primarily of children, suggest that the thyroid gland is one of the most radiosensitive sites for carcinogenesis. However, it has generally been thought that 131 I confers much less risk (per rad) than external radiation because of its low dose-rate. A review of the epidemiologic literature indicates that age at irradiation is also an important variable in defining thyroid cancer risk, with a lesser risk at older ages. The available human studies are reasonably consistent in affirming that risks following 131 I are small. However, the data on 131 I exposure are too sparse, particularly for childhood exposure, to determine how much of the observed diminution in risk is due to older ages at exposure and how much is attributable to the characteristics of 131 I exposure per se, such as low dose-rate. Since most of the existing studies have inadequacies in design, dose levels, dosimetry or number of subjects, additional studies are needed before the risk assessment of 131 I at lower dose levels in adult workers can be regarded as definitive

  20. Iodine 131 therapy patients: radiation dose to staff

    International Nuclear Information System (INIS)

    Castronovo, F.P. Jr.; Beh, R.A.; Veilleux, N.M.

    1986-01-01

    Metastasis to the skeletal system from follicular thyroid carcinoma may be treated with an oral dose of 131 I-NaI. Radiation exposures to hospital personnel attending these patients were calculated as a function of administered dose, distance from the patient and time after administration. Routine or emergency patient handling tasks would not exceed occupational radiation protection guidelines for up to 30 min immediately after administration. The emergency handling of several patients presents the potential for exceeding these guidelines. (author)

  1. [Prevention of recurrent amiodarone-induced hyperthyroidism by iodine-131].

    Science.gov (United States)

    Hermida, J S; Jarry, G; Tcheng, E; Moullart, V; Arlot, S; Rey, J L; Schvartz, C

    2004-03-01

    Amioradone-induced hyperthyroidism is a common complication of amiodarone therapy. Although definitive interruption of amiodarone is recommended because of the risks of aggravation of the arrhythmias, some patients may require the reintroduction of amiodarone several months after normalisation of thyroid function. The authors undertook a retrospective study of the effects of preventive treatment of recurrences of amiodarone-induced hyperthyroidism with I131. The indication of amiodarone therapy was recurrent, symptomatic, paroxysmal atrial fibrillation in 13 cases and ventricular tachycardia in 5 cases (M = 14, average age 64 +/- 13 years). The underlying cardiac disease was dilated cardiomyopathy (N = 5), ischaemic heart disease (N = 3), hypertensive heart disease (N = 2), arrhythmogenic right ventricular dysplasia (N = 2) or valvular heart disease (N = 2). Two patients had idiopathic atrial fibrillation. An average dose of 576 +/- 184 MBq of I131 was administered 34 +/- 37 months after an episode of amiodarone-induced hyperthyroidism. Amiodarone was reintroduced in 16 of the 18 patients after a treatment-free period of 98 +/- 262 days. Transient post-radioiodine hyperthyroidism was observed in 3 cases (17%). Sixteen patients (89%) developed hypothyroidism requiring replacement therapy with L-thyroxine. There were no recurrences of amiodarone-induced hyperthyroidism. After 24 +/- 17 months follow-up, the arrhythmias were controlled in 13 of the 16 patients (81%) who underwent the whole treatment sequence. The authors conclude that preventive treatment with I131 is an effective alternative to prevent recurrence of amiodarone-induced hyperthyroidism in patients requiring reintroduction of amiodarone to control their arrhythmias.

  2. Iodine-131 therapy for the treatment of multinodular goitre

    International Nuclear Information System (INIS)

    Akerman, R.L.; Howarth, D.M.

    1997-01-01

    Full text: The purpose of this study was to investigate the effectiveness of 131 l therapy for toxic and non-toxic multinodular goitre (MNG)in the patients treated with the standard dose of 4 x 555 MBq (total 2.2 Bq) and therefore give some indication as to the adequacy of this therapy. This was a retrospective study using information from patients' notes. All patients with large multinodular goitres who had radioiodine therapy for treatment of MNG since 1991 were selected. Data obtained included age, gender, pre, peri and post therapy symptoms and serial biochemical thyroid function results. Each patient was followed for a minimum of six months. The subjects were 35 patients (32 female, three male) with an age range of 37 - 87 years. 26 patients had non-toxic MNG, nine patients had toxic MNG, 24 patients had retrosternal or obstructive symptoms and five patients had had previous thyroid therapy. The patients with retrosternal or obstructive symptoms experienced a reduction in those symptoms. 8.6 per cent of the patients experienced no change at all in symptoms. 2.8 per cent of the patients experienced non-transient side effects (sore throat). 32.8 per cent of the patients experienced transient hyperthyroidism during 131 I therapy. In the toxic group, 77.8 per cent became euthyroid. 11.1 per cent became hypothyroid and 11.1 per cent remained hyperthyroid and required additional treatment. In the non-toxic group, 42.3 per cent became hypothyroid and 57.7 per cent remained euthyroid. The overall incidence of hypothyoidism was 34.4 per cent. The results of this study suggests 131 l therapy in the form of 4 x 555 MBq oral doses (one dose per month for four months) is effective, efficient, relatively risk-free, easy and generally well-tolerated treatment for toxic and non-toxic multinodular goitre

  3. Iodine-131 therapy for the treatment of hyperthyroidism

    International Nuclear Information System (INIS)

    Enkhtuya, B.; Tsevelmaa, L.; Erdenechimeg, S.

    2005-01-01

    Full text: Since 1997, radioactive iodine (I-131) has become the most widely used therapy for patients with hyperthyroidism cased by Graves' disease in the Mongolia. Our seven years clinical experience was reviewed to evaluate the efficacy of the therapy. We treated 150 patients (119 female and 31 male) with hyperthyroidism with I-131 (mean dose 8.2 mCi) between 1997 and 2004. The dose calculation was based on 24 hours thyroid uptake, thyroid gland size and degree of toxicity. We determined their thyroid status after 1 year in relation to age, pretreatment with an antithyroid drug, pretreatment thyroid size and whether or not there are thyroid nodules. Out of the 150 patients, 87(58%) were euthyroid, 30 (20%) hypothyroid at 1 year after treatment, and 33 patients (22%) had persistent hyperthyroidism and required second treatment. The patients who had persistent hyperthyroidism were younger in age, had larger thyroid glands, some of them had thyroid nodules and 27 patients (81%) pretreatment with anti-thyroid drugs for more than 6 months. Our results showed that the majority of patients with Graves' hyperthyroidism had a effective treatment. However, 22% of patients with younger age, larger thyroid glands, patients with thyroid nodules and who had anti-thyroid drugs for more than 6 months had undergone repeated treatment. A higher dose of I-131 maybe advisable in such patients. In order to establish correct treatment dose we may need more precise dosimetry study. (author)

  4. Improved monitoring procedure for Iodine -131 in radiochemical process laboratory

    International Nuclear Information System (INIS)

    Singh, Pratap; Yadav, R.K.B.; Anilkumar, S.; Gopalakrishnan, R.K.; Chakraborty, S.

    2016-01-01

    Radiation Hazard Control Unit at Isotope wing provides radiological safety support and advises for safe processing and production of radiopharmaceuticals. Tellurium Oxide (TeO 2 ), irradiated in a nuclear reactor, is processed in a process laboratory for separating 131 I using dry distillation technique. The workplace environment is being assessed for airborne radioactivity using installed Static Air Samplers (SASs). SASs contains two filter media (glass fibre and charcoal impregnated paper) to collect airborne 131 I radioactivity and laboratory air sampled at 50 litres per minutes (lpm). Personal Air Sampler (PAS) consists of three types of filters viz. a glass fibre, charcoal impregnated paper and cartridges containing activated charcoal granules. Three combinations were studied at a sampling rate of 5 lpm

  5. Mortality in patients treated for hyperthyroidism with iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Hall, P.; Lundell, G.; Holm, L.E. (Karolinska Hospital, Stockholm (Sweden))

    1993-03-01

    Causes of death were studied in 10552 Swedish hyperthyroid patients treated with [sup 131]I diagnosed between 1950 and 1975. The patients were followed for an average of 15 years and were matched with the Swedish cause of death register. A total of 5400 deaths were observed and the overall standardized mortality ratio was 1.47. The standardized mortality ratio for females was 1.50 compared to 1.31 in males. The most common cause of death was from cardiovascular diseases. Significantly elevated risks were also seen for tumours, diseases of the endocrine system, respiratory system, gastro-intenstinal system, and congenital malformations. In all causes of death, except tumours and trauma, decreasing standardized mortality ratios over time were seen. Patients followed for more than 10 years had significantly elevated risks for tumours, diseases of the endocrine, respiratory, and cardiovascular systems. Patients given higher [sup 131]I activity and younger patients had higher standardized mortality ratios than those given lower activity and older patients. The hyperthyroidism per se, rather than the [sup 131]I treatment, appeared to be the major explanation for the elevated mortality. 20 refs., 3 tabs.

  6. Mortality in patients treated for hyperthyroidism with iodine-131

    International Nuclear Information System (INIS)

    Hall, P.; Lundell, G.; Holm, L.E.

    1993-01-01

    Causes of death were studied in 10552 Swedish hyperthyroid patients treated with 131 I diagnosed between 1950 and 1975. The patients were followed for an average of 15 years and were matched with the Swedish cause of death register. A total of 5400 deaths were observed and the overall standardized mortality ratio was 1.47. The standardized mortality ratio for females was 1.50 compared to 1.31 in males. The most common cause of death was from cardiovascular diseases. Significantly elevated risks were also seen for tumours, diseases of the endocrine system, respiratory system, gastro-intenstinal system, and congenital malformations. In all causes of death, except tumours and trauma, decreasing standardized mortality ratios over time were seen. Patients followed for more than 10 years had significantly elevated risks for tumours, diseases of the endocrine, respiratory, and cardiovascular systems. Patients given higher 131 I activity and younger patients had higher standardized mortality ratios than those given lower activity and older patients. The hyperthyroidism per se, rather than the 131 I treatment, appeared to be the major explanation for the elevated mortality. 20 refs., 3 tabs

  7. Cancer risk after iodine-131 therapy for hyperthyroidism

    International Nuclear Information System (INIS)

    Holm, L.E.; Hall, P.; Wiklund, K.; Lundell, G.; Berg, G.; Bjelkengren, G.; Cederquist, E.; Ericsson, U.B.; Hallquist, A.; Larsson, L.G.

    1991-01-01

    Cancer incidence was studied in 10,552 patients (mean age, 57 years) who received 131I therapy (mean dose, 506 MBq) for hyperthyroidism between 1950 and 1975. Follow-up on these patients was continued for an average of 15 years. Record linkage with the Swedish Cancer Register for the period 1958-1985 identified 1543 cancers occurring 1 year or more after 131I treatment, and the standardized incidence ratio (SIR) was 1.06 (95% confidence interval = 1.01-1.11). Significantly increased SIRs were observed for cancers of the lung (SIR = 1.32; n = 105) and kidney (SIR = 1.39; n = 66). Among 10-year survivors, significantly elevated risks were seen for cancers of the stomach (SIR = 1.33; n = 58), kidney (SIR = 1.51; n = 37), and brain (SIR = 1.63; n = 30). Only the risk for stomach cancer, however, increased over time (P less than .05) and with increasing activity administered (P = not significant). The risk for malignant lymphoma was significantly below expectation (SIR = 0.53; n = 11). Overall cancer risk did not increase with administered 131I dose or with time since exposure. The absence of any increase in leukemia adds further support to the view that a radiation dose delivered gradually over time is less carcinogenic than the same total dose received over a short time. Only for stomach cancer was a possible radiogenic excess suggested

  8. Iodine-131 therapy for the treatment of multinodular goitre

    Energy Technology Data Exchange (ETDEWEB)

    Akerman, R.L.; Howarth, D.M. [John Hunter Hospital, Newcastle, NSW, (Australia). Department of Nuclear Medicine

    1997-09-01

    Full text: The purpose of this study was to investigate the effectiveness of {sup 131}l therapy for toxic and non-toxic multinodular goitre (MNG)in the patients treated with the standard dose of 4 x 555 MBq (total 2.2 Bq) and therefore give some indication as to the adequacy of this therapy. This was a retrospective study using information from patients` notes. All patients with large multinodular goitres who had radioiodine therapy for treatment of MNG since 1991 were selected. Data obtained included age, gender, pre, peri and post therapy symptoms and serial biochemical thyroid function results. Each patient was followed for a minimum of six months. The subjects were 35 patients (32 female, three male) with an age range of 37 - 87 years. 26 patients had non-toxic MNG, nine patients had toxic MNG, 24 patients had retrosternal or obstructive symptoms and five patients had had previous thyroid therapy. The patients with retrosternal or obstructive symptoms experienced a reduction in those symptoms. 8.6 per cent of the patients experienced no change at all in symptoms. 2.8 per cent of the patients experienced non-transient side effects (sore throat). 32.8 per cent of the patients experienced transient hyperthyroidism during {sup 131}I therapy. In the toxic group, 77.8 per cent became euthyroid. 11.1 per cent became hypothyroid and 11.1 per cent remained hyperthyroid and required additional treatment. In the non-toxic group, 42.3 per cent became hypothyroid and 57.7 per cent remained euthyroid. The overall incidence of hypothyoidism was 34.4 per cent. The results of this study suggests {sup 131}l therapy in the form of 4 x 555 MBq oral doses (one dose per month for four months) is effective, efficient, relatively risk-free, easy and generally well-tolerated treatment for toxic and non-toxic multinodular goitre.

  9. Low dose iodine-131 therapy in solitary toxic thyroid nodules

    International Nuclear Information System (INIS)

    Prakash, Rajeev

    1999-01-01

    Forty patients with solitary hyperfunctioning thyroid nodules were treated with relatively low dose radioiodine therapy, 131 I doses were calculated taking into account thyroid mass and radioiodine kinetics to deliver 100 μCi/g of estimated nodule weight corrected for uptake. Patients remaining persistently hyperthyroid at four months after the initial therapy were retreated with a similarly calculated dose. Cure of the hyperthyroid state was achieved in all patients, total administered dose in individual cases ranging from 3-17 mCi. 28 of the 40 patients required a single therapy dose. 36 patients were euthyroid after a 4.5 year mean follow-up period. Four cases developed post therapy hypothyroidism requiring replacement therapy. Nodules regressed completely in nine cases following 131 I treatment, with partial regression in size in 19 patients. Control of hyperthyroid state in cases of solitary toxic thyroid nodules can be satisfactorily achieved using relatively low dose radioiodine therapy with low incidence of post therapy hypothyroidism. (author)

  10. Radionuclide therapy of Sipple syndrome using iodine-131 metaiodobenzylguanidine

    International Nuclear Information System (INIS)

    Furusawa, Mitsuhiro; Shimomura, Osamu; Tomiguchi, Seiji; Hirota, Yoshihisa; Takahashi, Mutsumasa; Yamauchi, Jyoji; Iwaoka, Daisuke; Satoh, Tatsuo

    1992-01-01

    A 40-years-old female who had lung and liver metastases from malignant pheochromocytoma was treated with 3.7 GBq 131 I-MIBG (metaiodobenzylguanidine). After the treatment, 131 I-MIBG showed increased uptake in the metastatic lesions of the lung and liver. The size of tumor was no significant change on CT and MRI, but the intensity of liver metastases decreased gradually on MRI. Prior to the treatment, the levels of adrenaline and noradrenaline were high. One to three days after treatment, the level of these laboratory data further increased, but they gradually decreased in 1 to 3 months. These changes may be due to necrosis of tumor tissue. (author)

  11. Study of thyroid function, using iodine 131, in leprosy patients

    International Nuclear Information System (INIS)

    Tatit, E.D.; Carvalho, N.

    1973-01-01

    A study was made in a group of 117 leprosy patients in differents clinical conditions, under treatment, in drug rest or virgins of treatment. They were divided in sub-groups for the following tests: the radioiodine uptake of 2-24 hours; neck-thigh ratio; thyrobinding index; protein-bound radioiodine (PB 131 I) levels of plasma. The results led to the following conclusions: 1) Leprosy patients present a low uptake in conjunction with a decrease in the velocity of thyroid clearance in the majority of the cases. Even the remaining presented values within the low limit of normality; 2) In view of these results, the tests were repeated after thyroid stimulating hormone (TSH) with exogenous TSH, in the sub-group of patients virgin of treatment. With the positive response observed (increase in the uptake, in the neck-thigh ratio and the PB 131 I) the low uptake was considered secondary with regard to a deficit of the endogenous TSH; 3) The TBI and PB 131 I tests were not in sufficient agreement for an appraisal of the phase of organic binding and release of hormone [pt

  12. Evaluation of radiosensitivity and correlation between physical and biological dosimetry in a case of vascular radiology; Valoracion de la radiosensibilidad y correlacion entre dosimetria biologica y fisica en un caso de radiologia vascular

    Energy Technology Data Exchange (ETDEWEB)

    Montoro, A.; Sebastia, N.; Aparici, F.; Candela, C.; Soriano del Castillo, J. M.; Perez, J.; Gras, P.; Cervera, J.; Alonso, O.; Villaescusa, J. I.

    2013-07-01

    The threshold dose required to produce a deterministic effect or even differences in the degree of the effect produced vary between individuals due to idiopathic causes, at the age or underlying disease. According to this work based on the Society of Interventional Radiology and the Guidelines for patient radiation dose management greater than 60 minutes fluoroscopy time management it is an indirect indicator of a significant radiation dose. According to this guide, instructions post procedure in these cases included a follow-up of the patient. (Author)

  13. The comet assay as a dosimetric tool in evaluation of overexposure localized irradiation; El ensayo de cometa como herramienta de la dosimetria biologica en la evaluacion de sobreexposiciones fuertemente localizadas

    Energy Technology Data Exchange (ETDEWEB)

    Giorgio, Marina Di; Taja, Maria R.; Nasazzi, Nora [Autoridad Regulatoria Nuclear, Buenos Aires (Argentina); Bustos, Norma; Cavalieri, Hernan; Bolgiani, Alberto [Fundacion Fortunato Benaim, Buenos Aires (Argentina)

    2001-07-01

    With inhomogeneous exposures, as is characteristic in accidents, the skin may be an important organ in determining clinical prognosis, being dosimetric assessment a necessary requirement. In order to get information to be applied on the evaluation of skin biopsies without culture for an early assessment of irradiation consequences in locally irradiated individuals, contributing with the biophysical techniques, we evaluate the alkaline comet assay (for doses < 5 Gy) as a method for the detection of DNA radiation induced damage in keratinocytes from primary and secondary cultures obtained from medium thickness skin biopsies and epidermal cells, without culture, derived from the same sample of skin biopsies of patients requiring grafts. To extend the dose range (> 5 Gy), neutral comet assay was applied to keratinocytes from primary and secondary cultures and to a suspension of epidermal cells obtained from biopsies irradiated in vitro an afterwards processed to obtain the mentioned cellular suspension, in order to reproduce the closest condition to in vivo overexposure. The correlation of the obtained data with factors of the patient and the corresponding skin graft response, were evaluated. (author)

  14. Activities developed by the biological dosimetry laboratory of the Autoridad Regulatoria Nuclear - ARN of Argentina; Actividades desarrolladas por el laboratorio de dosimetria biologica de la Autoridad Regulatoria Nuclear de Argentina

    Energy Technology Data Exchange (ETDEWEB)

    Radl, A.; Sapienza, C. E.; Taja, M. R.; Bubniak, R.; Deminge, M.; Di Giorgio, M., E-mail: csapienza@arn.gob.ar [Autoridad Regulatoria Nuclear (ARN), Buenos Aires (Argentina)

    2013-07-01

    Biological dosimetry (DB) allows to estimate doses absorbed in individuals exposed to ionizing radiation through the quantification of stable and unstable chromosome aberrations (SCA and UCA). The frequency of these aberrations is referred to a calibration dose response curve (in vitro) to determine the doses of the individual to the whole body. The DB is a necessary support for programs of national radiation protection and response systems in nuclear or radiological emergencies in the event of accidental or incidental, single overexposure or large scale. In this context the Laboratory of Dosimetry Biological (LDB) of the Authority Regulatory Nuclear (ARN) Argentina develops and applies different dosimeters cytogenetic from four decades ago. These dosimeters provide a fact more within the whole of the information necessary for an accidental, complementing the physical and clinical dosimetry exposure assessment. The most widely used in the DB biodosimetric method is the quantification of SCA (dicentrics and rings Central) from a sample of venous blood. The LDB is accredited for the trial, under rules IRAM 301: 2005 (ISO / IEC 17025: 2005) and ISO 19238:2004. Test applies to the immediate dosimetry evaluation of acute exposures, all or a large part of the body in the range 0,1-5 Gy. In this context the LDB is part of the Latin American network of DB (LBDNet), BioDoseNet-who and response system in radiological emergencies and nuclear IAEA-RANET, being enabled to summon the LBDNet if necessary.

  15. Iodine-131 production by a dry method using reactor-irradiated elementary tellurium. Part 1 - Conditions for obtaining iodine emanation and its capture. Part 2 - comparative study of preparation conditions using Pyrex, stainless steel and alumina equipment. Part 3 - production on a semi-industrial scale; Production de l'iode 131 par voie seche a partir de tellure elementaire irradie a la pile. 1ere partie - Etudes des conditions pour obtenir l'emanation de l'iode et le capter. 2eme partie - Etude comparee des conditions pour effectuer cette preparation avec des appareils en Pyrex, en acier inoxydable et en alumine. 3eme partie - production a l'echelle semi-industrielle

    Energy Technology Data Exchange (ETDEWEB)

    Bardy, A; Beydon, J; Murthy, T S; Doyen, J B; Lefrancois, J [Commissariat a l' Energie Atomique, Saclay (France). Centre d' Etudes Nucleaires

    1967-04-15

    A previous report has described how iodine 131 can be prepared from elementary tellurium by a dry method which consists in treating irradiated tellurium at 400 degrees in argon. The possibility of carrying out this treatment in a stainless steel or alumina apparatus has been considered. The behavior of gaseous iodine 131 towards these materials has thus been studied. If the adsorption of iodine on stainless steel is superficial desorption is rapid at 250 degrees in oxygen or 400 degrees in argon. If the adsorption is chemical in nature it becomes necessary to heat to higher temperatures. Adsorption of iodine on alumina is very weak and the iodine can be desorbed rapidly. With these materials tests have been carried out on 300 gms of tellurium containing 41 curies of iodine 131; the yields were very satisfactory ( 98 per cent). (author) [French] La methode de preparation de l iode 131 par voie seche a partir de tellure elementaire decrite dans un precedent rapport consiste a traiter le tellure irradie a 400 degres sous argon. Nous avons examine la possibilite d effectuer ce traitement dans un appareil en acier inoxidable ou en alumine. Le comportement de l iode 131 gazeux vis a vis de ces materiaux a donc ete etudie. Si l adsorption de l iode sur l acier inoxidable est superficielle la desorption est rapide a 250 degres sous oxygene ou 400 degres sous argon. Si la fixation est de nature chimique il est necessaire de chauffer a des temperatures plus elevees. L adsorption de l iode sur l alumine est res faible et l iode peut etre desorbe rapideemnt. En employant ces materiaux des essais ont ete obtenus sur 300 g de tellure contenant 41 curies d iode 131 avec un bon rendement (98 pour cent). (auteur00.

  16. Biological treatment of chemical industry wastewater having toxic components; Degradazione per via biologica di reflui a componenti tossiche prodotti da una industria farmaceutica

    Energy Technology Data Exchange (ETDEWEB)

    Fabbricino, M.; Pepe, G. [Naples Univ. Federico 2., Naples (Italy). Dipt. di Ingegneria Idraulica ed Ambientale Girolamo Ippolito; Scevola, D. [Novartis Farma SpA, Torre Annunziata, NA (Italy); Fiorillo, S. [Impianto di depurazione di Cuma, Napoli Ovest, Licola di Pozzuoli, NA (Italy)

    2001-09-01

    In order to understand the capacity of an existing biomass to front the variations of wastewater influent characteristics and to evaluate the possibility of toxic components removal using biological processes, it is single out the intervention required to obtain the envisage efficiency of the activated sludge phase, following the arrival of toxic components. Together with experimental results on pilot scale, the performance of the industrial treatment plant is presented too, showing the effectiveness of activated carbon dosage in the biological phase to preserve the efficiency of the process despite of influent wastewater toxicity. [Italian] Il lavoro presenta l'indagine sperimentale condotta per rilevare la capacita' di adattamento della biomassa dell'impianto di depurazione di una industria farmaceutica a seguito della variazione delle caratteristiche del liquame influente, e la possibilita' di degradazione, per via biologica, delle componenti tossiche presenti nel refluo. Attraverso prove in scala pilota vengono evidenziati gli effetti causati dall'arrivo di tali componenti su di un impianto di ossidazione a fanghi attivi a regime, e vengono individuati gli interventi da apportare per garantire il raggiungimento degli standard richiesti nell'effluente. I risultati ottenuti vengono estesi all'impianto a scala reale di cui vengono illustrati i rendimenti depurativi in termini di abbattimento del carico inquinante.

  17. Remodelagem do sistema computacional para dosimetria em radioterapia por nêutrons e fótons baseado em métodos estocásticos - SISCODES

    OpenAIRE

    Bruno Machado Trindade

    2011-01-01

    O presente trabalho apresenta a remodelagem do Sistema Computacional para Dosimetria em Radioterapia por Nêutrons e Fótons Baseado em Métodos Estocásticos . SISCODES. Para isso mostra a proposta inicial e estado anterior do sistema, as modificações e expansões propostas e executadas, e o estado atual de desenvolvimento do sistema. Melhorias futuras são propostas ao final do trabalho. O SISCODES é um sistema que permite a execução de planejamento computacional 3D em radioterapia, através de si...

  18. Management of radioactive wastes from HNMD (Hospital Naval Marcilio Dias) and from IRD (Instituto de Radioprotecao e Dosimetria) due to the accident in Goiania

    International Nuclear Information System (INIS)

    Peres, S.S.; Silva, J.J.G.

    1988-01-01

    A description of the methods and procedures for the management of the radwastes from HNMD (Hospital Naval Marcilio Dias) and from IRD (Instituto de Radioprotecao e Dosimetria) due to the radioactive accident at Goiania City, is presented. Basically the radwastes are consituted by excreta of persons involved in the accident and materials used for medicals care of patients. The method employed for treatment of faeces was its aggregation in lime and cement and for the case of urine, ion exchange resing, was used. Others type of radwastes were compacted or simply conditionned. Many releases to the environment, were possible. (author) [pt

  19. Dosimetria e monitoração de feixes estreitos de raios-X, produzidos por acelerador linear de particulas, para aplicação em radiocirurgia

    OpenAIRE

    Jose Carlos Ferraz de Campos

    1986-01-01

    Resumo: O presente trabalho teve como objetivo principal investigar as características principais de dosimetria e monitoração de feixes finos de raios-x, e sua aplicação a um Acelerador Linear de Partículas de 4 MV, para seu emprego na Radiocirurgia. Com esta finalidade, construiu-se um sistema de colimação adicional, composto de 3 colimadores de Chumbo, que permite, a partir do campo mínimo protocolar produzido pelo acelerador, obter os feixes finos de 6, 10 e 15 mm de diâmetros. Um siste...

  20. Diagnosis of Intracranial Lesions by Gamma-Encephalography using Human Serum Albumin Labelled with Iodine-131; Diagnostic des lesions intracraniennes par la gamma-encephalographie a l'aide de la serumalbumine humaine marquee a l'iode 131; Diagnoz vnutricherepnykh povrezhdenij putem gamma-ehntsefalografii pri pomoshchi mechenoj iodom-131 albuminovoj syvorotki cheloveka; Diagnostico de las lesiones intracraneanas por gammaencefalografia mediante sero- albumina humana marcada con yodo-131

    Energy Technology Data Exchange (ETDEWEB)

    Planiol, Therese [Institut National d' Hygiene, Paris (France)

    1959-07-01

    Six hundred patients were examined by means of serum albumin labelled with iodine-131. Radioactivity was read twice with an scintillation counter in contact with the skull, two hours and twenty-four hours after the radioactive injection. Of 175 intracranial tumours, 150 were accompanied by a focus of persistent gamma hyperactivity. Of those not detected by the examination, half were tumours of the hemispheres and half of the posterior fossa and pineal body. Abscesses, haematomata and cirsoid aneurisms were detected. In one-third of the cases acute cerebro-vascular lesions produced abnormal readings, half of which had the peculiar appearance pathognomonic of softening (or thrombosis); the others resembled tumour graphs, the only difference being that the abnormal readings associated with acute vascular lesions disappeared in a few weeks. Two-thirds of these acute lesions were associated with a negative gamma-encephalogram. Arterial aneurisms, non-tumourous epileptogenic foci, and various purely neurological conditions gave normal results in 96 per cent of cases. Brain investigation by radioalbumin can provide valuable information not only on the presence and exact location of a neurosurgical injury but also on its nature. In particular, it seems very likely to detect a meningioma, glioblastoma or metastatic growth. These properties, together with information on positive diagnosis and location, make it a specially useful neurodiagnostic method. Gamma-encephalography also seems likely to be one of the most reliable ways of detecting relapses and of following-up the effects of medical treatment or radiotherapy. (author) [French] 600 malades ont ete examines a l'aide de la serumalbumine marquee a l'iode 131, les mesures de radioactivite etant faites par un compteur a scintillations place au contact du crane, en deux seances, deux heures et vingt-quatre heures apres l'injection radioactive. Sur 175 tumeurs intracraniennes, 150 se sont accompagnees d'un foyer d

  1. Iodine-131 saliva secretion in ablation treatment for thyroid cancer patients

    International Nuclear Information System (INIS)

    Nascimento, Ana C.H.; Brandao, Luis E.; Candeiro, Ricardo E.; Rebelo, Ana M.O.; Corbo, Rossana; Dutra, Janaina

    2008-01-01

    In general, well-differentiated thyroid cancer treatment consists in Na 131 I administration following total or a near total thyroidectomy. The activity of a single administration in the majority of nuclear centers ranges from 1 to 4 GBq for residual thyroid tissue elimination and ranges from 4 to 8 GBq for residual thyroid tissue as well as metastases elimination. The high magnitude of 131 I activities administered for thyroid cancer treatment can lead to side effects, where salivary gland dysfunctions are the most common observed. In the absence of thyroid gland, secondary tissues - iodide specific uptake, mainly the salivary glands, rise at the element body retention process. In addition, among nuclear medicine professionals, there is no consensus about suitable restrictions that must be observed by the hospital released patient to avoid 131 I contamination by saliva. The aim of this study is to evaluate qualitatively the secretion of 131 I by salivary glands after the administration of the radionuclide to thyroid cancer patients for ablation purposes. Well-differentiated thyroid cancer patients from Clementino Fraga Filho University Hospital (HUCFF) of Federal University of Rio de Janeiro (UFRJ) followed-up in the present study are female, adult and without additional health diseases detected. After 131 I administration for ablation purposes, saliva samples were collected systematically and counting rate was assessed using a NaI(Tl) scintillator detector. As the study is at an early stage, the preliminary results concern the possibility of conducting an evaluation of 131 I secreted in saliva using the proposed protocol. It can be seen that many factors have potential to influence the behaviour of 1 31 I secretion in saliva, for example the use of Na 131 I in solution or in capsules. It was observed two standards that can be defined according to these variables. (author)

  2. Comparison of two spreadsheets for calculation of radiation exposure following hyperthyroidism treatment with iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Vrigneaud, J.M. [CHU Bichat, nuclear medicine department, 75 - Paris (France); Carlier, T. [CHU Hotel Dieu, nuclear medicine department, 44 - Nantes (France)

    2006-07-01

    Comparison of the two spreadsheets did not show any significant differences provided that proper biological models were used to follow 131 iodine clearance. This means that even simple assumptions can be used to give reasonable radiation safety recommendations. Nevertheless, a complete understanding of the formalism is required to use correctly these spreadsheets. Initial parameters must be chosen carefully and validation of the computed results must be done. Published guidelines are found to be in accordance with those issued from these spreadsheets. Furthermore, both programs make it possible to collect biological data from each patient and use it as input to calculate individual tailored radiation safety advices. Also, measured exposure rate may be entered into the spreadsheets to calculate patient-specific close contact delays required to reduce the dose to specified limits. These spreadsheets may be used to compute restriction times for any given radiopharmaceutical, provided that input parameters are chosen correctly. They can be of great help to physicians to provide patients with guidance on how to maintain doses to other individuals as low as reasonably achievable. (authors)

  3. Radiation exposure to family members of patients with thyrotoxicosis treated with iodine-131

    International Nuclear Information System (INIS)

    Cappelen, Tone; Amundsen, Anne Lise; Kravdal, Gunnhild; Unhjem, Jan Frede; Foelling, Ivar

    2006-01-01

    The purpose of this study was twofold: (1) to measure the radiation exposure to family members of out-patients with thyrotoxicosis treated with radioiodine, 131 I, using the recommendations from the European Commission (EC) guidance and age-specific periods for behaviour restrictions; (2) to use the results to identify necessary restrictions to ensure recommended dose constraints. The study population comprised 76 family members (46 adults and 30 children below the age of 18) of 42 patients. The patients were treated with an average activity of 417 MBq (range 260-600 MBq). They received oral and written EC recommendations about behaviour restrictions (translated into Norwegian). On the day of treatment we repeated the oral instructions to the patient and an adult family member. The time periods for restrictions were 14 days for children aged 0-10 years, 7 days for persons aged 11-59 years and 3 days for persons aged 60 years and older. Family members wore a thermoluminescent dosimeter (TLD) on each wrist day and night for 2 weeks. The doses received were adjusted to give an estimate of the expected values if the TLDs had been worn indefinitely. Radiation doses well below the recommended dose constraints were measured for all adult family members and children, except one 2-year-old child; in the latter case the mother probably did not comply with the instructions given. The radiation dose to family members of thyrotoxic patients treated with up to 600 MBq of radioiodine is well below recommended dose constraints if EC instructions are given and compliance is adequate. The duration of restrictions for various age groups used in this study may be considered when establishing guidelines in Norway. (orig.)

  4. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart

    International Nuclear Information System (INIS)

    Nakajo, M.; Shimabukuro, K.; Yoshimura, H.; Yonekura, R.; Nakabeppu, Y.; Tanoue, P.; Shinohara, S.

    1986-01-01

    In order to establish the appropriate time for [ 123 I]MIBG human myocardial imaging to assess the adrenergic nerve activity, the time courses of metaiodobenzylguanidine (MIBG) intra- and extravesicular accumulation in the rat heart were estimated by using [ 131 I]MIBG and reserpine. In the heart, the intravesicular accumulation was relatively constant, while the extravesicular accumulation decreased rapidly from 5 min to 6 hr. The intravesicular percentage of the total cardiac tissue concentration reached a plateau value of 50% at 4 hr after i.v. injection of [ 131 I]MIBG. In the spleen, similar time courses were observed as those in the heart, both of these organs being richly innervated by adrenergic nerves. Along with the time activity difference previously observed in the human hearts, these results suggest that at 4 hr post i.v. injection, [ 123 I]MIBG myocardial imaging will best express the neuronal accumulation of the tracer and may be useful for the assessment of adrenergic function in various pathological conditions of the human heart

  5. Iodine-131 in milk 1961-62 and in thyroid glands of cattle and sheep 1962

    International Nuclear Information System (INIS)

    Hvinden, T.; Lillegraven, A.

    1976-03-01

    Cases of late effects from radioactive iodine uptake in children have renewed interest in this contaminant. I-131 data collected in Norway during periods following the nuclear weapons test series in 1961 and 1962 have been re-examined and collated with more recent data on natural iodine in the milk and thyroid glands from domestic animals. Some of the measured values may be interpreted as indications of an inverse relationship between the level of natural iodine and the uptake of I-131, but the material is too small and inconsistent to draw any conclusions. Obviously the uptake and concentration of I-131 in animal milk and thyroid glands are influenced by many factors besides the fallout amounts; at present it is not possible to determine their relative importance and set up a satisfactory model for the I-131 uptake. (Auth.)

  6. Biological dosimetry in patients with differenced thyroid carcinoma treated with Iodine-131

    International Nuclear Information System (INIS)

    Vallerga, M.; Taja, Maria R.; Radl, A.; Rojo, Ana M.; Deluca, G.; Di Giogio, Marina; Fadel, A.; Chebel, G.; Oneto, A.; Cabrejas, Mariana

    2007-01-01

    The differentiated thyroid carcinoma (DTC), constitutes the 90 % of the thyroid gland cancers. 80% of patients are cured after the initial therapy and 12% remained disease-free after successive treatments. The 24 patients included in this study represent a sample of the aforementioned 12% and 8%, with recurrence in the first decade post-treatment (local disease and/or recurrence at distance). The internal radiotherapy with 131 I in patients with DTC is used within the therapeutic schema as a step post-thyroidectomy. The success of the therapy is to get a lethal dose in the tumor tissue, which depends on the therapeutic activity and the retention of 131 I, without exceeding the dose of tolerance in healthy tissues. The most widespread way of administration is the empirical prescription which considers the clinical and laboratory parameters for its determination. In this work, the treatment protocol applied incorporates assessment by biological (DB) and internal (DI) dosimetry for estimating absorbed dose to the whole body and bone marrow to manage a personalized therapeutic dose for each patient. The biological dose estimation is based on the quantification of chromosomal aberrations, which is often referred to a dose-response curve in which lymphocytes are irradiated in vitro with 131 I, allowing to determine the dose in vivo of circulating lymphocytes patients [es

  7. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma

    International Nuclear Information System (INIS)

    Boucher, Eveline; Garin, Etienne; Guylligomarc'h, Anne; Olivie, Damien; Boudjema, Karim; Raoul, Jean-Luc

    2007-01-01

    Background/Aim: The therapeutic effect of intra-arterial injection of 131-iodine-labeled lipiodol for treatment of hepatocellular carcinoma in palliative or adjuvant settings has been promising. We report, the results of an open study of this therapy in cirrhotic patients with small hepatocellular carcinoma. Patients and method: Forty patients with hepatocellular carcinoma were given intra-arterial injections of 131-iodine-labeled lipiodol. These injections were repeated if necessary every 3 months. Tumor response (WHO criteria) was determined on CT scans performed after each treatment and every 3 months during the follow-up. Side effects and the cause of death were recorded. Therapeutic response and survival were analyzed. Results: The median number of treatment was 2 (1-4). There was one complete response, 18 partial responses (47.5% response rate); 19 had stable disease and 2 progressions. Overall survival rates (±CI 95%) at 1, 2 and 3 years were: 90 ± 4.7%, 60.3 ± 8%, and 39 ± 8.3%, respectively. Median survival was 27 months; 25 patients have died (4-56 months), 8 of tumor progression with a multifocal spread in the liver. Tolerance was good except for 2 patients who develop a fatal drug-related pulmonary insufficiency. Conclusion: These data suggest that intra-arterial therapeutic injection of 131-iodine-labeled lipiodol for treatment of hepatocellular carcinoma can provide high rate response and long survival for individuals not eligible for surgery or local treatment

  8. Iodine-131 uptake in a patient with thyroid cancer and rheumatoid arthritis during acupuncture treatment

    International Nuclear Information System (INIS)

    Otsuka, N.; Fukunaga, M.; Morita, K.; Ono, S.; Nagai, K.; Katagiri, M.; Harada, T.; Morita, R.

    1990-01-01

    A patient with thyroid carcinoma had abnormal accumulation of I-131 in the areas of both feet and hands on whole body scan. The sites of abnormal accumulation of I-131 were similar to those on bone scintigraphy. The radiographic examination of the lesions showed characteristic findings of rheumatoid arthritis, and the presence of small gold needles for acupuncture treatment was demonstrated. There were no findings of bone metastases. Although the mechanism of accumulation of I-131 in this patient is unknown, interpreters of I-131 whole body scintigraphs should keep this case in mind when acupuncture treatment has been done. The authors can only speculate on a common blood flow mechanism for enhanced HMDP and I-131 uptake in this arthritic patient who had been treated by acupuncture

  9. Occupational and public radiation protection in the treatment with iodine 131

    International Nuclear Information System (INIS)

    Di Trano, Jose L.; Rojo, Ana M.; Kunst, Juan J.

    2004-01-01

    A common radionuclide therapy carried out by nuclear medicine departments is the administration of 131 I for thyroid ablation and for hyperthyroid treatment. The administration of 140 a 600 MBq for hyperthyroid treatment and 3700 a 7400 MBq for carcinoma diseases is made after surgery to ablate thyroid tissues and metastasis. The revision of radiological protection was done on the occupational exposure of workers, members of the public and relatives of patients treated with 131 I. This paper presents the results of area and individual dosimetry to external exposure, surface activity and air concentration of 131 I carried out during the practice in the nuclear medicine department. An area survey in the isolation room allowed to determine exposure rate from surface activity and air concentration of 131 I. The patient clothes activity was determined as well as the activity excreted in urine and sweat. On the basis of this analysis, can be concluded that the annual effective dose for workers due to external and internal exposure, considering 40 iodine practice per year, reach values from 4 up to 30 mSv per year. The patients with cancer therapy treatment must be hospitalized during the first 48 hrs after iodine administration, in an isolated room taking into account the radioprotection of the staff, others patients and public during the isolation. The patients with hyperthyroid treatment do not need hospitalization but they must to follow the instructions given by the physician, which will take into account socioeconomic conditions. (author)

  10. Biodistribution and scintigraphy of iodine-131-iododeoxyadenosine in rats bearing breast cancer

    International Nuclear Information System (INIS)

    Kim, Seon Gu; Kim, Chang Guhn; Lee, Kang Mo

    1998-01-01

    I-131 labeled (2'-deoxy-2'-iodo-β-D-arabinofuranosyl) adenine (IAD) may be involved in DNA synthesis during active proliferation of tumor cells. We conducted this study to find out the biodistribution of IAD and it's feasibility for scintigraphic tumor imaging. Tosyl acetyl-adenosine was dissolved in acetonitrile, and I-131-NaI was added and heated to synthesize IAD. Female Fisher 344 rats inoculated with breast tumor cells were injected with 0.27 MBq of IAD. Rats were sacrificed at 0.5, 1, 2, 4, 24h and the % of injected dose per gram of tissue (%ID/g) was determined. For scintigraphy, rats bearing breast cancer were administered with 1.11 MBq of IAD and imaging was performed after 2 and 24h. Then, rat body was fixed and microtomized slice was placed on radiographic film for autoradiography. %ID/g of tumor was 0.74 (0.5h), 0.73 (1h), 0.55 (2h), 0.38 (4h), and 0.05 (24h), respectively. At 1h after injection, %ID/g of tumor was higher than that of heart (0.51). However, %ID/g of tumor was lower than blood (1.06), lung (0.77), and thyroid (177.71). At 4h, %ID/g of tumor in comparison with other tissue did not change. Tumor contrast expressed by tumor to blood ratio was 0.69 and tumor to muscle ratio was 5.11 at 1h. However, these ratios did not improve through 24h. On autoradiogram and scintigraphy at 2 and 24 hour, the tumor was well visualized. This results suggest that IAD may have a potential for tumor scintigraphy. However, further work is needed to improve localization in tumor tissue

  11. Optimizing a single fixed dose of Iodine-131 in Graves' Disease (An Experience)

    International Nuclear Information System (INIS)

    Khan, S.H.

    2007-01-01

    Full text: Kashmir is a Himalayan mountain state of India enclosed by high snow capped ridges of Pir Panjal Mountains at an average height of 4000-5000 meters above the sea level. For most of the 4 million inhabitants in this land locked valley, agriculture horticulture and handcrafts are the main source of income. Due to long and severe winters the terraced farming on the mountain slopes yield just a single crop of rice which is barely sufficient to meet the local needs of this staple diet. People are relatively poor with low annual per capita income. Goiter is endemic in the Valley of Kashmir. In a published report the overall prevalence of goiter among the school going children in Kashmir between the ages of 5 years is 45.2% (+ SEM) with urinary iodine excretion of 49 + 3.55 μg per gram of creatinine. The extremely shy people of Kashmir are casual towards the aesthetic aspects of their goiters but nevertheless seek medical advice when associated with physical symptoms. In a published study of 203 patients of thyrotoxicosis from Kashmir, Graves' disease was the commonest cause, accounting for 63% of patients. One hundred and twentyone patients of Graves' disease were prospectively studied for their response to a single fixed dose of I-131. Patients were randomly treated with two different fixed doses of I- 131. Sixty four patients belonging to Group-I received a fixed dose of 185 MBq (Low Dose) and 57 patients belonging to Group -2 received 370 MBq (High Dose) of I- 131. Following therapy all patients were evaluated at 3 months. Patients with normal or reduced thyroid hormone levels were termed as responders and those with persistently elevated levels of thyroid hormone were termed as non responders. The response rates among the two groups were analyzed for their statistical significance. Patients treated with the high fixed dose of 370 MBq revealed good response to therapy achieving a rate of 91.22%, while the response rate in the group of patients treated with low fixed dose of 185 MBq of I-131 was found to be significantly lower at 59.37%. On further analysis it was observed that the higher single fixed dose yielded a significantly higher cure rates irrespective of age, sex, thyroidal radioactive iodine uptake and pre-treatment hormonal status. There was no significant difference in the overall incidence of post-131 hypothyroidism at the end of 1 and 5 yeas following I-131 low or high single fixed dose of I-131. A steady rise in the percentage of patients becoming hypothyroid was noted between the 1 and 5 year period. The overall incidence of hypothyroidism at one and five years following I-131 therapy was found to be 48.76% and 82.64% respectively. The incidence of hypothyroidism appears to be higher in the present study, in comparison to several results reported in literature. This could be attributed to increased avidity of radioiodine to the available body iodine pool in the people living in the endemic area of iodine deficiency. Based on the results of this study we conclude that in an endemic area of iodine deficiency, a high single fixed dose of I-131 yields a higher cure rate as in non- endemic areas but the incidence of post I-131 hypothyroidism appears to be higher. However, this should not discourage physicians from choosing-I-131 as the first line of therapy for hyperthyroidism, considering the fact that hypothyroidism is easily managed by thyroid hormone supplementation, is cost effective and lastly, it (hypothyroidism) is part of the natural history of Graves' disease. (author)

  12. Effects of Glycosylation on Biodistribution and Imaging Quality of Necrotic Myocardium of Iodine-131-Labeled Sennidins.

    Science.gov (United States)

    Li, Ling; Zhang, Dongjian; Yang, Shengwei; Song, Shaoli; Li, Jindian; Wang, Qin; Wang, Cong; Feng, Yuanbo; Ni, Yicheng; Zhang, Jian; Liu, Wei; Yin, Zhiqi

    2016-12-01

    Sennidins are necrosis-avid agents for noninvasive assessment of myocardial viability which is important for patients with myocardial infarction (MI). However, high accumulation of radioactivity in the liver interferes with the assessment of myocardial viability. In this study, we compared sennidins with sennosides to investigate the effects of glycosylation on biodistribution and imaging quality of sennidins. Sennidin A (SA), sennidin B (SB), sennoside A (SSA), and sennoside B (SSB) were labeled with I-131. In vitro binding to necrotic cells and hepatic cells and in vivo biodistribution in rats with muscular necrosis were evaluated by gamma counting, autoradiography, and histopathology. Single photon emission computed tomography/computed tomography (SPECT/CT) images were acquired in rats with acute MI. The uptake of [ 131 I]SA, [ 131 I]SSA, [ 131 I]SB, and [ 131 I]SSB in necrotic cells was significantly higher than that in viable cells (p sennosides than those with [ 131 I]sennidins (p < 0.01). Autoradiography showed preferential accumulation of these four radiotracers in necrotic areas of muscle, confirmed by histopathology. SPECT/CT imaging studies showed better image quality with [ 131 I]SSB than with [ 131 I]SB due to less liver interference. Glycosylation significantly decreased the liver uptake and improved the quality of cardiac imaging. [ 131 I]SSB may serve as a promising necrosis-avid agent for noninvasive assessment of myocardial viability.

  13. Plant iodine-131 uptake in relation to root concentration as measured in minirhizotron by video camera:

    International Nuclear Information System (INIS)

    Moss, K.J.

    1990-09-01

    Glass viewing tubes (minirhizotrons) were placed in the soil beneath native perennial bunchgrass (Agropyron spicatum). The tubes provided access for observing and quantifying plant roots with a miniature video camera and soil moisture estimates by neutron hydroprobe. The radiotracer I-131 was delivered to the root zone at three depths with differing root concentrations. The plant was subsequently sampled and analyzed for I-131. Plant uptake was greater when I-131 was applied at soil depths with higher root concentrations. When I-131 was applied at soil depths with lower root concentrations, plant uptake was less. However, the relationship between root concentration and plant uptake was not a direct one. When I-131 was delivered to deeper soil depths with low root concentrations, the quantity of roots there appeared to be less effective in uptake than the same quantity of roots at shallow soil depths with high root concentration. 29 refs., 6 figs., 11 tabs

  14. Determination of intake and internal radiation dose for occupationally exposed workers to iodine 131

    International Nuclear Information System (INIS)

    Kharita, M. H.; Maghrabi, M.; Sadyya, A.

    2004-12-01

    Workers who prepare and inject radioactive Iodine I 131 doses at the medical centers in Syria are potentially exposed to the radioactive intake by ingestion or inhalation during preparation or injection processes. The received amount of the radioactive intake differs according to the amount of the I 131 that released during the preparation or injection processes, and to the work conditions and the applying ways of the radiation protection principles. Because of this radioactive intake, the thyroid gland may expose to amounts of I 131 which may negatively affect the health of the workers, so it is necessary to make routine monitoring for all workers who receive an intake of more than 10% of the annual intake limit which is (2*10 6 Bq/y) for I 131 . To make this monitoring process, it is necessary to use either the thyroid gland counter in order to know the concentrated amount of the radioactivity in the gland, or the analysis of a 24 hours urine sample of the exposed workers to determine the eliminated amount of the radioactivity using gamma spectrometry, also the two processes can be applied at the same time. Since the thyroid gland counter is not available, the analysis of urine sample was done to determine the concentrated amount of the radioactivity in urine, then to estimate the radioactive intake and the internal radioactive dose. The results of applying this method dictated that some workers work in safe conditions according to the radiation protection and there is no need for them to make routine monitoring . But the other workers receive a radioactive intake of about 10% yearly of the annual intake limit and that requires a routine periodical monitoring for those workers in addition to the necessity of applying the principles of the radiation protection during the work with I 131 . These principles and systems should indicate the basic requirement of radiation protection that must be available in the laboratory that deal with I 131 either for therapy or for diagnosis. (Authors)

  15. New bisphosphonate labeled with Iodine-131 for the palliative therapy for bone metastases pain

    International Nuclear Information System (INIS)

    Prats Capote, Anaís; Perera Pintado, Alejandro; León, Mariela; Hernández González, Ignacio; Leyva Montaña, René; Mocelo Castell, Raúl; O'Reilly, Beatriz; Calderón, Osmar; Griffith Pérez, Yoel; García Batle, Marisé; Rodríguez Tanty, Chryslaine

    2016-01-01

    The aim of this work was to obtain new bisphosphonate marked with 131I suitable for palliative treatment of bone metastases pain characteristics. Materials and Methods: It started with aromatic amino acids and the synthesis consisted of three stages: 1) Protection of amino groups by acetylation; 2) phosphonation protected amino acids with a mixture of phosphorous acid and phosphorus pentachloride; 3) Lack of protection of the amino groups by basic hydrolysis. The compounds obtained were characterized by IR, 1H NMR, RMN13-C mass. Los spectrometry bisphosphonic acids obtained were labeled with 131I using chloramine T and iodogen as oxidants. Stability of labeled compounds in aqueous solution was studied serum. 3 mg of 2-amino-3- (4-hydroxyphenyl) -1-hydroxypropyl-1,1-bisphosphonic acid labeled of 131I were administered to male wistar rats (170-190 g) through a lateral tail vein. The scintigraphic study was conducted at 2, 6 and 12 hours. Results: The yield of the reactions of the amino group protection four compounds ranged from 75 to 80%, while the phosphonation was between 50 and 60%. The radiochemical purity of 2-amino-3- (4-hydroxyphenyl) -1-hydroxypropyl-1,1- bisphosphonic acid labeled with 131I was (91.5 ± 1.4)% and its stability was satisfactory for 72h. Scintigraphic images suggest excretion by the kidneys of the compound and from 12 h post-administration begin to visualize bone structures of the animal, suggesting that the compound exhibits affinity for these tissues. Conclusions: A novel synthesis method with modifications that yielded the sodium salts of bisphosphonic acids starting from the respective aromatic amino acids was developed. 2-amino-3- (4-hydroxyphenyl) -1-hydroxypropyl-1,1-bisphosphonic acid 131I labeled was stable up to 72h and showed affinity for bone tissue. (author)

  16. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975

    International Nuclear Information System (INIS)

    Holm, L.E.

    1982-01-01

    The incidence of hypothyroidism was analyzed in 4,553 hyperthyroid patients treated with I-131 between 1951 and 1975. The average annual rate of hypothyroidism during the first 7 yr after therapy increased continuously for each 5-yr period of treatment, from 3.6% for patients treated between 1951 and 1955 to 7.7% for patients treated during the period from 1971 through 1975 (p<0.001). The increase in the incidence of hypothyroidism was seen before the introduction of TSH assays and when allowance was made for thyroid gland size, the age of the patient, and the experience of the radiotherapist. The use of TSH assays has probably resulted in an earlier recognition of hypothyroidism, which may explain why the most marked rise in the incidence of hypothyroidism was observed after the introduction of TSH assays

  17. Labelling of human serum albumin with iodine-131 for diagnosis in nuclear medicine

    International Nuclear Information System (INIS)

    Silva Valente Goncalves, R. da.

    1979-01-01

    Labelling of 131 I-human serum albumin with I-131 from a solution of 131 I-sodium iodide using chloramine T as an oxidant agent is studied. Parameters which can influence on the labelling yield like mass of human serum albumin, and chloramine T, pH of the reaction, reaction time and activity of 131 I are also studied. The purification of the labeled product by means of IRA-410 Amberlite ion-exchange resin in chloride form and the sterilization of the 131 I-human serum albumin by its passage through a 0,22μ millipore filter are carried out. The radiochemistry control of the final product by paper chromatography and the microbiological control by cultivation of microorganisms in fluid medium: nutrient broth, sodium thioglycollate broth and Sabouraud, are performed. The stability of the radiopharmaceutical until ten days after its preparation is analysed by means of radiochemical control. (Author) [pt

  18. Kinetics of Iodine 131 labelled fibrinogen in cancerous patients. Pharmacological study

    International Nuclear Information System (INIS)

    Boneu-Valmalette, Andree; Bugat, Roland; David, J.-F.; Combes, P.-F.

    1977-01-01

    The results obtained in a previous study using 131 I fibrinogen in cancerous patients suggested a local intravascular clotting process. In order to elucidate the mechanism of fibrinogen kinetic abnormalities different drugs including heparin, prednisone, ticlopidin, aspirin and indomethacin were administred in 68 patients and their effects evaluated by change in the 131 I fibrinogen disappearance rate. The results suggest that these drugs may counteract with the early stages of coagulation (kinin-forming system, factor XII) and that abnormal 131 I fibrinogen kinetic in cancer would be a non specific phenomenon [fr

  19. Radiological accident with Iodine-131 in the Radioisotope Division at IPEN-CNEN/SP (Brazil)

    International Nuclear Information System (INIS)

    Sanches, Matias Puga; Rodrigues, Demerval Leonidas

    1997-01-01

    The accident occurred in the first week of May 1995, in the Radioisotope Division-TPI, involving two tubes containing a total volume of 3 ml, aqueous solution of N Al 1 31, with 370 MBq and 1480 MBq activity is reported. Part of installation and six workers involved in the distribution process were contaminated with 131 I, but there were no contamination outside the building. The workers were decontaminated and the received radiation doses were evaluated by the Radiotoxicological Laboratory of IPEN-CNEN/SP together with IRD-CNEN/RJ. The building involved was closed and the activities stopped until the complete decontamination by the Radioprotection experts of IPEN-CNEN/SP. (author)

  20. Evaluation of biological analysis program for iodine 131; Avaliacao do programa de bioanalise para Iodo-131

    Energy Technology Data Exchange (ETDEWEB)

    Gaburo, J.C.; Todo, A.S.; Potiens Junior, A.; Oliveira, E.M.; Sordi, G.M.A.A. [Instituto de Pesquisas Energeticas e Nucleares (IPEN), Sao Paulo, SP (Brazil)

    1997-12-31

    A program for the occupational control of internal contamination for the Radioisotopes Division workers of the IPEN-CNEN/SP has been performed by in vitro and in vivo bioassay techniques, every two weeks. From the assessment of the monitoring program, two groups of workers were identified in accordance with their activities and handling frequency {sup 131} I. The groups A and B are exposed five and three days respectively every week. In this program, urinalysis methods, thyroid and whole body measurements have been evaluated over the year. The sampling scheme, performed every two week, was altered for weekly, in order to minimize the interpretation errors and to get a better estimative of the intake. This study also provides and evaluation of the cost for the weekly urinalysis sampling method. (author) 6 refs., 1 fig.; e-mail: janetegc at net.ipen.br

  1. Changing annual incidence of hypothyroidism after iodine-131 therapy for hyperthyroidism, 1951-1975

    International Nuclear Information System (INIS)

    Holm, L.E.

    1982-01-01

    The incidence of hypothyroidism was analyzed in 4,553 hyperthyroid patients treated with I-131 between 1951 and 1975. The average annual rate of hypothyroidism during the first 7 yr after therapy increased continuously for each 5-yr period of treatment, from 3.6% for patients treated between 1951 and 1955 to 7.7% for patients treated during the period from 1971 though 1975 (p less than 0.001). The increase in the incidence of hypothyroidism was seen before the introduction of TSH assays and when allowance was made for thyroid gland size, the age of the patient, and the experience of the radiotherapist. The use of TSH assays has probably resulted in an earlier recognition of hypothyroidism, which may explain why the most marked rise in the incidence of hypothyroidism was observed after the introduction of TSH assays

  2. Permanent Hypothyroidism after Radioactive Iodine(131I) Treatment in Diffuse Toxic Goiter

    International Nuclear Information System (INIS)

    Park, Soon Yang; Lee, Jung Sang; Lee, Hong Kyu; Koh, Chang Soon; Lee, Mun Ho

    1977-01-01

    Radioactive iodine (RAI), principally 131 I, effectively controls hyperthyroidism in the majority of patients. The subsequent development of hypothyroidism, however, has been of increasing concern since it was first pointed out by Chapman and Maloof in 1955. And the steady increase of late hypothyroidism during the passage of time was known with its relation with dosage of RAI. The authors have investigated the development of hypothyroidism in 935 patients with diffuse toxic goiter (DTG) who were treated with RAI ( 131 I) at the Seoul National University Hospital from 1960 to 1977 to reveal its relation with the number of RAI treatments, dosage of RAI, age of patients and exophthalmos with the following results. 1) The incidence of hypothyroidism by year after RAI therapy among 631 patients with DTG who were treated with single RAI regimen was 7.4% (1 year), 11.8% (2 year), 16.2% (3 year), 22.1% (4 year) and 25.5% (5 year), and that among 163 patients given multiple RAI treatments was 8.6% (1 year), 10.4% (2 year), 13.3% (3 year), 29.1% (4 year), and 54.1% (5 year) respectively showing much higher yearly increments from 4 years after RAI treatment in comparison with the former. 2) Among 550 patients in the lower dose group treated with single RAI regimen less than 5.0 mCi (Mean±S.D.: 4.3±0.6 mCi), the incidence of hypothyroidism by year after RAI treatment was 6.8% (1 year), 11.4% (2 year), 15.4% (3 year), while among 81 patients in the higher dose group given single RAI treatment not less than 5.5 mCi (Mean±S.D.: 6.3±0.5 mCi) it was 12.0% (1 year), 15.4% (2 year) and 20.4% (3 year) respectively. However, the duration till euthyroid state after RAI therapy in the two groups was 5.1±3.6 months and 4.8±2.8 months respectively showing no statistically significant difference (p>0.1). 4) The incidence of hypothyroidism after RAI treatment in patients younger than 30 years of age was 4.3% (1 year) and 7.7% (2 year); in patients from 30 years to 49 years of age, 5.8% (1 year) and 11.1% (2 year); and in those older than 50 years, 11.0% (1 year) and 14.4% (2 year). The data revealed rising incidence of hypothyroidism with increase of patients' age. 5) Among 116 patients with exophthalmos the incidence of hypothyroidism by year after RAI treatment was 7.1% (1 year) and 12.15 (2 year) while that among 184 patients without exophthalmos was 7.3% (1 year) and 12.2% (2 year) respectively. With the above data the authors could conclude that the hypothyroidism in patients with DTG who were treated by RAI developed more frequently than reported by others in Korea till now, and increased with the passage of time, the yearly increments from 4 years after RAI treatment increasing markedly in the multiple dose group, and the incidence could be reduced by decreasing the administered RAI dose not increasing the duration till euthyroid state after RAI therapy.

  3. Iodine 131 labeled GD2 monoclonal antibody in the diagnosis and therapy of human neuroblastoma

    International Nuclear Information System (INIS)

    Cheung, N.K.V.; Miraldi, F.D.

    1988-01-01

    High dose marrow ablative therapy followed by autologous bone marrow transplantation (ABMT) has prolonged survival in patients with neuroblastoma. Total body and focal irradiation play an integral role in the overall treatment of this disease. The biological basis for radiation is the radiosensitivity and the lack of sublethal repair in neuroblastoma cells. However, radiation therapy has not by itself been adequate because of the usual widespread nature of neuroblastoma and the inability to achieve selective tumor versus normal tissue delivery, especially at multiple tumor sites. Monoclonal antibodies are agents selected for their specificity for human tumors. In vivo they have the ability of targeting selectively to occult metastases. This paper discusses how the availability of radioisotopes and the development of conjugation chemistries have greatly expanded the potentials of these antibodies

  4. Lutetium-177 and iodine-131 loaded chelating polymer microparticles intended for radioembolization of liver malignancies

    Czech Academy of Sciences Publication Activity Database

    Hrubý, Martin; Škodová, Michaela; Macková, Hana; Skopal, Jan; Tomeš, Marek; Kropáček, Martin; Zimová, Jana; Kučka, Jan

    2011-01-01

    Roč. 71, č. 12 (2011), s. 1155-1159 ISSN 1381-5148 R&D Projects: GA ČR GPP207/10/P054; GA MŠk 1M0505 Institutional research plan: CEZ:AV0Z40500505; CEZ:AV0Z10480505 Keywords : macroporous chelating beads * radioembolization * quinoline-8-ol Subject RIV: CD - Macromolecular Chemistry Impact factor: 2.479, year: 2011

  5. Numerical simulations of atmospheric dispersion of iodine-131 by different models.

    Directory of Open Access Journals (Sweden)

    Ádám Leelőssy

    Full Text Available Nowadays, several dispersion models are available to simulate the transport processes of air pollutants and toxic substances including radionuclides in the atmosphere. Reliability of atmospheric transport models has been demonstrated in several recent cases from local to global scale; however, very few actual emission data are available to evaluate model results in real-life cases. In this study, the atmospheric dispersion of 131I emitted to the atmosphere during an industrial process was simulated with different models, namely the WRF-Chem Eulerian online coupled model and the HYSPLIT and the RAPTOR Lagrangian models. Although only limited data of 131I detections has been available, the accuracy of modeled plume direction could be evaluated in complex late autumn weather situations. For the studied cases, the general reliability of models has been demonstrated. However, serious uncertainties arise related to low level inversions, above all in case of an emission event on 4 November 2011, when an important wind shear caused a significant difference between simulated and real transport directions. Results underline the importance of prudent interpretation of dispersion model results and the identification of weather conditions with a potential to cause large model errors.

  6. Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs.

    Science.gov (United States)

    Abma, E; Peremans, K; De Vos, F; Bosmans, T; Kitshoff, A M; Daminet, S; Ni, Y; Dockx, R; de Rooster, H

    2018-01-04

    Hypericin (Hyp) is a necrosis-avid compound that can be efficiently labelled with radioiodine for both diagnostic and therapeutic purposes. Before 131 I-Hyp can be considered as a clinically useful drug in a combination therapy for canine cancer patients, evaluation of its toxicity is necessary. The aim of this study was to investigate the biodistribution and tolerance of a single dose administration of 131 I-Hyp. Three healthy dogs were included. 131 I-Hyp at a dose of 0.2 mg/kg and an activity of 185 MBq was intravenously injected. The effects on physical, haematological and biochemical parameters were characterized and the biodistribution and elimination pattern, the effective half-life and dose rate were assessed. Drug-related adverse events were limited to mild gastrointestinal signs, resolving within 48 hours. No significant differences were found in blood haematology and serum biochemistry before and after treatment. Following administration, highest percentage of injected dose (%ID ± SD) was found in the liver (5.5 ± 0.33), the lungs (4.17 ± 0.14) and the heart (3.11 ± 0.78). After 24 hours, highest %ID was found in colon (4.25 ± 1.45) and liver (3.45 ± 0.60). Clearance from all organs was effective within 7 days. Effective half-life was established at 80 hours, and the dose rate fell below <20 μSv/h at 1 m within 1 day. The current study reveals that single dose treatment with 131 I-Hyp at the described dose is well tolerated by healthy dogs and supports the use of radioiodinated hypericin in a combination therapy for canine cancer patients. © 2018 John Wiley & Sons Ltd.

  7. Radiation Exposure to Relatives of Patients Treated with Iodine-131 for Thyroid Cancer at Siriraj Hospital

    International Nuclear Information System (INIS)

    Tonnonchiang, S.; Sritongkul, N.; Chaudakshetrin, P.; Tuntawiroon, M.

    2012-01-01

    Thyroid carcinoma patients treated with I-131 are potential source of high radiation exposure to relatives who are knowingly and willingly exposed to ionizing radiation as a result of providing support and comfort to patients undergoing radionuclide therapy. The purpose of this study is to present the results of measurements of radiation doses to relatives who designated to care fornon self-supporting patients treated with radioiodine at Radionuclide Therapy Ward, Siriraj Hospital. Twenty caregivers of 20 patients underwent radioiodine therapy for thyroid cancers with a standard protocol were given specific instructions with regard to radiation safety and provided with electronic digital dosimeter (PDM 112) to continuously measure radiation dose received on the daily basis, during three days in the hospital. On the day of patients' release, in vivo bioassays were performed on caregivers to determine the thyroid uptake estimates. The 3-day accumulative doses to caregivers to patients receiving 5.55 GBq (n=11) and 7.4 GBq (n=9) of I-131 ranged from 37 to 333 μSv and 176 to 1920 μSv respectively depending on the extent and level of supports required. The thyroid uptake estimates in all caregivers were undetectable. Electronic dosimeters indicated a maximum whole-body effective dose of 1920 μSv was more than the public dose limit of 1 mSv but within the general dose constraint of 5 mSv. Radiation dose to caregivers of a non self-supporting hospitalized patient undergoing radioiodine therapy were well below the limits recommended by the ICRP and the IAEA. The patients can be comforted with confidence that dose to caregivers will be below the 5- mSv limit. This study provides guidance for medical practitioners to obtain practical radiation safety concerns associated with hospitalized patients receiving I-131 therapy especially when patients are comforted in the hospital ward by caregivers. (author)

  8. Side effects of rational dose iodine-131 therapy for metastatic well-differentiated thyroid carcinoma

    International Nuclear Information System (INIS)

    Van Nostrand, D.; Neutze, J.; Atkins, F.

    1986-01-01

    Benua, Leeper, and others (BEL) have advocated the estimation of radiation exposure to the blood to select a more rational maximum safe dose of radioiodine (dosimetry) to treat metastatic functioning well-differentiated thyroid carcinoma. After adopting the BEL dosimetry approach, we reviewed the immediate (during hospitalization) and intermediate (from discharge up to 3 mo) side effects after our initial 15 therapies in ten patients. The doses ranged from 51 mCi (1887 MBq) to 450 mCi (16.65 GBq). Immediate side effects were observed in 12/15 (80%), are described in detail, and were as follows: gastrointestinal 10/15, salivary 9/15, nonsalivary neck pain, swelling, etc. 2/15, pulmonary 0/15. Intermediate side effects were observed in 10/15 (67%), are described in detail, and were as follows: gastrointestinal 0/15, salivary 3/15, nonsalivary neck pain, swelling, etc. 3/15, nasal complaints 2/15, transient bone marrow suppression 9/10, pulmonary 0/15. No patient required blood transfusions or had complications secondary to reduced blood counts. All patient complaints resolved; however, several patients may have reduced baseline blood counts one year after therapy. No other long-term side effect has been noted but the mean follow-up has been only 15 mo. In our opinion, we have not observed any side effect to date which would contraindicate the continued use and evaluation of the BEL dosimetry approach

  9. Side effects of rational dose iodine-131 therapy for metastatic well-differentiated thyroid carcinoma

    Energy Technology Data Exchange (ETDEWEB)

    Van Nostrand, D.; Neutze, J.; Atkins, F.

    1986-10-01

    Benua, Leeper, and others (BEL) have advocated the estimation of radiation exposure to the blood to select a more rational maximum safe dose of radioiodine (dosimetry) to treat metastatic functioning well-differentiated thyroid carcinoma. After adopting the BEL dosimetry approach, we reviewed the immediate (during hospitalization) and intermediate (from discharge up to 3 mo) side effects after our initial 15 therapies in ten patients. The doses ranged from 51 mCi (1887 MBq) to 450 mCi (16.65 GBq). Immediate side effects were observed in 12/15 (80%), are described in detail, and were as follows: gastrointestinal 10/15, salivary 9/15, nonsalivary neck pain, swelling, etc. 2/15, pulmonary 0/15. Intermediate side effects were observed in 10/15 (67%), are described in detail, and were as follows: gastrointestinal 0/15, salivary 3/15, nonsalivary neck pain, swelling, etc. 3/15, nasal complaints 2/15, transient bone marrow suppression 9/10, pulmonary 0/15. No patient required blood transfusions or had complications secondary to reduced blood counts. All patient complaints resolved; however, several patients may have reduced baseline blood counts one year after therapy. No other long-term side effect has been noted but the mean follow-up has been only 15 mo. In our opinion, we have not observed any side effect to date which would contraindicate the continued use and evaluation of the BEL dosimetry approach.

  10. Clinical Investigation and Treatment of Thyroid Disease with Radioactive Iodine (131I)

    International Nuclear Information System (INIS)

    Lee, Mun Ho; Koh, Chang Soon; Ro, Heung Kyu; Koo, In Seu; Suh, Whan Jo; Lee, Kyung Ja; Lee, Hong Kyu; Lee, Chung Sang

    1970-01-01

    A summary of the clinical data of the 131 I-thyroid function tests and the therapeutic results of 131 I among the 2,658 patients of various thyroid diseases treated over the past 10 years from May 1960 to Oct. 1969 at the Radioisotope Clinic and Laboratory, SNUH were presented and discussed. 1) The patients examined consisted of 929 cases (34.9%) of diffuse toxic goiter, 762 cases (28.7%) of diffuse nontoxic goiter, 699 cases (26.3%) of nodular nontoxic goiter, 58 cases (2.2%) of nodular toxic goiter and 210 cases (7.9%) of hypothyroidism. 2) There were 300 (11.4%) male and 2358 (88.6%) female, showing a ratio of 1 : 8. 3) The majority of patients (79.1%) were in the 3rd-5th decade of their lives. 3) The normal ranges, diagnostic values of 131 I uptake test, 48 hrs serum activity, BMR and main subjective symptoms of various thyroid diseases were discussed. 5) In the 579 patients among 867 cases with hyperthyroidism treated with 131 I, 47.8% were confirmed to be cured completely after single therapeutic doses. 6) The complications of 131 I therapy were discussed and myxedema had developed in 6.75% of our patients. 7) The results of 131 I thyroid function tests were analysed among the 160 cases of thyroid diseases which were confirmed the diagnosis with histopathological measures.

  11. Recommendations for waste disposal of phosphorus-32 and iodine-131 for medical users. Handbook 49

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1951-11-02

    With the increasing use of radioactive isotopes by industry, the medical profession, and research laboratories, it is essential that certain minimal precautions be taken to protect the users and the public. The recommendations contained in this Handbook represent what is believed to be the best available opinions on the subject as of this date. As our experience with radioisotopes broadens, we will undoubtedly be able to improve and strengthen the recommendations for their safe handling, utilization, and disposal of wastes. Comments on those recommendations will be welcomed by the committee. One of the greatest difficulties encountered in the preparation of this Handbook lay in the uncertainty regarding permissible radiation exposure levels, particularly for ingested radioactive materials. The establishment of sound figures for such exposure still remains a problem of high priority for many conditions and radioactive substances. Such figures as are used in this report represent the best available information today. If, in the future, these can be improved upon, appropriate corrections will be issued. The subject will be under continuous study by the subcommittees mentioned above. The best available information on permissible radiation levels and permissible quantities of ingested radioactive material may be found in the Recommendations of the International Commission on Radiological Protection and the Supplement to these recommendations in NBS Handbook 47. It should be borne in mind, however, that even the values given in that Handbook may be subject to change. As the problem of the disposal of radioactive wastes varies over such wide limits, depending upon the usage to which the isotopes are put, the committee has decided that it will not be feasible to incorporate in one volume broad recommendations covering all situations and materials. This is the first of a series of such reports. The present Handbook has been prepared by the Subcommittee on Waste Disposal and decontamination.

  12. Comparison of two spreadsheets for calculation of radiation exposure following hyperthyroidism treatment with iodine-131

    International Nuclear Information System (INIS)

    Vrigneaud, J.M.; Carlier, T.

    2006-01-01

    Comparison of the two spreadsheets did not show any significant differences provided that proper biological models were used to follow 131 iodine clearance. This means that even simple assumptions can be used to give reasonable radiation safety recommendations. Nevertheless, a complete understanding of the formalism is required to use correctly these spreadsheets. Initial parameters must be chosen carefully and validation of the computed results must be done. Published guidelines are found to be in accordance with those issued from these spreadsheets. Furthermore, both programs make it possible to collect biological data from each patient and use it as input to calculate individual tailored radiation safety advices. Also, measured exposure rate may be entered into the spreadsheets to calculate patient-specific close contact delays required to reduce the dose to specified limits. These spreadsheets may be used to compute restriction times for any given radiopharmaceutical, provided that input parameters are chosen correctly. They can be of great help to physicians to provide patients with guidance on how to maintain doses to other individuals as low as reasonably achievable. (authors)

  13. Iodine-131 uptake in a patient with thyroid cancer and rheumatoid arthritis during acupuncture treatment

    Energy Technology Data Exchange (ETDEWEB)

    Otsuka, N.; Fukunaga, M.; Morita, K.; Ono, S.; Nagai, K.; Katagiri, M.; Harada, T.; Morita, R. (Kawasaki Medical School, Okayama (Japan))

    1990-01-01

    A patient with thyroid carcinoma had abnormal accumulation of I-131 in the areas of both feet and hands on whole body scan. The sites of abnormal accumulation of I-131 were similar to those on bone scintigraphy. The radiographic examination of the lesions showed characteristic findings of rheumatoid arthritis, and the presence of small gold needles for acupuncture treatment was demonstrated. There were no findings of bone metastases. Although the mechanism of accumulation of I-131 in this patient is unknown, interpreters of I-131 whole body scintigraphs should keep this case in mind when acupuncture treatment has been done. The authors can only speculate on a common blood flow mechanism for enhanced HMDP and I-131 uptake in this arthritic patient who had been treated by acupuncture.

  14. Diagnosis and treatment of a carcinoid tumor using iodine-131 meta-iodobenzylguanidine

    International Nuclear Information System (INIS)

    Hoefnagel, C.A.; Den Hartog Jager, F.C.; Van Gennip, A.H.; Marcuse, H.R.; Taal, B.G.

    1986-01-01

    Scintigraphy using I-131 meta-iodobenzylguanidine has been introduced as an effective method to detect pheochromocytomas and neuroblastomas, and the radiopharmaceutical also is applied in therapy of these tumors. The authors present a case of a metastatic gastric carcinoid tumor, another neural crest tumor, concentrating I-131 MIBG, which was documented by conventional scintigraphy and SPECT in correlation with CT scans and colloid scintigrams of the liver. Two therapeutic attempts in this patient, using I-131 MIBG, are described. The metabolic basis of this phenomenon is discussed, and the importance of I-131 MIBG imaging in the detection of neural crest tumors is underlined

  15. Thyroid cancer incidence among Swedish patients exposed to diagnostic doses of iodine-131: A preliminary report

    International Nuclear Information System (INIS)

    Hall, P.E.

    1996-01-01

    The level of risk associated with I-131 is not well defined but appears lower than equivalent doses of x-rays. To provide quantitative data on the risk of thyroid cancer following I-131 exposure, 34,104 patients surviving ≅ 5 years after I-131 administration between 1950-69 for diagnostic purposes were studied. The mean thyroid dose was estimated to be 1.1 Gy (range 0-40.5). A significantly increased risk of a subsequent thyroid cancer was found, however, the excess rates were based entirely on patients referred because of a suspicion of a thyroid tumor. There was no suggestion of an increasing risk with increasing dose or time since exposure. No significant excess risk was found among those less than 20 years of age at exposure. The absence of a risk among those over age 20 is consistent with studies of A-bomb survivors and implies that any type of exposure to ionizing radiation later in life is associated with a minimal cancer risk. (author). 23 refs, 4 tabs

  16. Effect of technetium-99m on iodine-131 thyroid uptake measurements

    International Nuclear Information System (INIS)

    Wasserman, H.J.; Klopper, J.F.; Erlank, P.

    1985-01-01

    Following administration of 2.5-5.0 mCi[/sup 99m/Tc]pertechnetate, several hundred microcuries may be present in the necks of hyperthyroid patients after 6 hr. Coincidence summing of Tc-99m photons may disturb I-131 uptake measurements in such patients if an oral diagnostic dose of I-131 is administered immediately after completion of a [/sup 99m/Tc]pertechnetate scintigram. Using a lower discriminator level of 300 keV, false increases of 10%-50% may occur at 6 hr. The 24-hr uptake is also affected if an I-131 predose measurement is performed after administration of the Tc-99m dose. The authors have shown that these errors may be prevented by using a 1-mm lead filter in front of the scintillation detector. The attenuation of Tc-99m photons by the filter effectively eliminates summation pulses while it reduces the I-131 count rate by approximately 28%

  17. Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol

    International Nuclear Information System (INIS)

    Ishimura, J.; Kawanaka, M.; Fukuchi, M.

    1989-01-01

    Forty-one patients with or without adrenocortical disorders were studied to evaluate the clinical usefulness of SPECT in adrenal imaging with I-131 Adosterol. In the SPECT images from this study, all glands with either normally functioning or hyperfunctioning adrenal cortices could be detected, while those glands with hypofunctioning adrenal cortices could not be detected. Particularly in transaxial and sagittal slices, the adrenal gland was identified posteriorly and was clearly distinguished from the gallbladder. In preliminary results using SPECT by a standard method, uptake in 68 detectable glands ranged from 1.7% to 4.9% in four glands with Cushing's syndrome, from 1.1% to 1.3% in seven glands with primary aldosteronism, and were distributed below 1.0% in the remaining glands with normally functioning adrenal cortices. These data show that it is possible to evaluate the adrenocortical functioning status simply by analyzing the SPECT images of the adrenal

  18. Clinical application of SPECT in adrenal imaging with iodine-131 6 beta-iodomethyl-19-norcholesterol

    Energy Technology Data Exchange (ETDEWEB)

    Ishimura, J.; Kawanaka, M.; Fukuchi, M.

    1989-04-01

    Forty-one patients with or without adrenocortical disorders were studied to evaluate the clinical usefulness of SPECT in adrenal imaging with I-131 Adosterol. In the SPECT images from this study, all glands with either normally functioning or hyperfunctioning adrenal cortices could be detected, while those glands with hypofunctioning adrenal cortices could not be detected. Particularly in transaxial and sagittal slices, the adrenal gland was identified posteriorly and was clearly distinguished from the gallbladder. In preliminary results using SPECT by a standard method, uptake in 68 detectable glands ranged from 1.7% to 4.9% in four glands with Cushing's syndrome, from 1.1% to 1.3% in seven glands with primary aldosteronism, and were distributed below 1.0% in the remaining glands with normally functioning adrenal cortices. These data show that it is possible to evaluate the adrenocortical functioning status simply by analyzing the SPECT images of the adrenal.

  19. Recommendations for waste disposal of phosphorus-32 and iodine-131 for medical users. Handbook 49

    International Nuclear Information System (INIS)

    1951-01-01

    With the increasing use of radioactive isotopes by industry, the medical profession, and research laboratories, it is essential that certain minimal precautions be taken to protect the users and the public. The recommendations contained in this Handbook represent what is believed to be the best available opinions on the subject as of this date. As our experience with radioisotopes broadens, we will undoubtedly be able to improve and strengthen the recommendations for their safe handling, utilization, and disposal of wastes. Comments on those recommendations will be welcomed by the committee. One of the greatest difficulties encountered in the preparation of this Handbook lay in the uncertainty regarding permissible radiation exposure levels, particularly for ingested radioactive materials. The establishment of sound figures for such exposure still remains a problem of high priority for many conditions and radioactive substances. Such figures as are used in this report represent the best available information today. If, in the future, these can be improved upon, appropriate corrections will be issued. The subject will be under continuous study by the subcommittees mentioned above. The best available information on permissible radiation levels and permissible quantities of ingested radioactive material may be found in the Recommendations of the International Commission on Radiological Protection and the Supplement to these recommendations in NBS Handbook 47. It should be borne in mind, however, that even the values given in that Handbook may be subject to change. As the problem of the disposal of radioactive wastes varies over such wide limits, depending upon the usage to which the isotopes are put, the committee has decided that it will not be feasible to incorporate in one volume broad recommendations covering all situations and materials. This is the first of a series of such reports. The present Handbook has been prepared by the Subcommittee on Waste Disposal and decontamination

  20. Influence of surgical or propylthiouracil pretreatment on the efficacy of iodine-131 therapy in hyperthyroidism

    International Nuclear Information System (INIS)

    Shi Genming; Xu Qin; Yang Yili; Ye Anfang; Zhu Chengyi

    2006-01-01

    Objective: To investigate the influence of surgical or propylthiouracil(PTU) pretreatment on the efficacy of radioactive iodine therapy in hyperthyroidism. Methods: A group (group 1) of 41 hyperthyroidism patients relapsed after surgery were treated with 131 I in our department from 2003 through 2004. During that period, another group (group 2) of 41 cases were selected randomly from patients untreated either surgically or chemically before oral administration of 131 I, and a third group (group 3) of 41 cases were selected randomly from those pretreated only with PTU. We analysed the results of these three groups of patients after followed-up for 3 and 6 months separately after 131 I therapy. Results: Approximately 90.24% (37/41 cases) and 92.68% (38/ 41 cases) of patients in group 2 without any pretreatment were cured 3 months and 6 months after 131 I treatment, respectively, and 9.76% (4/41 cases) and 7.32% (3/41 cases) of them did not respond to 131 I treatment. About 43.90% (18/41 cases) and 53.66 % (22/41 cases) of patients pretreated with PTU (group 3) were cured at 3 and 6 months, respectively, and approximately 56.10% (23/41 cases) and 46.34% (19/41 cases) of this group patients did not respond to 131 I treatment at 3 and 6 months, respectively (P 131 I treatment, respectively, and 31.71% (13/41) and 29.27% (12/ 41) of them did not respond to 131 I treatment (P 131 I treatment can affect the efficacy of 131 I therapy, resulting in reduction of the cure rate. (authors)

  1. Endobronchial administration of iodine-131 B72.3 monoclonal antibody in patients with lung cancer

    International Nuclear Information System (INIS)

    Del Vecchio, S.; Mansi, L.; Petrillo, A.; Camera, L.; Salvatore, M.; Sofia, M.; Marra, A.; Carratu, L.

    1991-01-01

    We tested the feasibility of endobronchial administration of radiolabelled monoclonal antibodies (MoAbs) and the biodistribution of the radiotracer. Ten patients with histological confirmed adenocarcinoma or squamous cell carcinoma were studied. Nine received 470 μCi (103 μg) of 131 I-B72.3, a monoclonal antibody reacting against TAG 72 antigen, while one patient received 502 μCi (291 μg) of 131 I-4C4, an indifferent antibody used for comparison in a negative control study. The radiolabelled antibody was administered through a flexible fiberoptic bronchoscope and placed on the tumour mass under visual monitoring. Scans with a large field-of-view gamma-camera showed retention of 131 I-B72.3 at the tumour site up to 6-9 days in six of eight patients. No other organs were visualized with the exception of faint activity in the gastrointestinal tract, bladder and thyroid. On the contrary, the indifferent antibody 131 I-4C4 was not retained at the tumour site 6 days after MoAbs administration, and more prominent activity was found in the gastrointestinal tract. In one patient the study was not technically adequate because of failure of the delivery system. The vascular compartment contained less than 3% of the administered dose. We conclude that endobronchial administration is a feasible technique and allows stable and specific targetting of bronchial tumours. Furthermore, the low activity found in the plasma and other organs suggests that this approach may be used to deliver therapeutic doses of MoAbs to lung cancers. (orig.)

  2. Uncertainty of inhalation dose coefficients for representative physical and chemical forms of iodine-131

    Science.gov (United States)

    Harvey, Richard Paul, III

    Releases of radioactive material have occurred at various Department of Energy (DOE) weapons facilities and facilities associated with the nuclear fuel cycle in the generation of electricity. Many different radionuclides have been released to the environment with resulting exposure of the population to these various sources of radioactivity. Radioiodine has been released from a number of these facilities and is a potential public health concern due to its physical and biological characteristics. Iodine exists as various isotopes, but our focus is on 131I due to its relatively long half-life, its prevalence in atmospheric releases and its contribution to offsite dose. The assumption of physical and chemical form is speculated to have a profound impact on the deposition of radioactive material within the respiratory tract. In the case of iodine, it has been shown that more than one type of physical and chemical form may be released to, or exist in, the environment; iodine can exist as a particle or as a gas. The gaseous species can be further segregated based on chemical form: elemental, inorganic, and organic iodides. Chemical compounds in each class are assumed to behave similarly with respect to biochemistry. Studies at Oak Ridge National Laboratories have demonstrated that 131I is released as a particulate, as well as in elemental, inorganic and organic chemical form. The internal dose estimate from 131I may be very different depending on the effect that chemical form has on fractional deposition, gas uptake, and clearance in the respiratory tract. There are many sources of uncertainty in the estimation of environmental dose including source term, airborne transport of radionuclides, and internal dosimetry. Knowledge of uncertainty in internal dosimetry is essential for estimating dose to members of the public and for determining total uncertainty in dose estimation. Important calculational steps in any lung model is regional estimation of deposition fractions and gas uptake of radionuclides in various regions of the lung. Variability in regional radionuclide deposition within lung compartments may significantly contribute to the overall uncertainty of the lung model. The uncertainty of lung deposition and biological clearance is dependent upon physiological and anatomical parameters of individuals as well as characteristic parameters of the particulate material. These parameters introduce uncertainty into internal dose estimates due to their inherent variability. Anatomical and physiological input parameters are age and gender dependent. This work has determined the uncertainty in internal dose estimates and the sensitive parameters involved in modeling particulate deposition and gas uptake of different physical and chemical forms of 131I with age and gender dependencies.

  3. Thyroid cancer incidence among Swedish patients exposed to diagnostic doses of iodine-131: A preliminary report

    Energy Technology Data Exchange (ETDEWEB)

    Hall, P E [Karolinska Hospital, Stockhom (Sweden). Dept. of General Oncology; Holm, L E [National Inst. of Public Health, Stockholm (Sweden)

    1996-08-01

    The level of risk associated with I-131 is not well defined but appears lower than equivalent doses of x-rays. To provide quantitative data on the risk of thyroid cancer following I-131 exposure, 34,104 patients surviving {approx_equal} 5 years after I-131 administration between 1950-69 for diagnostic purposes were studied. The mean thyroid dose was estimated to be 1.1 Gy (range 0-40.5). A significantly increased risk of a subsequent thyroid cancer was found, however, the excess rates were based entirely on patients referred because of a suspicion of a thyroid tumor. There was no suggestion of an increasing risk with increasing dose or time since exposure. No significant excess risk was found among those less than 20 years of age at exposure. The absence of a risk among those over age 20 is consistent with studies of A-bomb survivors and implies that any type of exposure to ionizing radiation later in life is associated with a minimal cancer risk. (author). 23 refs, 4 tabs.

  4. Iodine-131 labeled anti-CEA polyclonal antibody detection of gastrointestinal cancer

    International Nuclear Information System (INIS)

    Nabi, H.A.; Hinkle, G.H.; Olsen, J.O.; Haagensen, D.A.; Thurston, M.O.; Mojzisik, C.; Houchens, D.; Martin, E.W. Jr.

    1984-01-01

    To localize gastrointestinal tumor, 31 patients were injected with 1.7-2.1 mCi I-131 anti-CEA baboon polyclonal antibody. Whole body imaging at 48, 72, and occasionally 96 hrs was performed with a Signa Camera (Technicare) peaked at 364 keV with 20% window. Additional spot views were usually obtained. No subtraction methods were used. All patients had surgical and pathological confirmation of the nuclear medicine studies. Labeled antibody images were positive in 15 (8 recurrent or metastatic colorectal, 2 gastric, 1 pancreatic, 1 primary colon, and 1 breast metastatic to chest wall). In 1, antibody images were positive for metastatic deposits in para-aortic lymph nodes, but negative for primary rectal tumor. True negative images were observed in 6; false negative images in 9 (4 liver metastases, 2 rectal, 1 pancreatic, 1 mesenteric lymph node metastasis, 1 bone metastasis). In all cases, no correlation existed between preoperative CEA serum levels and imaging. I-131 labeled anti-CEA polyclonal antibody imaging proved highly efficient in detecting gastric cancer (2/2) and moderately efficient in detecting recurrent colorectal cancer (8/15). On the other hand, the I-131 labeled polyclonal anti-CEA antibody imaging was of limited value in detecting colon cancer (1/9), pancreatic cancer (1/4) and metastatic liver disease

  5. Transfer of iodine-131 from deposition-to-milk : estimation of pasture intake

    International Nuclear Information System (INIS)

    Dreicer, M.; Bouville, A.; Wachholz, B.W.

    1988-01-01

    In assessments of radiological transport of I-131 from fallout deposition to cow's milk, knowledge of the fraction of the dairy cow's diet that is due to fresh pasture is essential because it is the only portion of the feed that may be contaminated to a substantial extent. For studies involving past fallout events covering large geographic areas, such as the current effort by the National Cancer Institute to assess the exposure to I-131 received by the American people during the Nevada Test Site atmospheric weapons tests conducted during the 1950's, it is necessary to derive this estimate of pasture consumption from past records

  6. Normal values of iodine - 131 uptake in 24 hours, in Rio Grande do Norte, Brazil

    International Nuclear Information System (INIS)

    Oliveira Filho, T.F. de; Oliveira, C.F.F. de

    Thorough clinical exams on all patients come to the radioisotope Laboratory at UFRN, where carried out attempting to select those patients with thyroids considered to be clinically normal. After wayne tests for hypo and hyperthyroidism were carried out, 100 patients were considered to be fit for the research. All of them had an impalpable and asympitomatic thyroid. Waynes clinical indices were precisely revealed in 93% of cases. It was concluded that the normal values of uptake of 131 I during the 24 hours in RGN varied between 14% and 44% [pt

  7. Leak detection on underground fuel oil transfer line using radio tracer iodine-131

    International Nuclear Information System (INIS)

    Wickramanayake, D.G.L.; Ranjith, H.L.A.

    1998-01-01

    Leak detection study was carried out on the fuel oil transfer line of the Ceylon Petroleum Corporation using 131 I tracer. The study was carried out to determine whether the technique developed can be used in the field and to monitor the condition of the pipeline. Radiation safety assessment was made prior to the test. The dynamic pressurization technique was used. Any detectable leak was not shown at the detecting sensitivity of 0.40 mm 2 under the test conditions. The method reported is considered to be successful and economically viable. (author)

  8. Age and its influence on effects of iodine-131 in guinea pig thyroid glands

    International Nuclear Information System (INIS)

    Book, S.A.; McNeill, D.A.; Spangler, W.L.

    1980-01-01

    To identify the differences in age-related radiosensitivity of the thyroid gland to radioiodine exposure, we exposed fetal, neonatal, weanling, and adult guinea pigs to single graded doses of 131 I. Injected quantities ranged from 1 to 100 μCi 131 I, depending on the age group, and resulted in thyroid doses ranging from hundreds to tens of thousands of rad. At approximately 100 days of age (or 100 days after dosing for adults), a single microcurie of 131 I was given and animals were killed 1 day later to provide data on thyroid weight and percentage 131 I uptake. Analysis of these data and information on pathology suggested that the fetal and weanling guinea pig thyroid glands were more radiosensitive than the adult thyroid; the neonatal thyroid appeared less radiosensitive than that of the adult. The increase in radiosensitivity of the young thyroid glands over the adults, however, did not appear to be greater than twofold. Nevertheless, the demonstration of age-related radiosensitivity requires that it be considered by those who assess radiologic risks to human populations

  9. Chloridrate of N-isopropyl-p-iodoamphetamine labeled with Iodine-131. Biological distribution in laboratory animals

    International Nuclear Information System (INIS)

    Colturato, Maria Tereza; Muramoto, Emiko; Carvalho, Olga Goncalves de

    2000-01-01

    The development of this work was based on a great interest from the medical class in the utilization of chloridrate of N-isopropyl-p-iodoamphetamine (IMP) labeled with 123 I, for brain perfusion evaluation. Studies were performed to optimize the labeling parameters of IMP with 131 I using nucleophilic substitution: temperature and, time reaction, ascorbic acid mass, pH and relation IMP mass/radioiodo activity, and stability of the final product. Radiochemistry purity method used showed to be efficient, quick and of easily handling for routine production. Biological distribution studies were performed in mice to determine the percent administered dose in the blood, different organs and whole body after intravenous administration of the radiopharmaceutical. The product crossed the intact blood brain barrier, allowing a follow up of further studies after the intravenous administration of the radiopharmaceutical. The principal elimination route 131 I-IMP was the urinary. Based on the results from radiochemical purity, stability and biological behavior in laboratory animals, we concluded that the studied radiopharmaceutical presents all ideal characteristics for clinical use in brain studies in nuclear medicine. (author)

  10. Optimization of SPECT calibration for quantification of images applied to dosimetry with iodine-131

    International Nuclear Information System (INIS)

    Carvalho, Samira Marques de

    2018-01-01

    SPECT systems calibration plays an essential role in the accuracy of the quantification of images. In this work, in its first stage, an optimized SPECT calibration method was proposed for 131 I studies, considering the partial volume effect (PVE) and the position of the calibration source. In the second stage, the study aimed to investigate the impact of count density and reconstruction parameters on the determination of the calibration factor and the quantification of the image in dosimetry studies, considering the reality of clinical practice in Brazil. In the final step, the study aimed evaluating the influence of several factors in the calibration for absorbed dose calculation using Monte Carlo simulations (MC) GATE code. Calibration was performed by determining a calibration curve (sensitivity versus volume) obtained by applying different thresholds. Then, the calibration factors were determined with an exponential function adjustment. Images were performed with high and low counts densities for several source positions within the simulator. To validate the calibration method, the calibration factors were used for absolute quantification of the total reference activities. The images were reconstructed adopting two approaches of different parameters, usually used in patient images. The methodology developed for the calibration of the tomographic system was easier and faster to implement than other procedures suggested to improve the accuracy of the results. The study also revealed the influence of the location of the calibration source, demonstrating better precision in the absolute quantification considering the location of the target region during the calibration of the system. The study applied in the Brazilian thyroid protocol suggests the revision of the calibration of the SPECT system, including different positions for the reference source, besides acquisitions considering the Signal to Noise Ratio (SNR) of the images. Finally, the doses obtained with the simulations presented significant differences between the doses calculated according to their location and calibration factor used, also showing a tendency to overestimate the dose calculation with the use of standard central calibration. The results obtained will contribute to the optimization and better accuracy of therapeutic procedures in nuclear medicine. (author)

  11. Do the benefits of iodine-131 lipiodol therapy for HCC outweigh the radiation safety issues?

    International Nuclear Information System (INIS)

    Kitchener, M.I.; Barnden, L.R.

    2005-01-01

    Introduction: lodine-131 Lipiodol is a well recognised palliative treatment option for Hepatocellular carcinoma (HCC) unsuitable for surgical resection/transplantation. However, the biological and physical half-life of lodine-131 Lipiodol in this situation has significant implications for radiation protection. Methods: A retrospective study was performed to evaluate the practical radiation issues and treatment efficacy. 22 patients were referred for assessment and 12 received Lipiodol therapy, 5 having multiple doses. Administered doses ranged from 1.0-2.2 GBq. Results: Patients were hospitalised between 4 and 8 days, with discharge rates ranging between 16 and 61uSv/hr at 1 metre. The shorter hospital stays and highest discharge rates related to 2 patients (multiple doses) who had difficulty tolerating the in-hospital isolation. Only 4 patients had discharge rates < 25uSv/hr at 1 metre. 2 with reduced doses. Special exemption was required from the State Radiation Protection Branch (RPB) to allow early discharge. Patients were given a radiation precaution sheet on discharge (as per the FMC program) and asked to observe the restrictions including not returning to work for 14-24 days and avoiding close contact with young children for 25-44 days post-discharge. The measured radiation dose for a patient's spouse/carer was < lOOuSv on 2 occasions. The mean exposure for nurses per patient admission was 9.1 uSv. The TLD readings for the Interventional Radiologist and treating Nuclear Physician remained well within acceptable levels. 4 of the 12 patients have died at a mean of 16.25 months (range 13-20 months) after their first dose of lodine-131 Lipiodol. Of the other 7, 3 now have progressive disease but are alive 18, 36 and 41 months following their first dose. 4 are less than 12 months post-therapy. With the co-operation of the State RPB. the issues relating to radiation protection are manageable and these patients do receive a therapeutic benefit

  12. Thyroid γ ray measurement after iodine-131 therapy for Graves' disease

    International Nuclear Information System (INIS)

    Liu Jianfeng; Guo Qingling; Ye Genyao; Li Xin; Wang Anyu; Wang Ying; Zhu Hui; He Ling; Yuan Chao

    2004-01-01

    Objective: To study the thyroid 131 I uptake within 24 hours following 131 I therapy for Graves' disease. Methods: Eighteen hyperthyroidism patients were divided into two groups according to thyroid weight and radiotherapy dosage. Low-dose group and high-dose group received the mean dose 162.8 MBq (4.4 mCi) and 255.3 MBq (6.9 mCi), respectively. The γ ray dose rates from thyroids were measured in all patients at 1, 2, 4, 8,12 and 24 h after 131 I therapy. Results: γ ray dose rates were elevated rapidly at 1 hour and continued at high level between 2-12 h and slowly fell in 24 h after 131 I therapy. γ Rat curve of low-dose group was lower than that of high-dose group. Conclusion: There was a rapid absorption and concentration period in 1 h and slow metabolism and release period after 12 h in thyroid following radioiodine therapy of Graves' disease. The thyroids of hyperthyroidism patients displayed different γ ray curves. (author)

  13. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism

    International Nuclear Information System (INIS)

    Holm, L.E.; Lundell, G.; Israelsson, A.; Dahlgvist, I.

    1982-01-01

    We have studied the long-term incidence of hypothyroidism in 4,473 formerly hyperthyroid patients given I-131 therapy between 1951 and 1975. The mean age at the first I-131 treatment was 56 yr. Six percent developed hypothyroidism within one year of therapy, and 72% within 26 yr. Prior antithyroid medication did not affect the incidence of hypothyroidism. Patients cured with one dose of I-131 had a lower cumulative long-term incidence of hypothyroidism than those requiring more than one dose

  14. Vasoactive intestinal peptide (VIP) labelling with iodine-131 by direct method

    International Nuclear Information System (INIS)

    Colturato, M.T.; Silva, C.P.G. da; Araujo, E.B.

    2002-01-01

    The Vasoactive Intestinal Peptide (VIP) is a 28-amino acid polypeptide with a great numbers of receptors in tumoral cells, including adenocarcinomas and pancreatic and colon carcinomas. The VIP molecule contains two tyrosine residues, in positions 10 and 22, that are theoretically equally susceptible to iodination, The VIP was labeled with 131-iodine by direct method using Iodogen as oxidant agent: 15.03 mmol VIP + 0.10 nmol KI + [ 131 I]NaI + 13.9 mmol Iodogen; the final volume was adjust to 100 μL using 0.2 M phosphate buffer, pH 7.5 and the reaction proceed with stirring for 30 minutes at room temperature. The radiochemical purity was determined by electrophoresis (Whatman 1MM paper; 0.05 M barbital buffer; pH 8.6; 150 V; 40 minutes) that indicates low percent of free 131-iodine. The high performance liquid chromatography (HPLC) system using RPC 18 , 10 μm, 4 x 250mm column, was able to separate the different radiochemical species, only when an isocratic mixture of acetonitrile: 0.1% trifluoroacetic acid (27:73) was used, with 0.5 mL/min. flux. (author)

  15. Radioiodine uptake following iodine-131 therapy for Graves' disease: an early indicator of need for retreatment

    International Nuclear Information System (INIS)

    Carpentier, W.R.; Gilliland, P.F.; Piziak, V.K.; Petty, F.C.; McConnell, B.G.; Verdonk, C.A.; Ibarra, J.D.; Thompson, J.Q.

    1989-01-01

    Forty-five patients with Graves' disease were studied prospectively to determine if 24-hour I-131 uptake measurements alone or in combination with serum thyroid hormone levels at six weeks would determine the necessity for retreatment of the thyrotoxicosis. All patients with an I-131 uptake greater than 30% at six weeks required retreatment. No patient with an I-131 uptake of less than 15% required retreatment. Patients with uptakes between 15% and 30% were variable. An elevated free thyroxin index at 6 weeks is not helpful to determine which patients will remain thyrotoxic. Patients with a free thyroxin index within the normal range at six weeks can be predicted to be euthyroid by 12 weeks if their 24-hour I-131 uptake is between 15% and 30% and to be hypothyroid if their 24-hour I-131 uptake is below 15%. There was no difference between patient groups treated initially with antithyroid medication and those who were not

  16. Liquid dynamic in the retroperitoneum: study of albumin labelled with iodine-131

    International Nuclear Information System (INIS)

    Steinman, E.

    1990-01-01

    The retroperitoneal region in not very well-known, specially what concerns its behavior and dynamics, when there is presence of blood and other collections. Therefore, we decided to study the dissemination of the absorption of liquids, using for that a radioactive indicator deposited in different areas of the retroperitoneum. The chosen indicator was iodinated albumin (RIHSA). This study was performed in patients submitted to different types of surgical procedures, but in those who did not present retroperitoneum affections or previous surgeries. In all patients, the blood concentration rate of the indicator in determined times was determined and also the scintilografic image with 24, 48 and 72 hours after finished the surgical procedure was undertaken. It was observed that in the retroperitoneum, the indicator tend to be concentrated in the same place as it was injected at least up to 72 hours and that in the peritoneum the indicator migrates earlier to the abdominal cavity. Besides, the blood transference in retroperitoneum is performed on a slower manner when compared to the peritoneum, except for the anterior para renal area. Radioactive iodine injected in the retroperitoneum was earlier captured by the thyroid. The adopted technique is inocuous, simple, reproductible and quantified. (author)

  17. Late effects of iodine-131 in utero exposure: Toxicological effects in first generation of rats

    International Nuclear Information System (INIS)

    Liu, P.T.; Stevens, R.H.; Cole, D.A.; Lindholm, P.A.; Cheng, H.F.

    1984-01-01

    The authors have initiated studies to evaluate the possible immunotoxic effects to both the mother and offspring following an in utero exposure to /sup 131/I, and initial observations suggest induction of antitumor immunity as measured by cell-mediated immune (CMI) and antibody-dependent cell-mediated cytotoxicity (ADCC). The animal model selected for these studies was the Fischer F344 female rat intraperitoneally exposed to concentrations ranging from 4 to 3700 kBq of Na/sup 131/I during the gestation period of 16 to 18 days. The CMI results suggested the male offspring were 1.7 times more immunologically responsive than their sisters with a threshold detection level in the range of 9.25 kBq being observed. The parents of F/sub 1/ generation exposed to the /sup 131/I are now being evaluated for possible immunotoxicity according to: host resistance to E. coli endotoxin and blastogenenic responses to phytohemagglutin, concanavalin A, and lipopolysaccharide. The results of these studies suggest that perinatal /sup 131/I exposure exerts an immunotoxic effect upon the first generation

  18. Iodine-131 thyroid uptake results in travelers returning from Europe after the Chernobyl accident

    International Nuclear Information System (INIS)

    Castronovo, F.P. Jr.

    1987-01-01

    Thyroid screening measurements for 131 I were performed on 58 travelers returning from Eastern and Western Europe to Boston after the Chernobyl reactor accident on April 26, 1986. The travelers consisted of both Americans arriving home after business or vacation and European nationals visiting relatives in the Boston area. For purposes of dosimetry the population was divided into three subpopulations--adult (greater than 18 yr old), children (less than or equal to 18 yr old), and two individuals, 17 and 26 wk pregnant. Seventy-four percent of the population had detectable quantities of 131 I thyroid burdens, ranging from 1 nCi (37 Bq) to 900 nCi (33,300 Bq). The highest adult radiation dose equivalent was 5.18 mrem (51.8 mSv). The children, however, had considerably higher dose equivalents with one infant receiving 37 rem (370 mSv). Several other children were above 1 rem (10 mSv). The fetal dose equivalents were less than 14 mrem (140 mu Sv). The presence of rain dominated those testing positive for 131 I. Radioactive fallout from the Chernobyl accident contaminated a wide range of Europe and a large population subsequently ingested radioactivity. The children exhibited the highest thyroid radiation dose equivalents of the individuals monitored in the present study. The significance of this is presently unknown

  19. A comparison of the radiochemical stability of different iodine-131 labelled metaiodobenzylguanidine formulations for therapeutic use

    International Nuclear Information System (INIS)

    Wafelman, A.R.; Beijnen, J.H.; Hoefnagel, C.A.; Maes, R.A.A.

    1994-01-01

    The results of a stability study of three commercially available formulations of [ 131 I]MIBG for therapeutic use and an unstabilized formulation, stored under various conditions, are presented. The stability was followed for 20 days. In all formulations tested, free [ 131 I]iodide, formed by radiolysis, was the most important radiochemical impurity. The pharmaceutical formulation with the largest amount of stabilizer was radiochemically - but not chemically -most stable. (author)

  20. Separation of iodine-131 from water using isotopic exchange with iodine-starch compound

    International Nuclear Information System (INIS)

    Ignatov, V.P.; Kolomejtseva, I.V.

    1990-01-01

    Conditions of iodine isotopic exchange with iodine-starch compound (ISC) were studied with the aim of compound utilizatoin for radioactive iodine separation from solution. It is shown that in pH range from 2 to 7 the degree of iodine extraction and coefficient of its distribution practically do not depend on pH, at pH>7 ISC destruction (decolorizing) starts and iodine extraction decreases. Rapid method of iodine separation from solution is suggested. The method can be used in radiochemical techniques. The degree of extraction equals 80 %, a higher degree of extraction can not be achieved owing to ISC formation peculiarities

  1. Biological dosimetry of patients with differenced carcinoma of thyroid treated with Iodine-131

    International Nuclear Information System (INIS)

    Vallerga, M. B.; Rojo, A.M.; Taja, M.R.; Deluca, G.; Di Giorgio, M.; Fadel, A.; Cabrejas, M.; Valdivieso, C.

    2006-01-01

    The administration of I-131 to patient with Differentiated Thyroid Carcinoma (CaDiT) it is used inside the therapeutic outline as later step to the thyroidectomy. However, the good activity to give is of difficult determination due to factors such as, the variability in the capacity of tumoral reception of the I-131, distribution of the pharmaceutical, physiologic status, other associate pathologies, grade of advance of the illness, and previous treatments. Additionally, the activity to administer is dependent of the dose of tolerance in the healthy tissues; superior dose to 2 Gy in bone marrow, its could drive to myelotoxicity. At the moment, the form more extended of administration it is the empiric prescription that considers clinical parameters and of laboratory for their determination. Presently work, the protocol of applied treatment incorporates the evaluation for internal dosimetry and biological dosimetry to estimate absorbed dose in bone marrow. The biological estimate of the dose of these patients is based on the quantification of chromosomal aberrations whose frequency is referred to a curve-dose response in which the lymphocytes is irradiated in vitro with I-131, allowing to determine the in vivo dose to the patient's circulating lymphocytes. The objective of the present work is to determine the applicability of different cytogenetic essays in the estimate of the absorbed dose to the whole body or specific organs. Three patients were evaluated with CaDiT. Their treatment protocol consisted on a tracer administration of radioactive iodine of 74 - 111 MBq (2 - 3 mCi) and a therapy 7,4 - 11,1 GBq (200 - 300 mCi). Previous to the tracer administration and 8 days post-therapeutic administration took samples of veined blood that were evaluated by biological dosimetry by means of the application of the techniques: conventional cytogenetic Micronucleus and FISH (Hybridization in situ by Fluorescence). Starting from the frequencies of observed chromosomal aberrations it was considered absorbed dose to whole body. The obtained doses were compared by the different biological methods used. The evaluation by internal dosimetry of the data obtained tracer post-activity allowed to personalize the activity of I-131 to administer, starting from physical-mathematical models that consider the particular biokinetics of each patient (MIRD methodology). The doses estimated by the used biological dosemeters were consistent among them. It was discussed its scopes and limitations to be applied in the validation of the dosimetric estimation based on models, in order to administer a therapeutic dose protecting the patient of the adverse effects of the internal radiotherapy in organs that are not target of the same one. The acquired experience is considered of utility to give answer in cases of radioiodine incorporation in occupationally exposed personnel. (Author)

  2. Sistema computacional para dosimetria de nêutrons e fótons baseado em métodos estocásticos aplicado a radioterapia e radiologia

    Directory of Open Access Journals (Sweden)

    Bruno Machado Trindade

    2011-04-01

    Full Text Available OBJETIVO: Este artigo mostra um procedimento de conversão de imagens de tomografia computadorizada ou de ressonância magnética em modelo de voxels tridimensional para fim de dosimetria. Este modelo é uma representação personalizada do paciente que pode ser usado na simulação, via código MCNP (Monte Carlo N-Particle, de transporte de partículas nucleares, reproduzindo o processo estocástico de interação de partículas nucleares com os tecidos humanos. MATERIAIS E MÉTODOS: O sistema computacional desenvolvido, denominado SISCODES, é uma ferramenta para planejamento computacional tridimensional de tratamentos radioterápicos ou procedimentos radiológicos. Partindo de imagens tomográficas do paciente, o plano de tratamento é modelado e simulado. São então mostradas as doses absorvidas, por meio de curvas de isodoses superpostas ao modelo. O SISCODES acopla o modelo tridimensional ao código MCNP5, que simula o protocolo de exposição à radiação ionizante. RESULTADOS: O SISCODES vem sendo utilizado no grupo de pesquisa NRI/CNPq na criação de modelos de voxels antropomórficos e antropométricos que são acoplados ao código MCNP para modelar braquiterapias e teleterapias aplicadas a tumores em pulmões, pelve, coluna, cabeça, pescoço, e outros. Os módulos atualmente desenvolvidos no SISCODES são apresentados junto com casos exemplos de planejamento radioterápico. CONCLUSÃO: O SISCODES provê de maneira rápida a criação de modelos de voxels personalizados de qualquer paciente que podem ser usados em simulações por códigos estocásticos tipo MCNP. A combinação da simulação via MCNP com um modelo personalizado do paciente traz grandes melhorias na dosimetria de tratamentos radioterápicos.

  3. Personal monitoring services available at Institute for Radiation Protection of ENEA; Il servizo di dosimetria personale dell'Istituto per la Radioprotezione dell'ENEA

    Energy Technology Data Exchange (ETDEWEB)

    Fantuzzi, E.; Bonarelli, T. [ENEA Centro Ricerche Ezio Clementel, Bologna (Italy). Dipt. Ambiente

    1999-07-01

    Personnel monitoring provides the means to measure and record the radiation doses received by individual workers. The ionising radiation decree (230/95) set out the circumstances when the assessment and recording of person's exposure is legally required. Many employers issue dosemeters to staff even though there is no legal requirement to do so. This may be part of a quality assurance programme or as a reassurance measure. Dosemeter readings will serve to ensure compliance with legal dose limits and assure the employer that radiation exposure is as low as reasonably achievable. The ENEA (National Agency for New Technology, Energy and the Environment) IRP (Institute for Radiation Protection) individual monitoring service has been running for over 30 years. It offers personnel dosemeters which are based on its expertise and backed up by continual research and development. The report provides details of the dosemeters in use at IRP enable to decide which ones most suit the needs and shows IMS's organisation, customer and communications, dose reports form and administrative items. A short mention of future development will also be given. [Italian] La dosimetria individuale fornisce gli strumenti per misurare e registrare le dosi da radiazioni ionizzanti ricevute dai lavoratori esposti. Il decreto legislativo 230/95 stabilisce le circostanze in cui il monitoraggio individuale e' legalmente richiesto. Molti datori di lavoro forniscono dosimetri individuali anche quando non vi e' una richiesta legale spesso per seguire le regole di un programma di assicurazione di qualita' relativo alla radioprotezione o per ottenere una conferma che il principio ALARA sia soddisfatto. Il servzio di dosimetria personale dell'Istituto per la Radioprotezione dell'ENEA e' attivo da oltre 30 anni e offre dosimetri sviluppati sulla propria esperienza nelle tecniche dosimetriche che vengono continuamente aggiornati e adeguati rispecchiando lo stato dell

  4. Biological Monitoring for Plutonium-241; Detection du Plutonium-241 par Controles Biologiques; Dozimetriya Plutoniya-241 v biologicheskikh materialakh; Determinacion del Plutonio-241 en Sustancias Biologicas

    Energy Technology Data Exchange (ETDEWEB)

    Dalton, J. C.; McDonald, B. J.; Barnes, V. [United Kingdom Atomic Energy Authority, Windscale Works, Sellafield (United Kingdom)

    1965-10-15

    maximale admissible (0,9 {mu}Ci). On procede ensuite au dosage des isotopes emetteurs alpha du plutonium en exposant au disque, pendant une semaine, une plaque a emulsion nucleaire qui fait ensuite l'objet d'un examen visuel au microscope. (author) [Spanish] Los autores examinan el origen y las caracteristicas del {sup 241}Pu, prestando especial atencion a los riesgos que entrana para la salud y a los problemas que plantea su determinacion. Describen un aparato de recuento que se esta perfeccionando actualmente en Windscale, dentro del marco de un programa de vigilancia radiologica individual, para la determinacion cuantitativa de bajas actividades de {sup 241}Pu contenido en muestras. En la etapa actual de desarrollo, dicha tecnica es, por lo menos, tan sensible como los otros metodos conocidos y al mismo tiempo mas simple, rapida y economica. Ha sido ideada principalmente para su utilizacion en analisis de orina a fin de completar los datos ya obtenidos por determinacion autorradiografica de los emisores alfa isotopos del plutonio. La misma fuente en forma de disco se emplea para la determinacion del {sup 241}Pu, lo que simplifica la preparacion. Por intercambio anionico se procede primero a separar los isotopos del plutonio de la muestra de orina, o de otra sustancia biologica, en estado de gran pureza radioquimica. A continuacion se depositan por electrolisis sobre un disco de acero inoxidable. El recuento directo del espectro beta blando del {sup 241}Pu (energia maxima 20 keV, periodo 13,3 anos) se efectua con ayuda de un dispositivo de anticoincidencia formado por un contador proporcional de corriente gaseosa, de pequenas dimensiones, protegido por un contador de centelleo anular de material plastico. Gracias a las dimensiones del contador, todas las particulas beta del plutonio son absorbidas en el interior del aparato, mientras que las particulas alfa disipan cerca de la mitad de su energia en el material plastico. La geometria para ambas radiaciones es casi de 2

  5. Internal dose assessment in nuclear medicine: fetal doses due to radiopharmaceutical administration to the mother; Dosimetria interna en medicina nuclear: dosis absorbida en el feto por la administracion de radiofarmacos a la madre

    Energy Technology Data Exchange (ETDEWEB)

    Rojo, Ana M; Michelin, Severino C

    2004-07-01

    The objective of this publication is to present a guideline for the dose assessment through a comprehensive introduction of knowledge on ionizing radiation, radiation protection during pregnancy and fetal dosimetry for physician and other professionals involved in nuclear medicine practices. It contains tables with recommended dose estimates at all stages of pregnancy for many radiopharmaceuticals. Compounds for which some information was available regarding placental crossover are shown in shaded rows. It includes the most common diagnostic and therapy practices in nuclear medicine considering the four radioactive isotopes selected: {sup 99m}Tc, {sup 131}I, {sup 201}Tl and {sup 67}Ga. There is a special case included, it is when conception occurs after the iodine has been administered. In almost every case, the diagnostic benefit to the mother outweighs the risk of any irradiation of the fetus. However, there is one situation in which severe fetal injury can be incurred from administering a radiopharmaceutical to the mother, and that is use of iodine-131 therapy for ablation of the thyroid in cases of hyperthyroidism or carcinoma. Radioactive iodine readily crosses the placenta and concentrates in the fetal thyroid, where, because of its small organ mass, high radiation doses are received. (author)

  6. Investigaccion-accion en la sala de clases sobre las creencias de la cultura de la ciencia de un grupo de estudiantes universitarios y su relacion reciproca con el aprendizaje de las ciencias biologicas

    Science.gov (United States)

    Cordova-Santiago, Lizzette Astrid

    La investigacion---accion que se llevo a cabo en la sala de clases tenia como punto de partida las creencias de la cultura de la ciencia de un grupo de estudiantes universitarios para luego examinar sus implicaciones en el proceso de aprendizaje de las Ciencias Biologicas. ¿Que se supone que hagan las creencias en relacion con el aprendizaje? ¿En que consiste incorporar este aspecto a la practica educativa universitaria? Utilizando el modelo de Kemmis y McTaggart (1987) la investigacion-accion se planteo como un proceso dinamico en cuatro momentos en espiral constituidos por la planificacion, la accion, la observacion y la reflexion. Cada una de las fases tuvo una intencion retrospectiva y prospectiva formando una espiral de autorreflexion del conocimiento y la accion. Se llevaron a cabo audio grabaciones en clases y analisis de documentos. Ademas, la profesora-investigadora hizo un portafolio para reflexionar sobre las creencias de la cultura de la ciencia que tienen los estudiantes y las creencias del aprendizaje que tiene la profesora y sobre como la comprension de estos elementos ayudo a mejorar su practica educativa a traves del tiempo. Los resultados obtenidos apuntan a que las creencias de la cultura de la ciencia que tiene el grupo de estudiantes son diversas. Ellos si creen que la ciencia tiene una cultura la cual describieron como: complicada y desconocida que evoluciona constantemente, que es un conjunto de metodos, que es altamente tecnologica, que resuelve problemas de salud, ayuda a interpretar la realidad del mundo que los rodea y su origen y que existen unas intersecciones entre la ciencia y el poder. Sobre las creencias del proceso de aprendizaje de la profesora-investigadora, estas senalan que el modelaje de actores, la vision de la academia que tiene ella asi como la participacion y negociacion entre todos los involucrados en el proceso educativo, son factores que inciden en el proceso de aprendizaje.

  7. Age- and sex-specific estimation of dose to a normal thyroid from clinical administration of iodine-131

    International Nuclear Information System (INIS)

    Killough, G.G.; Eckerman, K.F.

    1986-09-01

    This report describes the derivation of an age- and sex-dependent model of radioiodine dosimetry in the thyroid and the application of the model to estimating the thyroid dose for each of 4215 patients who were exposed to 131 I in diagnostic and therapeutic procedures. In most cases, the data available consisted of the patient's age at the time of administration, the patient's sex, the quantity of activity administered, the clinically determined uptake of radioiodine by the thyroid, and the time after administration at which the uptake was determined. The model was made to conform to these data requirements by the use of age-specific estimates of the biological half-time of iodine in the thyroid and an age- and sex-dependent representation of the mass of the thyroid. Also, it was assumed that the thyroid burden was maximum at 24 hours after administration (the 131 I dose is not critically sensitive to this assumption). The metabolic model is of the form A(t) = K x (exp(-μ 1 t) - exp(-μ 2 t)) μCi where μ/sub i/ = λ/sub r/ + λ/sub i//sup b/ (i = 1, 2), λ/sub r/ is the radiological decay-rate coefficient, and the λ/sub i//sup b/ are biological removal-rate coefficients. The values of λ/sub i//sup b/ are determined by solving a nonlinear equation that depends on assumptions about the time of maximum uptake and the eventual biological loss rate (through which age dependence enters). An addendum (Appendix C) extends the method to other radioiodines and gives age- and sex-dependent dose conversion factors for most isotopes

  8. Biological (DB) and internal dosimetry (DI) in patients with differentiated thyroid carcinoma (CaDT) treated with iodine 131

    International Nuclear Information System (INIS)

    Fadel, Ana M.; Chebel, G.; Oneto, A.; Di Giorgio, Marina; Vallerga, Maria B.; Taja, Maria R.; Radl, A.; Rojo, Ana M.; Deluca, G.; Levi de Cabrejas, Mariana; Cabrejas, Raul C.

    2009-01-01

    The internal 131 I radiotherapy in patients with CaDT is used within the therapeutic scheme as a step post-thyroidectomy. The success of therapy is to achieve a lethal dose in the tumor tissue without exceeding the dose of tolerance in healthy tissues (doses greater than 2 Gy in bone marrow could lead to myelotoxicity). In this work, the treatment protocol applied incorporates assessment by biological (DB) and internal dosimetry (DI) for estimating doses to the whole body and bone marrow to administer a therapeutic personalized for each patient. The estimate biological dose is based in the quantification of chromosomal aberrations, which is referred to a dose-response curve. Objectives: 1) To estimate the absorbed dose to the whole body and bone marrow due to the administration of 131 I therapy in patients with CaDT, by applying three different cytogenetic tests: conventional cytogenetics, micronuclei (MN) and fluorescence in situ hybridization (FISH); 2) Assess the correlation of the results obtained by DB and DI for personalization of treatment. Materials and methods: We evaluated 24 patients with CaDiT by applying the cytogenetic tests mentioned and internal dosimetry (methodology Mird-Olinda). Internal dosimetry: We administered a tracer dose 74 to 111 MBq. Measurements were made of activity in whole body and blood. By adjusting the scheme was estimated MIRD dose in bone marrow and the maximum therapeutic activity to manage and secure. Through software Olinda was determined absorbed dose to the whole body for each patient. We considered patient-specific data (physical frame size, weight, hematocrit) to adjust the methodology in each particular case. It is assumed that the tracer activity administered has a kinetic in the body similar to the 131 I to be administered in therapeutic amounts. Biology Dosimetry : We performed for each patient taking 2 sequential venous blood samples to estimate the dose due to therapeutic activity in review: the first shows, pre-dose tracers (to assess the contribution of therapeutic doses above) and the second shows, 8 days post-therapeutic dose (in this period most of the energy of 131 I is deposited in the body and it is possible to assess the biological effect that this produces absorbed dose). These samples were applied techniques cytogenetics, MN and FISH. It assumes: 1) uniform distribution of 131 I in the body, because the total thyroidectomy; 2) that in the absence of bone metastases that compromise bone marrow estimated average dose to the whole body can be considered an approximation appropriate dosage bone marrow. The technique FISH estimated equivalent dose active in bone marrow. Results: A comparison of the doses received by 3 cytogenetic tests applied indicates that these methods are consistent with each other. The absorbed dose to the whole body estimated by DB correlate with those estimated by DI, p 131 I to administer in patients with CaDiT. These results support the advantage of applying quantitative methods of DI, who consider the patient's own parameters, in order to customize their therapy, with respect to the empirical method. In this context, the DB provides evidence for the validation of the DI. Also, from a clinical point of view, the DB conducted on samples from patients with previous treatments, before a new therapeutic administration, would assess the status cytogenetic (radiation damage and repair capacity). The dosimetry presented clinical importance in reducing potential complications hematologic. In cases with cumulative doses higher than 1000 mCi, it would be useful to indicate the need to consider other schemes therapeutic alternative to the administration of 131 I, such as chemotherapy or radiotherapy, reducing morbidity. (author)

  9. Radioactive iodine (131I) therapy for differentiated thyroid cancer in Japan. Current issues with historical review and future perspective

    International Nuclear Information System (INIS)

    Higashi, Tatsuya; Kudo, Takashi; Kinuya, Seigo

    2012-01-01

    Radioactive iodine (RAI, 131 I) has been used as a therapeutic agent for differentiated thyroid cancer (DTC) with over 50 years of history. Recently, it is now attracting attention in medical fields as one of the molecular targeting therapies, which is known as targeted radionuclide therapy. Radioactive iodine therapy (RIT) for DTC, however, is now at stake in Japan, because Japan is confronting several problems, including the recent occurrence of the Great East Japan Disaster (GEJD) in March 2011. RIT for DTC is strictly limited in Japan and requires hospitalization. Because of strict regulations, severe lack of medical facilities for RIT has become one of the most important medical problems, which results in prolonged waiting time for Japanese patients with DTC, including those with distant metastasis, who wish to receive RIT immediately. This situation is also due to various other factors, such as prolonged economic recession, super-aging society, and subsequent rapidly changing medical environment. In addition, due to the experience of atomic bombings in Hiroshima and Nagasaki, Japanese people have strong feeling of ''radiophobia ''. There is fear that GEJD and related radiation contamination may worsen this feeling, which might be reflected in more severe regulation of RIT. To overcome these difficulties, it is essential to collect and disclose all information about the circumstances around this therapy in Japan. In this review, we would like to look at this therapy through several lenses, including historical, cultural, medical, and socio-economic points of view. We believe that clarifying the problems is sure to lead to the resolution of this complicated situation. We have also included several recommendations for future improvements. (author)

  10. Evaluation of radiotherapy of patients with Graves' disease treated with fixed activities of 555 MBq of Iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Jose M.F. da; Filho, Joao A.; Junior, Manoel R. de S.; Mendonca, Keyla M.C., E-mail: josemarcosfs@yahoo.com.br, E-mail: jaf@ufpe.br, E-mail: manoel@de.ufpe.br, E-mail: keylamcm@yahoo.com.br [Universidade Federal de Pernambuco (UFPE), e-mail: Recife, PE (Brazil)

    2013-07-01

    Graves' disease treatment is done by radioiodine therapy (RIT), which destroys cells of the thyroid and reduces the synthesis of T{sub 3} and T{sub 4}; and surgery. In Brazil, applies RIT with fixed activities. Studies show that RIT should be based on individual biokinetics. There is controversy regarding the use of fixed activities or calculated. This study was conducted at the HC-UFPE in the period 2006-2010. Of the overall sample of 132 patients that entered the study, twenty-five of them formed a group chosen to estimate the maximum uptake of {sup 131}I and thyroid mass, to calculate the activity to be administered and the absorbed dose. All the patients were treated with fixed activities of 555 MBq {sup 131}I. Observed that 28% of patients received radioactivities above, 72% received radioactivities below, and nobody received no radioactivity as a real need. The group obtained an average rate of cure of (76 ± 5) % at 24 months of follow up, less than those obtained under the same conditions biokinetics and mean follow-up interval, among many, who have used doses of 250 Gy and 350 Gy and achieved cure rates approximately 90%. Doses received totaled 9,166 Gy, and 6,698 Gy were necessary, therefore were wasted 2,468 Gy. Were risk factors observed: extrapolation of interval of the thyroid function tests of three to six months to one to three years; economic difficulties, interfamily, socio emotional and to perform the tests requested and great distances between homes and hospital; among others; may be limitations that led to the contraposition that higher activities of {sup 131}I promote greater cure rate of GD. Results of univariate analysis - were statistically significant risk factors: female, thyroid mass between 31 g and 60 g and duration of the GD before of RIT > five years (p < 0.05). The factors sex and thyroid mass are consistent with other studies. The results suggest the use of optimized activities based on individual dosimetric parameters and the implementation of more effective public policies for the patient accompaniments, so that be decreased the radiological risks, detriments and unnecessary expenses. (author)

  11. Detriments of radioactive Iodine 131 in managing thyroid carcinoma - a retrospective study with review of the current scenario

    International Nuclear Information System (INIS)

    Mohan, Shaweta; Agnihotri, Gaurav

    2016-01-01

    Radioactive iodine (RAI) ablation following thyroidectomy is recommended for most patients diagnosed with papillary and follicular thyroid carcinoma. We performed a literature search on MEDLlNE and EMBASE, using keywords, such as, differentiated thyroid carcinoma, radioiodine therapy, "1"3"1I complications, adverse effects and side effects, and chose the most relevant studies till date to prepare this work on the side effects of RAIT (Radioactive Iodine Therapy) for thyroid cancer. We contacted authors of published studies where appropriate for further information. Also, the percentage incidence of the hazards was determined for North Indian population accessing data from Govt. Medical Colleges of Punjab, Haryana, and Postgraduate Institute of Medical Education and Research, Chandigarh. The most prominent side effect came out to be xerostomia with an incidence of 47%, followed by local neck pain and swelling (39%). The incidence of gastritis was also common (34%). Radioactive iodine therapy complications have been divided into early and late effects. Early complications include gastrointestinal symptoms, radiation thyroiditis, sialadenitis/xerostomia, bone marrow suppression, gonadal damage, dry eye, and nasolacrimal duct obstruction. Late complications include secondary cancers, pulmonary fibrosis, permanent bone marrow suppression, and genetic effects. As "1"3"1I is an efficacious form of treatment that can significantly decrease the rate of mortality, recurrence and metastasis, and as the side effects are often minor and well-tolerated, radio iodine therapy remains the principal mode of treatment for patients. (author)

  12. The optimization of treatment with radioactive iodine (131I) of the hypersecretive ''hot'' tumors of the thyroid

    International Nuclear Information System (INIS)

    Gorowski, T.; Zgliczynski, S.

    1987-01-01

    The studies have been carried out in 50 patients with hyperthyroidism associated with the presence of ''hot'' thyroid tumor. The effectiveness of treatment with a standard dose of radioactive iodine, a dose which after 48 hours following the administration caused an appearance of 5.55 MBq (150 μCi) of 131 I in 1 cubic centimeter of the tumor, has been determined. In each case the condition of the patient was evaluated several times before and after the treatment, basing on clinical examination, scintigraphy of the thyroid, the determinations of T 3 , T 4 and TSH concentrations and, when needed, also the determination of TSH after stimulation with TRH. The period of observation after the administration of the first therapeutic dose of radioactive iodine was between 2 and 19 years (mean 6.5 years). The results obtained indicated that in 40 among 50 patients (80%) hyperthyroidism disappeared after administration of a single dose of radioactive iodine calculated as specified above. In two of these patients (4%) hypothyroidism resulted. In the remaining 10 patients (20%) the treatment with radioactive iodine had to be repeated. This resulted in disappearance of hyperthyroidism also in these 10 patients, bringing the total amount of cured patients to 50 (100%), and increasing the amount of patients with hypothyroidism to barely 3 cases (6%). 23 refs., 2 tabs. (author)

  13. Sub-stoichiometric isotope dilution analysis method for the determination of iodine in common salts using iodine-131 tracer

    International Nuclear Information System (INIS)

    Singh, Vivek; Garg, A.N.

    1994-01-01

    A sub-stoichiometric isotope dilution analysis (SIDA) method was developed for the determination of iodine in different brands of common salts. An aqueous salt solution containing 131 I tracer and NaI as carrier is oxidized by tartaric acid and KIO 3 and the liberated iodine is extracted with CCl 4 . To the extract an aqueous solution of AgNO 3 is added in substoichiometric amount to obtain a colloidal solution of AgI. On adding sodium thiosulfate solution, the NaI so formed passes into aqueous solution, which is then counted. Several different brands of salt were analysed. The method is especially suitable for the determination of microgram amounts of iodide in the presence of excess of chloride. (Author)

  14. Evaluation of local hospital discharge for thyroid cancer patients treated with Iodine-131; comparison with internationally accepted release criteria

    International Nuclear Information System (INIS)

    Stylianou-Markidou, E.; Peraticou, A.; Constantinou, C.; Giannos, A.; Aritkan, A.V.; Dimitriadou, D.; Frangos, S.

    2007-01-01

    Full text: Aim: Patients with Thyroid Cancer treated with I-131 in our institution, stay in a shielded room for two days, or until they emit less than 40 μSv/hr at 1m, based on the Cyprus legislation for radiation protection. Other countries have different regulations and public dose limits, and their hospital discharge guidelines vary accordingly. The purpose of this study is to evaluate local hospital discharge regulations, make a comparison with other countries' accepted release criteria, and find where improvements can be made. Methods: 267 patients were treated with I-131 (activity 1.8-8.9GBq) from September 2001 to April 2007. The dose equivalent rate (DER) was measured within 30 min of the administration at a distance of 1 m from the patient. Measurements at 1m were also obtained before the release of the patient. For a group of these patients, measurements were also carried out a week after the treatment with I-131. The doses given to members of the public, from each of the above patients, were calculated using the Total Effective Dose Equivalent (TEDE) concept, which is based on the line source model. For 10% of these patients, measurements of the dose emitted to surroundings were taken, using two different methods. (a) Doses were measured with TLD dosimeters placed at specific points of the room during the two day restriction of the patient in the shielded room. These points were at bedside, at 1 m from the patient's bed, at 3m from the patient's bed, in the shower area, and at the side of the toilet. (b) On the day of release, personal dosimeters were given to a member of the immediate family (carer) of the patient for a minimum of five days. The skin dose and dose at approximately 10cm depth were measured by the National personnel monitoring for radiation protection authority of Cyprus. Results: Our calculation of the TEDE values indicated that, had the patients been released just after the administration of the radiopharmaceutical, members of the public within 1 m of the patient, would have received a dose varying between 1.11mSv-5.46mSV, with 96% of the cases resulting in a dose greater than 2mSv to members of the public. The measurements carried out on 10% of the patients showed that during the first 2 days after administration, with the patient restricted in the specially shielded room, the dose received by TLD dosimeters ranged as follows: (a) At bedside, from 2.1mSv to 4mSv (b) At 1m from the patient, from 1.0mSv to 2.5mSv (c) At 3m from the patient, from 0.5mSv to 0.9mSv (d) In the shower area, from 0.7mSv to 1.7mSv (e) At the side of the toilet, from 0.7mSv to 8.7mSv. The doses measured from the personal dosimeters given to these patients' relatives, after a minimum of 5 days from the hospital discharge, ranged between 0.05mSv to 0.62mSv for skin, and from 0.03mSv to 0.59mSv at 10cm depth. Discussion and Conclusions: The E.U. directive on 'Radiation protection following I-131 therapy' separates the members of the family and possible carers into three different categories based on age, and sets different dose limits per treatment for each of them. It also goes a step further and sets a limit 0.3mSv as the upper limit for this type of exposure to third parties. In some States of the U.S.A, patients treated I-131 are released to go home after the administration of the radiopharmaceutical, with written behavioral instructions, but under the dose constraint that the effective dose to any other individual from the discharged patient is not likely to exceed 5mSv. This is considerably less stringent than the public exposure limit of 1mSv adopted in Cyprus and the E.U. In Australia, as in Cyprus and the EU, the patients are admitted to shielded rooms until the dose rate at 1m from the patient in reduced to 25 μSv/hr. The public should again not be exposed to more than 1mSv from these patients. Again, in the case that a patient should require assistance, the dose to the carer should not exceed 5mSv. The conclusion from our study is that the minimum time a patient should spend in the shielded room, in order for the dose limit to the public will not exceed, is two days. This limit in Cyprus and the EU is set to 1mSv/yr. For those Iodine patients who require the assistance of a carer, the dose limit for voluntary carers is set to 5mSv per treatment session, in Cyprus. (author)

  15. Synthesis and In Vitro and In Vivo Evaluation of Iodine-131-Labeled Folates: Potential Molecular Diagnostic and Therapeutic Radiopharmaceuticals

    International Nuclear Information System (INIS)

    Al Jammaz, I.

    2009-01-01

    Molecular targeting imaging has a great potential to be able to image molecular changes that are currently defined as predisease states which facilitate earlier detection of cancer and consequently, the greatest chance of cure. Advancement of scintigraphic imaging and radiotherapy is highly determined by development of more specific radiotracers. The Membrane-associated-folic acid receptor is a glycosylphospstidylinositol protein that overexpressed in approximately 100% of serious ovarian adenocarcinomas and various epithelial cancers including cervical, colorectal and renal cancers. Meanwhile, this receptor is highly restricted in most normal tissues which make these tumors as an excellent candidates for molecular targeting imaging and therapy through the folate receptor system. As part of our on-going research effort to develop prosthetic precursors for radiohalogenation of bioactive molecules, we have previously reported the synthesis and biological characterization of [ 18 F]- fluorobenzene and pyridine carbohydrazide-folate conjugates ([ 18 F]-SFB and [ 18 F]-SFP-folates). We here report the synthesis and biological characterization of [ 131 I]-iodobenzenecarbohydrazide-folate conjugate ([ 131 I]-SIB-folate) as a potential therapeutic radiopharmaceutical. The synthetic approaches for preparation of [ 131 I]iodobenzene carbohydrazide-folates ([ 131 I]-SIB-folate) entailed sequence of reactions. Hydrazide-folate was reacted with N-succinimidyl-m-[131I]-iodobenzoate-carboxylate ([ 131 I]-SIB) to give [ 131 I]-SIB-folate conjugate. Radiochemical yield was greater than 80% and synthesis times were ranging between 40-45 min. Radiochemical purity was also greater than 97% without HPLC purification. These synthetic approaches hold considerable promise as rapid and simple method for the radiohalogenation of folate in high radiochemical yield in short time. In vitro tests on KB cell line has shown that significant amount of the radioconjugate associated with cell fractions and in vivo characterization in normal CBA/J mice revealed rapid blood clearance of this radioconjugate with excretion predominantly by the hepatobiliary system. In vivo tumor targeting capacity of this radioconjugate in athymic mice with folate-receptor-positive human KB cell tumor xenografts is currently in progress. (author)

  16. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans?

    Energy Technology Data Exchange (ETDEWEB)

    Davidson, J. [Departments of Medicine and Nuclear Medicine, Glasgow Royal Infirmary, Glasgow (United Kingdom); McDougall, I.R. [Division of Nuclear Medicine, Stanford University School of Medicine, Stanford, CA (United States)

    2000-04-01

    The purpose of the study was to determine how often the thymus is visualized on whole-body radioiodine scans. One hundred and seventy-five patients had 325 diagnostic scans and 200 post-treatment scans. Activity in the mediastinum possibly consistent with the thymus was seen on seven scans in six patients. Four of these were diagnostic scans (three were second follow-up scans, and the fourth, a third follow-up scan). Three post-treatment scans demonstrated mediastinal uptake. Only one patient had persistent mediastinal uptake on both a post-treatment scan and a subsequent follow-up diagnostic scan. None of these six patients were treated as a result of this finding and none has clinical or biochemical evidence of metastatic disease. (orig.)

  17. How frequently is the thymus seen on whole-body iodine-131 diagnostic and post-treatment scans?

    International Nuclear Information System (INIS)

    Davidson, J.; McDougall, I.R.

    2000-01-01

    The purpose of the study was to determine how often the thymus is visualized on whole-body radioiodine scans. One hundred and seventy-five patients had 325 diagnostic scans and 200 post-treatment scans. Activity in the mediastinum possibly consistent with the thymus was seen on seven scans in six patients. Four of these were diagnostic scans (three were second follow-up scans, and the fourth, a third follow-up scan). Three post-treatment scans demonstrated mediastinal uptake. Only one patient had persistent mediastinal uptake on both a post-treatment scan and a subsequent follow-up diagnostic scan. None of these six patients were treated as a result of this finding and none has clinical or biochemical evidence of metastatic disease. (orig.)

  18. Rhenium-188 as an alternative to Iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS)

    International Nuclear Information System (INIS)

    Dadachova, E.; Bouzahzah, B.; Zuckier, L.S.; Pestell, R.G.

    2002-01-01

    The sodium-iodide symporter (NIS), which transports iodine into the cell, is expressed in thyroid tissue and was recently found to be expressed in approximately 80% of human breast cancers but not in healthy breast tissue. These findings raised the possibility that therapeutics targeting uptake by NIS may be used for breast cancer treatment. To increase the efficacy of such therapy it would be ideal to identify a radioactive therapy with enhanced local emission. The feasibility of using the powerful beta-emitting radiometal 188 Re in the form of 188 Re-perrhenate was therefore compared with 131 I for treatment of NIS-expressing mammary tumors. In the current studies, using a xenografted breast cancer model induced by the ErbB2 oncogene in nude mice, 188 Re-perrhenate exhibited NIS-dependent uptake into the mammary tumor. Dosimetry calculations in the mammary tumor demonstrate that 188 Re-perrhenate is able to deliver a dose 4.5 times higher than 131 I suggesting it may provide enhanced therapeutic efficacy

  19. Evaluation of radiotherapy of patients with Graves' disease treated with fixed activities of 555 MBq of Iodine-131

    International Nuclear Information System (INIS)

    Silva, Jose M.F. da; Filho, Joao A.; Junior, Manoel R. de S.; Mendonca, Keyla M.C.

    2013-01-01

    Graves' disease treatment is done by radioiodine therapy (RIT), which destroys cells of the thyroid and reduces the synthesis of T 3 and T 4 ; and surgery. In Brazil, applies RIT with fixed activities. Studies show that RIT should be based on individual biokinetics. There is controversy regarding the use of fixed activities or calculated. This study was conducted at the HC-UFPE in the period 2006-2010. Of the overall sample of 132 patients that entered the study, twenty-five of them formed a group chosen to estimate the maximum uptake of 131 I and thyroid mass, to calculate the activity to be administered and the absorbed dose. All the patients were treated with fixed activities of 555 MBq 131 I. Observed that 28% of patients received radioactivities above, 72% received radioactivities below, and nobody received no radioactivity as a real need. The group obtained an average rate of cure of (76 ± 5) % at 24 months of follow up, less than those obtained under the same conditions biokinetics and mean follow-up interval, among many, who have used doses of 250 Gy and 350 Gy and achieved cure rates approximately 90%. Doses received totaled 9,166 Gy, and 6,698 Gy were necessary, therefore were wasted 2,468 Gy. Were risk factors observed: extrapolation of interval of the thyroid function tests of three to six months to one to three years; economic difficulties, interfamily, socio emotional and to perform the tests requested and great distances between homes and hospital; among others; may be limitations that led to the contraposition that higher activities of 131 I promote greater cure rate of GD. Results of univariate analysis - were statistically significant risk factors: female, thyroid mass between 31 g and 60 g and duration of the GD before of RIT > five years (p < 0.05). The factors sex and thyroid mass are consistent with other studies. The results suggest the use of optimized activities based on individual dosimetric parameters and the implementation of more effective public policies for the patient accompaniments, so that be decreased the radiological risks, detriments and unnecessary expenses. (author)

  20. Long-term follow-up results in children and adolescents treated with radioactive iodine (131I) for hyperthyroidism

    International Nuclear Information System (INIS)

    Safa, A.M.; Schumacher, O.P.; Rodriguez-Antunez, A.

    1975-01-01

    To evaluate the long-term results of 131 I therapy for children, the course of 87 patients (three to 18 years old, 24 boys and 63 girls) treated from 1949 through 1968, for hyperthyroidism due to Graves's disease was studied. Dose of 131 I per patient ranged from 2.9 to 31 mCi (mean +- S. D., 9.75 +- 6.5). Patients were followed for five to 24 years (mean, 12.3 +- 3.5). Hyperthyroidism was controlled in 85 within one to 14 months (mean, 3.3 +- 2.6). Recurrence of thyrotoxicosis due to toxic diffuse goiter, observed in only one case after 11 years, was successfully re-treated with 131 I. Reproductive history and health status of the progeny of 131 I-treated patients were not different from those of the general population. No deaths and no cancer or leukemia were observed in patients or their offspring. The major cause of goiter regrowth was Hashimoto's thyroiditis. Hypothyroidism developed in 35 of 76 patients (46 percent). 131 I deserves further use in treatment of hyperthyroid children with Graves's disease

  1. Clinical application and observation of curative effect in the near future of iodine-131 therapy in juvenile patients with hyperthyroidism

    International Nuclear Information System (INIS)

    Chen Huilin; Liang Jun; Liang Fengyun

    2004-01-01

    Objective: To assess clinical application of 131 I therapy and observation of curative effect in the near future after treatment in juvenile patients with hyperthyroidism Methods: 44 juvenile patients with hyperthyroidism were divided two subgroups of that children and early youths .The dosage of 131 I were respectively 135.1±34.0(3.65±0.92), 200.2±64.0 MBq(5.41±1.73 mCi). The curative effect belonged in four kinds being to fully recovered, quite a lot, fail to respond to medical and hypothyroidism at six month slater or from then. Results: 46 times treatment were gave and therapy effect was same in every subgroups. The effective rate of total was 89.1% and rater on clinical hypothyroidism was 4.3%. Conclusions: It had an obvious effect that 131 I therapy for juvenile patients with hyperthyroidism. 131 I therapy was also a firmly good select because a well ratio effect/cost. (authors)

  2. Does remnant from differentiated thyroid micro-carcinoma patients really not be treated with Iodine-131 ablation?

    International Nuclear Information System (INIS)

    D'Antuono, F.; Gallicchio, R.; Venetucci, A.; Giacomobono, S.; Tempone, A.; Di Leo, A.; Storto, G.; Nardelli, A.; Pellegrino, T.; Gattozzi, D.

    2015-01-01

    Full text of publication follows. Aim: Remnant ablation by radioiodine is generally not recommended in patients presenting uni- or multifocal cancer <1 cm, without other higher risk features. We retrospectively studied low-risk patients (pts) with differentiated thyroid cancer (DTC) less than 1 cm recruited for radioiodine therapy (RAI). Methods: 91 pts (79 women, age 49.4 ± 10 years) with DTC were recruited for RAI. Pts underwent pre-therapy ultrasonography (US), those with suspected/ambiguous lymph-nodes were excluded and proposed for cytology. Treated pts underwent post-therapeutic whole body scan (WBSt) completed by neck/chest SPECT-CT, when necessary (e.g. evidence of uptake outside of thyroid bed). A target lesion on SPECT-CT was defined as an identifiable lymph-nodal site presenting a matched significant iodine uptake. Patients were followed up for 13 ± 2 months thereafter. Results: All pts/cancers were pT1. Mean histological diameter was (0.66 ± 0.25) cm. Six patients were excluded because of clear nodal involvement at US. Thirty (35%) out of 85 pts had suspicious WBSt as per lymph-nodal involvement which was confirmed at the following SPECT-CT acquisition in most part of pts (25/30; 83 %). Overall detected target lesions was 34, ten (29%) had interim positive fine needle cytology. Conclusions: a significant part of low risk DTC patients, for whom RAI is not recommended, presents an incidental evidence of lymph-nodal involvement at WBSt confirmed by SPECT-CT, when performed. Such setting would have not been treated by I-131. Indications for RAI in DTC low risk patients could be revised at least considering a different dimensional cut-off for the primary lesion. (authors)

  3. Iodine-131-labelled CDR grafted monoclonal antibody huA33 metastatic colorectal carcinoma: A case study

    International Nuclear Information System (INIS)

    Thomas, D.L.; Lee, F.T.; Scott, A.M.

    1997-01-01

    Full text: A 58-year-old woman was diagnosed with metastatic colorectal carcinoma two years after initial surgery for sigmoid carcinoma. As part of the staging work-up she was initially referred for a 18 F-FDG PET scan at the PET Centre. FDG PET scans of the abdomen and pelvis demonstrated multiple hepatic lesions, but there was no evidence of disease outside the liver. On the basis of extensive hepatic disease, the patient was scheduled for a laparotomy for insertion of an hepatic artery catheter for chemotherapy. In view of her clinical presentation, the patient was eligible for a Phase 1 trial with 131 l-labelled huA33, and agreed to participate. HuA33 is a humanised CDR-grafted recombinant monoclonal antibody directed against an antigen found on >95 per cent of all colorectal carcinomas, and on small bowel and colonic mucosa. The phase 1 trial is a protein dose escalation study designed to examine the biodistribution, pharmacokinetics, dosimetry and safety profile of huA33, and sequential gamma camera images of the whole body were obtained daily until seven days post infusion. SPECT images were obtained on day 6. Excellent localisation of 131 l-huA33 was seen in hepatic lesions. Calculation of whole body retention and tumour uptake was performed, and pharmacokinetic analysis also undertaken. Biopsies of tumour obtained at surgery were used to quantitate tumour uptake and cellular trafficking of 131 l-huA33. On the basis of this phase 1 study, future therapeutic trials of 131 I-huA33 are planned

  4. Radioiodine uptake following iodine-131 therapy for Graves' disease: an early indicator of need for retreatment

    Energy Technology Data Exchange (ETDEWEB)

    Carpentier, W.R.; Gilliland, P.F.; Piziak, V.K.; Petty, F.C.; McConnell, B.G.; Verdonk, C.A.; Ibarra, J.D.; Thompson, J.Q.

    1989-01-01

    Forty-five patients with Graves' disease were studied prospectively to determine if 24-hour I-131 uptake measurements alone or in combination with serum thyroid hormone levels at six weeks would determine the necessity for retreatment of the thyrotoxicosis. All patients with an I-131 uptake greater than 30% at six weeks required retreatment. No patient with an I-131 uptake of less than 15% required retreatment. Patients with uptakes between 15% and 30% were variable. An elevated free thyroxin index at 6 weeks is not helpful to determine which patients will remain thyrotoxic. Patients with a free thyroxin index within the normal range at six weeks can be predicted to be euthyroid by 12 weeks if their 24-hour I-131 uptake is between 15% and 30% and to be hypothyroid if their 24-hour I-131 uptake is below 15%. There was no difference between patient groups treated initially with antithyroid medication and those who were not.

  5. Transient hypothyroidism in iodine-131 treated thyrotoxicosis - a review of cases from 1970-1984 at JRRMMC

    International Nuclear Information System (INIS)

    Reyes, E.B.; de la Cruz, C.; Gonzales, V.L.

    1988-01-01

    This review was conducted to determine the minimum dose of radioactive iodine necessary to show signs and symptoms of thyrotoxicosis among Filipinos, to determine the incidence of hypothyroidism secondary to radioactive treatment and to determine if some cases of hypothyroidism following radioactive iodine treatment are only transient and replacement therapy could be withheld or not. A total of 212 patients who had I-131 therapy was evaluated (177 female and 35 male). Of this number 19 or 8.9% developed hypothyroidism. After three years, 14 or 74% of the hypothyroids were noted. Easy fatigability ranked first of the patients complaints, followed by dry skin, sleepiness, numbness of extremities, and joint pains. Results of this study indicate that there is a definite, although low incidence of hypothyroidism following I-131 therapy (8.9%). (ELC). 6 refs.; 6 tabs

  6. Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases

    International Nuclear Information System (INIS)

    Kubota, K.; Som, P.; Brill, A.B.; Sacker, D.F.; Meinken, G.E.; Srivastava, S.C.; Atkins, H.L.

    1989-01-01

    Our previous studies have shown that a significant amount of the diamine derivative 131 I-N,N,N'-trimethyl-N'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3- propanediamine (HIPDM) is taken up and retained by the normal pancreas. Therefore, we studied the uptake of [ 13 1I]HIPDM in various pathophysiological models in mice (chronic alcoholism, diabetes with beta-cell atrophy and obesity with beta-cell hypertrophy) and compared to 14 C-L-Tryptophan (TRY) distribution in order to determine the factors influencing their pancreatic uptake. In normal animals, the pancreas uptake of TRY was generally higher than HIPDM. In diabetes, the relative concentration of both compounds was higher over the controls; however, in obesity, TRY showed lower accumulation than in controls while HIPDM showed no significant difference. Chronic ethanol (20%) ingestion increased TRY uptake in the pancreas compared to controls (36.88 ± 3.21 vs. 30.03 ± 4.17% ID/g; p less than 0.01) after 5 wk study period, but it decreased by 10 wk (22.36 ± 0.95% ID/g; p less than 0.005). There were no significant changes in [ 131 I]HIPDM distribution in alcoholics as compared to the controls. Radioiodinated HIPDM has potential advantages over [ 11 C]TRY for pancreatic imaging since conventional imaging techniques can be employed. Our data, however, suggest that 11 C-L-TRY is a more sensitive indicator of various pancreatic disorders

  7. [Complete hormonal and metabolic response after iodine-131 metaiodobenzylguanidine treatment in a patient diagnosed of malignant pheochromocytoma].

    Science.gov (United States)

    García Alonso, M P; Balsa Bretón, M A; Paniagua Correa, C; Castillejos Rodríguez, L; Rodríguez Pelayo, E; Mendoza Paulini, A; Ortega Valle, A; Penín González, J

    2013-01-01

    Radiolabeled metaiodobenzylguanidine is an analogue of norepinephrine used to localize tumors that express the neurohormone transporters, specifically those derived from the neural crest having a neuroendocrine origin. It is also used to treat non-surgical metastases derived from them. A review of the literature revealed symptomatic improvements associated to a decrease in hormone levels in a significant percentage of patients after (131)I-MIBG treatment. However, complete tumor remission has been described only in very few cases and hardly ever when bone metastases exist. We present a case of a patient diagnosed of malignant pheochromocytoma who achieved complete hormonal and metabolic response after (131)I-MIBG treatment (600 mCi) in spite of the presence of bone metastases. Copyright © 2012 Elsevier España, S.L. and SEMNIM. All rights reserved.

  8. Aplicativo para dosimetria interna usando a distribuição biocinética de fótons baseada em imagens de medicina nuclear

    Directory of Open Access Journals (Sweden)

    Viriato Leal Neto

    2014-10-01

    Full Text Available Objetivo: Este artigo apresenta uma forma de se obterem estimativas de dose em pacientes submetidos a tratamentos radioterápicos a partir da análise das regiões de interesse em imagens de medicina nuclear. Materiais e Métodos: Foi desenvolvido o software denominado DoRadIo (Dosimetria das Radiações Ionizantes, que recebe as informações sobre os órgãos fontes e o órgão alvo e retorna resultados gráficos e numéricos. As imagens de medicina nuclear utilizadas foram obtidas de catálogos disponibilizados por físicos médicos. Nas simulações utilizaram-se modelos computacionais de exposição constituídos por fantomas de voxels acoplados ao código Monte Carlo EGSnrc. O software foi desenvolvido no Microsoft Visual Studio 2010 com o modelo de projeto Windows Presentation Foundation e a linguagem de programação C#. Resultados: Da aplicação das ferramentas foram obtidos: o arquivo para otimização das simulações Monte Carlo utilizando o EGSnrc, a organização e compactação dos resultados dosimétricos com todas as fontes, a seleção das regiões de interesse, a contagem da intensidade dos tons de cinza nas regiões de interesse, o arquivo das fontes ponderadas e, finalmente, todos os resultados gráficos e numéricos. Conclusão: A interface de usuários pode ser adaptada para uso em clínicas de medicina nuclear como ferramenta computacional auxiliar na estimativa da atividade administrada.

  9. Experience in the patients management which received treatments with radioactive iodine ({sup 131}I). Measurements and dosimetry pertaining to the personnel related; Experiencia en el manejo de pacientes que recibieron tratamientos con yodo radiactivo ({sup 131}I). Mediciones reglamentarias y dosimetria del personal relacionado

    Energy Technology Data Exchange (ETDEWEB)

    Ruiz J, A [Instituto Nacional de la Nutricion Salvador Zubiran, Departamento de Medicina Nuclear, Tlalpan, 14000 Mexico D.F. (Mexico)

    1999-07-01

    In the INNSZ there are administering ablative doses of radioactive iodine to patients with problems of the thyroid gland from 40 years ago. Starting from 1992 was initiated the restlessness to inform to the patients verbally and in writing over the measurements of radiological safety that must be followed for the protection of their families. In this work it is commented, the benefits obtained with the patients and the teachings to give to the personnel what attend the patients which receive treatments with iodine-131 and must be hospitalized. It is commented too over the standardization standing of the patients discharged whom received radioactive material and lastly, it was make a dosimetric study of the nurses, radiotherapeutic and control area. (Author)

  10. Scientific production of the Radioprotection and Dosimetry Institute (IRD): preliminary bibliometric evaluation of the journal articles; Producao cientifica do Instituto de Radioprotecao e Dosimetria (IRD): avaliacao bibliometrica preliminar dos artigos de periodicos

    Energy Technology Data Exchange (ETDEWEB)

    Gusmao Pedrini, A de [Instituto de Radioprotecao e Dosimetria (IRD), Rio de Janeiro, RJ (Brazil); [Universidade do Estado, Rio de Janeiro, RJ (Brazil). Inst. de Biologia; [Universidade Santa Ursula, Rio de Janeiro, RJ (Brazil). Centro de Ciencias Biologicas

    1994-12-31

    A total of 114 articles (1974-1991, this last year the most productive) in 28 periodicals were published. The periodical core production is made up of: Health Physics, Radiation Protection Dosimetry, Radioprotecao e Dosimetria, Radiologia Brasileira. 53% were written in cooperation with 33 institutions. The 155 authors and 376 authorship were mainly in collective and triple-authorship articles. Mean productivity/author was 2.8 articles which is lower than that of Price. The most productivity author produced 14 articles + 19 co-authors in 7 periodicals on environmental radiation protection while 88 authors produced 1 article. The productive elite (12 authors) accounted for 72 articles, 26% above the average according to Lotka, with 111 out of a total of 376 authorships in 20 periodicals. The elite forms an inter departmental communication network with authors who write about environmental, occupational and individual radiation protection. (author). 17 refs, 1 tab.

  11. Concepciones y concepciones alternativas de estudiantes universitarios/as de biologia y futuros maestros/as de Ciencia de escuela secundaria sobre la teoria de evolucion biologica por seleccion natural

    Science.gov (United States)

    Morales Ramos, Egda M.

    La teoria de evolucion biologica (TEB) por seleccion natural es uno de los conceptos unificadores mas importantes del curriculo de Biologia. En Puerto Rico se han hecho pocas investigaciones que abunden sobre las concepciones y concepciones alternativas (CA) que tienen los estudiantes universitarios/as de Biologia y los maestros/as de Ciencia del nivel secundario sobre esta teoria. La politica publica educativa actual establece mediante documentos normativos como los Estandares de contenido y Expectativas de grado del Programa de Ciencias [Puerto Rico Core Standards] la ensenanza de esta teoria. Sin embargo, no se encontraron preguntas sobre la seleccion natural en los ejercicios de practica provistos por el Departamento de Educacion para las pruebas estandarizadas lo cual puede influir para que no se ensene adecuadamente. Las preguntas de investigacion fueron 1. ¿Cuales son las concepciones y concepciones alternativas de estudiantes universitarios/as y de los futuros maestros y maestras de Ciencia sobre la TEB? 2. ¿Cuales conceptos que seleccionan los estudiantes universitarios/as y los futuros maestros y maestras de Ciencia sobre la TEB coinciden con lo aceptado como valido por la comunidad cientifica? y 3. ¿Como comparan las respuestas de la prueba original. v. Entendiendo el cambio biologico que mide concepciones y CA sobre la TEB por seleccion natural, con las de la traducida al idioma espanol? Se utilizo el metodo cuantitativo con un diseno de investigacion transversal por encuesta. La tecnica principal para recopilar los datos fue una prueba con doce items, que formo parte de un instrumento para el cual se recopilaron diversas fuentes de evidencia acerca de su validez. Las muestras estuvieron formadas por 69 estudiantes de Ciencias Naturales y por 16 estudiantes futuros maestros y maestras del nivel secundario de la UPR-RP. Se utilizaron estadisticas descriptivas, analisis de Ji cuadrado y se calcularon los coeficientes alfa de Cronbach y de Spearman

  12. Neutron dosimetry; Dosimetria de neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Fratin, Luciano

    1993-12-31

    A neutron irradiation facility was designed and built in order to establish a procedure for calibrating neutron monitors and dosemeters. A 185 GBq {sup 241} Am Be source of known is used as a reference source. The irradiation facility using this source in the air provides neutron dose rates between 9 nSv s{sup -1} and 0,5 {sup {mu}}Sv s{sup -1}. A calibrated 50 nSv s{sup -1} thermal neutron field is obtained by using a specially designed paraffin block in conjunction with the {sup 241} Am Be source. A Bonner multisphere spectrometer was calibrated, using a procedure based on three methods proposed by international standards. The unfold {sup 241} Am Be neutron spectrum was determined from the Bonner spheres data and resulted in a good agreement with expected values for fluence rate, dose rate and mean energy. A dosimetric system based on the electrochemical etching of CR-39 was developed for personal dosimetry. The dosemeter badge using a (n,{alpha}) converter, the etching chamber and high frequency power supply were designed and built specially for this project. The electrochemical etching (ECE) parameters used were: a 6N KOH solution, 59 deg C, 20 kV{sub pp} cm{sup -1}, 2,0 kHz, 3 hours of ECE for thermal and intermediate neutrons and 6 hours for fast neutrons. The calibration factors for thermal, intermediate and fast neutrons were determined for this personal dosemeter. The sensitivities determined for the developed dosimetric system were (1,46{+-} 0,09) 10{sup 4} tracks cm{sup -2} mSv{sup -1} for thermal neutrons, (9{+-}3) 10{sup 2} tracks cm{sup -2} mSV{sup -1} for intermediate neutrons and (26{+-}4) tracks cm{sup -2} mSv{sup -1} for fast neutrons. The lower and upper limits of detection were respectively 0,002 mSv and 0,6 mSv for thermal neutrons, 0,04 mSv and 8 mSv for intermediate neutrons and 1 mSv and 12 mSv for fast neutrons. In view of the 1990`s ICRP recommendations, it is possible to conclude that the personal dosemeter described in this work is sufficiently sensitive to thermal and intermediate neutrons but fast neutron monitoring ar radiological protection level would require an integration period of over a month. The proposed dosimetric procedure is based on the conjugated use of the developed personal dosemeter and the Bonner multisphere spectrometer. (author) 58 refs., 31 figs., 12 tabs.

  13. Neutron dosimetry; Dosimetria de neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Fratin, Luciano

    1994-12-31

    A neutron irradiation facility was designed and built in order to establish a procedure for calibrating neutron monitors and dosemeters. A 185 GBq {sup 241} Am Be source of known is used as a reference source. The irradiation facility using this source in the air provides neutron dose rates between 9 nSv s{sup -1} and 0,5 {sup {mu}}Sv s{sup -1}. A calibrated 50 nSv s{sup -1} thermal neutron field is obtained by using a specially designed paraffin block in conjunction with the {sup 241} Am Be source. A Bonner multisphere spectrometer was calibrated, using a procedure based on three methods proposed by international standards. The unfold {sup 241} Am Be neutron spectrum was determined from the Bonner spheres data and resulted in a good agreement with expected values for fluence rate, dose rate and mean energy. A dosimetric system based on the electrochemical etching of CR-39 was developed for personal dosimetry. The dosemeter badge using a (n,{alpha}) converter, the etching chamber and high frequency power supply were designed and built specially for this project. The electrochemical etching (ECE) parameters used were: a 6N KOH solution, 59 deg C, 20 kV{sub pp} cm{sup -1}, 2,0 kHz, 3 hours of ECE for thermal and intermediate neutrons and 6 hours for fast neutrons. The calibration factors for thermal, intermediate and fast neutrons were determined for this personal dosemeter. The sensitivities determined for the developed dosimetric system were (1,46{+-} 0,09) 10{sup 4} tracks cm{sup -2} mSv{sup -1} for thermal neutrons, (9{+-}3) 10{sup 2} tracks cm{sup -2} mSV{sup -1} for intermediate neutrons and (26{+-}4) tracks cm{sup -2} mSv{sup -1} for fast neutrons. The lower and upper limits of detection were respectively 0,002 mSv and 0,6 mSv for thermal neutrons, 0,04 mSv and 8 mSv for intermediate neutrons and 1 mSv and 12 mSv for fast neutrons. In view of the 1990`s ICRP recommendations, it is possible to conclude that the personal dosemeter described in this work is sufficiently sensitive to thermal and intermediate neutrons but fast neutron monitoring ar radiological protection level would require an integration period of over a month. The proposed dosimetric procedure is based on the conjugated use of the developed personal dosemeter and the Bonner multisphere spectrometer. (author) 58 refs., 31 figs., 12 tabs.

  14. Thrombus imaging with indium-111 and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab')2 and Fab fragments

    International Nuclear Information System (INIS)

    Rosebrough, S.F.; Grossman, Z.D.; McAfee, J.G.

    1988-01-01

    We have previously reported successful imaging of fresh (2-4 hr old) and aged (1-5 days old) canine thrombi with 131 I-labeled intact monoclonal antibody (MAb) specific for fibrin. We now report thrombus imaging with 131 I-labeled F(ab')2 and Fab and 111 In-labeled intact MAb, F(ab')2, and Fab. Indium-111-labeled F(ab')2 proved to be the best imaging agent due to less nonspecific binding in the liver than whole IgG. Image quality was improved by the higher administered dose permissible with 111 In and its better physical characteristics for imaging, compared to 131 I. Immunofluorescence of fresh human histologic sections showed intact MAb and F(ab')2 binding to thrombi, pulmonary emboli, and atherosclerotic plaques, strengthening the feasibility of clinical thrombus imaging

  15. Synthesis and biodistribution of novel magnetic-poly(HEMA-APH) nanopolymer radiolabeled with iodine-131 and investigation its fate in vivo for cancer therapy

    Science.gov (United States)

    Avcıbaşı, Uğur; Avcıbaşı, Nesibe; Akalın, Hilmi Arkut; Ediz, Melis; Demiroğlu, Hasan; Gümüşer, Fikriye Gül; Özçalışkan, Emir; Türkcan, Ceren; Uygun, Deniz Aktaş; Akgöl, Sinan

    2013-10-01

    Herein, we investigated the biological uptake, distribution, and radiopharmaceutical potential of a novel molecule based on 2-hydroxyethyl methacrylate (HEMA) and anilinephtalein (APH) in the metabolism of Albino Wistar rats. In order to achieve this, we synthesized APH using organic synthesis methods and copolymerized APH with HEMA using a common polymerization method, surfactant-free emulsion polymerization. In the presence of Fe3O4 particles, we obtained a new generation magnetic-nano-scale polymer, magnetic-poly(HEMA-APH). This new molecule was chemically identified and approved by several characterization methods using Fourier transform infrared spectroscopy, scanning electron microscope, energy dispersive X-ray spectroscopy, electron spin resonance, atomic force microscope, and Zeta particle-size analysis. To evaluate the biological activity in live metabolism and anti-cancer potential of mag-poly(HEMA-APH), molecule was radioiodinated by a widely used labeling technique, iodogen method, with a gamma diffuser radionuclide, 131I. Thin-layer radiochromatography experiments demonstrated that 131I binded to nanopolymer with the labeling yield of 90 %. Lipophilicity and stability experiments were conducted to determine the condition of cold and labeled mag-poly(HEMA-APH) in rat blood and lipid medium. Results demonstrated that radioiodinated molecule stayed as an intact complex in rat metabolism for 24 h and experimental lipophilicity was determined as 0.12 ± 0.02. In vivo results obtained by imaging and biological distribution experiments indicated that mag-poly(HEMA-APH) labeled with 131I [131I-mag-poly(HEMA-APH)] highly incorporated into tissues of the uterus, the ovarian, the prostate, and the lungs in rat metabolism. Based on these results, it may be evaluated that novel mag-poly(HEMA-APH) molecule labeled with 131I is a compound which has a significant potential for being used as an anti-cancer agent. Certain results can only be obtained whether this molecule is applied to adenocarcinoma cell models and tumor-bearing animals.

  16. Management of patient with hepatocellular carcinomas by in situ injection of iodine-131 labelled lipiodol solution (Lipiocis) in the Biophysics and Timone APHM University Hospital Central Service

    International Nuclear Information System (INIS)

    Sigrist, S.

    2008-01-01

    The aim of this work was to determine what are the prognosis factors in term of global expectation of life at patient receiving a treatment by Lipiocis, to estimate the tolerance at this treatment in order to choose patient which will be the best candidates to this treatment and to define more precisely the criteria of patient inclusion and follow-up. A study including 35 patient having received one or several Lipiocis injections between May 2003 and May 2007 has been carried out. The results of this study are given. Lipiocis seems to be a well tolerated treatment which has proved its efficiency. (O.M.)

  17. Relative value of thallium-201 and iodine-131 scans in the detection of recurrence or distant metastasis of well differentiated thyroid carcinoma

    Energy Technology Data Exchange (ETDEWEB)

    Lin Jen-Der; Weng Hsiao-Fen; Lu Wen-Tsoung [Division of Endocrinology and Metabolism, Chang Gung Memorial Hospital (Taiwan, Province of China); Kao Pan-Fu; Huang Miau-Ju [Department of Nuclear Medicine, Chang Gung Memorial Hospital, Taiwan (Taiwan, Province of China)

    1998-07-01

    Radioactive iodine ({sup 131}I) has been found to be more sensitive and more specific than thallium-201 for the detection of distant metastases and thyroid remnants in the neck in cases of well-differentiated thyroid carcinoma. {sup 201}Tl has been deemed particularly useful in localizing metastases or recurrence in patients with a negative {sup 131}I scan and abnormal levels of serum thyroglobulin (Tg). This study aimed to: (1) determine the value of {sup 201}Tl imaging in localizing metastases or recurrence in patients with well-differentiated thyroid carcinoma, and (2) evaluate the false-positive and false-negative results of {sup 131}I and {sup 201}Tl scintigraphy. Sixty-two thyroid remnant ablated patients who underwent simultaneous postoperative {sup 201}Tl and {sup 131}I scans and and serum Tg determinations were evaluated. Fifty patients had papillary thyroid carcinomas and 12 had follicular thyroid carcinomas. {sup 201}Tl imaging was performed before the {sup 131}I studies. Of the 62 patients who underwent {sup 201}Tl imaging studies, 24 were found to have positive results, with local recurrence or distant metastases. Patients with positive results in the {sup 201}Tl imaging studies tended to be older, were mor often male, had higher Tg levels and had a higher recurrence rate. Of these 24 patients, ten had negative diagnostic or therapeutic {sup 131}I scans. Concurrently, serum Tg levels were less than 5 ng/ml in five of these ten patients. Three patients were deemed false positive by {sup 201}Tl scans; one had a parotid tumour, one a periodontal abscess and one lung metastasis. Among the 38 patients with negative {sup 201}Tl scans, 11 had positive findings on {sup 131}I scans. Three had distant metastases: two with lung metastases and one with bone metastases. Patients with false-positive results on {sup 131}I scans included those with biliary tract stones, ovarian cysts, and breast secretion. Of the 27 patients with negative {sup 201}Tl and {sup 131}I scans, 15 had elevated serum Tg levels. Among these, local recurrence followed by lung metastases was manifested in a 49-year-old male with papillary thyroid carcinoma. In conclusion, both {sup 131}I and {sup 201}Tl scans are useful in the detection of recurrence or distant metastasis of well differentiated thyroid cancers. {sup 201}Tl scan could in particular be used in patients with a negative {sup 131}I scan in conjunction with an elevated Tg level. (orig.) With 8 figs., 3 tabs., 27 refs.

  18. Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131

    Energy Technology Data Exchange (ETDEWEB)

    Rosario, Pedro Weslley Souza [Clinica de Endocrinologia e Metabologia (CEPCEM), Belo Horizonte, MG (Brazil). Centro de Estudos e Pesquisa]. E-mail: pedrorosario@globo.com; Borges, Michelle A.R.; Costa, Graciela B.C.; Resende, Leonardo L.; Padrao, Eduardo L.; Barroso, Alvaro L.; Purish, Saulo [Santa Casa de Belo Horizonte, MG (Brazil). Dept. de Tireoide. Servico de Endocrinologia; Santa Casa de Belo Horizonte, MG (Brazil). Servico de Medicina Nuclear

    2007-01-15

    Objective: To evaluate the positive predictive value of detectable Tg during T4 therapy (Tg on T4) in patients with thyroid cancer after total thyroidectomy and remnant ablation, discussing the work-up in this situation and the empirical indication of {sup 131}I. Patients and methods: Initially, 234 low-risk patients [tumor {<=} 5 cm, completely resected, no extensive extrathyroid invasion (pT4)] submitted to total thyroidectomy and ablation with {sup 131}I (3.7-5.5 GBq) who presented no ectopic uptake on RxWBS were studied. Of these, 23 patients with detectable Tg on T4 (> 1 ng/ml) during the first year after initial therapy were selected. Results: Metastases were detected by neck US in 7 patients, by chest CT in 2 and by US and CT in 3. Four of five patients with lung metastases upon CT had a positive RxWBS. Eleven patients with negative US and CT received a new {sup 131}I dose (without DxWBS), and RxWBS showed ectopic uptake in 3 patients. Among the patients with negative RxWBS, 7 remained free of apparent disease and Tg was declining (5 with undetectable Tg on T4 at the end of the study). One patient presented an increase in Tg and FDG-PET was positive for lymph node and bone metastases. Conclusions: All patients with Tg on T4 > 5 ng/ml presented apparent disease. In these cases, even when US and CT are negative, the administration of a therapeutic dose of {sup 131}I (without DxWBS) and FDG-PET are recommended. Among patients with detectable Tg on T4 {<=} 5 ng/ml and negative US and CT, only 12% presented ectopic uptake on RxWBS. These cases could be followed up by monitoring Tg on T4, and RxWBS and FDG-PET should only be performed if this marker does not decrease after 1-2 years. (author)

  19. Age dependency in the absorption of radioactive Iodine (131I) in the thyroid and total body of newborn, pubertal and adult fischer 344 rats

    International Nuclear Information System (INIS)

    Nitta, Yumiko; Endo, Satoru; Fujimoto, Nariaki; Kamiya, Kenji; Ohtaki, Megu; Hayakawa, Norihiko; Takada, Jun; Hoshi, Masaharu

    1998-01-01

    In this study, activities of 131 I in the thyroid, total body and blood were measured for rats of three different ages to estimate the movement of 131 I in the body, the absorbed doses were calculated in the thyroid and total body under the exposed condition of iodine deficiency and sufficiency, and the standard curves for the determination of absorbed doses in the thyroid and total body were obtained for rats of newborn, pubertal and adult. Authors used female rats of Fisher 344 strain in this experiment and set up twelve experimental group of different ages (1, 4 and 9 weeks old), and divided each age group into one standard diet (SD) group and three iodine deficient diet (IDD) groups. Rats were intravenously injected once with 131 I in 0.9% saline with the activity of 0.38, 1.03 and 9.42 kBq per g weight. In the thyroid and total body, the absorbed dose values increased in an injected activity-dependent manner, and those of 1-week-old rats were significantly higher than those of 4- and 9-weeks old rats. The absorbed dose values in IDD-treated groups were higher than those in the SD-treated groups. The speed of 131 I accumulation into the thyroid and that of 131 I excretion from the body was slow in 1-week-old groups. The data also showed that most of injected 131 I distributed in the thyroid and blood in 4- and 9-week-old groups but not in the 1-week-old group, indicating that 131 I is pooled in certain tissues or organs except the thyroid in rats of the 1-week-old group at which the development of the thyroid has not been completed. Standard curves were obtained for the estimation of absorbed doses in the thyroid and total body on the bases of injected activity of 131 I for each age group of rats. These standard curves are to be used in the carcinogenesis experiment which compare the effectiveness of internal with external irradiation under the condition of iodine deficiency or sufficiency in the rats of different ages. (K.H.)

  20. Comparison of oral iodine-131-cellulose and indium-111-DTPA as tracers for colon transit scintigraphy: Analysis by colon activity profiles

    International Nuclear Information System (INIS)

    Smart, R.C.; McLean, R.G.; Gaston-Parry, D.; Barbagallo, S.; Bruck, C.E.; King, D.W.; Lubowski, D.Z.; Talley, N.A.

    1991-01-01

    In 11 normal subjects and 11 patients with a clinical diagnosis of constipation, oral 131I-cellulose and 111In-DTPA were compared simultaneously as tracers for radionuclide colon transit scintigraphy. Visual assessment of the images revealed no differences between tracers. Quantitation was performed using total and segmental percent retention and the derived value of clearance half-time. In addition, profiles of the activity distribution along the length of the colon were generated and the mean position of the activity in the colon calculated. For all indices, the results were similar in both normal subjects and constipated patients when comparing tracers, although marked differences were present between normal subjects and constipated patients for each tracer. Indium-111-DTPA was easy to administer and dosimetry was more acceptable than for 131I-cellulose, especially in constipated patients. It is concluded that 111In-DTPA is the preferred tracer for oral colon transit scintigraphy

  1. Clinical comparison of technetium-99m-EC, technetium-99-m-MAG3 and Iodine-131-OIH in renal disorders

    International Nuclear Information System (INIS)

    Kabasakal, L.; Turoglu, T.; Oensel, C.

    1995-01-01

    Technetium-99m-ethylenedicysteine has recently been developed for renal function studies. The pharmacokinetics of 99m Tc-EC were studied by constant infusion technique and compared with 99m Tc-MAG3 and 131 I-OIH in 11 patients with various renal disorders. After giving a 7.4 MBq 131 I-OIH and 90-110 MBq 99m Tc-EC or 99m Tc-MAG3 bolus, a constant infusion (MBq/ml) 99m Tc--agent and 0.07 MBq/m 131 I-OIH was started. Sixteen blood and five urine samples were obtained over three hr. The renal clearance of 99m Tc-EC was higher than than of 99m Tc-MAG3. The 99m Tc-EC/OIH and 99m Tc-MAG3/OIH ratios were 0.75 ± 0.05 and 0.55 ± 0.10 (p=0.00087), respectively. The distribution volume of 99m Tc-EC was also higher than that of 99m Tc-MAG3 (15722 ± 4644 and 9509 ± 2788 ml/1.73m 2 , respectively; p=0.072). The 99m Tc-EC/OIH and 99m Tc-MAG/OIH distribution volume ratios were 1.03 ± 0.14 and 0.55 ± 0.10, respectively (p = 0.0003). The 60-min excretion values of 99m Tc-EC and 99m Tc-MAG3 were compared to that of OIH. The 99m Tc-EC/OIH and 99m Tc-MAG3/OIH excretion ratios were 0.96 ± 0.06 and 1.07 ± 0.10, respectively (p=0.162). The protein binding of 99m -EC and OIH were found to be 34% ±4 and 66% ±5, respectively (p 99m Tc-EC was negligible (3% ±1.2) in comparison to OIH (27% ±3; p 99m Tc-EC. This agent has good potential for renal function evaluation. 32 refs., 5 tabs

  2. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography

    International Nuclear Information System (INIS)

    Tsuruta, Masako; Nagayama, Yuji; Yokoyama, Naokata; Izumi, Motomori; Nagataki, Shigenobu

    1993-01-01

    In the present series of studies, the long-term (four year) effect of 80 Gy of 131 I treatment was evaluated in patients with hyperthyroid Graves' disease whose thyroid volumes have been accurately estimated with a high resolution ultrasound scanner. One year after 131 I treatment, 23.1% (3 out of 13 patients) remained hyperthyroid, 69.2% (9 out of 13) became euthyroid, and 7.7% (1 out of 13) were in a hypothyroid state. Since three patients in a hyperthyroid state one year after treatment were subsequently treated with either antithyroid drugs or additional 131 I treatment, the remaining ten patients (9 euthyroid and 1 hypothyroid patients) have been followed up for three more years. Two patients developed a hypothyroid state three years after treatment and one patient four years after treatment. Overall, 60% (6 out of 10 patients) were in a euthyroid state and 40% (4 out of 10) in a hypothyroid state, four years after 80 Gy 131 I treatment. There was no significant difference between eu- and hypo-thyroid groups in the sex ratio, age, radiation doses, therapeutic dose, thyroid gland volume, 24-hr 131 I uptake, the effective half-life of 131 I in the thyroid or the duration of hyperthyroidism. In our preliminary studies, the incidence of late hypothyroidism in our 131 I treatment is similar to those previously reported. These suggest that uncertain factor(s), such as inhomogeneity of iodine distribution in the thyroid, unequal sensitivity of the thyroid cells to the radiation, and/or persistent destructive effects of the autoimmune process may influence the long-term effect of 131 I treatment of Graves' disease. (author)

  3. Contribution of radio-iodine 131 in the treatment of Grave's Basedow disease in the department of nuclear medicine of Ibn Sina Hospital in Rabat

    International Nuclear Information System (INIS)

    Mbodj, M.; Amjad, I.; Guerrouj, H.; Ben Rais, N.A.

    2009-01-01

    One hundred and twenty-nine Grave's Basedow diseases in any gender and variable age patients, coming from several cities of Morocco, were randomized in a study of radio-iodine treatment who took place at the nuclear medicine department of Ibn Sina Hospital (Rabat, Morocco) during the period (from January 2001 to December 2008). The radio-iodine treatment was a first, second or third option and radio-iodine activities delivered varied (from 222 to 555 MBq 6 to 15 mCi) according to the age, the thyroid volume, the degree of hyperthyroidism and socio-economical situation. The high amounts of 131 I were reserved especially to the patients who live far and whose socio-economic level is low with an aim of quickly obtaining an easily controllable state of hypothyroidism by a substitute treatment. The results showed that: (1) 57.36% of patients reverted to euthyroidism (n = 74) with a patient having received two 131 I cures. The second cure was justified by recurrence of hyperthyroidism after the first cure; (2) 34.88% passed in hypothyroidism (n = 45) with three patients having received two cures of 131 I, the second cure was justified by recurrence of hyperthyroidism after the first cure in two patients and by the persistence of the hyperthyroidism after the first cure for the third patient. The average time of passage in hypothyroidism was 4.5 months; (3) 7.76% had remained in hyperthyroidism after the radioactive iodine treatment. Finally, 92.24% of our patients treated by radioactive iodine had passed in euthyroidism or hypothyroidism against 7.76% whose hyperthyroidism had persisted or occurred. (authors)

  4. The role of FDG-PET/CT in differentiated thyroid cancer patients with negative iodine-131 whole-body scan and elevated anti-Tg level.

    Science.gov (United States)

    Asa, Sertac; Aksoy, Sabire Yılmaz; Vatankulu, Betül; Aliyev, Anar; Uslu, Lebriz; Ozhan, Meftune; Sager, Sait; Halac, Metin; Sonmezoglu, Kerim

    2014-12-01

    In the follow-up of differentiated thyroid cancer (DTC) after a successful total-near total thyroidectomy and I-131 ablation therapy, anti-thyroglobulin antibodies (anti-Tg) may be persistently or progressively increased in the patients with an undetectable serum thyroglobulin (Tg) level. In these cases, further investigation was performed to search for recurrence/metastases. The aim of our study was clarifying the role of FDG-PET/CT in detecting recurrence/metastasis in patients with DTC with negative serum Tg and elevated anti-Tg level. A total of 40 patients (32 female, 8 male; mean age: 43.15 years (22-65); mean age at diagnosis: 39.08 (16-64)) with DTC who had undetectable serum Tg and elevated anti-Tg level after a successful initial therapy were included in the study. All of the patients had serum anti-Tg of >40 IU/ml and underwent FDG-PET/CT to search for recurrence/metastasis. Twenty patients (50 %) had recurrence/metastasis on FDG-PET/CT while the other 20 had no pathologic findings. Of the 20 patients who had positive FDG-PET/CT, 12 had a histopathological final diagnosis of which 11 were true positive (TP) and 1 was false positive (FP). On the other hand, 16 of the 40 patients had a histopathological final diagnosis of which 11/16 had TP, 1/16 FP, 3/16 false negative (FN) and 1/16 true negative (TN) findings by PET/CT. The final diagnosis was made by clinical follow-up in the remaining 24 patients. Of these, 8 patients were PET positive, and in 1 (12.5 %) of 8 patients a decrease in serum anti-Tg level, in 2 (25 %) patients a saw-toothed pattern and in 5 (62.5 %) a progressive increase in the serum anti-Tg level were noted during the follow-up. Of the 16 of 24 patients who were diagnosed by clinical follow-up, in 8 a (50 %) decrease in serum anti-Tg level, in 6 (37.5 %) a saw-toothed pattern, and in 2 (12.5 %) a progressively increased anti-Tg level was seen. Of the 40 patients, 14 (35 %) had a diagnosis of recurrence/metastasis finally, with PET/CT detecting 11 (78.6 %) of them. The value of a persistently or progressively increased serum anti-Tg level in the follow-up of DTC in the prediction of recurrence/metastasis is controversial. However, it is reported that FDG-PET can be useful in the detection of recurrence/metastasis. We conclude from the available data that PET/CT can be effectively used in the detection of recurrence/metastasis in the follow-up of patients with DTC and negative serum Tg and a persistently/progressively increased anti-Tg level. Besides, one half of the patients were FDG negative, meaning that further studies are needed to assess the prognostic-clinical value of PET negativity.

  5. Synthesis and biodistribution of novel magnetic-poly(HEMA-APH) nanopolymer radiolabeled with iodine-131 and investigation its fate in vivo for cancer therapy

    Energy Technology Data Exchange (ETDEWEB)

    Avc Latin-Small-Letter-Dotless-I bas Latin-Small-Letter-Dotless-I , Ugur, E-mail: uguravcibasi@yahoo.com [Celal Bayar University, Department of Chemistry, Faculty of Arts and Science (Turkey); Avc Latin-Small-Letter-Dotless-I bas Latin-Small-Letter-Dotless-I , Nesibe [Ege University, Ege Higher Vocational School (Turkey); Akal Latin-Small-Letter-Dotless-I n, Hilmi Arkut; Ediz, Melis; Demiroglu, Hasan [Celal Bayar University, Department of Chemistry, Faculty of Arts and Science (Turkey); Guemueser, Fikriye Guel [Celal Bayar University, Department of Nuclear Medicine, Faculty of Medicine (Turkey); Oezcal Latin-Small-Letter-Dotless-I skan, Emir; Tuerkcan, Ceren [Ege University, Department of Biochemistry, Faculty of Science (Turkey); Uygun, Deniz Aktas [Adnan Menderes University, Department of Chemistry, Faculty of Arts and Science (Turkey); Akgoel, Sinan [Ege University, Department of Biochemistry, Faculty of Science (Turkey)

    2013-10-15

    Herein, we investigated the biological uptake, distribution, and radiopharmaceutical potential of a novel molecule based on 2-hydroxyethyl methacrylate (HEMA) and anilinephtalein (APH) in the metabolism of Albino Wistar rats. In order to achieve this, we synthesized APH using organic synthesis methods and copolymerized APH with HEMA using a common polymerization method, surfactant-free emulsion polymerization. In the presence of Fe{sub 3}O{sub 4} particles, we obtained a new generation magnetic-nano-scale polymer, magnetic-poly(HEMA-APH). This new molecule was chemically identified and approved by several characterization methods using Fourier transform infrared spectroscopy, scanning electron microscope, energy dispersive X-ray spectroscopy, electron spin resonance, atomic force microscope, and Zeta particle-size analysis. To evaluate the biological activity in live metabolism and anti-cancer potential of mag-poly(HEMA-APH), molecule was radioiodinated by a widely used labeling technique, iodogen method, with a gamma diffuser radionuclide, {sup 131}I. Thin-layer radiochromatography experiments demonstrated that {sup 131}I binded to nanopolymer with the labeling yield of 90 %. Lipophilicity and stability experiments were conducted to determine the condition of cold and labeled mag-poly(HEMA-APH) in rat blood and lipid medium. Results demonstrated that radioiodinated molecule stayed as an intact complex in rat metabolism for 24 h and experimental lipophilicity was determined as 0.12 {+-} 0.02. In vivo results obtained by imaging and biological distribution experiments indicated that mag-poly(HEMA-APH) labeled with {sup 131}I [{sup 131}I-mag-poly(HEMA-APH)] highly incorporated into tissues of the uterus, the ovarian, the prostate, and the lungs in rat metabolism. Based on these results, it may be evaluated that novel mag-poly(HEMA-APH) molecule labeled with {sup 131}I is a compound which has a significant potential for being used as an anti-cancer agent. Certain results can only be obtained whether this molecule is applied to adenocarcinoma cell models and tumor-bearing animals.

  6. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth

    Energy Technology Data Exchange (ETDEWEB)

    Dadachova, Ekaterina [Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, NY 10461 (United States)]. E-mail: edadacho@aecom.yu.edu; Nguyen, Andrew [Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY 10461 (United States); Lin, Elaine Y. [Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461 (United States); Gnatovskiy, Leo [Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461 (United States); Lu, Ping [Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, NY 10461 (United States); Pollard, Jeffrey W. [Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461 (United States)

    2005-10-01

    Introduction: Novel therapeutic modalities are needed for breast cancer patients in whom standard treatments are not effective. Mammary gland sodium/iodide symporter has been identified as a molecular target in breast cancers in humans and in some transgenic mouse models. We report the results of a therapy study with {sup 131}I{sup -} and {sup 188}ReO{sub 4} {sup -} of breast cancer in polyoma middle T oncoprotein (PyMT) transgenic mice endogenously expressing the Na{sup +}/I{sup -} symporter (NIS). Methods: PyMT mice (12-13 weeks old) with one palpable tumor of 0.5-0.8 cm in diameter were used. For the therapy studies, PyMT mice were (1) treated with two intraperitoneal injections of 1.5 mCi of {sup 188}ReO{sub 4} {sup -} 1 week apart, (2) pretreated for 1 week with 5 {mu}g of triiodothyronine (T3) followed by two intraperitoneal injections of 1.5 mCi of {sup 131}I{sup -} 1 week apart or (3) left untreated. The tumor and normal organ uptakes were assessed by scintigraphic imaging. The thyroid function of treated and control animals was evaluated at the completion of the study by measuring the T3/thyroxine (T4) ratio in their blood. Results: There was significant uptake of {sup 131}I{sup -} and {sup 188}ReO{sub 4} {sup -} in the primary palpable tumors as well as in nonpalpable tumors, stomachs and thyroids. The tumor uptake after the second injection was 10 times lower in comparison with the first injection. Tumor growth was significantly inhibited in both the {sup 131}I{sup -} and {sup 188}ReO{sub 4} {sup -} groups in comparison with the control group, and tumors in the {sup 188}ReO{sub 4} {sup -} group increased in size significantly less than in the {sup 131}I{sup -} group. The T3/T4 ratios were calculated to be 27 and 25 for the control group and the {sup 188}ReO{sub 4} {sup -} group, respectively; for {sup 131}I{sup -}, both the T3 and T4 levels were below detection limit, demonstrating much less effect on the thyroids of treatment with {sup 188}ReO{sub 4} {sup -} than with {sup 131}I{sup -}. Conclusions: These results prove that NIS expression in breast tumors in animal models allows specific, efficient and safe treatment with a variety of radionuclides transported by NIS.

  7. Preliminary study of the distribution of dose in patients with Graves' disease undergoing examination of uptake of iodine-131 using Monte Carlo simulation

    International Nuclear Information System (INIS)

    Schwarcke, Marcelo; Marques, Tatiana; Nicolucci, Patricia; Baffa, Oswaldo; Bornemann, Clarissa

    2010-01-01

    Patients with Graves disease have a high hormonal disorder, which causes behavioral changes. One way to treat this disease is the use of high doses of 131 Iodine, requiring that the patient carries out the examination of 131 I uptake to estimate the activity to be administered. Using these data capture and compared with the simulated data using the Monte Carlo code PENELOPE is possible to determine a distribution of dose to the region surrounding the thyroid. As noted the difference between the simulated values and the experimentally obtained were 10.36%, thus showing the code of simulation for accurate determination of absorbed dose in tissue near the thyroid. (author)

  8. Management of low-risk patients with thyroid carcinoma and detectable thyroglobulin on T4 after thyroidectomy and ablation with iodine-131

    International Nuclear Information System (INIS)

    Rosario, Pedro Weslley Souza; Borges, Michelle A.R.; Costa, Graciela B.C.; Resende, Leonardo L.; Padrao, Eduardo L.; Barroso, Alvaro L.; Purish, Saulo; Santa Casa de Belo Horizonte, MG

    2007-01-01

    Objective: To evaluate the positive predictive value of detectable Tg during T4 therapy (Tg on T4) in patients with thyroid cancer after total thyroidectomy and remnant ablation, discussing the work-up in this situation and the empirical indication of 131 I. Patients and methods: Initially, 234 low-risk patients [tumor ≤ 5 cm, completely resected, no extensive extrathyroid invasion (pT4)] submitted to total thyroidectomy and ablation with 131 I (3.7-5.5 GBq) who presented no ectopic uptake on RxWBS were studied. Of these, 23 patients with detectable Tg on T4 (> 1 ng/ml) during the first year after initial therapy were selected. Results: Metastases were detected by neck US in 7 patients, by chest CT in 2 and by US and CT in 3. Four of five patients with lung metastases upon CT had a positive RxWBS. Eleven patients with negative US and CT received a new 131 I dose (without DxWBS), and RxWBS showed ectopic uptake in 3 patients. Among the patients with negative RxWBS, 7 remained free of apparent disease and Tg was declining (5 with undetectable Tg on T4 at the end of the study). One patient presented an increase in Tg and FDG-PET was positive for lymph node and bone metastases. Conclusions: All patients with Tg on T4 > 5 ng/ml presented apparent disease. In these cases, even when US and CT are negative, the administration of a therapeutic dose of 131 I (without DxWBS) and FDG-PET are recommended. Among patients with detectable Tg on T4 ≤ 5 ng/ml and negative US and CT, only 12% presented ectopic uptake on RxWBS. These cases could be followed up by monitoring Tg on T4, and RxWBS and FDG-PET should only be performed if this marker does not decrease after 1-2 years. (author)

  9. Is radioactive iodine-131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?

    International Nuclear Information System (INIS)

    Souza, Marcelo Cruzick de; Momesso, Denise P.; Vieira Neto, Leonardo; Vaisman, Mario; Vaisman, Fernanda; Corbo, Rossana; Martins, Rosangela Aparecida Gomes

    2016-01-01

    Objective: Much controversy relates to the risk of non-synchronous second primary malignancies (NSSPM) after radioactive iodine treatment (RAI-131) in differentiated thyroid cancer (DTC) patients. This study evaluated the relationship between RAI-131 and NSSPM in DTC survivors with long-term follow-up. Materials and methods: Retrospective analysis of 413 DTC cases was performed; 252 received RAI-131 and 161 were treated with thyroidectomy alone. Exclusion criteria were: prior or synchronous non-thyroidal malignancies (within the first year), familial syndromes associated to multiple neoplasms, ionizing radiation exposure or second tumors with unknown histopathology. Results: During a mean follow-up of 11.0 ± 7.5 years, 17 (4.1%) patients developed solid NSSPM. Patients with NSSPM were older than those without (p = 0.02). RAI-131 and I-131 cumulative activity were similar in patients with and without NSSPM (p = 0.18 and p = 0.78, respectively). Incidence of NSSPM was 5.2% in patients with RAI-131 treatment and 2.5% in those without RAI-131 (p = 0.18). Using multivariate analysis, RAI-131 was not significantly associated with NSSPM occurrence (p = 0.35); age was the only independent predictor (p = 0.04). Under log rank statistical analysis, after 10 years of follow-up, it was observed a tendency of lower NSSPM-free survival among patients that received RAI-131 treatment (0.96 vs. 0.87; p = 0.06), what was not affected by age at DTC diagnosis. Conclusion: In our cohort of DTC survivors, with a long-term follow-up period, RAI-131 treatment and I-131 cumulative dose were not significantly associated with NSSPM occurrence. A tendency of premature NSSPM occurrence among patients treated with RAI-131 was observed, suggesting an anticipating oncogenic effect by interaction with other risk factors. (author)

  10. Evaluation of Iodine-131 dispersion after accident in Nuclear Angra Power Plant using the model of aquatic dispersion, SisBahia

    International Nuclear Information System (INIS)

    Aguiar, Andre Silva de; Alvim, Antonio Carlos Marques

    2014-01-01

    It was inserted, in the cooling system of the nucleus, a LOCA, where 431 m 3 of coolant was lost. Such an inventory contained 3,04 x 10 10 Bq / m 3 and iodine was released near the beach Itaorna, Angra dos Reis - RJ. Applying the model in the proposed scenario (Angra 1 and Angra 2 in operation and 3 in with varying capture and discharge with the discharge gradually reduced after the accident), the dilution of the specific activity of radionuclides reached lower values after 22 hours, the reference levels for seawater 131 I (7,40 x 10 2 Bq / m 3 ). After 54 hours, levels of the radionuclide, in the area of indirect influence, are already below minimum activity values detected by the laboratory for environmental monitoring of the CNAAA (5,0 x 10 1 Bq / m 3

  11. Representation of a model of radionuclide transfer in food chains following deposition of strontium-90, cesium-137 and iodine-131 on areas for agricultural use

    International Nuclear Information System (INIS)

    Proehl, G.

    1990-09-01

    The 'SINK' model (contaminants in food chains - FORTRAN 77) was used in an attempt to predict the amounts of radioactivity building up in animal and vegetable foods after one single deposition of Sr-90, Cs-137 and I-131. The model is described in detail. The input quantities include such factors as time-integrated concentration of activity in the air just above the ground, physicochemical form of the radionuclides, activity deposited with precipitation and amount of rain to fall in any particular case. The model was so designed as to take account of 18 different plants, 11 animal products and 14 kinds of processed nutrients. The radionuclide contents of vegetable foods were calculated with reference to the season of the year, at which deposition took place. The estimations of the activity concentrations in animal foods were in each case based on different fudder rations. (orig./HP) [de

  12. Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter

    DEFF Research Database (Denmark)

    Nielsen, Viveque Egsgaard; Bonnema, Steen Joop; Boel-Jørgensen, Henrik

    2006-01-01

    measurements of thyroid size and function and patient satisfaction. RESULTS: Baseline median goiter volume was 51 mL (range, 20-99 mL) in the placebo group and 59 mL (range, 25-92 mL) in the thyrotropin group (P = .75). At 12 months, the mean +/- SEM relative goiter reduction was 46.1% +/- 4.0% in the placebo...

  13. Application of computational models to estimate organ radiation dose in rainbow trout from uptake of molybdenum-99 with comparison to iodine-131

    International Nuclear Information System (INIS)

    Martinez, N.E.; Johnson, T.E.; Pinder, J.E.

    2016-01-01

    This study compares three anatomical phantoms for rainbow trout (Oncorhynchus mykiss) for the purpose of estimating organ radiation dose and dose rates from molybdenum-99 ( 99 Mo) uptake in the liver and GI tract. Model comparison and refinement is important to the process of determining accurate doses and dose rates to the whole body and the various organs. Accurate and consistent dosimetry is crucial to the determination of appropriate dose-effect relationships for use in environmental risk assessment. The computational phantoms considered are (1) a geometrically defined model employing anatomically relevant organ size and location, (2) voxel reconstruction of internal anatomy obtained from CT imaging, and (3) a new model utilizing NURBS surfaces to refine the model in (2). Dose Conversion Factors (DCFs) for whole body as well as selected organs of O. mykiss were computed using Monte Carlo modeling and combined with empirical models for predicting activity concentration to estimate dose rates and ultimately determine cumulative radiation dose (μGy) to selected organs after several half-lives of 99 Mo. The computational models provided similar results, especially for organs that were both the source and target of radiation (less than 30% difference between all models). Values in the empirical model as well as the 14 day cumulative organ doses determined from 99 Mo uptake are compared to similar models developed previously for 131 I. Finally, consideration is given to treating the GI tract as a solid organ compared to partitioning it into gut contents and GI wall, which resulted in an order of magnitude difference in estimated dose for most organs. - Highlights: • Existing computational models for the internal dosimetry of trout are applied to 99 Mo uptake. • Consideration is given to the effect of alternate source distribution in the gut. • A hybrid computational phantom is developed. • At 14 days post-release, 99 Mo and 131 I provide similar contributions to organ dose. • Pros and cons of the main types of computational phantoms are discussed.

  14. Development and comparison of computational models for estimation of absorbed organ radiation dose in rainbow trout (Oncorhynchus mykiss) from uptake of iodine-131

    International Nuclear Information System (INIS)

    Martinez, N.E.; Johnson, T.E.; Capello, K.; Pinder, J.E.

    2014-01-01

    This study develops and compares different, increasingly detailed anatomical phantoms for rainbow trout (Oncorhynchus mykiss) for the purpose of estimating organ absorbed radiation dose and dose rates from 131 I uptake in multiple organs. The models considered are: a simplistic geometry considering a single organ, a more specific geometry employing additional organs with anatomically relevant size and location, and voxel reconstruction of internal anatomy obtained from CT imaging (referred to as CSUTROUT). Dose Conversion Factors (DCFs) for whole body as well as selected organs of O. mykiss were computed using Monte Carlo modeling, and combined with estimated activity concentrations, to approximate dose rates and ultimately determine cumulative radiation dose (μGy) to selected organs after several half-lives of 131 I. The different computational models provided similar results, especially for source organs (less than 30% difference between estimated doses), and whole body DCFs for each model (∼3 × 10 −3 μGy d −1 per Bq kg −1 ) were comparable to DCFs listed in ICRP 108 for 131 I. The main benefit provided by the computational models developed here is the ability to accurately determine organ dose. A conservative mass-ratio approach may provide reasonable results for sufficiently large organs, but is only applicable to individual source organs. Although CSUTROUT is the more anatomically realistic phantom, it required much more resource dedication to develop and is less flexible than the stylized phantom for similar results. There may be instances where a detailed phantom such as CSUTROUT is appropriate, but generally the stylized phantom appears to be the best choice for an ideal balance between accuracy and resource requirements. - Highlights: • Computational models (phantoms) are developed for rainbow trout internal dosimetry. • Phantoms are combined with empirical models for 131 I uptake to estimate dose. • Voxel and stylized phantoms predict similar organ radiation doses from 131 I uptake. • Direct and indirect approaches to calculating organ dose are compared. • The voxel phantom is more accurate, but requires more resource dedication to develop

  15. Correction of count losses due to deadtime on a DST-XLi (SMVi-GE) camera during dosimetric studies in patients injected with iodine-131

    International Nuclear Information System (INIS)

    Delpon, G.; Ferrer, L.; Lisbona, A.; Bardies, M.

    2002-01-01

    In dosimetric studies performed after therapeutic injection, it is essential to correct count losses due to deadtime on the gamma camera. This note describes four deadtime correction methods, one based on the use of a standard source without preliminary calibration, and three requiring specific calibration and based on the count rate observed in different spectrometric windows (20%, 20% plus a lower energy window and the full spectrum of 50-750 keV). Experiments were conducted on a phantom at increasingly higher count rates to check correction accuracy with the different methods. The error was less than +7% with a standard source, whereas count-rate-based methods gave more accurate results. On the assumption that the model was paralysable, preliminary calibration allowed an observed count rate curve to be plotted as a function of the real count rate. The use of the full spectrum led to a 3.0% underestimation for the highest activity imaged. As count losses depend on photon flux independent of energy, the use of the full spectrum during measurement allowed scatter conditions to be taken into account. A protocol was developed to apply this correction method to whole-body acquisitions. (author)

  16. Radiation protection of people in contact with patient treated with metabolic radiotherapy using iodine-131 in nuclear medicine - case of the Laboratoire des Radio-Isotopes(LRI) Anpandrianomby

    International Nuclear Information System (INIS)

    RAMAROJAONA, H.

    2008-01-01

    In the aim to propose recommendations for radiation protection of those in contact with patients, simulations were performed for restricting the radiation hazards to the family and the members of the public coming into contact with a patient treated with 131 Iode for a thyroid pathology. The simulated dose constraint was 0,3 mSv for the family. According to the regulation in radiation protection in Madagascar, annual dose limit for the public is 1mSv and 20 mSv for the workers. Several contact patterns were tested: contact to the workers, daily visits, public transports, return to work, sleeping with partner and close contact with children. The recommendations duration was evaluated both as a function of the administered activity (out-patient) or the residual activity (discharged inpatient) by measuring the dose rate at 1 m distance from the patient. [fr

  17. Vasoactive intestinal peptide (VIP) labelling with iodine-131 by direct method; Marcacao do peptideo intestinal vasoativo (VIP) com iodo-131 por metodo direto

    Energy Technology Data Exchange (ETDEWEB)

    Colturato, M.T.; Silva, C.P.G. da; Araujo, E.B. [Instituto de Pesquisas Energeticas e Nucleares (IPEN), Sao Paulo, SP (Brazil). Centro de Radiofarmacia

    2002-07-01

    The Vasoactive Intestinal Peptide (VIP) is a 28-amino acid polypeptide with a great numbers of receptors in tumoral cells, including adenocarcinomas and pancreatic and colon carcinomas. The VIP molecule contains two tyrosine residues, in positions 10 and 22, that are theoretically equally susceptible to iodination, The VIP was labeled with 131-iodine by direct method using Iodogen as oxidant agent: 15.03 mmol VIP + 0.10 nmol KI + [{sup 131} I]NaI + 13.9 mmol Iodogen; the final volume was adjust to 100 {mu}L using 0.2 M phosphate buffer, pH 7.5 and the reaction proceed with stirring for 30 minutes at room temperature. The radiochemical purity was determined by electrophoresis (Whatman 1MM paper; 0.05 M barbital buffer; pH 8.6; 150 V; 40 minutes) that indicates low percent of free 131-iodine. The high performance liquid chromatography (HPLC) system using RPC{sup 18}, 10 {mu}m, 4 x 250mm column, was able to separate the different radiochemical species, only when an isocratic mixture of acetonitrile: 0.1% trifluoroacetic acid (27:73) was used, with 0.5 mL/min. flux. (author)

  18. Analysis of factors affecting the outcome of Graves disease patients treated with two regimens of fixed Iodine-131 doses (10 mCi and 15 mCi)

    International Nuclear Information System (INIS)

    Machado, Ana C.B.; Santos, Roberto B.; Chaves, Fatima R.; Romaldini, Joao H.; Ward, Laura S.

    2005-01-01

    Full text: The use of fixed doses of radioiodine ( 131 I) simplifies the approach to treatment for Graves' disease (GD) patients with potential cost savings. In order to evaluate factors that may affect the outcome of 2 different regimens of 131 I, we prospectively examined 128 patients with overt thyrotoxicosis from GD, as confirmed by suppressed serum TSH, presence of TRAb, increased serum T 3 and FT 4 values. Group 1 comprised 76 patients who received a fixed dose of 10 mCi and Group 2=52 patients who received a fixed dose of 15 mCi. 36 patients did not use any antithyroid drugs and 92 patients used methimazole that was withdrawn at least 5 days before radioiodine administration. Antithyroid drugs treatment was restarted at least 7 days following 131 I therapy when needed. Baseline serum TSH and FT 4 levels were measured at 3, 6, 9 and 12 months after treatment. The groups were similar concerning age, gender, smoke, eye disease, goiter size, serum T 3 , FT 4 , TRAb, anti-Tg and anti-TPO levels as well as 24-hour 131 I or Tec-uptake values and thyroid scan. Clinical outcome was evaluated at the end of 1-year follow-up and cure of hyperthyroidism was defined as clinical and laboratory evidence of either euthyroidism or hypothyroidism in the absence of antithyroid drugs. The cure rate obtained was similar in groups 1 and 2: 73.7% and 80.8%, respectively (p=0.35). Hypothyroidism was diagnosed in 56.5% and 71.15% of the patients from groups 1 and 2, respectively (p=0.13). There was no correlation between clinical features, thyroid uptake, antibodies, serum hormones and outcome. However, logistic regression analysis demonstrated that patients with larger thyroids (weight >60 g) that, consequently, received a lower dose of radioiodine in MBq/g, had 2.4 times less chance to cure (95% Cl=1.18-4.96). The use of fixed doses of radioiodine ( 131 I) simplifies the approach to treatment for Graves' disease (GD) patients with potential cost savings. In order to evaluate factors that may affect the outcome of 2 different regimens of 131 I, we prospectively examined 128 patients with overt thyrotoxicosis from GD, as confirmed by suppressed serum TSH, presence of TRAb, increased serum T 3 and FT 4 values. Group 1 comprised 76 patients who received a fixed dose of 10 mCi and Group 2=52 patients who received a fixed dose of 15 mCi. 36 patients did not use any antithyroid drugs and 92 patients used methimazole that was withdrawn at least 5 days before radioiodine administration. Antithyroid drugs treatment was restarted at least 7 days following 131 I therapy when needed. Baseline serum TSH and FT 4 levels were measured at 3, 6, 9 and 12 months after treatment. The groups were similar concerning age, gender, smoke, eye disease, goiter size, serum T 3 , FT 4 , TRAb, anti-Tg and anti-TPO levels as well as 24-hour 131 I or Tec-uptake values and thyroid scan. Clinical outcome was evaluated at the end of 1-year follow-up and cure of hyperthyroidism was defined as clinical and laboratory evidence of either euthyroidism or hypothyroidism in the absence of antithyroid drugs. The cure rate obtained was similar in groups 1 and 2: 73.7% and 80.8%, respectively (p=0.35). Hypothyroidism was diagnosed in 56.5% and 71.15% of the patients from groups 1 and 2, respectively (p=0.13). There was no correlation between clinical features, thyroid uptake, antibodies, serum hormones and outcome. However, logistic regression analysis demonstrated that patients with larger thyroids (weight >60 g) that, consequently, received a lower dose of radioiodine in MBq/g, had 2.4 times less chance to cure (95% Cl=1.18-4.96). Conclusion: Fixed doses of 10 mCi and 15 mCi provided similar cure rates. Outcome was not influenced by any factor but the thyroid size. We proposed that 10 mCi should be the routine treatment dose for all GD patients, reseving 15 mCi to individuals with large goiters. (author)

  19. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography

    Energy Technology Data Exchange (ETDEWEB)

    Tsuruta, Masako; Nagayama, Yuji; Yokoyama, Naokata; Izumi, Motomori; Nagataki, Shigenobu (Nagasaki Univ. (Japan). School of Medicine)

    1993-08-01

    In the present series of studies, the long-term (four year) effect of 80 Gy of [sup 131]I treatment was evaluated in patients with hyperthyroid Graves' disease whose thyroid volumes have been accurately estimated with a high resolution ultrasound scanner. One year after [sup 131]I treatment, 23.1% (3 out of 13 patients) remained hyperthyroid, 69.2% (9 out of 13) became euthyroid, and 7.7% (1 out of 13) were in a hypothyroid state. Since three patients in a hyperthyroid state one year after treatment were subsequently treated with either antithyroid drugs or additional [sup 131]I treatment, the remaining ten patients (9 euthyroid and 1 hypothyroid patients) have been followed up for three more years. Two patients developed a hypothyroid state three years after treatment and one patient four years after treatment. Overall, 60% (6 out of 10 patients) were in a euthyroid state and 40% (4 out of 10) in a hypothyroid state, four years after 80 Gy [sup 131]I treatment. There was no significant difference between eu- and hypo-thyroid groups in the sex ratio, age, radiation doses, therapeutic dose, thyroid gland volume, 24-hr [sup 131]I uptake, the effective half-life of [sup 131]I in the thyroid or the duration of hyperthyroidism. In our preliminary studies, the incidence of late hypothyroidism in our [sup 131]I treatment is similar to those previously reported. These suggest that uncertain factor(s), such as inhomogeneity of iodine distribution in the thyroid, unequal sensitivity of the thyroid cells to the radiation, and/or persistent destructive effects of the autoimmune process may influence the long-term effect of [sup 131]I treatment of Graves' disease. (author).

  20. Determination of behaviour of the corn weevil Sitophilus zeamais, Motschulsky, 1855 (Coleoptera, Curculionidae) in corn, rice and wheat grains by using radioactive tracer iodine-131

    International Nuclear Information System (INIS)

    Pacheco, I.A.

    1989-01-01

    The dispersion behaviour and distribution pattern of Sitophilus zeamais Motschulsky, 1855 through a bulk of corn, rice and wheat,leaving from a infestation focus, was investigated by means of tracer methodology. Adults insects were labeled with the gamma emitter 131 I, through bath in Na 131 I solution and released onto the top of grain mass deposited in cylinders each 430 mm height and 195 mm in diameter, filled to 20 mm of the top with grains. The cylinders were enclosed with lids. The insects were detected through the bulk of the grain by means of a crystal scintillator, in fourteen sites, zero 3, 6, 12, 24, 48, 72, 96 and 120 hours after releasing. (author)

  1. Age-dependent exposure to radioactive iodine (131I) in the thyroid and total body of newborn, pubertal and adult fischer 344 rats

    International Nuclear Information System (INIS)

    Nitta, Yumiko; Fujimoto, Nariaki; Kamiya, Kenji; Hoshi, Masaharu; Endo, Satoru

    2001-01-01

    Female rats of the Fischer 344 strain at ages of 1, 4 and 9 weeks were exposed to 131 I intraperitoneally with activities of 0.38, 1.03 and 3.42 kBq per gram of body weight under the condition of iodine deficiency. The absorbed doses in the thyroid increased linearly depending on the injected activities. Irradiation at 1 week old caused heavier exposure than those at 4 and 9 weeks old by 7.5 and 7.7 times, respectively; however, damage of the thyroid tissue was more obvious in the 4-week-old groups than in the 1-week-old groups. The absorbed doses in the total body were proportional to the square root of the injected activities. The one-week-old groups were exposed more heavily than the 4- and 9-week-old groups by 3.6 and 4.7 times, respectively, shown by the slow excretion of 131 I with the values of effective half-life of 131 I activity (T eff ). An IDD-treatment was not so effective to enhance the 131 I absorption in the total body, as in the thyroid. No matter how the iodine concentration in the blood changed, the 1-week-old groups could not react to normalize the level. We drew standard curves, which enabled us to estimate the absorbed doses in the thyroid and the total body in the case of the injected activities of 131 I for the newborn, pubertal and adult rats. (author)

  2. Treatment with rhenium-188-perrhenate and iodine-131 of NIS-expressing mammary cancer in a mouse model remarkably inhibited tumor growth

    International Nuclear Information System (INIS)

    Dadachova, Ekaterina; Nguyen, Andrew; Lin, Elaine Y.; Gnatovskiy, Leo; Lu, Ping; Pollard, Jeffrey W.

    2005-01-01

    Introduction: Novel therapeutic modalities are needed for breast cancer patients in whom standard treatments are not effective. Mammary gland sodium/iodide symporter has been identified as a molecular target in breast cancers in humans and in some transgenic mouse models. We report the results of a therapy study with 131 I - and 188 ReO 4 - of breast cancer in polyoma middle T oncoprotein (PyMT) transgenic mice endogenously expressing the Na + /I - symporter (NIS). Methods: PyMT mice (12-13 weeks old) with one palpable tumor of 0.5-0.8 cm in diameter were used. For the therapy studies, PyMT mice were (1) treated with two intraperitoneal injections of 1.5 mCi of 188 ReO 4 - 1 week apart, (2) pretreated for 1 week with 5 μg of triiodothyronine (T3) followed by two intraperitoneal injections of 1.5 mCi of 131 I - 1 week apart or (3) left untreated. The tumor and normal organ uptakes were assessed by scintigraphic imaging. The thyroid function of treated and control animals was evaluated at the completion of the study by measuring the T3/thyroxine (T4) ratio in their blood. Results: There was significant uptake of 131 I - and 188 ReO 4 - in the primary palpable tumors as well as in nonpalpable tumors, stomachs and thyroids. The tumor uptake after the second injection was 10 times lower in comparison with the first injection. Tumor growth was significantly inhibited in both the 131 I - and 188 ReO 4 - groups in comparison with the control group, and tumors in the 188 ReO 4 - group increased in size significantly less than in the 131 I - group. The T3/T4 ratios were calculated to be 27 and 25 for the control group and the 188 ReO 4 - group, respectively; for 131 I - , both the T3 and T4 levels were below detection limit, demonstrating much less effect on the thyroids of treatment with 188 ReO 4 - than with 131 I - . Conclusions: These results prove that NIS expression in breast tumors in animal models allows specific, efficient and safe treatment with a variety of radionuclides transported by NIS

  3. Study allowing a decision-making from the activity calculation of a iodine 131 source detected in a dump at the incineration facility

    International Nuclear Information System (INIS)

    Houy, J.C.; Laugle, S.

    2000-01-01

    This study is divided in six parts: the first one details the determination of the different threshold in order to make the decision; the second part is the description of the gantry placed at the incineration factory; the third part is devoted to the gantry calibration by detector; the fourth part concerns the theoretical determination of the rates ratio in function of the source position in the truck; the fifth part makes the concordance between the theoretical calculations and the practice measures; the sixth part expresses the source activity and position determination in the truck with the decision-making. To conclude, the alarm threshold adjustment of the Rennes incineration factory is set to twice the background noise without taking into account of the source position in the domestic wastes truck. The alarm setting off can be carried out for a low activity source situated close to the truck wall and conversely, do not detect a MBq source situated in the middle of the truck. This alarm should be set off from a calculation program, taking into account the detectors report, in order to estimate the activity and the position of the source in the truck and to determine the decision making for the management of these wastes. (N.C.)

  4. Localization of hypefunctioning parathyroid glands by means of thallium-201 and iodine-131 subtraction scintigraphy in patients with primary and secondary hyperparathyroidism

    International Nuclear Information System (INIS)

    Suehiro, Mitsuko; Fukuchi, Minoru

    1992-01-01

    The accuracy of the preoperative localization of hyperfunctioning parathyroid glands by subtraction scintigraphy with 201 Tl and 131 I was evaluated by comparison with the operative findings. The subjects were 67 consecutive patients with hyperparathyroidism (HPT), including 24 with primary and 43 with secondary HPT. In primary HPT, surgery revealed 26 adenomas weighing 0.26-15.80 g (mean±SD; 3.01±3.04 g). Two patients had double adenomas. Scintigraphy correctly localized 25/26 adenomas (96.2%) in primary HPT for a sensitivity, specificity, and accuracy of 96.2%, 98.5%, and 97.9%, respectively. In secondary HPT, 163 hyperplastic glands weighing 0.03-5.08 g (0.85±0.93 g) were found. Scintigraphy correctly localized 79 glands (48.5%) weighing 0.03-5.08 g (1.19±1.10 g), but 84 glands (51.5%) weighing 0.04-2.70 g (0.51±0.50 g) were not detected. Thus, the sensitivity, specificity, and accuracy of scintigraphy were respectively 48.5%, 100%, and 51.2%, in secondary HPT. These results show that scintigraphy with 201 Tl and 131 I can be used to locate abnormal parathyroid glands with an efficacy equal to or better than that of the conventional methods with 201 Tl and 99m Tc or 201 Tl and 123 I. (author)

  5. Assessment of iodine-131 transfer to cow's milk and to man resulting from the Nevada weapons tests of the 1950's

    International Nuclear Information System (INIS)

    Bouville, A.; Wachholz, B.W.; Dreicer, M.; Beck, H.L.

    1988-01-01

    The main pathway to man from fallout I-131 is, for most individuals, via the grass-cow-milk chain. In order to assess I-131 exposures for persons in each county of the contiguous U.S. the following estimates must be made : the activities of I-131 deposited on soil and pasture grass, the resulting I-131 concentrations in cow's milk, and the quantity of I-131 ingested by man. The most significant atmospheric weapons tests with respect to fallout occurred in the 1950's, during which time most of the monitoring of environmental radioactivity consisted of gross beta or gamma measurements. Assessments of exposures due to I-131 can be inferred from the original measurements of gross beta or gamma activity, from current or past measurements of radionuclides other than I-131, or from mathematical models

  6. Individual monitoring of external exposure in terms of personal dose equivalent, H{sub p}(d); Dosimetria personale esterna in termini di equivalente di dose personale, H{sub p}(d). Atti. Giornata di studio, Bologna, 28 febbraio 2001

    Energy Technology Data Exchange (ETDEWEB)

    Fantuzzi, E. [ENEA, Div. Protezione dell' Uomo e degli Ecosistemi, Centro Ricerche Ezio Clementel, Bologna (Italy)

    2001-07-01

    The institute for Radiation Protection of ENEA - Bologna has organised a one day-workshop on the subject: Individual monitoring of external exposure in terms of personal dose equivalent, H{sub p}(d). The aim of the workshop was the discussion of the new implications and modifications to be expected in the routine individual monitoring of external radiation, due to the issue of the Decree 241/00 (G.U. 31/8/2000) in charge since 01/01/2001. The decree set up in Italian law the standards contained in the European Directive EURATOM 96/29-Basic Standards for the Protection of Health of Workers and the General Public against Dangers arising from Ionizing Radiation. Among others, the definition of the operational quantities for external radiation for personal and environmental monitoring, H{sub p}(d) e H{sup *}(d) respectively as defined by ICRU (International Commission for Radiation Units and Measurements), requires to update the methods of measurements and calibration of the personal dosemeters and environmental monitors. This report collects the papers presented at the workshop dealing with the Personal Dose Equivalent, H{sub p}(d), the conversion coefficients, H{sub p}(d)/K{sub a} e H{sub p}(d)/{sub ,} obtained through Monte Carlo calculations published by ICRU and ICRP (International Commission for Radiation Protection), the new calibration procedures and the practical implication in the routine of individual monitoring in terms of H{sub p}(d). Eventually, in the last chapter, the answers to Frequently Asked Questions (FAQ) are briefly reported. [Italian] L'Istituto per la Radioprotezione dell'ENEA di Bologna ha organizzato una giornata di studio Dosimetria personale esterna in termini di equivalente di dose personale, H{sub p}(d). Lo scopo della giornata e' stato quello di discutere le novita' e le modifiche da apportare alle pratiche di monitoraggio dell'esposizione esterna alle radiazioni ionizzanti, a seguito dell'entrata in vigore

  7. Introduction to Life Science (Introduccion a la Ciencia Biologica).

    Science.gov (United States)

    Barnhard, Diana; And Others

    These materials were developed to meet an expressed need for bilingual materials for a secondary school Life Science Course. Eight units were prepared. These include the following topics: (1) Introduction to the Scientific Method; (2) The Microscope; (3) The Cell; (4) Single-celled Protists, Plants, and Animals; (5) Multicellular Living Things;…

  8. Auto-organizzazione biologica, memoria distribuita e sviluppo della conoscenza

    Directory of Open Access Journals (Sweden)

    Mirko Di Bernardo

    2015-01-01

    Full Text Available The essay focuses, through the use of a specific epistemological approach related to complexity theory in its extended version, on issues of border regarding the close relationship that exists between cognition and life, such as the idea of memory as a multisystemic and distributed natural process, the genesis of meaning in the context of the deep processes of self-organization, and the relationship - at the level of higher cognitive activity proper to man - between perception, learning (assimilation of information and thought (morphogenesis in action. With respect to the possible delineation of new models for what concerns the process of knowledge development, the text shows the recent results of research regarding an unprecedented frontier closely linked with the emergence of a real conceptual revolution at the level of the analysis of that particular entanglement of information, meaningful complexity, memory, causality, teleology and intentionality that characterizes the unfolding of the natural forms of human cognition. In such a context, the mnemonic function is set up as a dynamic and deep process of reconstruction and a connection of internal self-reflection operations, rather than as a mere "storage" of data in a static mental space. Just as the world of the first monadic order, on which stands the classical measure of Shannon information, appears related to the existence of specific forms of invariance and the definition of unique areas of measurement, in terms of higher orders, however, we have the presence of specific dichotomies, of different potentials that are given simultaneously, an evolutionary bricolage which is realized by successive interlocking states and yet tied together in a holistic manner within a process of dialectical synthesis between form, function and meaning.

  9. The Why and How of Nuclear Accident Dosimetry; Dosimetrie en cas d'Accident Nucleaire: Raison d'Etre et Modalites; 041e 0411 041e 0421 041d 041e 0412 0414 ; Dosimetria en Casos de Accidente Nuclear: Justificacion y Modalidades

    Energy Technology Data Exchange (ETDEWEB)

    Vallario, E. J.; Wasson, H. R. [United States Atomic Energy Commission, Washington, DC (United States)

    1965-06-15

    des accidents nucleaires risquent de se produire. Lors de la mise au point d'un tel programme, il convient d'etudier certains parametres fondamentaux, a savoir: a) une methode permettant de trier les membres du personnel victimes d'un accident nucleaire; b) un systeme fixe (dispositif primaire) capable de determiner, avec un degre d'exactitude convenu la dose de premier choc a son emplacement meme; c) la necessite de disposer d''appareils secondaires'; d) la necessite de munir le personnel d'un dispositif donnant des indications sur le spectre et le flux afin de faciliter l'extrapolation de la dose en permettant de passer du dispositif fixe a l'emplacement de la personne exposee. La cellule de detection neutronique du systeme devrait renseigner sur le flux et le spectre, de maniere a obtenir des indications qualitatives appropriees dans l'evaluation de la dose. Les degres d'exactitude devront etre fixes d'apres l'etat actuel des connaissances. D'autre part, la cellule de detection gamma devrait permettre de mesurer ce rayonnement dans les limites des intensites d'interet biologique, soit entre 10 et 10{sup 3}r. Pour qu'un systeme de dosimetrie en cas d'accident soit efficace, le nombre d'appareils doit etre suffisant et leur emplacement bien choisi ; il faut aussi pouvoir les recuperer facilement. Si ces conditions sont remplies, on doit obtenir des donnees satisfaisantes sur toute l'etendue du spectre de fission. (author) [Spanish] La finilidad de un programa eficaz de dosimetria es la evaluacion de la dosis de neutrones y rayos gamma resultante de un accidente nuclear. A este respecto, el autor examina las limitaciones que presenta el dosimetro de pelicula, y trata ademas de la experiencia adquirida con ocasion de determinados accidentes nucleares, experiencia que ha demostrado la necesidad de establecer un programa eficaz de dosimetria en las instalaciones en que no se excluya la posibilidad de que se produzcan accidentes de esta clase. Para establecer un programa

  10. High-Dose Ionizing Radiation Photographic Dosimetry; Mesure, par des Methodes Photogra Phiques, de Doses Elevees de Rayonnements Ionisants; 0424 041e 0422 041e 0413 0420 0414 ; Dosimetria Fotografica de Dosis Elevadas de Radiaciones Ionizantes

    Energy Technology Data Exchange (ETDEWEB)

    Trousil, J.; Bucina, I. [Institute for Research Production and Application of Radioisotopes Prague, Czechoslovakia (Czech Republic)

    1965-06-15

    ionizantes comprendidas entre 10 mr y 1000 r (para rayos gamma y rayos X de elevada energia). Con arreglo a este metodo, se utilizan dos peliculas con emulsiones diferentes, montadas en el mismo estuche. El metodo se caracteriza esencialmente por el hecho de que permite evaluar dosis comprendidas entre los limites indicados, sin necesidad de saber si se produjo una exposicion a dosis mas elevadas, con un margen de error inferior a {+-}25 en todo el intervalo (limite de seguridad 95%); ademas permite determinar con una precision satisfactoria la energia de las radiaciones a que la pelicula estuvo expuesta. Se examinan los aparatos, peliculas y tratamiento quimicos necesarios para esas mediciones. Se explica el principio de construccion de un densitometro que permite medir el ennegrecimiento de la pelicula con una precision constante en el intervalo comprendido entre D = 0 y D = 6. De este modo es posible aprovechar toda la zona de ennegrecimiento de la pelicula correspondiente a dicho intervalo. Como no se utiliza iotomultiplicador, los riesgos de iluminacion excesiva se reducen al minimo, por lo que el aparato resulta apropiado para mediciones corrientes. Ademas se indican los parametros que han de satisfacer las peliculas dosimetricas para poder detectar dosis elevadas, y se comparan las caracteristicas de las peliculas dosimetricas FOMA y ORWO en lo que respecta a la medicion de dosis elevadas. Con un progreso en la dosimetria de dosis elevadas, cabe mencionar el metodo de revelado retardado que se describe con detalle, con arreglo al cual se anaden al revelador compuestos del tipo nitrobenzimidazol y benzotriazol, en concentracion adecuada. En el caso de emulsiones lentas con elevado contenido de plata, esta tecnica permite medir exposiciones de dosis gamma (rayos X de elevada energia) de hasta 10{sup 3}r, o aun mayores, si no es menester una evaluacion precisa en un intervalo de hasta 100 r. Se describe el efecto retardador de los productos quimicos anadidos al revelador

  11. Long term atmospheric radioxenon measurements and iodine-131 detections over Europe in 2011 and 2012; Langzeitmessungen von Radioxenon in der Atmosphaere und Jod-131 Nachweis in Europa in 2011 und 2012

    Energy Technology Data Exchange (ETDEWEB)

    Schlosser, C.; Bieringer, J.; Krais, R.; Konrad, M.; Kumberg, T.; Schmid, S. [Bundesamt fuer Strahlenschutz, Freiburg (Germany); Ross, J.O. [Bundesanstalt fuer Geowissenschaften und Rohstoffe, Hannover (Germany)

    2014-01-20

    The German Federal Office for Radiation Protection (Bundesamt fuer Strahlenschutz, BfS) continuously monitors the activity concentration of {sup 133}Xe in ground level air in Germany since 1976. Since 2004, Xenon is measured at Schauinsland in samples with 24 hours sampling time with the automated system SPALAX as part of the International Monitoring System (IMS) of the Comprehensive Nuclear-Test-Ban Treaty (CTBT). Furthermore the BfS operates two high air volume samplers, one in Freiburg and one at the monitoring station Schauinsland. The surveillance of radioactive traces in the atmosphere is part of the German monitoring program of the Integrated Measurement and Information System (IMIS). The available data set allow the study of trends over long time periods and therefore the influence of different sources. Possible sources and their contribution could be investigated by the methods of Atmospheric Transport Modelling (ATM). Beside radioactive xenon isotopes also the medical isotope {sup 131}I is released in traces into the atmosphere and the detection at single trace analysis stations is not exceptional. However, in autumn 2011 and spring 2012 traces of this radioisotope were detected over longer periods over Europe. These events clearly showed the importance of a fast, transboundary and comprehensive data exchange between institutions to identify and localize the source.

  12. Radiological accident with Iodine-131 in the Radioisotope Division at IPEN-CNEN/SP (Brazil); Acidente radiologico com iodo-131 nas instalacoes da Divisao de Radioisotopos do IPEN-CNEN/SP (Brasil)

    Energy Technology Data Exchange (ETDEWEB)

    Sanches, Matias Puga; Rodrigues, Demerval Leonidas [Instituto de Pesquisas Energeticas e Nucleares (IPEN), Sao Paulo, SP (Brazil)

    1997-12-31

    The accident occurred in the first week of May 1995, in the Radioisotope Division-TPI, involving two tubes containing a total volume of 3 ml, aqueous solution of N Al{sup 1}31, with 370 MBq and 1480 MBq activity is reported. Part of installation and six workers involved in the distribution process were contaminated with {sup 131} I, but there were no contamination outside the building. The workers were decontaminated and the received radiation doses were evaluated by the Radiotoxicological Laboratory of IPEN-CNEN/SP together with IRD-CNEN/RJ. The building involved was closed and the activities stopped until the complete decontamination by the Radioprotection experts of IPEN-CNEN/SP. (author) 2 refs., 1 fig., 1 tab.; e-mail: msanches at net.ipen.br; dirodri at net.ipen.br

  13. Tests on the measurement of iodine-131 in milk using anionic ion-exchangers; Essais relatifs au dosage de l'iode 131 dans le lait au moyen d'echangeur d'ion anionique

    Energy Technology Data Exchange (ETDEWEB)

    Jeanmaire, L; Patti, F; Daburon, M L; Gros, R; Bertrand, S [Commissariat a l' Energie Atomique, Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1966-07-01

    The milk produced by a cow contaminated by a single ingestion has been passed over a Dowex 1 resin to fix the iodine it contained, The percentage amount fixed, originally around 100 per cent, falls to 50 per cent after 15 days. (authors) [French] Le lait d'une vache contaminee par ingestion unique a ete passe sur resine Dowex 1 pour fixer l'iode qu'il contenait. Le pourcentage de fixation, qui a l'origine est voisin de 100 pour cent, tombe a 50 pour cent au bout de 15 jours. (auteurs)

  14. Intra ovaries thyroid cancer with intraperitoneal, osseous and pulmonary metastases fixing iodine 131; Cancer thyroidien intra-ovarien avec metastases intraperitoneale, osseuse et pulmonaires fixant l'iode 131

    Energy Technology Data Exchange (ETDEWEB)

    Bernard, A.M.; Barge, M.L.; Le Dortz, L.; Herry, J.; Devillers, A. [Centre Eugene-Marquis, Service de medecine nucleaire, 35 - Rennes (France); Vauleon, E.; Kerbrat, P. [Centre Eugene-Marquis, service d' oncologie medicale, 35 - Rennes (France)

    2010-07-01

    Purpose: Intra ovaries localizations of differentiated thyroid cancer are rare. A few metastatic localizations were described. The presented file is this one of bone and lung metastases localizations discovered 14 years after a bilateral ovaries surgery for a mature teratoma with double epidermic and thyroid compound, taking aspect of an ovaries goiter, with changes. Conclusions: In front of the discovery of an ovary goiter, a careful histopathologic examination is necessary, in search of malignant lesions that may be treated by ira-therapy. (N.C.)

  15. Testing of environmental transfer models using data from the atmospheric release of Iodine-131 from the Hanford site, USA, in 1963. Report of the Dose Reconstruction Working Group of the Biosphere Modelling and Assessment (BIOMASS) Programme, Theme 2

    International Nuclear Information System (INIS)

    2003-03-01

    The IAEA Programme on BIOsphere Modelling and ASSessment (BIOMASS) was launched in Vienna in October 1996. The programme was concerned with developing and improving capabilities to predict the transfer of radionuclides in the environment. The programme had three themes: Theme 1: Radioactive Waste Disposal. The objective was to develop the concept of a standard or reference biosphere for application to the assessment of the long term safety of repositories for radioactive waste. Theme 2: Environmental Releases. BIOMASS provided an international forum for activities aimed at increasing the confidence in methods and models for the assessment of radiation exposure related to environmental releases. Two Working Groups addressed issues concerned with the reconstruction of radiation doses received by people from past releases of radionuclides to the environment and the evaluation of the efficacy of remedial measures. Theme 3: Biosphere Processes. The aim of this Theme was to improve capabilities for modelling the transfer of radionuclides in particular parts of the biosphere identified as being of potential radiological significance and where there were gaps in modelling approaches. This topic was explored using a range of methods including reviews of the literature, model inter-comparison exercises and, where possible, model testing against independent sources of data. Three Working Groups were established to examine the modelling of: (1) long term tritium dispersion in the environment; (2) radionuclide uptake by fruits; and (3) radionuclide migration and accumulation in forest ecosystems. This report describes results of the studies undertaken by the Dose Reconstruction Working Group under Theme 2

  16. Dicarbonic acid anilides containing radioactive iodine (iodine 131, 123, 125, or 132) as well as their metal and amine salts; methods for the preparation of these compounds and of radioactive functional diagnostics containing them

    International Nuclear Information System (INIS)

    Buttermann, G.

    1976-01-01

    A method for the preparation of dicarbonic acid anilides containing radioactive iodine is described. The initial substances are N,N dimethyl-p-toluene sulfonamide, N,N bis-dimethyl aminosulfon, or dimethyl sulfon, or mixtures of these, which are heated in aqueous solution or in a melt with an alkali or alkaline earth radioiodide as carrier-free as possible. From the water-soluble salts of the obtained iodine-labelled dicarbonic acid anilides aqueous solutions are produced with 1 mg up to 5 g iodine-labelled dicarbonic acid anilide per 10 ml and an activity of 0.025 and 25 mCi per ml with physiologically compatible bases as radioactive functional diagnostics. (RB) [de

  17. The Importance of Dosimetry to the Medical Management of Persons Accidentally Exposed to High Levels of Radiation; Le Role de la Dosimetrie Dans les Soins Medicaux a Donner aux Personnes Accidentellement Exposees a de Fortes Doses de Rayonnement; 0417 041d 0410 0427 0414 ; Importancia de la Dosimetria para el Tratamiento Medico de las Personas Accidentalmente Expuestas a Dosis Elevadas de Radiaciones

    Energy Technology Data Exchange (ETDEWEB)

    Andrews, G. A.; Lushbaugh, C. C. [Medical Division, Oak Ridge Institute of Nuclear Studies (United States); Auxier, J. A. [Health Physics Division, Oak Ridge National Laboratory, Oak Ridge, TN (United States)

    1965-06-15

    Radiation accidents continue to occur sporadically and it appears that there is no hope of eliminating them entirely. The management of patients exposed to large doses of radiation is constantly improving because of increasing ability to prevent and treat infection and to control haemorrhage. The possible effectiveness of temporary bone marrow grafts offers promise of a further reduction in mortality. The use of this growing biological information is closely related to, and to a large extent dependent upon, improvements in physical dosimetry for radiation accidents. (author) [French] Des accidents provoques par les rayonnements continuent a se produire de temps a autre et il ne semble guere que l'on puisse esperer les eliminer entierement. Toutefois, le traitement des sujets exposes a de fortes doses de rayonnement ne cesse de s'ameliorer; on parvient, en effet, dans une mesure croissante a empecher et a traiter l*infection ainsi qu'a arreter l'hemorragie. Comme la greffe temporaire de la moelle des os semble devoir donner des resultats, on peut s*attendre a une nouvelle reduction du taux de mortalite. L'application de ces connaissances biologiques sans cesse accrues est fonction, dans une large mesure, des ameliorations apportees a la dosimetrie physique des accidents nucleaires. (author) [Spanish] De vez en cuando se siguen produciendo accidentes de irradiacion y las perspectivas de evitarlos por completo parecen ser bastante remotas. El tratamiento de las victimas expuestas a dosis elevadas de radiaciones mejora constantemente debido a la creciente posibilidad de prevenir y tratar las infecciones, y de controlar las hemorragias. Tambien es posible que la eficacia de ios injertos temporales de medula osea se traduzca en una disminucion de la mortalidad. El aprovechamiento de estos conocimientos biologicos cada vez mas amplios guarda una estrecha relacion con los perfeccionamientos en materia de dosimetria fisica en caso de accidentes de irradiacion. (author

  18. Determination on Mice and other Organisms of the RBE of High-Energy Protons and Electrons; Efficacite Biologique Relative sur la Souris et d'Autres Organismes des Protons et des Electrons De Haute Energie; Opredelenie obeh pri obluchenii myshej i drugikh organizmov protonami i ehlektronami vysokikh ehnergij; Determinacion de la Eficacia Biologica Relativa de los Protones y de los Electrones de Elevada Emergia en el Raton y en Otros Organismos

    Energy Technology Data Exchange (ETDEWEB)

    Bonet-Maury, P.; Baarli, J.; Kahn, T.; Dardenne, G.; Frilley, M.; Deysine, A. [Institut du Radium, Paris (France)

    1964-03-15

    The general effects of 157- and 592-MeV protons and 150- and 950-MeV electrons were observed on mice exposed to lethal doses of whole-body irradiation. The irradiated animals displayed the same general symptoms as those produced by X - or gamma-rays. The biological tests did not bring to light any particular phenomenon which can be considered as characteristic of these high-energy particles. As determined in four tests (LD{sub 50}, average expectation of life and diminution of thymus and testicles), the RBE is close to 1. This corresponds to the mean LET of the particles and, in the case of the protons, does not appear to be increased by the higher local LET of the spallation fragments. (author) [French] Les effets generaux des protons de 157 et 592 MeV et des electrons de 150 et 950 MeV oiit ete observes sur des souris irradiees in toto, a des doses letales. Les animaux irradies presentent les memes symptomes generaux que ceux produits par les rayonnements de reference X ou {gamma}. Aucun phenomene caracteristique de ces particules de haute energie n'a pu etre mis en evidence avec les tests biologiques choisis. Lfefficacite biologique relative determinee sur 4 tests (DL{sub 50}, survie moyenne, reduction du thymus et des testicules) est peu differente de 1; cette EBR correspond au TEL moyen des particules et, pour les protons, ne parait pas augmentee par le TEL local plus eleve des etoiles de spallation. (author) [Spanish] Se han observado los efectos generales de los protones de 157 y 592 MeV y de los electrones de 150 y 950 MeV sobre ratones expuestos in toto, a dosis letales de radiaciones. Los animales irradiados presentan los mismos sintomas generales que los producidos por los rayos X o los rayos gamma adoptados como radiaciones de referencia. Los ensayos biologicos llevados a cabo no han puesto de manifiesto ningun fenomeno caracteristico de la accion de estas particulas de elevada energia. La eficacia biologica relativa determinada en cuatro ensayo (DL

  19. The influential factors of 131I treatment for hyperthyroidism

    International Nuclear Information System (INIS)

    Tan Benxu

    2003-01-01

    Many factors such as iodine-131 uptake, effective half-life, thyroid volume, and antithyroid drugs affect the iodine-131 dose for every hyperthyroid patient. The outcome of radioiodine therapy in hyperthyroidism is decided by all of these factors

  20. Whole-body counting installation for assessment of internal contamination in workers

    International Nuclear Information System (INIS)

    Oliveira, C.A.N.; Cunha, P.G.; Lipsztein, J.L.; Bertelli, L.N.; Fonseca, A.M.G.; Ramalho, A.T.

    1985-01-01

    A whole-body counting installation for assessment of internal contamination in workers has recently been added to the Bioassay Division of the Instituto de Radioprotecao e Dosimetria, Comissao Nacional de Energia Nuclear (IRD/CNEN). For the last two years the laboratory has been monitoring personnel involved in uranium mining and milling activities, monazite industry workers and nuclear medicine staff dealing with iodine-131 and technetium-99. Uptakes of radionuclides by the different organs and also dose equivalents are evaluated through the use of mathematical models. The IRD whole-body counter unit was specially designed to detect a variety of internally deposited radionuclides which emit photons in the energy range of 15 keV to 3 MeV. It consists of a monitoring room (2.5x2.5x2.5 m internal dimension), with 0.15 m thick steel walls, internally lined with 0.3 cm lead, 0.15 cm cadmium and 0.05 cm thick copper sheets. The facility is equipped with three different size NaI(T1) detectors and three 12.7 cm diameter phoswich detectors. (author)

  1. Thermoluminescence in medical dosimetry; Termoluminiscencia en dosimetria medica

    Energy Technology Data Exchange (ETDEWEB)

    Rivera, T., E-mail: trivera@ipn.mx [IPN, Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Av. Legaria 694, Col. Irrigacion, 11500 Mexico D. F. (Mexico)

    2011-10-15

    The dosimetry by thermoluminescence (Tl) is applied in the entire world for the dosimetry of ionizing radiations specially to personal and medical dosimetry. This dosimetry method has been very interesting for measures in vivo because the Tl dosimeters have the advantage of being very sensitive in a very small volume and they are also equivalent to tissue and they do not need additional accessories (for example, cable, electrometer, etc.) The main characteristics of the diverse Tl materials to be used in the radiation measures and practical applications are: the Tl curve, the share homogeneity, the signal stability after the irradiation, precision and exactitude, the response in function with the dose and the energy influence. In this work a brief summary of the advances of the radiations dosimetry is presented by means of the thermally stimulated luminescence and its application to the dosimetry in radiotherapy. (Author)

  2. The personal dosimetry in Mexico; La dosimetria personal en Mexico

    Energy Technology Data Exchange (ETDEWEB)

    Salazar, M.A. [Proxtronics/ Asesoria Integral en Dosimetria Termoluminiscente S.A. de C.V., Canal de Miramontes 2030-14, Col. Educacion, 04400 Mexico D.F. (Mexico)]. e-mail: aidtsa@avantel.net

    2006-07-01

    The Personal Dosimetry in Mexico, has an approximately 30 year-old history; and it had been and it is at the moment, one of the more important resources with which the personnel that works with ionizing radiation sources counts for its protection. The Personal Dosimetry begins with the film dosimetry, technique that even continues being used at the present time by some users, and the main reason of its use is for economic reasons. At the moment this technique, it has been surpassed, by the Thermoluminescent dosimetry, which has taken a lot of peak, mainly by the technological development with which it is counted at the present time; what has given as a result that this technique becomes tip technology; that supported in the characteristic of the used materials, as the handling and processing of the information associated with the new PC, digitizer cards, software etc, what has allowed increases it potential. In this work the current necessities of the market are presented as well as an analysis of the future real necessities in Mexico, at national level, the companies that provide this service and that they spread to satisfy this necessity of the market, including the different used technologies are also mentioned. The application ranges, at the same time, of the advantages and disadvantages of the different systems of Personal Dosimetry in the market. The companies that at the moment provide the service of Personal Dosimetry, its use materials and equipment in indistinct form, for the monitoring of gamma radiation, beta particles, different qualities of x-ray radiation, and sometimes neutrons. The monitoring of the exposed personnel at the diverse sources of ionizing radiation mentioned is carried out in many occasions without having with the materials (detectors), neither the appropriate infrastructure and therefore without the quality control that guarantees a correct evaluation of the dose equivalent, as a result of the exposure to the ionizing radiations; it is for what is considered that this work is important since the main objective of the Personal Dosimetry is that of the protection of people, that is to say the one of avoiding risks in the health of the workers involved with the radiations. (Author)

  3. Dosimetry of industrial sources; Dosimetria de fuentes industriales

    Energy Technology Data Exchange (ETDEWEB)

    Vega C, H.R.; Rodriguez J, R.; Manzanares A, E.; Hernandez V, R.; Ramirez G, J. [Universidad Autonoma de Zacatecas, 98068 Zacatecas (Mexico); Rivera M, T. [CICATA-IPN, 11500 Mexico D.F. (Mexico)]. e-mail: fermineutron@yahoo.com

    2007-07-01

    The gamma rays are produced during the disintegration of the atomic nuclei, its high energy allows them to cross thick materials. The capacity to attenuate a photons beam allows to determine the density, in line, of industrial interest materials as the mining. By means of two active dosemeters and a TLDs group (passive dosimetry) the dose rates of two sources of Cs-137 used for determining in line the density of mining materials were determined. With the dosemeters the dose levels in diverse points inside the grave that it harbors the sources and by means of calculations the isodoses curves were determined. In the phase of calculations was supposed that both sources were punctual and the isodose curves were calculated for two situations: naked sources and in their Pb packings. The dosimetry was carried out around two sources of {sup 137}Cs. The measured values allowed to develop a calculation procedure to obtain the isodoses curves in the grave where the sources are installed. (Author)

  4. Relative dosimetry by Ebt-3; Dosimetria relativa por EBT3

    Energy Technology Data Exchange (ETDEWEB)

    De Leon A, M. A.; Rivera M, T. [IPN, Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Av. Legaria 694, 11500 Mexico D. F. (Mexico); Hernandez O, J. O., E-mail: madla16@hotmail.com [Hospital General de Mexico, Dr. Balmis 148, Col. Doctores, 06726 Mexico D. F. (Mexico)

    2015-10-15

    In the present work relative dosimetry in two linear accelerator for radiation therapy was studied. Both Varian Oncology systems named Varian Clinac 2100-Cd and MLC Varian Clinac i X were used. Gaf Chromic Ebt-3 film was used. Measurements have been performed in a water equivalent phantom, using 6 MV and 18 MV photon beams on both Linacs. Both calibration and Electron irradiations were carried out with the ionization chamber placed at the isocenter, below a stack of solid water slabs, at the depth of dose maximum (D max), with a Source-to-Surface Distance (SSD) of 100 cm and a field size of 10 cm x 10 cm. Calibration and dosimetric measurements photons were carried out under IAEA-TRS 398 protocol. Results of relative dosimetry in the present work are discussed. (Author)

  5. Dosimetry of {beta} extensive sources; Dosimetria de fuentes {beta} extensas

    Energy Technology Data Exchange (ETDEWEB)

    Rojas C, E.L.; Lallena R, A.M. [Departamento de Fisica Moderna, Universidad de Granada, E-18071 Granada (Spain)

    2002-07-01

    In this work, we have been studied, making use of the Penelope Monte Carlo simulation code, the dosimetry of {beta} extensive sources in situations of spherical geometry including interfaces. These configurations are of interest in the treatment of the called cranealfaringyomes of some synovia leisure of knee and other problems of interest in medical physics. Therefore, its application can be extended toward problems of another areas with similar geometric situation and beta sources. (Author)

  6. Retrospective dosimetry in irradiated foods; Dosimetria retrospectiva en alimentos irradiados

    Energy Technology Data Exchange (ETDEWEB)

    Calderon, T [Universidad Autonoma de Madrid, Facultad de Ciencias, Dpto. Quimica Agricola, Geologia, Geoquimica, Cantoblanco, Madrid (Spain)

    1999-07-01

    The main objective of this communication is to show the potentiality of certain minerals which accompany the foods (grasses, spices and seasonings) as potential dosemeters and its possible application in the absorbed dose calculations by the same in its hygienic sanitary treatment. (Author)

  7. Dosimetry of High-Energy Protons by Measurement of Beryllium-7 Formed in the Tissues; Dosimetrie des Protons de Haute Energie par Mesure de Beryllium-7 Forme dans les Tissus; 041e 0422 041d 041e 0421 0414 ; Dosimetria Relativa Mediante Berillo-7 Despues de Irradiar con Protones de Altas Energias (600 Mev Y 3 Gev)

    Energy Technology Data Exchange (ETDEWEB)

    Legeay, G. [Service Biologique et Veterinaire des Armees, Detache au D.P.S. (France); Commissariat a l' Energie Atomique, Centre d' Etudes Nucleaires de Fontenay-aux-Roses (France); Court, L.; Prat, L [Service de Sante des Armees, Detaches au D.P.S. (France); Commissariat a l' Energie Atomique, Centre d' Etudes Nucleaires de Fontenay-aux-Roses (France); Jeanmaire, L.; Daburon, M. L. [Commissariat a l' Energie Atomique (France); Nucleaires de Fontenay-aux-Roses, Centre d' Etudes [France; De Kerviler, H.; Tardy-Joubert, P. [Service de Protection Contre les Radiations, Centre d' Etudes Nucleaires de Saclay (France)

    1965-06-15

    compara las actividades determinadas experimentalmente y las calculadas en funcion de la energia a partir de los valores de las secciones eficaces actualmente admitidos. Dado que la irradiacion accidental del ser humano en haces protonicos es siempre localizada, se han efectuado experimentos consistentes en la irradiacion de la cabeza de conejos Fauve de Bourgogne de unos 2 kg de peso. Se comprobo que la actividad inducida en la cabeza es, en relacion a la que se observa en el resto del cuerpo, del orden de 1,8 {+-} 5. A pesar de cierta difusion el {sup 7}Be se puede detectar durante los primeros dias que siguen a la irradiacion. Por tanto, queda demostrado que este tipo de dosimetria relativa permite formarse una idea concreta del orden de magnitud de la irradiacion recibida accidentalmente. (author) [Russian] V ramkah biologicheskih jeksperimentov, provedennyh na sinhrociklotrone issledovatel'skogo jadernogo centra CERN v Zheneve s primeneniem protonov v 600 Mjev, i na sinhrotrone ''Saturn'' v issledovatel'skom jadernom centre Sakle s pomoshh'ju gamma-spektrografii, issledovalas' navedennaja radioaktivnost' u zhivyh sushhestv. I esli bol'shinstvo navedennyh radioizotopov (gamma-izluchatelej) imejut ochen' korotkij period poluraspada, to berillij-7, poluchaemyj v rezul'tate reakcij rasshheplenija na atomah kisloroda, ugleroda i azota, v chastnosti, daet pik aktivnosti, kotoryj bystro otdeljaetsja ot vsego spektra pri urovne jenergij v 479 kjev. Period poluraspada berillija-7 ravnyj 54,5 dnja pozvoljaet registrirovat' ego v techenie dostatochno prodolzhitel'nogo vremeni. Issledovanie, provedennoe Uajcarom na krysah, kotorye byli oblucheny in toto dozami mezhdu 400 i 800 rad, s protonami v 600 Mjev, i dozami 200 i 1000 rad, s protonami v 3 Gjev, daet linejnuju harakteristiku aktivnosti berillija-7 v zavisimosti ot pogloshhennoj dozy na 1 g tkani. Jeksperimental'nye rezul'taty sravnivalis' s raschetnymi, proizvedennymi s uchetom zavisimosti ot jenergii i na baze sechenij

  8. Planned Procedures for Fast Determination of Radiation Levels and Personnel Dosimetry in Connection with Radiological Accidents; Methodes de Dosimetrie Rapide du Personnel en Cas d'Accident Radiologique; 041f 041b 0410 041d 0414 ; Servicio Organizado de Determinacion Rapida de los Niveles de Radiacion y de Dosimetria del Personal en Caso de Accidente Radiologico

    Energy Technology Data Exchange (ETDEWEB)

    Edvardsson, K. -A.; Wahlberg, T. [AB Atomenergi, Studsvik (Sweden)

    1965-06-15

    medios de comunicacion con el interior y con el exterior. En materia de dosimetria individual, interesa, a la vez obtener lo antes posible los datos preliminares aproximados de la intensidad de la exposicion interna y externa, asi como, dentro de un plazo prudencial, datos bastante exactos, de la exposicion a que ha estado expuesta cada persona. Diversos equipos de determinacion de dosis, conocidos con el nombre de patrullas de reconocimiento, recorren los diversos sectores del recinto de la instalacion a fin de efectuar una evaluacion general de los riesgos. Esas patrullas que entran en accion tan pronto como se recibe la alarma estan provistas de instrumentos portatiles y recorren en automovil una serie de itinerarios previamente determinados en el emplazamiento. Los ensayos practicos realizados han puesto de manifiesto que las informaciones reunidas por las diversas patrullas llegan a la oficina central transcurridos 10-15 min despues de darse la alarma, permitiendo obtener una vision clara de los niveles de radiacion dentro y fuera de los diversos edificios. Los aparatos portatiles incluyen dispositivos para muestreo rapido del aire que funcionan segun el principio del eyector de aire. Las dosis individuales de irradiacion externa se evaluan con ayuda de dosimetros de pelicula, por activacion de dosimetros de criticidad, asi como por analisis de la actividad del pelo y de la sangre. La contaminacion interna se determina mediante antropogammametria y analisis radiometrico de las excreta. Para delimitar los campos de radiacion creados por un accidente, existen diversos puntos fijos de control equipados con dosimetros de varios tipos, a cuya lectura se procede lo antes posible despues de producirse el supuesto accidente. (author) [Russian] Obshhestvo po atomnoj jenergii Shvecii imeet special'nuju avarijnuju organizaciju, kotoraja nachinaet funkcionirovat' kak tol'ko poluchen signal o tom, chto sozdalos' chrezvychajnoe polozhenie v svjazi s bol'shoj radiacionnoj opasnost

  9. In Vivo and Air Dosimetry of Fission-Spectrum Neutrons; Dosimetrie In Vivo et dans l'Air du Spectre des Neutrons de Fission; Dozimetriya v vozdukhe i dozimetriya In Vivo nejtronov spektra deleniya; Dosimetria In Vivo y en el Aire de Neutrones de un Espectro de Fision

    Energy Technology Data Exchange (ETDEWEB)

    Mobley, T. S.; Engel, R. E.; Godden, W. R. [Kirtland Airforce Base, New Mexico (United States); Penikas, V. T. [AFIT, Wright-Patterson Air Force Base, Ohio, with Duty Station at University of Rochester, School of Medicine and Dentistry, Rochester, NY (United States)

    1964-03-15

    laterales a une distance mediane de 200 cm ou de 175 cm du centre de l ' assemblage critique. La dose de neutrons mesuree dans l ' air etait de 161 {+-} 5 ,5 rad a 200 cm et de 242 {+-} 16.6 rad a 175 cm. A ces distances, la dose gamma etait respectivement de 33 {+-} 2,4 et 42 {+-} 2,5 r. Les doses d'entree et de sortie ainsi que la dose a l ' insertion variaient selon l'elevation de temperature due aux bouffees de neutrons, la distance du reacteur, l 'orientation des feuilles par rapport au reacteur et l'epaisseur et la composition de tissus attenuants. (author) [Spanish] Con el proposito de evaluar la configuracion de la dosis profunda durante la exposicion a neutrones de un espectro de fisionalos autores han ideado un metodo de dosimetria neutronica in vivo que aplicaron a ovejas. Utilizaron para estos estudios un reactor pulsante analogo al GODIVA II del Laboratorio Cientifico de Los Alamos. Dicho conjunto funciona de forma de producir impulsos de 50 {mu}s de amplitud, medida a la mitad de la altura maxima, y un ascenso de temperatura del combustible de unos 100 Degree-Sign C. Ademas, prepararon 'apositos ' subcutaneos que contienen una lamina de oro recubierta de cadmio, una lamina de oro sin recubrir y tres dosimetros de varilla de vidrio, termoluminiscentes, en un recipiente de plomo al litio revestido de vidrio. Estos apositos se introdujeron en el tejido subcutaneo, a ambos lados del cuerpo, y sirvieron para medir el flujo integrado de neutrones termicos y la dosis gamma, a medida que la irradiacion neutronica se aplica 'lateralmente'. Los apositos abdominales se prepararon en forma semejante a los subcutaneos; constan de una esfera de boro que contiene laminas de umbral de fision (Pu, Np, U) recubiertas de cadmio, una pastilla de azufre y los mismos tres tipos de dosimetros que forman parte del aposito subcutaneo. El aposito dosimetrico se sujeto al pilar anterior del rumen del animal 18 h antes de someterlo a la exposicion. En la memoria se describe la tecnica de

  10. Nuclear Accident Dosimetry at Argonne National Laboratory; Dosimetrie dans les Cas d'Accidents Nucleaires au Laboratoire National d'Argonne; 0421 041b 0423 0416 0411 0410 0414 ; Dosimetria en Casos de Accidente Nuclear en el Laboratorio Nacional de Argonne

    Energy Technology Data Exchange (ETDEWEB)

    Anderson, L. L.; Duffy, T. L.; Sedlet, J.; O' Neil, D. P. [Argonne National Laboratory, Argonne, IL (United States)

    1965-06-15

    cellules au cuivre, a l'indium et aux composes du soufre. Les auteurs calculent la fluence totale des neutrons en utilisant le spectre corrige en conjonction avec une fonction de probabilite de capture et le resultat pour le sodium du sang. On peut alors obtenir une ou plusieurs specifications de la dose des neutrons, en appliquant la fonction de conversion appropriee aux renseignements obtenus sur le spectre. L'element de l'ensemble dosimetre primaire destine a mesurer les rayons gamma contient des baguettes fluorescentes et un dosimetre a thermoluminescence en plus du dosimetre chimique a deux phases. Le dosimetre gamma de l'ensemble secondaire est une.solution de polyacrylamide qui se degrade sous l'effet des rayons gamma. On calcule la dose absorbee a partir de la valeur mesuree du changement de viscosite de la solution. Le memoire signale les difficultes que presentent l'evaluation des resultats, le choix de l'emplacement et la stabilite pendant le stockage. Des methodes sont etablies pour le dosage du phosphore-32 dans les matieres biologiques, lequel vise a obtenir la dose de neutrons rapides, a analyser les matieres prelevees dans le milieu ambiant pour y doser les produits resultant de l'activation par les neutrons et a determiner le nombre total de fissions. Le controle administratif des operations de dosimetrie est facilite par un manuel qui enumere les emplacements des appareils, precise les methodes de manipulation et de comptage et donne les formules de calcul de la dose. (author) [Spanish] El informe resume las medidas cuya adopcion se preve actualmente en el Laboratorio Nacional de Argonne para evaluar las dosis recibidas a consecuencia de un accidente de criticidad. Discute principalmente dos tipos de dosimetro que se encuentran en el comercio e indica los resultados de calibraciones independientes que se ejecutaron en el citado laboratorio. La red primaria de dosimetria esta constituida por detectores de umbral perfeccionados en el Laboratorio Nacional de

  11. Study of phosphors determination in biological samples; Estudo da determinacao de fosforo em amostras biologicas

    Energy Technology Data Exchange (ETDEWEB)

    Oliveira, Rosangela Magda de

    1994-12-31

    In this paper, phosphors determination by neutron activation analysis in milk and bone samples was studied employing both instrumental and radiochemical separation methods. The analysis with radiochemistry separation consisted of the simultaneous irradiation of the samples and standards during 30 minutes, dissolution of the samples, hold back carrier, addition precipitation of phosphorus with ammonium phosphomolibdate (A.M.P.) and phosphorus-32 by counting by using Geiger-Mueller detector. The instrumental analysis consisted of the simultaneous irradiation of the samples and standards during 30 minutes, transfer of the samples into a counting planchet and measurement of the beta radiation emitted by phosphorus-32, after a suitable decay period. After the phosphorus analysis methods were established they were applied to both commercial milk and animal bone samples, and data obtained in the instrumental and radiochemical separation methods for each sample, were compared between themselves. In this work, it became possible to obtain analysis methods for phosphorus that can be applied independently of the sample quantity available, and the phosphorus content in the samples or interference that can be present in them. (author). 51 refs., 7 figs., 4 tabs.

  12. DESNITRIFICACION BIOLOGICA USANDO SUSTRATOS SOLIDOS ORGANICOS NATURALES COMO DONANTE DE ELECTRONES Y FUENTE DE CARBONO

    OpenAIRE

    DEAGO DE LEON, EUCLIDES MANUEL

    2014-01-01

    Los estudios sobre el aprovechamiento de Sustratos Sólidos Orgánicos Naturales (SSON) como fuentes alternativas de carbono orgánico, son importantes para establecer la factibilidad de su aplicación en la desnitrificación del agua. Los estudios sobre la materia indican que es posible usar SSON; sin embargo, aspectos como la liberación del carbono orgánico no está claramente establecido. En este estudio se bordaron los siguientes aspectos (i) factores que controlan la liberación ...

  13. Vita biografica vs. Vita biologica. la questione dell’anthropos in Karl Löwith

    Directory of Open Access Journals (Sweden)

    Gambardella, Fabiana

    2012-12-01

    Full Text Available This work focuses on Karl Löwith’s anthropology. Despite the great number of anthropological studies carried out at the beginning of 20th Century and aimed at describing human nature by means of natural science (biology, ethology, zoology, Löwith elaborates an anthropology based on the concept of biographical life. Man is not a simple living being, he is also an unnatural being that produces himself through the relationship with the other within a shared world.

  14. USBF-system of biological wastewater treatment; Elsistema USBF en la depuracion biologica de aguas residuales

    Energy Technology Data Exchange (ETDEWEB)

    Ampudia Gutierrez, J.

    2003-07-01

    An advanced system of biological wastewater treatment, has been developed by the company Depuralia. This system brings up a technological innovation, which has been awarded with several international awards. The wastewater treatment, occurs in an activated sludge reactor of extended aeration with a very low mass loading, with a nitrification-denitrification process, and water separation-clarification by upflow sludge blanket-filtration. The arrangement of a compact biological reactor enables complex wastewater treatment. High efficiency of the separation through sludge filtration provides functionality of the equipment with high concentration of activated sludge, with less implementation surface and volume. The elements of the biological reactor are described, the advantages are enumerated, and the results obtained in several accomplishments are shown; in the industrial as well as in the urban water treatment plants. (Author) 9 refs.

  15. Triterpenos aislados de corteza de Bursera graveolens (Burseraceae y su actividad biologica

    Directory of Open Access Journals (Sweden)

    Jorge Robles

    Full Text Available Bursera graveolens (Burseraceae, known in Colombia as "sasafrás", is useful for its medicinal properties and is rich in secondary metabolites. In our research, we carried out antimicrobial tests of several fractions and ethanolic extracts from aerial parts against Bacillus subtilis and Staphylococcus aureus, that showed growth inhibitory activity when applied at 250 mg/mL for extracts and 150 mg/mL for fractions. We carried out an antiinflamatory assay also, that showed 71% of inhibition by extracts (81% of Indomethacin and 70% of inhibition by fractions (78% of Indomethacin. Phytochemical investigation of the bark of Bursera graveolens (Burseraceae yielded three tetracyclic triterpene acids that have oxygenation in C-3, carboxylic acid in C-21 and unsaturation in C-24 and have been identified as 3-oxotirucalla-8,24-dien-21-oic acid (b-elemonic acid, 3a-hydroxytirucalla-8,24-dien-21-oic acid (a-elemolic acid and 3a-hydroxytirucalla-7,24-dien-21-oic acid. The isolated compounds were identified using spectroscopic methods including one and two-dimensional Nuclear Magnetic Resonance (COSY, HMQC, HMBC, NOESY experiments and comparison with published data. This is the first report of the isolated compounds in Bursera graveolens and they have a very important chemotaxonomic significance within the Burseraceae family and related families from the order Rutales.

  16. Structure, reactivity, and biological properties of hidantoines; Estrutura, reatividade e propriedades biologicas de hidantoinas

    Energy Technology Data Exchange (ETDEWEB)

    Oliveira, Silvania Maria de; Silva, Joao Bosco Paraiso da [Universidade Federal de Pernambuco (UFPE), Recife, PE (Brazil). Dept. de Quimica Fundamental]. E-mail: paraiso@ufpe.br; Hernandes, Marcelo Zaldini [Universidade Federal de Pernambuco (UFPE), Recife, PE (Brazil). Dept. de Ciencias Farmaceuticas; Lima, Maria do Carmo Alves de; Galdino, Suely Lins; Pitta, Ivan da Rocha [Universidade Federal de Pernambuco (UFPE), Recife, PE (Brazil). Dept. de Antibioticos

    2008-07-01

    Hydantoin (imidazolidine-2,4-dione) is a 2,4-diketotetrahydroimidazole discovered by Baeyer in 1861. Thiohydantoins and derivatives were prepared, having chemical properties similar to the corresponding carbonyl compounds. Some biological activities (antimicrobial, anticonvulsant, schistosomicidal) are attributed to the chemical reactivity and consequent affinity of hydantoinic rings towards biomacromolecules. Therefore, knowledge about the chemistry of hydantoins has increased enormously. In this review, we present important aspects such as reactivity of hydantoins, acidity of hydantoins, spectroscopy and crystallographic properties, and biological activities of hydantoin and its derivatives. (author)

  17. Isolamento, caratterizzazione strutturale e valutazione dell'attività biologica di metaboliti secondari di origine vegetale

    OpenAIRE

    Incollingo, Filomena

    2011-01-01

    La tematica di ricerca di questo dottorato si inserisce nell’ambito della chimica delle sostanze naturali. In particolare l’attenzione si è soffermata alle piante officinali e alle piante impiegate nella medicina popolare e alla purificazione e all’isolamento dei metaboliti secondari presenti in maggiore quantità attraverso tecniche cromatografiche quali: cromatografia su colonna, cromatografia su strato sottile, HPLC (high pressure liquid chromatography), DCCC (cromatografia liquida in cont...

  18. SISTEMA DE APRENDIZAJE COLABORATIVO BASADO EN INFRAESTRUCTURA GRID (SACGRID): APLICACIONES EN CIENCIAS BIOLOGICAS Y BIOTECNOLOGIA

    OpenAIRE

    ROSENBLAT GUELFENBEIN, PABLO

    2013-01-01

    Xentinelas Xelulares es un video juego que transporta al jugador a la realidad del Sistema Inmune, de una forma innovadora y entretenida, develando cómo funciona este intrincado sistema de protección de nuestro organismo. Luego que el estudiante construye sus propias bacterias a partir componentes básicos, éstas invaden el cuerpo a través de una herida en el pie. de manera implacable, se replican geométricamente y de cada división surgen dos nuevas bacterias temiblemente iguales q...

  19. Contribution of radio-iodine 131 in the treatment of Grave's Basedow disease in the department of nuclear medicine of Ibn Sina Hospital in Rabat; Apport de l'iode 131 dans le traitement de la maladie de Basedow dans le service de medecine nucleaire de l'hopital Ibn Sina de Rabat

    Energy Technology Data Exchange (ETDEWEB)

    Mbodj, M.; Amjad, I. [Faculte de Medecine de Dakar, Lab. de Biophysique et de Medecine Nucleaire, UCAD, Dakar (Senegal); Guerrouj, H.; Ben Rais, N.A. [Hopital Ibn Sina de Rabat, Service de Medecine Nucleaire, Rabat (Morocco)

    2009-10-15

    One hundred and twenty-nine Grave's Basedow diseases in any gender and variable age patients, coming from several cities of Morocco, were randomized in a study of radio-iodine treatment who took place at the nuclear medicine department of Ibn Sina Hospital (Rabat, Morocco) during the period (from January 2001 to December 2008). The radio-iodine treatment was a first, second or third option and radio-iodine activities delivered varied (from 222 to 555 MBq 6 to 15 mCi) according to the age, the thyroid volume, the degree of hyperthyroidism and socio-economical situation. The high amounts of {sup 131}I were reserved especially to the patients who live far and whose socio-economic level is low with an aim of quickly obtaining an easily controllable state of hypothyroidism by a substitute treatment. The results showed that: (1) 57.36% of patients reverted to euthyroidism (n = 74) with a patient having received two {sup 131}I cures. The second cure was justified by recurrence of hyperthyroidism after the first cure; (2) 34.88% passed in hypothyroidism (n = 45) with three patients having received two cures of {sup 131}I, the second cure was justified by recurrence of hyperthyroidism after the first cure in two patients and by the persistence of the hyperthyroidism after the first cure for the third patient. The average time of passage in hypothyroidism was 4.5 months; (3) 7.76% had remained in hyperthyroidism after the radioactive iodine treatment. Finally, 92.24% of our patients treated by radioactive iodine had passed in euthyroidism or hypothyroidism against 7.76% whose hyperthyroidism had persisted or occurred. (authors)

  20. Possibilities of long duration generation of vapour of iodine 131 in the air for its trapping in French activated carbons; Possibilites de generation de longue duree dans l'air de vapeur d'iode 131 en vue de son piegeage par les charbons actifs francais

    Energy Technology Data Exchange (ETDEWEB)

    Billard, F.; Chevalier, G.; Pradel, J.

    1962-12-17

    As previous studies performed on activated carbon showed that it was necessary to possess a long duration iodine generator to determine the scope of application of some advanced theories concerning the trap mechanism of different forms of radio-iodines, the authors present a generator which uses the high temperature oxidation of sodium iodide by an air stream or an oxygen stream. A version of this apparatus using a 5 Curie source is planned to check the operation of a trap of 100.000 m{sup 3}/h with a purification coefficient of 10{sup 4}, and aimed at being mounted on the venting circuit of a nuclear reactor enclosure [French] Les etudes que nous avons effectuees sur les charbons actifs nous ont montre qu'il etait necessaire de posseder un generateur d'iode de longue duree pour preciser le domaine d'application de certaines theories avancees concernant le mecanisme de piegeage des differentes formes de radioiodes. Un generateur utilisant l'oxydation de l'iodure de sodium a chaud par un courant d'air ou d'oxygene est decrit. Une version de cet appareil utilisant une source de 5 curies est prevue pour verifier le bon fonctionnement d'un piege de 100.000 m{sup 3}/h ayant un coefficient d'epuration de 10{sup 4} est destine a etre place sur le circuit de ventilation de l'enceinte d'un reacteur nucleaire. (auteurs)

  1. Preliminary study of the distribution of dose in patients with Graves' disease undergoing examination of uptake of iodine-131 using Monte Carlo simulation; Estudo preliminar da distribuicao de dose em pacientes com doenca de Graves submetidos a exame de captacao de iodo-131 utilizando simulacao Monte Carlo

    Energy Technology Data Exchange (ETDEWEB)

    Schwarcke, Marcelo; Marques, Tatiana; Nicolucci, Patricia; Baffa, Oswaldo, E-mail: mschwarcke@usp.b [Universidade de Sao Paulo (FFCLRP/USP), Ribeirao Preto, SP (Brazil). Faculdade de Filosofia, Ciencias e Letras. Dept. de Fisica e Matematica; Bornemann, Clarissa [Hospital de Caridade Astrogildo de Azevedo, Santa Maria, RS (Brazil). Servico de Medicina Nuclear de Santa Maria

    2010-06-15

    Patients with Graves disease have a high hormonal disorder, which causes behavioral changes. One way to treat this disease is the use of high doses of {sup 131} Iodine, requiring that the patient carries out the examination of {sup 131}I uptake to estimate the activity to be administered. Using these data capture and compared with the simulated data using the Monte Carlo code PENELOPE is possible to determine a distribution of dose to the region surrounding the thyroid. As noted the difference between the simulated values and the experimentally obtained were 10.36%, thus showing the code of simulation for accurate determination of absorbed dose in tissue near the thyroid. (author)

  2. Evaluation of Iodine-131 dispersion after accident in Nuclear Angra Power Plant using the model of aquatic dispersion, SisBahia; Avaliacao da dispersao de iodo-131 apos um acidente na usina de Angra utilizando o modelo de dispersao aquatica, SisBahia

    Energy Technology Data Exchange (ETDEWEB)

    Aguiar, Andre Silva de; Alvim, Antonio Carlos Marques, E-mail: aguiargm@gmail.com, E-mail: aalvim@gmail.com [Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ (Brazil). Centro de Tecnologia; Simoes Filho, Francisco Fernando Lamego, E-mail: flamego@ien.gov.br [Instituto de Engenharia Nuclear (IEN/CNEN-RJ), Rio de Janeiro, RJ (Brazil)

    2014-07-01

    It was inserted, in the cooling system of the nucleus, a LOCA, where 431 m{sup 3} of coolant was lost. Such an inventory contained 3,04 x 10{sup 10} Bq / m{sup 3} and iodine was released near the beach Itaorna, Angra dos Reis - RJ. Applying the model in the proposed scenario (Angra 1 and Angra 2 in operation and 3 in with varying capture and discharge with the discharge gradually reduced after the accident), the dilution of the specific activity of radionuclides reached lower values after 22 hours, the reference levels for seawater {sup 131}I (7,40 x 10{sup 2} Bq / m{sup 3}). After 54 hours, levels of the radionuclide, in the area of indirect influence, are already below minimum activity values detected by the laboratory for environmental monitoring of the CNAAA (5,0 x 10{sup 1} Bq / m{sup 3}.

  3. E1B-attenuated onco lytic adenovirus enhances antitumor effect of radionuclide therapy by P53-independent way: cellular basic for radionuclide-viral therapy

    Energy Technology Data Exchange (ETDEWEB)

    Zhenwei, Zhang [Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (China); Shanghai Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai (China); Hua, Wu; Xuemei, Zhang [Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan (China); Xinyuan, Liu [Shanghai Institute of Biochemistry and Cell Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai (China)

    2004-07-01

    Purpose: Chemotherapy or external radiation therapy can potentiate the therapeutic effect of E1 B-attenuated oncolytic adenovirus. In this study, the antitumor efficacy of oncolytic adenovirus combined with internal radionuclide therapy was evaluated. Methods: Firstly, viral replication was examined by plaque assay and Southern blotting, after oncolytic adenovirus, ZD55, was exposed to iodine-131. Cell viability was evaluated qualitatively by crystal violet staining and quantitatively by MTT assay. FACS analysis was performed to determine the synergic proapoptotic effect of iodine-131 combined with ZD55. Results: Irradiation of iodine-131 does not influence ZD55 viral DNA replication. In combination with ZD55, iodine-131 can efficiently kill tumor cells in a p53-independent model. ZD55 augments the proapoptotic effect of iodine-131. Conclusion: Radionuclide-viral therapy might be a novel tool for treatment of hepatocarcinoma. (authors)

  4. Biologic fixation of nitrogen in irradiated rhizobium strips; Fixacao biologica do nitrogenio em estirpes de rizobianas irradiadas

    Energy Technology Data Exchange (ETDEWEB)

    Caribe, Rebeka Alves; Colaco, Waldeciro [Pernambuco Univ., Recife, PE (Brazil). Dept. de Energia Nuclear

    2002-07-01

    Native Rhizobium sp. and Bradyrhizobium sp. isolates from the root nodules of bean and cowpea were selected. Six isolates, and the SEMIA 4077 (R. leguminosarum bv. phaseolus) and SEMIA 6145 (Bradyrhizobium sp) strains used as references, were irradiated with ultraviolet light (R-uv) and gamma rays (R-{gamma}). The D{sub 37} values for the rhizobial strain SEMIA 4077 were 43 J.m{sup -2} (UV) and 32 Gy (R-{gamma}) and for the SEMIA 6145 were 45 J.m{sup -2} (UV) and 35 Gy (R-gamma). Through a greenhouse experiment the irradiated isolates were inoculated on bean (P. vulgaris L., cv. Princesa) and on cowpea [Vigna unguiculata, (L.) Walp, cv. IPA-206] seedlings, in an attempt to evaluate the sensitivity of the host plants, and possible effects on their nodulation. Differences in responses to nodulation due to the effect of irradiation were observed for the isolates tested. Significantly differences were observed only for nodules dry matter yield of the IPA-206 cultivar. Gamma irradiated treatment were statistically superior to treatments with ultraviolet light in relation. (author)

  5. Biological quality of the waters of the river Barbana; Calidad biologica de las aguas del rio Barbana

    Energy Technology Data Exchange (ETDEWEB)

    Garrido Gonzalez, J.; Membiela Iglesia, P.; Vidal Lopez, M. [Universidad de Vigo (Spain)

    1998-07-01

    The results of a water quality study supported with physicochemical data in the Barbana stream (Galicia, NW Iberian Penninsula) are shown. 39 taxons have been captured and determined to evaluate the macro invertebrate community as a water quality indicator through the use of the BMWP` biotic index. The results show the variations in values at the different seasons of the year in a polluted stream, an forward conclusions about the significance of seasonality in water quality studies. (Author) 8 refs.

  6. Biological treatment in clarificated purines pilot plant; Depuracion biologica en plant piloto del clarificado de los purines

    Energy Technology Data Exchange (ETDEWEB)

    Bosque Hernandez, J. L. del; Martin Sanchez, J. L. [Universidad de Salamanca (Spain)

    2004-07-01

    With the purpose of eliminating the environmental problem that suppose the residuals, denominated. Purines, it is necessary to treat them so that they can take advantage. for it, in the part I of the work, the treatment that facilitates the operation of separation of the solid in suspension of the raw purin that allows to decrease the matter organic present in the liquid phase, settled down as well as, the increase of the power fertilizer in the solid phase. The part II of this investigation have as purpose the treatment of the phase it liquidates obtained previously to adapt it for their use like water of industrial type and the solid phase as fertilizer. (Author) 5 refs.

  7. Biological treatment of waste waters of high salt content; Depuracion biologica de efluentes con alto contenido salino

    Energy Technology Data Exchange (ETDEWEB)

    Perez, A.I.; Goytia, M.; Muguruza, I.; Blanco, F. [GAIKER, Zamudio (Spain)

    1996-09-01

    The fish canning industry, a national industrial sector of economical significance, generates high volumes of wastewater containing a high organic load and salt concentration. In addition to other problems presented for the aerobic biological treatment of these effluents, the presence of a high chloride concentration produces an inhibitory effect on the growth of aerobic microorganisms. In this work the inhibitory effect of chloride has been analyzed by means of a biokinetic study carried out using the electrolytic respirometry techniques and tuna boiling water as wastewater. This kind of study is highly appropriated for the search of solutions to specific problems created during the treatment of different industrial sectors wastewater. (Author) 10 refs.

  8. PROCESOS FOTOSENSIBILIZADOS MEDIADOS POR PRODUCTOS DE GLICACION AVANZADA. EFECTOS SOBRE SISTEMAS DE IMPORTANCIA BIOLOGICA EN EL LENTE OCULAR.

    OpenAIRE

    FUENTEALBA PATIÑO, DENIS ALBERTO; FUENTEALBA PATIÑO, DENIS ALBERTO

    2009-01-01

    La reacción no enzimática de proteínas con azúcares (glicación o reacción de Maillard), lleva a la formación de una gran variedad de compuestos denominados productos de glicación avanzada (AGEs) y su acumulación en sistemas biológicos está relacionada con 194p.

  9. 5. Conference cycle. The radiations and the Biological Sciences; 5. Ciclo de conferencias. Las radiaciones y las Ciencias Biologicas

    Energy Technology Data Exchange (ETDEWEB)

    Balcazar G, M.; Chavez B, A

    1991-06-15

    Nuclear technologies and their development have influenced many aspects of modern life. Besides used for electricity production nuclear technologies are applied in many other fields, especially in biological sciences. In genetics and molecular biology they enable research resulting in increased food production and better food preservation. Usage in material sciences lead to new varieties of plastics or improved characteristics. Nuclear applications are used in pe troleum industries and in forecasting geothermic power. Radiobiology and radiotherapy enable diagnosis and therapy of several diseases, e.g. cancer. Nuclear technologies also contribute to preserve the environment. They offer methods to analyse as well as decrease the environmental impacts. The 5. conference cyle entitled 'The Radiations and the Biological Sciences' aims to inform students of biological sciences about new nuclear technologies applied in their field of interest.

  10. Preparation methods, reactivity and biological importance of 4-thiazolidinones; Metodos de obtencao, reatividade e importancia biologica de 4-tiazolidinonas

    Energy Technology Data Exchange (ETDEWEB)

    Liesen, Andre P.; Aquino, Thiago M. de; Goes, Alexandre J.S. [Universidade Federal de Pernambuco (UFPE)e, PE (Brazil). Dept. de Antibioticos]. E-mail: ajsg@ufpe.br; Lima, Jose G. de; Faria, Antonio R. de; Alves, Antonio J. [Universidade Federal de Pernambuco (UFPE)e, PE (Brazil). Dept. de Ciencias Farmaceuticas

    2008-07-01

    Molecules containing the 4-thiazolidinone ring are known to possess a wide range of biological properties including antimicrobial and antiinflammatory activities among others. These compounds can be synthesized by cyclization reactions involving alpha-haloacetic acid or alpha-mercaptoacetic acid and employed in several chemoselective reactions. Comprehensive reviews have been written on 4-thiazolidinones in 1961 by Brown and in 1980 by Singh et al. In the recent literature, some new synthesis methods for 4-thiazolidinone derivatives and several reactions have been reported. These advances warrant to review the chemical and biological properties of compounds with this important heterocycle employed in synthetic organic chemistry and medicinal chemistry (author)

  11. Thiosemicarbazones: preparation methods, synthetic applications and biological importance; Tiossemicarbazonas: metodos de obtencao, aplicacoes sinteticas e importancia biologica

    Energy Technology Data Exchange (ETDEWEB)

    Tenorio, Romulo P.; Goes, Alexandre J.S. [Universidade Federal de Pernambuco, Recife, PE (Brazil). Dept. de Antibioticos]. E-mail: ajsg@ufpe.br; Lima, Jose G. de; Faria, Antonio R. de; Alves, Antonio J.; Aquino, Thiago M. de [Universidade Federal de Pernambuco, Recife, PE (Brazil). Dept. de Ciencias Farmaceuticas

    2005-11-15

    Thiosemicarbazones are a class of compounds known by their chemical and biological properties, such as antitumor, antibacterial, antiviral and antiprotozoal activity. Their ability to form chelates with metals has great importance in their biological activities. Their synthesis is very simple, versatile and clean, usually giving high yields. They are largely employed as intermediates, in the synthesis of others compounds. This article is a survey of some of these characteristics showing their great importance to organic and medicinal chemistry. (author)

  12. Persistência biologica de ametryn, diuron e oxyfluorfen no solo Biological persistence of ametryn, diuron, and oxyfluorfen in soil

    Directory of Open Access Journals (Sweden)

    Luis Antonio Peñaherrera-Colina

    2005-10-01

    Full Text Available Realizou-se este trabalho com o objetivo de avaliar a persistência biológica de herbicidas de pré-emergência em condições de casa-de-vegetação utilizando a aveia (Avena sativa L. como planta teste. O experimento foi instalado na Estação Experimental Boliche, Província de Guayas, Equador entre outubro e dezembro de 2002. O delineamento experimental foi de blocos ao acaso com quatro repetições, em esquema fatorial (3 x 4 x 4 + 1, envolvendo aplicações de três herbicidas (ametryn a 2,0 kg ha-1, diuron a 3,2 kg ha-1 e oxyfluorfen a 0,48 kg ha-1 no solo, mais uma testemunha sem aplicação de herbicida. Após as aplicações este foi amostrado em quatro profundidades (0-5, 5-10, 10-15 e 15-20 cm, em quatro épocas distintas (10, 20, 30 e 40 dias após aplicação. As amostras foram coletadas do campo utilizando-se cilindros de PVC. Nessas amostras cultivou-se aveia para as avaliações de persistência biológica dos produtos. Não se observaram efeitos dos tratamentos na germinação da aveia até os 40 dias após a aplicação (daa. Maior sintoma visual de fitotoxicidade e menor acúmulo de matéria seca total (MST, matéria seca da parte aérea (MAS e matéria seca da raiz (MSR foram observadas em plantas de aveia cultivadas em amostras de solo tratadas com diuron coletadas na camada de 0-5 cm aos 10, 20, 30 e 40 dias. A aveia mostrou alta sensibilidade aos herbicidas testados e desses produtos o diuron foi o que apresentou a maior persistência e a menor mobilidade no solo.This investigation had the objective of evaluating the biological persistence of pre-emergence herbicides under greenhouse conditions. Oat plants were used as test organisms. The experiment was established at Boliche Experiment Station, Província Guayas, Ecuador from October to December/2002. The experimental design was a randomized block, in a 3 x 4 x 4 + 1 factorial scheme, involving three herbicides (ametryn at 2.0 kg ha-1, diuron at 3.2 kg ha-1, and oxyfluorfen at 0.48 kg ha-1, plus a control. After herbicide applications soils were sampled in four different depths (0-5, 5-10, 10-15, and 15-20 cm at four dates (10, 20, 30, and 40 days after herbicide applications. Soil layers were colleted from field using PVC pipes, which were planted with 10 oat seeds. The herbicides did not promote oat seeds emergence reduction. Diuron at the 0-5 cm layer showed the highest visual symptoms of phytotoxicity and the lowest production of dry matter (total, shoots, and roots per oat plants at all sampling dates (10, 20, 30, and, 40 days after herbicide applications. Oat plants showed good sensitivity to the herbicide residues. Diuron was more persistent in the soil when compared with ametryn and oxyfluorfen.

  13. Molecular biology applications to infectious diseases diagnostic; Aplicaciones de la Biologica Molecular al diagnostico de enfermedades infecciosas

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2001-07-01

    This project goes directed to the applications of the techniques of molecular biology in hepatitis virus.A great advance of these techniques it allows its application to the diagnose molecular and it becomes indispensable to have these fundamental tools in the field of the Health Public for the detection precocious, pursuit of the treatment, the one predicts and the evolution of the patient hepatitis bearing virus technical.Use of molecular biology to increase the handling and the control of the patients with hepatitis B and C and to detect an adult numbers of positive cases by means of the training and integration of all the countries participating.Implement the technique of PCR to identify the virus of the hepatitis B and C,implement quantification methods and genotipification for these virus.

  14. 5. Conference cycle. The radiations and the Biological Sciences; 5. Ciclo de conferencias. Las radiaciones y las Ciencias Biologicas

    Energy Technology Data Exchange (ETDEWEB)

    Balcazar G, M; Chavez B, A

    1991-06-15

    Nuclear technologies and their development have influenced many aspects of modern life. Besides used for electricity production nuclear technologies are applied in many other fields, especially in biological sciences. In genetics and molecular biology they enable research resulting in increased food production and better food preservation. Usage in material sciences lead to new varieties of plastics or improved characteristics. Nuclear applications are used in pe troleum industries and in forecasting geothermic power. Radiobiology and radiotherapy enable diagnosis and therapy of several diseases, e.g. cancer. Nuclear technologies also contribute to preserve the environment. They offer methods to analyse as well as decrease the environmental impacts. The 5. conference cyle entitled 'The Radiations and the Biological Sciences' aims to inform students of biological sciences about new nuclear technologies applied in their field of interest.

  15. Preparation and dosimetry of radiotherapeutic particles for arthropaties; Preparacion y dosimetria de particulas radioterapeuticas para artropatias

    Energy Technology Data Exchange (ETDEWEB)

    Gonzalez Z, M A [Departamento de Medicina Nuclear, Instituto Nacional de Pediatria (Mexico); Ferro F, G [Departamento de Materiales Radiactivos, Instituto nacional de Investigaciones Nucleares, Salazar, Estado de Mexico C.P. 52045 (Mexico); Rivera M, T; Azorin N, J [Departamento de Fisica, UAM Iztapalapa, Mexico D.F. (Mexico)

    1999-07-01

    It was developed a new formulation of macro aggregates of Samarium 153 ({sup 153} Sm-MH) for the arthropaties treatment. The radio pharmaceutic was prepared by reaction of Samarium 153 chloride (SmCl{sub 3}) in aqueous environment with sodium boron hydride in NaOH 0.5 N. The microscopic analysis shown that the particles have an average size of 4% m (range 1-14 {mu} m). The velocity of sedimentation was 0.008 cm/min with high stability in vitro in human serum. The biological studies in healthy rabbits, shown that the complex is retained inside the articulation still eight days after of the administration of the radiopharmaceutical. Likewise, it is presented the data of absorbed dose in the different target organs, which was determined by thermoluminescent dosimetry (TLD) through the use of a REMCAL phantom (radiation equivalent manikin calibration). (Author)

  16. Implementation of an alanine dosimetry service; Puesta en marcha de un servicio de dosimetria de alanima

    Energy Technology Data Exchange (ETDEWEB)

    Gago Arias, A.; Nunez Pelaez, N.; Peteiro Vilaseco, E.; Gomez Rodriguez, F.; Gonzalez Castano, D. M.

    2011-07-01

    This work facing the implementation of an alanine dosimetry service, linked to the installation of Co{sub 6}0 Radio physics Laboratory (LP) and Paramagnetic Resonance Service of the University of Santiago de Compostela (USC).

  17. Update Dosimetry Service internal staff Tecnatom; Actualizacion del servicio de dosimetria personal interna de TECNATOM

    Energy Technology Data Exchange (ETDEWEB)

    Bravo, B.; Marchena, P.; Alonso, A.; Navarro, E.; Serrano, E.

    2010-07-01

    The beginning of decommissioning of nuclear facilities and other industrial national context conditions have been a very significant increase in the need for such services, which have been almost overwhelmed by the demand. To provide a solution to this situation, Tecnatom decided to run as a new internal dosimetry service indirect measures to complement its renowned capabilities of direct measures. To perform this task, Tecnatom has signed a collaboration agreement with the Laboratory of Radiochemistry of Geocisa, all with the objective of characterizing contamination by alpha emitters or beta different analytical techniques.

  18. State of the art of solid state dosimetry; Estado da arte em dosimetria do estado solido

    Energy Technology Data Exchange (ETDEWEB)

    Souza, Susana O., E-mail: sosouza@ufs.br [Universidade Federal de Sergipe (UFS), Sao Cristovao, SE (Brazil); Yamamoto, Takayoshi [Radioisotope Research Center, Osaka University (Japan); D' Errico, Francesco, E-mail: francesco.derrico@yale.edu [Yale University, School of Medicine, CT (United States)

    2014-07-01

    Passive solid-state detectors still dominate the personal dosimetry field. This article provides state of the art in this field and summarizes the most recent works presented on TL, OSL and RPL during the 17th International Conference on Solid State Dosimetry held in Recife in September 2013. The Article contains in particular the techniques Thermoluminescence (TL), Optically Stimulated Luminescence (OSL), radio photoluminescence (RPL). Thermoluminescence has the biggest advantage of the wide availability of commercial materials for dosimetry, and the nature tissue-equivalent of several of these materials. The limitation of the TL dosimetry presents fading luminance signal and the need for high temperatures to obtain the signal. The Optically Stimulated Luminescence has the advantages of high sensitivity, the possibility of multiple reading, while its limit is the need to use response compensating filters in addition to the high cost of equipment and dosimeters still restricted very few options trading . The radio photoluminescence has a reading that is completely non-destructive, but their dosimeters present lack of tissue-equivalent and a high cost. Presents the details of the techniques and the advantages and limitations of each of these will be discussed.

  19. Design of a system for neutrons dosimetry; Diseno de un sistema para dosimetria de neutrones

    Energy Technology Data Exchange (ETDEWEB)

    Ceron, P.; Rivera, T. [IPN, Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Legaria No. 694, Col. Irrigacion, 11500 Mexico D. F. (Mexico); Paredes G, L. [ININ, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico); Azorin, J. [Universidad Autonoma Metropolitana, Unidad Iztapalapa, San Rafael Atlixco 186, Col. Vicentina, 09340 Mexico D. F. (Mexico); Sanchez, A. [IPN, Escuela Superior de Fisica y Matematicas, Av. Instituto Politecnico Nacional s/n, Col. San Pedro Zacatenco, 07738 Mexico D. F. (Mexico); Vega C, H. R., E-mail: victceronr@hotmail.com [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas (Mexico)

    2014-08-15

    At the present time diverse systems of detection of neutrons exist, as proportional counters based on BF{sub 3}, He{sub 3} and spectrometers of Bonner spheres. However, the cost and the complexity of the implementation of these systems put them far from the reach for dosimetric purposes. For these reasons a system of neutrons detection composed by a medium paraffin moderator that forms a 4π (spheres) arrangement and of several couples of thermoluminescent dosimeters TLD 600/TLD 700. The response of the system presents a minor repeatability to 5% in several assays when being irradiated with a {sup 239}PuBe source and a deviation of 13.8% in the Tl readings of four different spheres. The calibration factor of the system with regard to the neutrons source which was of 56.2 p Sv/nc also was calculated. These detectors will be used as passive monitors of photoneutrons in a radiotherapy room with lineal accelerator of high energy. (Author)

  20. Dosimetry with slow films in Interventional Radiology; Dosimetria con peliculas lentas en Radiologia Intervencionista

    Energy Technology Data Exchange (ETDEWEB)

    Ten, J.I.; Guibelalde, E.; Fernandez, J.M.; Canevaro, L.; Ramirez, R.; Vano, E. [Grupo de Fisica Medica. Departamento de Radiologia. Facultad de Medicina. Universidad Complutense de Madrid. Martin Lagos s/n CP 28040, Madrid (Spain)

    1998-12-31

    In this work it is presented a method for evaluation of patients doses in Interventional Radiology (RI). The method proposed in this work allows the simultaneous valoration of the product dose-area (PDA), the dose in the patient skin (DES) and the distribution of the irradiated fields, all of they together with their corresponding dose levels. The latter sometimes can be essential since the possible damages in skin depend not only of the doses, but also the irradiated area. The method has been resulted adequate for to evaluate doses to patients in Interventional Radiology procedures. It was possible to apply it as a routine form seeing that its not interfering significantly in the normal development of the medical intervention. The fundamental advantages of this dosimetric method in relation with the unique PDA measure or with the utilization of TLD is that it provide information about the total irradiated area, distribution and length of fields, collimation and wedge used besides that allow to determine the most irradiated zone. The visualization of the irradiated regions and the length fields utilized suggest the possibility to optimize the realization protocols of the interventional procedure in the cases in which it is considered that the doses have been very elevated. (Author)

  1. Advances in electron dosimetry of irregular fields; Avances en dosimetria de electrones de campos irregulares

    Energy Technology Data Exchange (ETDEWEB)

    Mendez V, J. [Departamento de Radioterapia, Instituto de Enfermedades Neoplasicas, Avenida Angamos Este 2520, Lima 34 (Peru)

    1998-12-31

    In this work it is presented an advance in Electron dosimetry of irregular fields for beams emitted by linear accelerators. At present diverse methods exist which are coming to apply in the Radiotherapy centers. In this work it is proposed a method for irregular fields dosimetry. It will be allow to calculate the dose rate absorbed required for evaluating the time for the treatment of cancer patients. Utilizing the results obtained by the dosimetric system, it has been possible to prove the validity of the method describe for 12 MeV energy and for square field 7.5 x 7.5 cm{sup 2} with percentile error less than 1 % . (Author)

  2. Thermoluminescent dosimetry in computed tomography for pediatric patients; Dosimetria termoluminiscente en tomografia computada para pacientes pediatricos

    Energy Technology Data Exchange (ETDEWEB)

    Medrano S, A. C.; Medina A, O.; Hidalgo T, S.; Azorin N, J., E-mail: alicesar1993@hotmail.com [Universidad Autonoma Metropolitana, Unidad Iztapalapa, Av. San Rafael Atlixco 186, Col. Vicentina, 09340 Mexico D. F. (Mexico)

    2015-10-15

    Computed tomography (CT) in conjunction with interventional radiology, is considered as high-dose radiological procedure, so the optimization of the dose is necessary. Exposure to ionizing radiation in pediatric CT is of particular interest because the children are up to 10 times more sensitive to radiation than adults, the late somatic and genetic effects of radiation. The exposure and risk associated with ionizing radiation in CT is best characterized by the absorbed dose to each organ. Thermoluminescent dosimeters of LiF: Mg, Ti are best suited for this purpose due to its characteristics such as high sensitivity, small size and its equivalence with the tissue. The results of dose measurements -in vivo- to the three types of CT studies (skull, thorax and abdomen) are presented. These results indicate that lower doses were obtained in skull study, while the highest was one of abdomen. (Author)

  3. Dosimetry of ionizing radiations by Electron paramagnetic resonance; Dosimetria de radiaciones ionizantes por resonancia paramagnetica electronica

    Energy Technology Data Exchange (ETDEWEB)

    Azorin N, J [UAM-I, Av. San Rafael Atlixco 186, 09340 Mexico D.F. (Mexico)

    2005-07-01

    In this work, some historical and theoretical aspects about the Electron Paramagnetic Resonance (EPR), its characteristics, the resonance detection, the paramagnetic species, the radiation effects on inorganic and organic materials, the diagrams of the instrumentation for the EPR detection, the performance of an EPR spectrometer, the coherence among EPR and dosimetry and, practical applications as well as in the food science there are presented. (Author)

  4. Improvements in the Tl dosimetry for Radiotherapy; Mejoras en la dosimetria Tl para Radioterapia

    Energy Technology Data Exchange (ETDEWEB)

    Bustos, S.; Velez, G.; Rubio, M. [CEPROCOR. Arenales 230 Juniors Cordoba 5000 (Argentina)

    1998-12-31

    The thermoluminescent dosimetry (TLD) in vivo has been demonstrated to be one of the most reliable for the control of radiotherapeutic treatments, but the delay in the response is the main disadvantage in its applicability. In this work are presented important improvements and it is demonstrated that maintaining the accuracy and reliability of the technique, it is possible to accelerate the response times at a few hours. To realize this work is utilized a lecturer Harshaw 4000, dosemeters LiF-TLD-100 chips (3.1 x 3.1 x 0.89 mm{sup 3}) and rods (1 x 1 x 6 mm{sup 3}). With the implementation of a glow curve analysis program developed in CIEMAT, its obtained a Tl peaks separation in such manner rapid and accurate, by that the thermal treatment of dosemeters may be reduced at one unique annealing pre-irradiation for 1 hr at 400 Centigrade. It is realized a periodical and individual calibration of the TLD and a study of the factors which influencing the ratio Tl signal-dose as linearity, correction by energy, directional response and pride of Tl signal. the results of this study are introducing in a calculation list specially designed and which allows to obtain absorbed dose by TLD starting of the dates (dosimetric peaks area) which appear of the glow curves analysis. The dose is obtained with an accuracy less than 5 %. The dosemeters already irradiated (in vivo) are analysed and informed in only four hours, allowing a greater control of the treatment and a correction of the possible errors for the next session, still in bi fractional treatments. The method implemented results thus accurate, rapid and reliable. (Author)

  5. Thermoluminescent dosimetry in fluoroscopy of pediatric patients; Dosimetria termoluminiscente en fluoroscopia de pacientes pediatricos

    Energy Technology Data Exchange (ETDEWEB)

    Garcia V, E.; Azorin N, J. [Universidad Autonoma Metropolitana, Unidad Iztapalapa, Departamento de Fisica, San Rafael Atlixco 186, Col. Vicentina, 09340 Ciudad de Mexico (Mexico); Hidalgo T, S.; Dies S, P., E-mail: azorin@xanum.uam.mx [Hospital Infantil de Mexico Federico Gomez, Dr. Marquez 162, Col. Doctores, 06720 Ciudad de Mexico (Mexico)

    2016-10-15

    The use of thermoluminescent dosimeters in the area of medical physics and especially in radiology is of paramount importance to guarantee the quality of a particular study, which for this reason the need to verify by means of measurements of peripheral dose in studies of esophagogastroduodenal series by fluoroscopy using TLD of LiF:Mg, Ti. For this the necessary measurements were carried out directly in patients of the Children s Hospital of Mexico Federico Gomez. Previously characterized the dosimeters were used the graphs of the linear equation to obtain the absorbed dose of each dosimeter and was found that the values of the absorbed dose in each patient changes for various reasons like the anatomy, thickness of the tissues, age and exposure time during the study and was verify that none of the studies performed on patients exceeded dose levels that could affect healthy organs. (Author)

  6. Internal dosimetry in nuclear medicine procedures; Dosimetria interna por procedimientos en medicina nuclear

    Energy Technology Data Exchange (ETDEWEB)

    Carrera Magarino, F.; Salgado Garcia, C.; Ruiz Manzano, P.; Rivas Ballarin, M. A.; Jimenez Hefernan, A.; Sanchez Segovia, J.

    2011-07-01

    The Department of Radio Physics and Radiation Protection, University Hospital Lozano Blesa Zaragoza presented a calculus textbook to estimate patient doses in diagnostic nuclear medicine. In this paper present an updated version referred Book of calculation.

  7. Course on internal dosimetry in nuclear medicine; Curso de dosimetria interna en medicina nuclear

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2004-07-01

    This documentation was distributed to the participants in the Course of Internal Dosimetry in Nuclear Medicine organised by the Nuclear Regulatory Authority (ARN) of Argentina and held in Buenos Aires, Argentina, August 9-13, 2004. The course was intended for people from IAEA Member States in the Latin American and Caribbean region, and for professionals and workers in medicine, related with the radiation protection. Spanish and English were the languages of the course. The following subjects were covered: radioprotection of the patient in nuclear medicine; injuries by ionizing radiations; MIRD methodology; radiation dose assessment in nuclear medicine; small scale and microdosimetry; bone and marrow dose modelling; medical internal dose calculations; SPECT and image reconstruction; principles of the gamma camera; scattering and attenuation correction in SPECT; tomography in nuclear medicine.

  8. Personnel thermoluminescent dosimetry of plane pilots; Dosimetria personal termoluminiscente de pilotos aviadores

    Energy Technology Data Exchange (ETDEWEB)

    Azorin V, J.C. [Universidad Nacional Autonoma de Mexico, Facultad de Ciencias, 04510 Mexico D.F. (Mexico); Rivera M, T. [Universidad Autonoma Metropolitana Iztapalapa, Departamento de Fisica, 09340 Mexico D.F. (Mexico); Azorin N, J. [Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, IPN, 11500 Mexico D.F. (Mexico)

    1999-07-01

    In this work are presented the results of the research realized in the pilots of commercial planes of the different flight equipment existing. The results obtained show that the pilots receive during their work, doses of ionizing radiation greater than the limit recommended by the International Commission of Radiological Protection. (Author)

  9. Retrospective dosimetry of nail by Electron Paramagnetic Resonance; Dosimetria retrospectiva de unha por Ressonancia Paramagnetica Eletronica

    Energy Technology Data Exchange (ETDEWEB)

    Giannoni, Ricardo A., E-mail: giannoni@ird.gov.br [Instituto de Radioprotecao e Dosimetria (IRD/CNEN-RJ), Rio de Janeiro, RJ (Brazil); Rodrigues Junior, Orlando, E-mail: rodrijr@ipen.br [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil)

    2015-07-01

    The purpose of this study is to characterize samples of human nails, subjected to irradiation of high doses through Technical Electron Paramagnetic Resonance (EPR). The goal is to establish a dose/response relationship in order to assess dose levels absorbed by individuals exposed in radiation accidents situations, retrospectively. Samples of human nails were irradiated with gamma radiation, and received a dose of 20 Gy. EPR measurements performed on samples before irradiation identified EPR signals associated with defects caused by the mechanical action of the sample collection. After irradiation other species of free radicals, associated with the action of gamma radiation, have been identified.

  10. Thermoluminescent dosemeter in a X-ray diffractometer; Dosimetria termoluminiscente en un difractometro de rayos X

    Energy Technology Data Exchange (ETDEWEB)

    Mendoza A, D.; Gonzalez M, P.; Falcon B, T. [Instituto Nacional de Investigaciones Nucleares, A.P. 18-1027, Mexico D.F. (Mexico); Castano, V.M. [Instituto de Fisica, UNAM, Laboratorio Juriquilla, A.P. 1-1010, C.P. 76001, Queretaro (Mexico)

    1999-07-01

    In this work it was presented the results obtained of the dosimetry which was realized in a X-ray diffractometer for powders, trademark Siemens D5000, using the thermoluminescent signal generated by the X-rays in the commercial dosemeter TLD-100 of Harshaw, US. In according to the results obtained, the radiation quantity received by an analysed material in the diffractometer, will be proportional to exposure time and it can vary from unities until tenths of grays. These results are very outstanding when are analysed crystalline materials in a diffractometer, for knowing the present crystalline phases, mainly if these are highly sensitive to the ionizing radiation, as it is the case of the thermoluminescent materials. (Author)

  11. Answer to request on the ININ internal dosimetry; Respuesta a encuesta sobre dosimetria interna del ININ

    Energy Technology Data Exchange (ETDEWEB)

    Alfaro L, M.M. [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico)

    1999-05-15

    In this report it is presented the reply to CNSNS asking for information about the methodology for the evaluation of the occupational dose due to internal contamination. The characteristics of the installation, type and dimensions of the shield room, construction materials, type of detecting, calibration geometries, type of used phantom, intervals of energy of the calibration, type of routine measurements, detection limit for Cs-137 and Co-60, code to carry out the analysis of the spectra, evaluation of the measurement data, whole body system type armchair with anthropomorphic phantom, whole body system of vertical scanning, distribution and location diagram of the internal dosimetry laboratory there are among the treated aspects. (Author.

  12. Dosimetry of a Cesium 137 source; Dosimetria de una fuente de Cesio 137

    Energy Technology Data Exchange (ETDEWEB)

    Torres R, J.G.; Manzanares A, E.; Vega C, H.R. [Unidades Academicas de Estudios Nucleares, Universidad de Zacatecas (Mexico)

    2005-07-01

    It was carried out a dosimetric study of a source of Cesium 137 used in investigations of Radiobiology. This radionuclide has a half life of 30.07 years and it emits photons of 661.657 keV with a probability of 85.2%. The source has been used in a series of experiments trending to observe the cellular response before the gamma rays, as well as for the calibration of equipment of radiological protection. For such reason it is important to determine the dosimetric properties. In this work it was determined the absorbed dose that this source takes when being placed in the center from a methylmethacrylate badge to three distances, 5, 10 and 15 cm. The dose was measured with thermoluminescent dosemeters and it was calculated by means of Monte Carlo method, also was derived an expression that allows to determine the dose starting from the information of the activity of the source and of the distance regarding the same one. (Author)

  13. Management of patient with hepatocellular carcinomas by in situ injection of iodine-131 labelled lipiodol solution (Lipiocis) in the Biophysics and Timone APHM University Hospital Central Service; Prise en charge des patients atteints d'hepatocarcinome par injection in situ d'une solution de lipiodol radiomarque a l'iode 131 (Lipiocis) au sein du service central de biophysique et de medecine nucleaire du CHU Timone APHM

    Energy Technology Data Exchange (ETDEWEB)

    Sigrist, S

    2008-07-01

    The aim of this work was to determine what are the prognosis factors in term of global expectation of life at patient receiving a treatment by Lipiocis, to estimate the tolerance at this treatment in order to choose patient which will be the best candidates to this treatment and to define more precisely the criteria of patient inclusion and follow-up. A study including 35 patient having received one or several Lipiocis injections between May 2003 and May 2007 has been carried out. The results of this study are given. Lipiocis seems to be a well tolerated treatment which has proved its efficiency. (O.M.)

  14. Radiation protection - radionuclides - Synthesis sheets: Thorium-232 (ED 4317), Gallium-67 (ED 4314), Indium-111 (ED 4315), Chromium-51 (ED 4313), Thallium-201 (ED 4312), Phosphorus-33 (ED 4316), Fluorine- 18 (ED 4311), Yttrium-90 (ED 4310), Americium-241 (ED 4308), Strontium-90 (ED 4309), Sulfur-35 (ED 4307), Iodine-125 (ED 4306), Phosphorus-32 (ED 4305), Iodine-123 (ED 4304), Tritium (ED 4303), Carbon-14 (ED 4302), Technetium-99m (ED 4301), Iodine-131 (ED 4300)

    International Nuclear Information System (INIS)

    Deligne, Jean-Michel; Sert, Gilles; Rannou, Alain; Vidal, Jean-Pierre; Aubert, Bernard; Despres, Alain; Donadille, Laurent; Biau, Alain; Pihet, Pascal; Vial, Eric; Gambini, Denis-Jean; Gauron, Christine; Servent, Jean-Pierre; Moureaux, Patrick; Girod, Michel; Ammerich, Marc; Herbelet, Gilbert; Lahaye, Thierry; Le Dirac'h, Bertrand; Le Guen, Bernard; Manin, Jean-Pierre; Roussille, Francoise; Frot, Patricia

    2013-12-01

    For each radionuclide, this document presents its characteristics (origin, radio-physical properties, biological properties), gives an overview of its uses, indicates and discusses its dosimetric parameters (for internal or external exposure), indicates radiation detection and contamination measurement techniques, gives an overview of means of protection (for premises, against external or internal exposure), describes the delimitation and control of premises, describes aspects related to personnel classification, training and medical monitoring, comments the issue of effluents and wastes, indicates administrative procedures related to the authorization and declaration of possession and use of sealed and unsealed sources, addresses the issue of transport, and describes what is to be done in case of incident or accident

  15. Gamma-scintigraphy

    International Nuclear Information System (INIS)

    Desgrez, H.A.

    1960-06-01

    Gamma-scintigraphy is a medical technique making it possible to fix the image of certain organs after the concentration in these of emitting radioactive products. It is already widely used in the case of the thyroid gland with iodine-132 by applying the isotope iodine 131. The study of the liver and gall bladder is carried out using colloidal gold 198 and Bengal pink marked with iodine 131. Serum albumin marked with iodine 131 makes it possible to study rachidian blockages. Other applications can already be foreseen in this direction. (author) [fr

  16. Biochemical changes in blood caused by radioisotopes

    International Nuclear Information System (INIS)

    Zapol'skaya, N.A.; Fedorova, A.V.

    1975-01-01

    The changes were studied occurring in some biochemical indicators in blood at chronic peroral administration of strontium-90, cesium-137 and iodine-131 in amounts resulting in accumulation of commensurable doses in critical organs corresponding to each isotope

  17. Leucemia Mielóide Aguda t(8;21 após tratamento de hipertiroidismo com iodo radioativo: Leucemia secundária?

    Directory of Open Access Journals (Sweden)

    Bahia Daniella M.M.

    2002-01-01

    Full Text Available Acute leukemia following treatment with Iodine131 is a rare event. The possible carcinogenic effect of Iodine131 is still not clear and a large series of cases did not show an increased incidence of cancer. A case of AML t(8;21, three years after Iodine131 treatment for hyperthyroidism, is reported. Secondary AML with t(8;21 is described following exposure to drugs that target topoisomerase II and radiotherapy. The controversial potential of Iodine131 as a leukemogenic agent and the fact that t(8;21 is also found in de-novo AML, emphasize the problem in establishing a relationship between these events although this potential can not be ruled out.

  18. Disease: H00032 [KEGG MEDICUS

    Lifescience Database Archive (English)

    Full Text Available ] ... Radium-224 and its decay products [CPD:C16455] Radioiodines, short-lived isotopes, including iodine131, from atomic reactor accid...ents and nuclear Thyroglobulin [HSA:7038] [KO:K10809] So

  19. Leucemia Mielóide Aguda t(8;21 após tratamento de hipertiroidismo com iodo radioativo: Leucemia secundária?

    Directory of Open Access Journals (Sweden)

    Daniella M.M. Bahia

    2002-04-01

    Full Text Available Acute leukemia following treatment with Iodine131 is a rare event. The possible carcinogenic effect of Iodine131 is still not clear and a large series of cases did not show an increased incidence of cancer. A case of AML t(8;21, three years after Iodine131 treatment for hyperthyroidism, is reported. Secondary AML with t(8;21 is described following exposure to drugs that target topoisomerase II and radiotherapy. The controversial potential of Iodine131 as a leukemogenic agent and the fact that t(8;21 is also found in de-novo AML, emphasize the problem in establishing a relationship between these events although this potential can not be ruled out.

  20. Thyroid gland irradiations and thyroid cancers; Critical bibliographic journal; Irradiations de la thyroide et cancers thyroidiens. Revue bibliographique critique

    Energy Technology Data Exchange (ETDEWEB)

    Vitauxa, F. [CHI Le Raincy-Montfermeil, Faculte X. Bichat, Lab. de Biophysique, Service de Medecine Nucleaire, 93 - Le Raincy-Montfermeil (France)

    2007-07-15

    The large increase in the incidence of thyroid cancer among children who were mainly less than five years old at the time of the Chernobyl accident is still a major concern for endocrinologists and nuclear medicine physicians. Epidemiological studies have focused solely on iodine-131. However, past knowledge on thyroid irradiation (medical use of iodine-131, radioactive fallout on Marshall islands and the Nevada and Hanford site releases) as well as number of recent works (about low-dose irradiation) raise question on the role of other factors. It is here shown that post-Chernobyl thyroid irradiation is complex and that all factors (iodine-131, but also short lived isotopes of iodine and external irradiation) should be considered. Finally, one needs to think about some of the present medical uses of iodine-131 and especially to the treatment of hyperthyroidism in young subjects. (author)

  1. Working rules for medical application of radioactive substances

    International Nuclear Information System (INIS)

    Gloebel, B.

    1982-01-01

    After incorporation of radioactive substances radiation exposure is detectable only in case of iodine 125 and iodine 131. Organizational measures should improve the protection of personnel. According to the experience gained decontamination successes are possible between 1 and 99%, however they evade forecasting. With iodine 131 it is necessary to make for accelerated discharge resp. prevent further penetration from the extrathydroidal space into the thyroid gland. (DG) [de

  2. Years of experience in the diagnosis and treatment of thyroid cancer

    International Nuclear Information System (INIS)

    Yaker Valle, Isaac

    2004-01-01

    The objective is to demonstrate that the patients with thyroid cancer and metastases, in the long term have had a very good response to high radiation doses with iodine 131, since 1,5 Ci in the treatment, without having observed complications that should alter significantly the quality and quantity life. Also, to promote the initial use of more high doses of iodine 131 in those patients hospitalized with diagnosis of thyroid cancer

  3. Tests of some methods to remove I-131 from contaminated tap water

    International Nuclear Information System (INIS)

    Tagami, Keiko; Uchida, Shigeo

    2011-01-01

    Following the Fukushima Daiichi Nuclear Power Plant accident, iodine-131 concentrations in tap water higher than 100 Bq L"-"1 were reported by several local governments in the Kanto Plain in March 2011. To remove iodine-131 from tap water, five methods were tested in this study, that is, (1) boiling, (2) adding charcoals from oak or bamboo, (3) activated charcoals, (4) water purifiers, and (5) reverse osmosis (RO) treatments. Boiling was shown to be not effective in removing iodine-131 from tap water; indeed even higher concentrations may result from the liquid-volume reduction accompanying this process. Adding charcoals and activated charcoal treatment could not remove iodine-131, because no reduction of iodine-131 was observed in tap water samples after these treatments. Only limited effect was found with water purifiers with first several portions; no effect was expected with further water treatment. On the other hand, the RO showed high iodine-131 removal percentage of more than 95%, although the method needs about 5-10 L water to obtain 1 L of RO treated water. (author)

  4. Altering iodine metabolism in the calf by feeding iodine-binding agents

    International Nuclear Information System (INIS)

    Miller, J.K.; Swanson, E.W.; Lyke, W.A.; Byrne, W.F.

    1975-01-01

    Effects of feeding cottonseed meal and anion-exchange resin on iodine absorption and excretion by calves were investigated. Each additional amount of resin fed from 0.3 to 3.5 g/kg body weight further increased fecal excretion from single oral iodine-131 and intravenous iodine-125 doses. By feeding 3 to 10 g cottonseed meal/kg body weight, excretion of oral iodine-131 given daily was increased 7 to 94 percent in feces and reduced as much as 35 percent in urine, but plasma iodine-131 was not changed. Introducing 1 g resin/kg body weight daily into the diet increased fecal iodine-131 excretion three to five times that with cottonseed meal alone and reduced both plasma and urinary iodine-131. The same amount of resin fed daily had similar effects on excretion of iodine-131 injected subcutaneously each day. Although iodine depletion by a highly efficient iodine binder (resin) in the gastrointestinal tract is probable, iodine binding by a natural feed constituent (cottonseed meal) was relatively inefficient. (U.S.)

  5. Altering iodine metabolism in the calf by feeding iodine-binding agents

    International Nuclear Information System (INIS)

    Miller, J.K.; Swanson, E.W.; Lyke, W.A.; Byrne, W.F.

    1975-01-01

    Effects of feeding cottonseed meal and anion-exchange resin on iodine absorption and excretion by calves were investigated. Each additional amount of resin fed from 0.3 to 3.5 g/kg body weight further increased fecal excretion from single oral iodine-131 and intravenous iodine-125 doses. By feeding 3 to 10 g cottonseed meal/kg body weight, excretion of oral iodine-131 given daily was increased 7 to 94 percent in feces and reduced as much as 35 percent in urine, but plasma iodine-131 was not changed. Introducing 1 g resin/kg body weight daily into the diet increased fecal iodine-131 excretion three to five times that with cottonseed meal alone and reduced both plasma and urinary iodine-131. The same amount of resin fed daily had similar effects on excretion of iodine-131 injected subcutaneously each day. Although iodine depletion by a highly efficient iodine binder (resin) in the gastrointestinal tract is probable, iodine binding by a natural feed constituent (cottonseed meal) was relatively inefficient. (auth)

  6. Radiation protection review in nuclear medicine and analysis of new medical techniques. ACDOS-5-P-3 project. Final report, part 1

    International Nuclear Information System (INIS)

    Di Trano, Jose L.; Rojo, Ana M.; Kunst, Juan J.; Saule, Fabian A.; Ponce, Lujan E.; Fruttero, Nestor H.

    2002-01-01

    One of the more common radionuclide therapies performs by nuclear medicine departments is the administration of iodine 131 for thyroid ablation and for hyperthyroidism treatment. The revision of radiological protection was done on the occupational exposure of workers, member of the public and relatives of patients treated with iodine 131. This paper present the results from area and individual dosimetry to external exposure, surface activity and air concentration of iodine 131 carried out during the practice in the nuclear medicine department. An area survey in the isolation room allowed determined exposure rate surface activity and air concentration of iodine 131. The patients clothes was measured besides the activity excreted in urine and sweat. An instructive form for patients and relatives after iodine 131 treatment was proposed and the physicians with a clear explanation should give it. The international regulation aspect (USA, European Union, and some countries from South America) were reviewed and the wide range of criteria were analyzed mainly about the discharched of patients. An actual trend of taking into account the individual metabolic parameters and economic situation was discussed in the paper included: 'Patient specific dosimetry for radioprotection purpose in the thyroid cancer treatment with iodine 131'. (author)

  7. Calibration of CDTN-whole body counter for in vivo measurements of I-131

    International Nuclear Information System (INIS)

    Oliveira, Cassio M.; Silva, Tania V. da; Alonso, Thessa C.; Squair, Peterson L.

    2009-01-01

    Iodine-131 is frequently used in nuclear medicine services for diagnosis and therapy of thyroid diseases. Furthermore, the Nuclear Technology Development Centre (CDTN/CNEN), in Belo Horizonte, uses Iodine-131 for radiobiology and radiopharmacy researches. The increasing use of this radionuclide for medical and research purposes as well as its high volatility creates a demand for feasible methodologies to perform occupational control of internal contamination. Therefore the objective this work is to develop methods of in vivo bioassay for evaluation Iodine-131 incorporation by using NaI(Tl) 6'' x 4'' scintillation detector of the CDTN-Whole Body Counter (WBC). Such detector was calibrated for in vivo measurements with a neck-thyroid phantom, simulating Iodine-131 incorporation. The chosen counting geometry was lying under monitoring bed of CDTNWBC. A methodology for bioassay data interpretation, based on standard ICRP 56 model was established with software AIDE (activity internal dose estimate) version 6.0. It was concluded that in vivo measurements have sufficient sensitivity for the monitoring of Iodine-131 through CDTN-Whole Body Counter. Therefore, the CDTN-Whole Body Counter equipment of Belo Horizonte are ready to attend suspicion intake cases of Iodine- 131 (author)

  8. Calibration of CDTN-whole body counter for in vivo measurements of I-131

    Energy Technology Data Exchange (ETDEWEB)

    Oliveira, Cassio M.; Silva, Tania V. da; Alonso, Thessa C.; Squair, Peterson L. [Centro de Desenvolvimento da Tecnologia Nuclear (CDTN-CNEN/MG), Belo Horizonte, MG (Brazil)], e-mail: cmo@cdtn.br

    2009-07-01

    Iodine-131 is frequently used in nuclear medicine services for diagnosis and therapy of thyroid diseases. Furthermore, the Nuclear Technology Development Centre (CDTN/CNEN), in Belo Horizonte, uses Iodine-131 for radiobiology and radiopharmacy researches. The increasing use of this radionuclide for medical and research purposes as well as its high volatility creates a demand for feasible methodologies to perform occupational control of internal contamination. Therefore the objective this work is to develop methods of in vivo bioassay for evaluation Iodine-131 incorporation by using NaI(Tl) 6'' x 4'' scintillation detector of the CDTN-Whole Body Counter (WBC). Such detector was calibrated for in vivo measurements with a neck-thyroid phantom, simulating Iodine-131 incorporation. The chosen counting geometry was lying under monitoring bed of CDTNWBC. A methodology for bioassay data interpretation, based on standard ICRP 56 model was established with software AIDE (activity internal dose estimate) version 6.0. It was concluded that in vivo measurements have sufficient sensitivity for the monitoring of Iodine-131 through CDTN-Whole Body Counter. Therefore, the CDTN-Whole Body Counter equipment of Belo Horizonte are ready to attend suspicion intake cases of Iodine- 131 (author)

  9. The biological quality of Sieve downriver the Sabatta waster water plant; La qualita biologica del fiume Sieve a valle del depuratore di Rabatta

    Energy Technology Data Exchange (ETDEWEB)

    Banchetti, Rosalba; Gasperini, Federico; Bicocchi, Allegra; Cecchini, Agnese; Nolan, Brigitte; Stramaccia, Tania [Pisa Univ., Pisa (Italy). Dipartimento di etologia, ecologia ed evoluzione

    2005-10-15

    An evaluation study of the environmental condition of Sieve river, based on the Extended Biotic Index method (E.B.I.) applied to macro invertebrates was carried out in 2003. Three sampling locations were selected upriver and downriver a depuration plant and upriver of the confluence of a tributary that flow into the Sieve, the Ensa. The monitoring, carried out in two separate campaigns, in winter and spring, revealed how efficient is the sludge-active plant in determining a good quality of the water. Moreover Bilancino reservoir, with constant discharges, keeps Sieve river flow with a constant regime all through the year, avoiding the summer dry-up of the river and allowing the settlement of a biodiversified macrobenthonic community. [Italian] Nal 2003 e stato condotto uno studio di valutazione dello stato ecologico del fiume Sieve sulla base della comunita di macroinvertebrati, usando il metodo dell'I.B.E. (Indice Biotico Esteso). Sono stati scelti tre punti di campionamento a monte e a valle dello scarico di un impianto di depurazione, in funzione dal 1998, che tratta reflui di origine civile. Il monitoraggio eseguito ha rivelato l'utilita dell'impianto a fanghi attivi nel determinare un netto miglioramento della qualita delle acque.

  10. Development of software for management of radioactive waste in biological research and clinical assistance; Desenvolvimento do software para gerenciamento de rejeitos radioativos em pesquisa biologica e assistencia clinica

    Energy Technology Data Exchange (ETDEWEB)

    Maciel, Bianca; Mattos, Maria Fernanda S.S.; Medeiros, Regina B. [Universidade Federal de Sao Paulo (UNIFESP/EPM), Sao Paulo, SP (Brazil). Dept. de Diagnostico por Imagem. Nucleo de Protecao Radiologica; Franca Junior, Jose Antonio de, E-mail: fernanda@cfhr.epm.b, E-mail: rbitelli@cfhr.epm.b, E-mail: jafjunior@unifesp.b [Universidade Federal de Sao Paulo (UNIFESP/EPM), Sao Paulo, SP (Brazil). Dept. de Tecnologia da Informacao. Div. de Sistema de Informacao

    2011-10-26

    This paper describes the development of software which facilitates the automation of this process by mean of the Safety Analysis Report generating a data base allowing the statistic analysis and elaboration of radioactive wastes inventory. The software was developed in PHP language and the information is stored in a data base generated in Oracle and organized in different tables which allows to calculate the storage time of waste and to register the specificities of radioisotopes, cadastral data of the professionals which handle that radioisotope and also the characteristics of handling laboratories. That tool collaborates for a effective control on the use of radioisotopes in research laboratories and assistance areas as well

  11. Etymology of transition metal biomolecules as a learning aid in Biological Chemistry; A etimologia de biomoleculas com metais de transicao como auxiliar na aprendizagem de Quimica Biologica

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Jose A.L. da, E-mail: pcd1950@ist.utl.pt [Universidade Tecnica de Lisboa (Portugal). Instituto Superior Tecnico. Centro de Quimico Estrutural

    2013-11-01

    Numerous functional biomolecules are associated with metals, i.e. the metallobiomolecules; more specifically, some are dependent on transition metals required for several crucial biological roles. Nevertheless, their names can lead to ambiguous interpretations concerning the properties and performances of this group of biological molecules. Their etymology may be useful by providing a more perceptive insight into their features. However, etymology can lead to incongruous conclusions, requiring an especially careful approach to prevent errors. Examples illustrating these subjects shall be examined (author)

  12. Potencial Insecticida de Extractos de MeliaAzederach L (Meliaceae. Actividad Biologica y Efectos sobre Spodoptera Frugiperda J.E: Smith

    Directory of Open Access Journals (Sweden)

    Vergara Ruiz Rodrigo

    1997-12-01

    Full Text Available En la búsqueda de alternativas de Spodoptera frugiperda J.E. Smith (Lepidoptera: Noctuidae, diferentes al uso de insecticidas se planifico esta investigación con el objetivo de precisas las propiedades insecticidas de extractos de Melia azederach L. para el control de larvas en estado L2. El trabajo se adelantó en Laboratorios de la Universidad del Tolima en Ibagué, ubicados en una zona de vida correspondiente al bosque húmedo Montano Bajo (bh-MB, las condiciones de temperatura fueron de 28 ±2°C y 70%de humedad relativa. Estos trabajos se realizaron durante 1994 y 1995. Los extractos se obtuvieron empleando tres solventes: alcohólico y etéreo trabajando con un diseño complemente al azar con arreglo factorial 3ˆ2, con 5 replicaciones. Antes de hacer las aplicaciones de los extractos se procedió a verificar su actividad biológica sobre Artemia salina. La dieta alimenticia natural y la cría masiva de Spodoptera frugiperda, se organizó de tal forma que se pudiera obtener material para toda la investigación. Después de efectuados los tratamientos se hicieron lecturas de mortalidad hasta los 6 días y porteriormente se continuaron realizando observaciones bioecológicas sobre los individuos sobrevivientes, hasta el estado adulto y etapa de oviposición El análisis de mortalidad demostró que los extractos tienen un efecto antialimentario sobre las larvas del insecto-plaga, siendo el extracto alcohólico en su dosis alta el mejor. Al efectuar el establecimiento de las dosis letales medidas se precisó que se pueden trabajar concentraciones entre 1.000-3.000 ppm para obtener óptimos resultados. El efecto antialimentario de los extractos produce en los individuos sobrevivientes una prolongación de la duración en días de las fases de su ciclo de vida.

  13. Assessment of environmental radiological findings in a service experimental biological irradiation; Evaluacion de los resultados radiologicos ambientales en un servicio de irradiacion biologica experimental

    Energy Technology Data Exchange (ETDEWEB)

    Macias Dominguez, M. T.; Barros, C.; Hernandez, D.; Pina Zapardiel, R.

    2013-07-01

    This paper presents the evaluation of the data dosimetric environmental obtained in the last 4 years in different areas of work related to the techniques of irradiation, with special attention to the levels of radiation to areas of free access, to ensure that the dose in these dependencies are lower than the doses to members of the public. (Author)

  14. VARIABILIDAD TEMPORAL DE LA SURGENCIA Y LA ZMO, Y SU EFECTO SOBRE LA PRODUCTIVIDAD BIOLOGICA EN UN SISTEMA COSTERO DEL NORTE DE LA CORRIENTE DE HUMBOLDT

    OpenAIRE

    GUIÑEZ ARAYA, MARCOS IGNACIO

    2012-01-01

    Mejillones del Sur (23ºS), es una bahía orientada hacia el norte y ubicada a orillas del desierto más seco del planeta (Atacama). Esta bahía es parte del centro de surgencia de Punta Angamos, localizado en la zona norte del sistema de corrientes de Humboldt. En la bahía de Mejillones se han registrado valores de producción primaria media de 3170 mg C m-2 d-1 y una abundante diversidad fitoplanctónica. En esta bahía se han realizado una serie de estudios sobre la composición y estructura de...

  15. Vegetation composition of the UCM Biological Field Station Finca de Ontalba; Composicion vegetal de la Estacion Biologica de la UCM Finca de Ontalba

    Energy Technology Data Exchange (ETDEWEB)

    Castoldi, E.; Molina, J. A.

    2012-07-01

    A vegetation study in the Biological Field Station of the Complutense University of Madrid named Finca de Ontalba, located in Guadarrama Mountains (North Madrid), was carried out. We identified 12 plant communities grouped in the following seven vegetation types: 1) Hygrophilous and aquatic communities; 2) Meadows; 3) Pioneer community of open disturbed soils; 4) Nitrophilous tall-herb vegetation of forest edge; 5) Forest-edge herbaceous community; 6) Forest-edge scrub community; and 7) Forest vegetation. The interest of the Station for research studies is pointed out. Its scope includes primary succession, amphibious environment, soil moisture gradient, ecotones, and forested environment. Besides, the Biological Station hosts a freshwater habitat type listed in the European Community Directive (92/43/EEC) which corresponds to water courses of plain or montane levels with Ranunculion fluitantis and Callitricho- Batrachion vegetation (habitat code 3260). (Author)

  16. Viabilidade da utilização de amostras biologicas obtidas de dentes humanos para obtenção de perfis geneticos de DNA

    OpenAIRE

    Leonardo Soriano de Mello Santos

    2009-01-01

    Resumo: Alguns fatores relacionados ao estado e lugares que dentes humanos se encontram, nos que diz respeito a estes enquanto amostras com finalidade forense, ainda constituem desafio ao que tange o uso dos mesmos como material para obtenção de perfis genéticos de DNA. Este estudo visou comparar a extração de DNA feita a partir de dentes humanos com a extração por meios de amostras de sangue fixadas em papel FTA® utilizadas como grupo controle, de maneira a comparar os alelos mapeados e defi...

  17. Biological eleimination of nitrogen and phosphorus: Field results and modelling aspects. Rimozione biologica di azoto e fosforo: Risultati su scala reale ed aspetti modellistici

    Energy Technology Data Exchange (ETDEWEB)

    Malpei, F.; Andreattola, G.; Canziani, R. (Politecnico di Milano, Milan (Italy))

    1992-07-01

    The processes described in this article can be easily adapted to existing biological activated sludge plants which eliminate nitrogen and provide for considerable savings with respect to traditional chemical precipitation methods, as well as the disposal of exhausted sludge. This article assesses this innovative combined nitrogen and the removal efficiencies of phosphorus removal method by analyzing the basic process schemes and real plant and simulated operating results.

  18. A computer program for monitoring the biological treatment of waste waters (CDBAR); Programa informatico para el control de la depuracion biologica de aguas residuales (CDBAR)

    Energy Technology Data Exchange (ETDEWEB)

    Bove Porta, J.; Milan Cabre, D.

    2001-07-01

    The problems, such as bulking, foaming, etc., involved in managing a waste water treatment plant (WWTP) employing an activated sludge biological process have a biochemical origin. Correcting them requires identifying the micro-organisms responsible for the pathology in question, whether the problems are due to there being too many or too few of these organisms. It is therefore necessary to have a good microscope and staff trained in identifying such micro-organisms. Never the less, to attain speed and efficiency, it is necessary to have more means. That is why the CDBAR project was carried out. This is a simple computer application that includes numerous photographs of microscopic organisms from samples taken in Spain and Portugal. Once the anomaly has been identified, the computer application it-self includes a program of corrective actions that will allow the biological reactor, the most important part of a WWTP, to function normally. Finally, a glossary has been prepared so that the meaning of any term can be looked up quickly and easily. (Author) 16 refs.

  19. Protease activated receptors (PARS) mediation in gyroxin biological activity; Mediacao dos receptores ativados por proteases (PARs) em atividades biologicas da giroxina

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Jose Alberto Alves da

    2009-07-01

    Gyroxin is a serine protease enzyme from the South American rattlesnake (Crotalus durissus terrificus) venom; it is only partially characterized and has multiple activities. Gyroxin induces blood coagulation, blood pressure decrease and a neurotoxic behavior named barrel rotation. The mechanisms involved in this neurotoxic activity are not known. Whereas gyroxin is a member of enzymes with high potential to become a new drug with clinical applications such as thrombin, batroxobin, ancrod, tripsyn and kalicrein, it is important to find out how gyroxin works. The analysis on agarose gel electrophoresis and circular dichroism confirmed the molecules' integrity and purity. The gyroxin intravenous administration in mice proved its neurotoxicity (barrel rotation). In vivo studies employing intravital microscopy proved that gyroxin induces vasodilation with the participation of protease activated receptors (PARs), nitric oxide and Na+K+ATPase. The leukocytes' adherence and rolling counting indicated that gyroxin has no pro inflammatory activity. Gyroxin induced platelet aggregation, which was blocked by inhibitors of PAR1 and PAR4 receptors (SCH 79797 and tcY-NH{sub 2}, respectively). Finally, it was proved that the gyroxin temporarily alter the permeability of the blood brain barrier (BBB). Our study has shown that both the protease-activated receptors and nitric oxide are mediators involved in the biological activities of gyroxin. (author)

  20. Control of the surface radioactive contamination in the field of biological research; Control de la contaminacion radiactiva superficial en el ambito de la investigacion biologica

    Energy Technology Data Exchange (ETDEWEB)

    Calvo, S.; Encina, A. de la; Gaspar, J.; Macias, M. T.; Sanchez, A.; Usera, F.

    2012-11-01

    The manipulation of unsealed sources in biomedical research involves significant risk of radioactive contamination. the aim of this study has been to analyze the radioactive contamination occurring in the field of biomedical research, assessing its magnitude, identifying the equipment that can be contaminated with higher probability and monitoring the evolution of the contaminations production taking into account the radioisotopes and the activities uses, and the radiation protection control applied. The data used for this study correspond to a very lengthy period of time and it have been collected in the radioactive facility, of the Centro Nacional de Biotecnologia (CSIC), a very large biological research centre that can be used perfectly as a reference for this area. The results obtained show a gradual and significant decrease in the incidence of the radioactive contamination. This is due to the optimization of radiation protection standards applied and the implementation or a systematic operational radiation protection program. (Author) 13 refs.

  1. Flow rate and biological quality of the water in the river Anoia; Caudal y calidad biologica de las aguas del rio Anoia

    Energy Technology Data Exchange (ETDEWEB)

    Munne, A.; Prat, N. [Departamento d`Ecologia, Facultat de Biologia, Universitat de Barcelon, Barcelona (Spain)

    1997-04-01

    Floods and droughts are typical in Mediterranean rivers, with large annual and inter annual fluctuations in flow. This is the case of the river Anoia in which in addition, water is intensively used for agriculture, industry and urban supply. This causes the flow to be scarce in summer and an increase in river pollution due to the lack dilution. We studied the river during two consecutive springs and summers (1994-1995) with very different hydrology. While in 1994 the basin was subject to a severe drought, in 1995 the climate was milder. As a result in 1995 the main river maintained a continuous flow throughout mos of its length and in most of the tributaries, while in 1994 flow was intermittent in the main channel and the tributaries. Lower fluxes in 1994 resulted in increased pollution which can be measured by both the physico-chemical characteristics of the water and biotic indices. As the basin is used in headwaters for agriculture, water in the upper part is rich in nitrogen an phosphorus, leading to eutrophication process with Cladophora abundant in the river, although the macro invertebrate community is still rich. In the middle part of the basin, in summer, the community is reduced in abundance and diversity due to the water abstraction and pollution, especially in 1994. In the lower part of the area studied, the river is devoid of macro invertebrates due to the inadequate water sewage treatment and the lack of dilution. In this study we compare the evolution of biological water quality in the two sampled years by two different biotic indices (BILL and BMWP). (Author) 15 refs.

  2. Herbicides synthesis and biological tests to determine its activity on the weeds; Sintesis de herbicidas y pruebas biologicas para determinar su actividad sobre la maleza

    Energy Technology Data Exchange (ETDEWEB)

    Romero M, Artemisa [Universidad Autonoma Metropolitana-Xochimilco, Mexico, D. F. (Mexico); James M, Guillermo [Universidad Autonoma Metropolitana-Xochimilco, Mexico, D. F. (Mexico); Miramontes F, Benjamin [Universidad Autonoma Metropolitana-Xochimilco, Mexico, D. F. (Mexico); Haro C, Jorge [Universidad Autonoma Metropolitana-Iztapalapa, Mexico, D.F. (Mexico)

    1995-02-01

    Four derivatives of Dicamba (2-methoxy-3, 6-dichlorobenzoic acid) were obtained: 2-methoxy-3, 6-dichlorobenzyl alcohol, 2-methoxy-3, 6-dichlorobenzaldehyde, 2-methoxy-3, 6-dichlorobenzaldoxime, tested on weed, and 2-methoxy-3, 6-dichlorobenzylamine. The weeds were Taraxacum officinale Weber, Amaranthus silvester and Sonchus oleraceus L. The oxime did not show activity on Amaranthus silvester, all the substances were active on the other two weeds. [Spanish] Se sintetizaron cuatro derivados del herbicida Dicamba (acido 2-metoxi-3, 6-diclorobenzoico), y se hicieron pruebas de la actividad de tres de ellos sobre maleza de Xochimilco. Se probaron el alcohol 2-metoxi-3, 6-diclorobencilico, 2-metoxi-3, 6-diclorobenzaldehido, 2-metoxi-3, 6-diclorobenzaldoxima. La maleza fue Taraxacum officinale Weber (Diente de leon), Amaranthus silvester (Amaranto silvestre) y Sonchus oleraceus L. (Sonchus). En amaranto, la oxima fue el unico que no presento actividad. En diente de leon y Sonchus, todas las sustancias probadas presentaron actividad.

  3. Optimization of a radiochemistry method for plutonium determination in biological samples; Optimizacion del metodo radioquimico para determinar plutonio en muestras biologicas

    Energy Technology Data Exchange (ETDEWEB)

    Cerchetti, Maria L; Arguelles, Maria G [Comision Nacional de Energia Atomica, Ezeiza (Argentina). Laboratorio de Dosimetria Personal y de Area

    2005-07-01

    Plutonium has been widely used for civilian an military activities. Nevertheless, the methods to control work exposition have not evolved in the same way, remaining as one of the major challengers for the radiological protection practice. Due to the low acceptable incorporation limit, the usual determination is based on indirect methods in urine samples. Our main objective was to optimize a technique used to monitor internal contamination of workers exposed to Plutonium isotopes. Different parameters were modified and their influence on the three steps of the method was evaluated. Those which gave the highest yield and feasibility were selected. The method involves: 1-) Sample concentration (coprecipitation); 2-) Plutonium purification; and 3-) Source preparation by electrodeposition. On the coprecipitation phase, changes on temperature and concentration of the carrier were evaluated. On the ion-exchange separation, changes on the type of the resin, elution solution for hydroxylamine (concentration and volume), length and column recycle were evaluated. Finally, on the electrodeposition phase, we modified the following: electrolytic solution, pH and time. Measures were made by liquid scintillation counting and alpha spectrometry (PIPS). We obtained the following yields: 88% for coprecipitation (at 60 C degree with 2 ml of CaHPO{sub 4}), 71% for ion-exchange (resins AG 1x8 Cl{sup -} 100-200 mesh, hydroxylamine 0.1N in HCl 0.2N as eluent, column between 4.5 and 8 cm), and 93% for electrodeposition (H{sub 2}SO{sub 4}-NH{sub 4}OH, 100 minutes and pH from 2 to 2.8). The expand uncertainty was 30% (NC 95%), the decision threshold (Lc) was 0.102 Bq/L and the minimum detectable activity was 0.218 Bq/L of urine. We obtained an optimized method to screen workers exposed to Plutonium. (author)

  4. The nitrogen biological fixing as support for renewable energy production; A fixacao biologica de nitrogenio como suporte para a producao de energia renovavel

    Energy Technology Data Exchange (ETDEWEB)

    Quesada, Diego Mureb; Frade, Catia; Resende, Alexander; Polidoro, Jose Carlos; Reis, Veronica Massena; Boddey, Robert; Alves, Bruno Jose Rodrigues; Urquiaga, Segundo [EMBRAPA, Seropedica, RJ (Brazil). Setor de Agrobiologia; Xavier, Deise [EMBRAPA, Juiz de Fora, MG (Brazil). Gado de Leite

    2000-07-01

    Recently, rapid-growing grasses which possess the C4 photosynthetic pathway such as Miscanthus and Pennisetum spp. have been considered as prime candidates for the production of bio-fuels. In the case of Pennisetum purpureum (Elephant grass) and related hybrids, the genotypes studied until now have generally been selected for high production of forage for cattle under high N fertiliser additions. For forage production it is desirable that the tissues have high protein content. However, for biomass production the priority should be for carbon accumulation and the highest possible biomass production per unit of applied fertiliser. The manufacture of N fertiliser involves a very high cost in terms of fossil energy, and if large additions are made the grass biomass produced may have only a little more (or even less) calorific value than that utilised in the manufacture of the fertiliser. This completely negates the prime objective of bio fuel production which the replacement of energy derived from non-renewable fossil sources with that derived from solar radiation. Recently the team headed by Dr Johanna Doebereiner at EMBRAPA Agrobiologia have shown that several tropical grasses (including sugar cane and elephant grass) are able to obtain significant quantities of N through the action of associated endo phytic N{sub 2}-fixing bacteria. Derived from this line of reasoning a study is being conducted in the field to select appropriate genotypes of Pennisetum purpureum which are efficient is biomass production in soil of very low N fertility. In the first stage four genotypes have been selected : Gramafante, Cameroon, BAG 02 and Roxo, which have been the most productive over a 5 year period without N fertiliser addition.A complementary study is underway to evaluate biomass production and quantify the N{sub 2} fixation input. Preliminary results are promising and show that these materials produce well without N fertiliser application a with a contribution of approximately 30 % of plant N derived from N{sub 2}-fixing, which can be regarded as very satisfactory for a graminaceous specie. (author)

  5. Alpha process with biological elimination of nitrogen. Application of mathematical models; Proceso alpha con eliminacion biologica de nitrogeno. Aplicacion de modelos matematicos

    Energy Technology Data Exchange (ETDEWEB)

    Rodriguez, J. C.; Lopez-Carrasco, M. D.; Cortacans, J. A.; Larrea, L.; Larrea, A.

    1999-07-01

    This article illustrates the advantages of a step feed process for the biological elimination of nitrogen by presenting the experiments carried out by INFILCO at a pilot plant in San Sebastian. This arrangement, also known as the alpha (alternative phase step feed) process, reduces the volume of the biological reactor, eliminates the need for internal recycling and optimised the consumption of the organic matter used for denitrication. This article also demonstrates the possibility of employing a mathematical model as a tool in assessing, designing and operating full scale treatment plants for typically urban sewage. (Author) 6 refs.

  6. A design of Biological Network in the Basin of Jucar; El diseno de la Red Biologica en la Cuenca del Jucar

    Energy Technology Data Exchange (ETDEWEB)

    Martinez Mas, J F; Correcher Martinez, E; Pinon, A; Martinez Muro, M A; Pujante Mora, A M

    2002-07-01

    In this study results obtained in the design of the Biological Network carried out during the year 2000 in 221 sampling points in 106 rivers of the environment of the Confederation Hidrografica of the Jucar are presented. The Biological network is based in the analysis of hydro morphological physical, chemical and biological parameters (macro invertebrates, diatoms, macrofits and fishes) that allow to know the ecological status of the studied rivers. The quality of the rivers were stablished with BMWP index and completed with the calculation in some selected sampling sites of other indexes: 1CG, macrofits index (IM), diatoms index (ID), ecotrofic index (IE). The results indicate the division of the study area in three big groups: the sampling sites located in the headwaters and small streams, with an excellent conservation state and with the presence of indicative species, the medium upland river sites which are regulated by reservoirs and dams, and the lowland rivers with the biggest accumulation of contamination and the biggest population density. (Author) 13 refs.

  7. Type tests to the automatic system of thermoluminescent dosimetry acquired by the CPHR for personnel dosimetry; Pruebas tipo al sistema de dosimetria termoluminiscente automatico adquirido por el CPHR para dosimetria personal

    Energy Technology Data Exchange (ETDEWEB)

    Molina P, D.; Pernas S, R. [Centro de Proteccion e Higiene de las Radiaciones (CPHR), Calle 20, No. 4113 e/ 41 y 47, Miramar, Ciudad de la Habana (Cuba)]. e-mail: daniel@cphr.edu.cu

    2005-07-01

    The CPHR individual monitoring service acquired an automatic RADOS TLD system to improve its capacities to satisfy the increasing needs of their national customers. The TLD system consists of: two automatic TLD reader, model DOSACUS, a TLD irradiator and personal dosimeters card including slide and holders. The dosimeters were composed by this personal dosimeters card and LiF: Mg,Cu,P (model GR-200) detectors. These readers provide to detectors a constant temperature readout cycle using hot nitrogen gas. In order to evaluate the performance characteristics of the system, different performance tests recommended by the IEC 1066 standard were carried out. Important dosimetric characteristics evaluated were batch homogeneity, reproducibility, detection threshold, energy dependence, residual signal and fading. The results of the tests showed good performance characteristics of the system. (Author)

  8. Type tests to the automatic thermoluminescent dosimetry system acquired by the CPHR for personal dosimetry; Pruebas tipo al sistema de dosimetria termoluminiscente automatico adquirido por el CPHR para dosimetria personal

    Energy Technology Data Exchange (ETDEWEB)

    Molina P, D.; Pernas S, R.; Martinez G, A. [Centro de Proteccion e Higiene de las Radiaciones (CPHR), Calle 20 No. 4113 e/41 y 47. Playa, C.P. 11300, A.P. 6195, C.P. 10600 La Habana (Cuba)

    2006-07-01

    The CPHR individual monitoring service acquired an automatic RADOS TLD system to improve its capacities to satisfy the increasing needs of their national customers. The TLD system consists of: two automatic TLD reader, model DOSACUS, a TLD irradiator and personal dosimeters card including slide and holders. The dosimeters were composed by this personal dosimeters card and LiF:Mg,Cu,P (model GR-200) detectors. These readers provide to detectors a constant temperature readout cycle using hot nitrogen gas. In order to evaluate the performance characteristics of the system, different performance tests recommended by the IEC 1066 standard were carried out. Important dosimetric characteristics evaluated were batch homogeneity, reproducibility, detection threshold, energy dependence, residual signal and fading. The results of the tests showed good performance characteristics of the system. (Author)

  9. Use of radiological evaluation system from the Instituto de Radioprotecao e Dosimetria in the analysis of recent radiation accidents; Utilizacao do sistema de avaliacao radiologica do Instituto de Radioprotecao e Dosimetria na analise de acidentes radiologicos recentes

    Energy Technology Data Exchange (ETDEWEB)

    Silva, Rodolfo Julio da

    2013-07-01

    The response to an emergency situation involving ionizing radiation requires the joint participation of professionals from various kind of knowledge, belonging to public and private organizations (in the local, state and federal levels). The theme radiation tends to be an additional challenging factor - considering that it's, usually, remembered for its macabre and ominous aspect, in spite of the benefits provided by it - which makes the implementation of actions to protect the public, emergency professionals, the environment and property, very difficult. To this, we can add the complicating factor that, in most cases, the technician (holder of basic or advanced on the subject) is far !Tom the place where this action unfolds. The accident/incident takes the form of a radioactive source (sometimes orphaned, one that gone astray or even stolen) that is found by a person unaware of the risks to which they are being exposed or, let not forget about it, the non-observance of safety standards in industries and workplaces, by their own operators. Thus, before integrating emergency response plans with conventional plans specific to the prompt response to radiological emergencies, it is necessary that some measures had been anticipated and that some actions had, already, been planned - with the intention of mitigate health, psychological and economical damage, in ali of kind. To do this, since in the course of the second decade of the second millennium, and since you own a portable personal computer (Note or Netbook), or even with a mobile device (cellular) with a bit more resources, both of them previously updated, a responder (or even a qualified technician that is next to that fact) may already guide, at least, about a safety distances !Tom the source. Since he had knowledge about some characteristics of the source (its individual data), he can plan ahead about the possible serious situation that unfolds itself and emergency responders will find, when it get to the site. With the situation assessments done, the formal emergency team triggered will can prepare itself (with personnel and technical-materials facilities) to resolve the incident in the shortest time and with the least possible risks. (author)

  10. Computerized dosimetry of I-125 sources model 6711; Dosimetria computarizada de las fuentes de I-125 modelo 6711

    Energy Technology Data Exchange (ETDEWEB)

    Isturiz, J [Centre de Radiotherapie du Parc, Dijon (France)

    2001-07-01

    It tries on: physical presentation of the sources; radiation protection; mathematical model of I-125 source model 6711; data considered for the calculation program; experimental com probation of the dose distribution; exposure rate and apparent activity; techniques of the use given to the sources I-125; and the calculation planning systems. [Spanish] Trata sobre presentacion fisica de las fuentes, radioproteccion, modelo matematico de las fuentes I-125 modelo 6711, datos considerados en el programa de calculo, comprobacion experimental de la distribucion de dosis, tasa de exposicion y actividad aparente, tecnicas de utilizacion de las fuentes I-125; y los sistemas de planificacion del calculo de las dosis.

  11. Dosimetry of wires and single ribbons of Iridium 192; Dosimetria de alambres y ribbons individuales de Iridio-192

    Energy Technology Data Exchange (ETDEWEB)

    Mazzucco, L.D. [Centro Medico Nuclear S.R.L. San Juan (Argentina)

    1998-12-31

    The objective of this work is in order to present in table formats the dosimetry of wires and single ribbons of Iridium with lengths 1-12 cm for each one linear source along the bisector which is perpendicular at tissue sources (water) computed for linear activity 1 mCi/cm in the case of wires, and 1 mCi/seed for ribbons. The above tables are of direct use, adaptable at particular cases so they facilitate logarithmic graphics of doses in function of the distance for interpolation and use in the treatments planning. It was shown that for two sources with identical linear activity and total length, one of the equidistant seeds at 1 cm (ribbon) and one wire on the other hand, the differences in dose rates in near positions can be about the 15% so corroborating that it is not possible to use wire tables for seeds neither vice versa. Moreover it was elaborated tables of practical direct use for dose rate in water at c Gy/hr for wires and Ribbons 1-12 cm length and from 0.5-10 cm of distance in the perpendicular bisector at the Iridium implant. (Author)

  12. Development of a guidance guide for dosimetry in computed tomography; Desenvolvimento de um guia orientativo para dosimetria em tomografia computadorizada

    Energy Technology Data Exchange (ETDEWEB)

    Fontes, Ladyjane Pereira

    2016-07-01

    Due to frequent questions from users of ionization chambers pencil type calibrated in the Instrument Calibration Laboratory of the Institute of Energy and Nuclear Research (LCI - IPEN), on how to properly apply the factors indicated in their calibration certificates, a guide was prepared guidance for dosimetry in computed tomography. The guide includes guidance prior knowledge of half value layer (HVL), as it is necessary to know the effective beam energy for application quality for correction factor (kq). The evaluation of HVL in TC scanners becomes a difficult task due to system geometry and therefore a survey was conducted of existing methodologies for the determination of HVL in clinical beams Computed Tomography, taking into account technical, practical and economic factors. In this work it was decided to test a Tandem System consists of absorbing covers made in the workshop of IPEN, based on preliminary studies due to low cost and good response. The Tandem system consists of five cylindrical absorbing layers of 1mm, 3mm, 5mm, 7mm and 10mm aluminum and 3 cylindrical absorbing covers 15mm, 25mm and acrylic 35mm (PMMA) coupled to the ionization chamber of commercial pencil type widely used in quality control tests in dosimetry in clinical beams Computed tomography. Through Tandem curves it was possible to assess HVL values and from the standard curve pencil-type ionization chamber, Kq find the appropriate beam. The elaborate Guide provides information on how to build the calibration curve on the basis of CSR, to find the Kq and information for construction Tandem curve, to find values close to CSR. (author)

  13. Calculation of absorbed dose in water by chemical Fricke dosimetry; Calculo de dose absorvida na agua por dosimetria quimica Fricke

    Energy Technology Data Exchange (ETDEWEB)

    Rodrigues, Adenilson Paiva, E-mail: adenilson-fisica@hotmail.com.br [Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ (Brazil); Meireles, Ramiro Conceicao [Fundacao do Cancer, Rio de Janeiro, RJ (Brazil)

    2016-07-01

    This work is the result of a laboratory activity performed in Radiological Sciences Laboratory (CRL), linked to the State University of Rio de Janeiro (UERJ). This practice aimed to determine the absorbed dose to water, through the primary calibration method called dosimetry Fricke, which consists of ferrous ions (Fe + 2) to ferric (Fe + 3), generated by water radiolysis products which is the structural change of water molecule caused by ionizing radiation. A spectrophotometer was used to extract data for analysis at a wavelength (λ) 304 and 224 nm with function of measuring the absorbance using bottles with irradiated and nonirradiated Fricke solution. (author)

  14. Thermoluminescent dosimetry in dentistry students in radiological training; Dosimetria termo-luminiscente en estudiantes de odontologia en entrenamiento radiologico

    Energy Technology Data Exchange (ETDEWEB)

    Loya, M.; Duarte, R. [Escuela de Odontologia, Universidad Autonoma de Chihuahua (Mexico); Montero, M.E. [CIMAV, Chihuahua (Mexico); Gonzalez, P.R. [ININ, 52045 Ocoyoacac, Estado de Mexico (Mexico); Ojeda, S.L.; Sanin, L.H. [Facultad de Enfermeria y Nutriologia, Chihuahua (Mexico)

    2007-07-01

    Full text: In this work, the obtained results of the mensuration of the equivalent one are presented of dose (E), in students of the career of Dentistry who during their training in radiology complete the three lists of patient, odontologist and observer. The study one carries out with 35 students (Odontologists), 7 men and 28 women, with ages between 20 and 24 years. A characterization of risk was made following the methodology of the Agency for the environmental control of United States (EPA), counting the number of shots in each list, during the time of training. The effective energy of the X rays used was of 24 KeV. The irradiation technique understood two modalities; the first one with 3 shots of 1.25 seconds and the second with 5 shots of 0.6 seconds. The measurement of E, was carried out with thermoluminescent dosemeters (TL) of LiF:Mg,Cu,P+PTFE, developed in the National Institute of Nuclear Research (ININ). The homogenization of the dosemeters showed a variation in its response to the radiation of 1.85%DS. For the odontologist position, the dosemeters was placed to the height of the chest and the measurement was multiplied by the number of shots that it was 304. The E value was of 3.62 mSv/four-month (11 mSv/year), without any safety equipment and of 2.02 mSv/four-month (6.14 mSv/year), when was considered the scenario for this position with use of vest and lead collar, like safety equipment, diminishing E, almost 50%. In the case of the corresponding position to patient, E, it was measured in different organs of interest, the obtained results are compared with the international standards. Recommendations are given for similar cases. (Author)

  15. Dose measurements in dental radiology using thermoluminescent dosimetry;Medicoes de dose em radiodiagnostico odontologico utilizando dosimetria termoluminescente

    Energy Technology Data Exchange (ETDEWEB)

    Chiara, Ana Claudia M. de; Costa, Alessandro M. [Universidade de Sao Paulo (FFCLRP/USP), Ribeirao Preto, SP (Brazil). Faculdade de Filosofia, Ciencias e Letras; Pardini, Luiz Carlos [Universidade de Sao Paulo (FORP/USP), Ribeirao Preto, SP (Brazil). Faculdade de Odontologia

    2009-07-01

    The aim of this work was the implementation of a code of practice for dosimetry in dental radiology using the technique of thermoluminescent dosimetry. General principles for the use of thermoluminescent dosimeters were followed. The irradiations were performed using ten X-ray equipment for intra-oral radiography and an X-ray equipment for panoramic radiography. The incident air kerma was evaluated for five different exposure times used in clinical practice for intra-oral radiographs. Using a backscatter factor of 1.2, it was observed that approximately 40% of the entrance skin dose values found for intra-oral radiographs are above the diagnostic reference level recommended in national regulation. Different configurations of voltage and current were used representing the exposure as a child, woman and man for panoramic radiographs. The results obtained for the air kerma area product were respectively 53.3 +- 5.2 mGy.cm{sup 2}, 101.5 +- 9.5 mGy.cm{sup 2} and 116.8 +- 10.4 mGy.cm{sup 2}. The use of thermoluminescent dosimetry requires several procedures before a result is recorded. The use of dosimeters with ionization chambers or semiconductors provides a simple and robust method for routine measurements. However, the use of thermoluminescent dosimetry can be of great value to large-scale surveys to establish diagnostic reference levels. (author)

  16. Dosimetry computer module of the gamma irradiator of ININ; Modulo informatico de dosimetria del irradiador gamma del ININ

    Energy Technology Data Exchange (ETDEWEB)

    Ledezma F, L. E.; Baldomero J, R. [ININ, Gerencia de Sistemas Informaticos, Carretera Mexico-Toluca s/n, 52750 Ocoyoacac, Estado de Mexico (Mexico); Agis E, K. A., E-mail: luis.ledezma@inin.gob.mx [Universidad Autonoma del Estado de Mexico, Facultad de Ingenieria, Cerro de Coatepec s/n, Ciudad Universitaria, 50100 Toluca, Estado de Mexico (Mexico)

    2012-10-15

    This work present the technical specifications for the upgrade of the dosimetry module of the computer system of the gamma irradiator of the Instituto Nacional de Investigaciones Nucleares (ININ) whose result allows the integration and consultation of information in industrial dosimetry subject under an outline client-server. (Author)

  17. Differences between cross-section libraries for neutron dosimetry; Diferencas entre bibliotecas de secoes de choque para dosimetria de neutrons

    Energy Technology Data Exchange (ETDEWEB)

    Tardelli, T.C.; Stecher, L.C.; Coelho, T.S.; Castro, V.A. De; Cavalieri, T.A.; Menzel, F.; Giarola, R.S.; Domingos, D.B.; Yoriyaz, H., E-mail: tiago.tardelli@gmail.com [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil). Centro de Engenharia Nuclear

    2013-08-15

    Absorbed dose calculations depend on a consistent set of nuclear data used in simulations in computer codes. Nuclear data are stored in libraries, however, the information available about the differences in dose caused by different libraries are rare. The libraries are processed by a computer system to be able to be used by a radiation transport code. One of the systems capable of processing nuclear data is the NJOY system. The objective of this study is to evaluate the nuclear data libraries for neutrons available in the literature, and to quantify the differences in absorbed dose obtained using the libraries JENDL 4.0, JEFF 3.3.1 and ENDF/B.VII. The absorbed dose calculation was performed on a simple geometric model, as spheres, and in anthropomorphic model of the human body based on the ICRP-110 for neutron transport simulation using the MCNP5 code. The results were compared with literature data. The results obtained with cross sections from the libraries JEFF and ENDF/B.VII have shown to be identical in most cases, except for one case where the difference has exceeded 10%. The results obtained with JENDL library has shown to be considerably different in most cases comparing to other two libraries. Some differences were over 200%. The dose calculations showed differences between the libraries, which is justified by differences in the cross sections. It has been observed that the cross sections values of certain nuclides assume quite different values in different libraries. These differences in turn cause considerable differences in dose calculations. (author)

  18. Application of numerical analysis methods to thermoluminescence dosimetry; Aplicacion de metodos de analisis numerico a la dosimetria por termoluminiscencia

    Energy Technology Data Exchange (ETDEWEB)

    Gomez Ros, J M; Delgado, A

    1989-07-01

    This report presents the application of numerical methods to thermoluminescence dosimetry (TLD), showing the advantages obtained over conventional evaluation systems. Different configurations of the analysis method are presented to operate in specific dosimetric applications of TLD, such as environmental monitoring and mailed dosimetry systems for quality assurance in radiotherapy facilities. (Author) 10 refs.

  19. Thermoluminescent dosimetry in the radiodiagnostic area of the INNSZ; Dosimetria termoluminiscente en el area de radiodiagnostico del INNSZ

    Energy Technology Data Exchange (ETDEWEB)

    Azorin V, J.C.; Azorin N, J.; Rivera M, T. [Universidad Autonoma Metropolitana-Iztapalapa, 09340 Mexico D.F. (Mexico)

    1998-12-31

    During the year 1997 the Secretaria de Salud through the Direccion de Riesgos Radiologicos published the Mexican Official Standard about the medical diagnostic using X-rays in the Diario Oficial de la Federacion. They are of obligatory observance for all hospitals and radiological rooms which have medical diagnostic with X-ray equipment in the country. These standards were emitted with the purpose improve the conditions as for safety and radiological protection it is referred employing this type of ionizing radiation emitter equipment. Also it is presented the evaluation results about conditions existing about in thirteen X-ray medical diagnostic rooms in the Instituto Nacional de la Nutricion with the purpose of providing the radiological protection means toward the occupationally exposure personnel. It was realized measurements of each one of the blinding barriers for the X-ray equipment and it was suggested the appointments arrangement. (Author)

  20. Use of the calorimeter in the dosimetry for electron accelerators; Uso del calorimetro en la dosimetria para aceleradores de electrones

    Energy Technology Data Exchange (ETDEWEB)

    Chavez B, A

    1991-02-15

    The measure of different radiation types, with specific dosemeters, requires that the absorbed dose should be measured with accuracy by some common standard. The existent problem around the dosimetry of accelerated electrons has forced to the development of diverse detector types that after having analyzed the characteristics; dependability and reproducibility are used as dosemeters. Recently the calorimeters have been developed, with the purpose of carrying out dosimetry for electron accelerators. The RISO laboratory in Denmark, in it 10 MeV accelerator had been used for the dosimetry those water calorimeters, later on, using the principle of the water calorimeter, it was designing one similar, for the accelerator of 400 keV. Recently manufactured simple calorimeters of graphite have been used, which can be used in both accelerators of 10 MeV and 400 keV. (Author)

  1. Accreditation ISO/IEC 1705 in dosimetry: Experience and results; Acreditacion ISO/IEC 17025 en dosimetria: Experiencia y resultados

    Energy Technology Data Exchange (ETDEWEB)

    Martin Garcia, R.; Navarro Bravo, T.

    2013-07-01

    The objective of this work is to present the experience in the process of accreditation of the radiation dosimetry service in which there are trials for the determination of radiation doses due to internal and external exhibitions. Is They describe the aspects that were considered for the design and development of a system of quality and results after its implementation. A review of the benefits accreditation has been reported to the organization is finally made. (Author)

  2. Dosimetry of professionals involved in radio guided surgery; Dosimetria de los profesionales involucrados en la cirugia radioguiada

    Energy Technology Data Exchange (ETDEWEB)

    Barreto, A. C.; Cardoso, G.; Ferreira, L. S.; Santos, A. I.

    2013-07-01

    The procedure of sentinel node localization is important because it allows less invasive staging of breast cancer. With the capture probe after intradermal injection of the radiopharmaceutical, the surgeon can identify the location of the sentinel node. The use of radioactive materials, generated considerable concern in terms of radiation exposure. The main objective is to evaluate the possible individual dose of each professional involved in the process of radio-location. (Author)

  3. Dosimetry of the patient and occupational in interventional procedures; Dosimetria del paciente y ocupacional en procedimientos intervencionistas

    Energy Technology Data Exchange (ETDEWEB)

    Andisco, D. [Universidad de Buenos Aires, Facultad de Medicina, Paraguay 2155, C1121AAA Buenos Aires (Argentina); Bourel, V.; Schmidt, L.; Fernandez, N., E-mail: dandisco@fmed.uba.ar [Universidad Favaloro, Facultad de Ciencias e Ingenieria, Solis 453, C1078AAI, Buenos Aires (Argentina)

    2014-08-15

    The big necessity to estimate the entrance doses in skin that the patients receive when are exposed to interventional procedures and the personal dosimetry of the professionals that work in these procedures in operating room, has taken to the analysis of different possibilities that allow to carry out these estimates. The objective of this work was to analyze the possibility of using Optically Stimulated Luminescence dosimeters; comparing the results with ionizing cameras and electronic personal dosimeters. To carry out these estimates, we work with a X-ray equipment Phillips Allure, acrylic phantoms, a dosimetry system formed by ionization camera and dosimeter UNIDOS E, OSL (Nano dots) dosimeters and electronic lavalieres Aloka brand, PDM 117 models. To estimate the doses that the patients receive, entrance dose was measured in skin and in personal dosimetry inside places where the medical professionals are habitually located in different situations among 5 and 60 irradiation min. In the case of direct radiation, the OSL (Nano dots) present reliable readings and only were dispersed values for the measurements of secondary radiation. The measured values and the linking among them were also analyzed. The OSL (Nano dot) dosimetry behaves reliable way when is located in the ranges of more dose to 0,1 mGy, according to the maker indications and fundamentally for direct beams of the hemodynamics equipment being ideal for the measurement of entrance dose in skin. For the Nano dots use in personal dosimetry the results should be read carefully for values major to 0,1 mGy and being completely inappropriate for minor values. (Author)

  4. A new implementation of multichannel radiochromic film dosimetry; Una nueva implementacion del analisis multicanal para la dosimetria mediante peliculas radiocromicas

    Energy Technology Data Exchange (ETDEWEB)

    Rodriguez Rodriguez, C.; Martin Martin, G.; Bermudez Luna, R.; Lopez Fernandez, A.; Tores Olombrada, M. V. de

    2014-07-01

    The aims of this paper are to carry out a new implementation of the multichannel radiochromic film dosimetry (Micke A, Lewis D, Yu X. Multichannel film dosimetry with nonuniformity correction. Med Phys 2011;38:2523-34), to quantify the variation in gamma index as compared to the single channel film dosimetry, and to determine if the procedure achieves similar results by means of a different scanner that the one used by Micke et al. Radiochromic EBT2 films and a Microtek 9000 XL scanner were used. Our procedure simplifies the system calibration splitting it into two factors, manufactured batch and digitalization specific. Absorbed dose spatial distributions from an open radiotherapy beam without any modulation and 20 IMRT treatments were determined. Their gamma index maps were calculated and a comparison of the results from single channel and multichannel dosimetry was performed. A 5% mean increase in concordance was obtained by using the multichannel film dosimetry. Our results are similar to those reported by Micke et al. even though we are using a different scanner. (Author)

  5. Radiation chemical dosimetry by means of nitrate-nitrite; Dosimetria quimica de la radiacion aplicacion del sistema nitrato-nitrito

    Energy Technology Data Exchange (ETDEWEB)

    Tormo Ferrero, M J

    1977-07-01

    The different chemical systems used in dosimetry and the selection criteria for them are described. The general topics in dosimetry with alkali nitrates as well as the phenomena occurring in their radiolysis are also treated. The possibility of application in dosimetric areas useful in radiosterilization and industrial processes is studied too. (Author) 22 refs.

  6. A definitive method for dosimetry with radiochromic movie; Un metodo definitivo para la dosimetria con pelicula radiocromica

    Energy Technology Data Exchange (ETDEWEB)

    Miras del Rio, H.; Arrans Lara, R.

    2013-07-01

    Despite the undoubted benefits of radiochromic film as a two-dimensional radiation detector, the manufacturing process and characteristics of scanners make to present some inherent difficulties that result that its use is complex, tedious, and if not performed so appropriate, imprecise. A protocol that simplifies the calibration process while reducing the number of films used for this purpose is proposed systematically corrects several difficulties, both inherent in the manufacture of the film as the reader and, what is more important achieves levels comparable to those of other more widespread use detectors accuracy. (Author)

  7. Study of dosimetry CT in Skull for pediatric patients; Estudio de dosimetria TC en craneo para pacientes pediatricos

    Energy Technology Data Exchange (ETDEWEB)

    Ramos Amores, D.; Serna Berna, A.; Mata Colodro, F.; Puchades Puchades, V.

    2013-07-01

    The dose that receiving the patients in CT studies is the highest that can be received in a study of Radiology. If patients are children and we do studies with the same parameters as adults, they will receive a higher dose of radiation. This work seeks to expose the result of a dosimetric study on CT for children aged 0-15, carried out at the Hospital General Universitario de Santa Lucia in Cartagena during the year 2012. (Author)

  8. EPR dosimetry in tooth enamel by x radiation; Dosimetria EPR en esmalte dental irradiado con rayos X

    Energy Technology Data Exchange (ETDEWEB)

    Dubner, Diana; Perez, Maria del Rosario; Gisone, P. [Autoridad Regulatoria Nuclear, Buenos Aires (Argentina)] E-mail: ddubner@cae.arn.gov.ar; Fainstein, C.; Winkler, E. [Comision Nacional de Energia Atomica (CNEA), San Carlos de Bariloche (Argentina). Centro Atomico Bariloche]|[Universidad Nacional de Cuyo, Mendoza (Argentina). Inst. Balseiro; Saravi, Margarita [Comision Nacional de Energia Atomica (CNEA) (Argentina). Centro Atomico Ezeiza; Davila, Francisco [Ateneo Argentino de Odontologia, Buenos Aires (Argentina)

    2001-07-01

    Tooth enamel, extracted from molars, was irradiated with 66 keV X-rays, with doses up to 1 Gy. The preparation of the powder samples is described, as well as the protocol for the acquisition and processing of the spectra. The radiation induced paramagnetism is measured, at room temperature, by ESR spectroscopy. The ESR spectra is well described considering two paramagnetic species, with magnetic moments (in units of Bohr magnetrons) g=2,0041, and g1=2,0018, g2=1,9972. The ESR data (peak-to-peak amplitude per mg, hpp/mg, vs dose D), for doses 0 Gy

  9. Dosimetria “in vivo” para implantes ginecologicos de cancer de cervix, con braquiterapia de alta tasa de dosis (hdrb

    OpenAIRE

    Guillen G., Oscar O.; Duran S., Rosalia

    2009-01-01

    SOLCA Guayaquil en el Servicio de Braquiterapia dispone de un equipo de carga diferida de alta tasa de dosis, Microselectron HDR de la Empresa Nucletron, equipado con una fuente de Ir192, para la realización de tratamiento a pacientes portadores de cáncer en diferentes localizaciones. Se usa un maniquí de sólido de PMMA tipo 9193, de la PTW con el objetivo de determinar la tasa de kerma en aire de la fuente de Ir192, cuyo error no supera el 0.5%. Adicionalmente, se establece un mecanismo ...

  10. Use of radiological evaluation system from the Instituto de Radioprotecao e Dosimetria in the analysis of recent radiation accidents

    International Nuclear Information System (INIS)

    Silva, Rodolfo Julio da

    2013-01-01

    The response to an emergency situation involving ionizing radiation requires the joint participation of professionals from various kind of knowledge, belonging to public and private organizations (in the local, state and federal levels). The theme radiation tends to be an additional challenging factor - considering that it's, usually, remembered for its macabre and ominous aspect, in spite of the benefits provided by it - which makes the implementation of actions to protect the public, emergency professionals, the environment and property, very difficult. To this, we can add the complicating factor that, in most cases, the technician (holder of basic or advanced on the subject) is far !Tom the place where this action unfolds. The accident/incident takes the form of a radioactive source (sometimes orphaned, one that gone astray or even stolen) that is found by a person unaware of the risks to which they are being exposed or, let not forget about it, the non-observance of safety standards in industries and workplaces, by their own operators. Thus, before integrating emergency response plans with conventional plans specific to the prompt response to radiological emergencies, it is necessary that some measures had been anticipated and that some actions had, already, been planned - with the intention of mitigate health, psychological and economical damage, in ali of kind. To do this, since in the course of the second decade of the second millennium, and since you own a portable personal computer (Note or Netbook), or even with a mobile device (cellular) with a bit more resources, both of them previously updated, a responder (or even a qualified technician that is next to that fact) may already guide, at least, about a safety distances !Tom the source. Since he had knowledge about some characteristics of the source (its individual data), he can plan ahead about the possible serious situation that unfolds itself and emergency responders will find, when it get to the site. With the situation assessments done, the formal emergency team triggered will can prepare itself (with personnel and technical-materials facilities) to resolve the incident in the shortest time and with the least possible risks. (author)

  11. Course of training in Specific internal dosimetry for the patient; Curso de capacitacion en dosimetria interna especifica para el paciente

    Energy Technology Data Exchange (ETDEWEB)

    Rojo, A.M.; Michelin, S.C. [Dosimetria Interna, Autoridad Regulatoria Nuclear, Av. Del Libertador 8250 CP (429BNP), Buenos Aires (Argentina); Gomez P, I.M. [Sociedad Argentina de Radioproteccion, Av. del Libertador 8250, Buenos Aires (Argentina)]. e-mail: arojo@cae.arn.gov.ar

    2006-07-01

    In this work the experience obtained in a course organized in Argentina to qualify professionals in the radiopharmaceutical dosimetry using the methodology MIRD and the patient's images is presented. The motivation to carry out it was based on the continuous development of new radiopharmaceuticals with therapeutic purposes that makes necessary the knowledge of the distribution of the absorbed dose to be able to establish the dose-response relationship. The main objective was the study of the biokinetic model and those techniques available that starting from images can contribute information of specific parameters of the patient to calculate with more accuracy the doses in the tumor and in different organs. In the design of the program of this course it was considered to approach the different focuses for the calculation of specific dose of the patient and includes the following topics: the patient's radiological protection, new concepts in damages by radiations (bystander effect), methodology for the internal dosimetry by radiopharmaceuticals, dosimetric systems (MIRD/ICRP), revision of the physical phantoms, design of kinetic studies, compartmental models, calculation tools and the demonstration of the programs SAAM and OLINDA; calculation of activity starting from the patient's images (planar and SPECT). Principles of the gamma camera: the dispersed radiation, calculation of the activity with planar images, the attenuation, correction of the dispersed radiation, collimation problems. SPECT: the common method of reconstruction, basic principles, method of filtered over head projection and iterative methods (MLEM/OSEM), measurement of the attenuation maps, problems of the penetration in the collimator (I-131, I-123), effects of partial volume, incorporation of corrections in an iterative reconstruction. Dosimetry in bone marrow, discussion of study cases of new radiopharmaceuticals. Internal dosimetry in small scale for electrons and photons. Perspectives of the Monte Carlo method in the internal dosimetry. Dose calculation with the LundAdose program of the 'Lund University'. The development of these theoretical practice activities including conferences of foreign experts and practices in reference centers of Argentina, took place in Buenos Aires in August, 2004 during one week on complete time. This was the mark for the conjunct work of professionals of different specialties (doctors, physical, biochemical) of the national and regional environment. The survey carried out at the end of this first course showed the interest for a continuity in the in agreement upgrade to the technological advances in this topic, what allows us to conclude that the formation of those involved professionals should be faced in the region countries in permanent form. (Author)

  12. Dosimetry in medical specialist in procedures of interventionist radiology; Dosimetria en medico especialista en procedimientos de radiologia intervencionista

    Energy Technology Data Exchange (ETDEWEB)

    Gaona, E. [Universidad Autonoma Metropolitana, Unidad Xochimilco, Calz. del Hueso 1100, Col. Villa Quietud, 04960 Mexico D. F. (Mexico); Vazquez V, J. A.; Rivera M, T. [IPN, Centro de Investigacion en Ciencia Aplicada y Tecnologia Avanzada, Av. Legaria 694, 11500 Mexico D. F. (Mexico); Izeta G, A. C. [Hospital Central Militar, Periferico y Av. Ejercito Nacional s/n, 11200 Mexico D. F. (Mexico); Azorin V, J. C. [Universidad de Guanajuato, Instituto de Fisica, Loma del Bosque 103, 37150 Leon, Guanajuato (Mexico); Arreola, M., E-mail: gaen1310@correo.xoc.uam.mx [Shands Hospital at University of Florida, Department of Radiology, PO Box 100374, Gainesville, FL 32610-0374 (United States)

    2014-08-15

    In this work are presented the experimental results of determining the dose in different body parts, measured by thermoluminescent dosimeters, to medical specialists of implantation procedures of definitive cardiac pacemaker. The medical personnel in ten intervention procedures were controlled according to the procedure type, pathological indication, fluoroscopy time and machine generating estimates of the patient doses. The doses to the extremities of the cardiologist were measured by means of thermoluminescent dosimeters (TLD). The domains of first level in the hand are in the index finger of the left and the right hand. The medium doses of the skin in the eyes, a report of the dose received during each type of intervention procedure in the glandular thyroid and fingers of the cardiologists is made. The results represent the integrated dose to the cardiologist, received during the implantation procedures of definitive cardiac pacemaker in the same patient. By a half time of detection of 70 minutes for patient, the half dose of the skin, received for the right and left hand, ascended to 1,4 mSv, under the glove. In conclusion, the dose average for the dosimeters of the thyroid gland and forehead was varied from 0,41 up to 1,14 mSv for study. The exposure to the X-rays is a topic to consider, more important every time on the development of systematic procedures little invasive, including the angiography, catheter, worker and patient. (Author)

  13. Tl dosimetry around equipment s for dental radiography; Dosimetria TLD en torno a equipos para radiografia dental

    Energy Technology Data Exchange (ETDEWEB)

    Medrano, E.; Robles G, M. A. [Universidad Autonoma de Zacatecas, Unidad Academica de Odontologia, Apdo. Postal 336, 98000 Zacatecas (Mexico); Vega C, H. R.; Letechipia de L, C.; Hernandez D, V. M., E-mail: edumeco@yahoo.com.mx [Universidad Autonoma de Zacatecas, Unidad Academica de Estudios Nucleares, Cipres No. 10, Fracc. La Penuela, 98068 Zacatecas (Mexico)

    2014-08-15

    The ambient dose equivalent around X-rays units used in dentistry has been measured. The radiation that escapes of the tail stock of the X-rays equipment was also measured, and the dose in the surfaces of a polyethylene spherical mannequin and other of water, used to represent the patient and the operator, respectively. The study was realized with thermoluminescent dosimeters of the type 100. The operation conditions of the X-rays units were varied when the ambient dose equivalent was measured. In the other measurements the equipment s were operated to 70 k Vp and 8 m A. In the ambient dose equivalent was found asymmetry, likewise the due dose to the radiation that escapes of one of tail stocks was also asymmetric. The dose values in the mannequins went minors to the recommended reference values. (Author)

  14. Estimations of internal dosimetry: practical calculations of incorporated activity; Estimaciones de dosimetria interna: calculos practicos de actividad incorporada

    Energy Technology Data Exchange (ETDEWEB)

    Cortes C, A. [CNSNS, Dr. Barragan 779, 03020 Mexico D.F. (Mexico)

    2003-07-01

    The National Commission of Nuclear Security and Safeguards (CNSNS) carries out periodically measurements of corporal activity to Occupationally Exposed Personnel (POE) to determine that the received doses are in according to that settled down in the General Regulation of Radiological Security. In this work the results of the incorporated activity estimates starting from the results of the measurements that were carried out in the one CNSNS laboratory are presented, with which it should be determine lastly the internal dose. Its were used different methodologies to estimate the incorporated activity: estimate with isolated data, estimate with global data and method of the best estimate, demonstrating this last to be the more appropriate to determine the internal dose. (Author)

  15. A new method for dosimetry with films radiochromic; Un nuevo metodo para la dosimetria con peliculas radiocromica

    Energy Technology Data Exchange (ETDEWEB)

    Mendez Carot, I.

    2013-07-01

    in this paper a new method is presented and the results of the comparison between the calibration is summarized based on a planning reference and calibration obtained from the irradiated fragments measure different dose levels multichannel compare dosimetry based on the weighted average dosimetry described by Micke et al.(present in the FilmQAPro software) and, finally, show different results obtained with the method proposed in several applications clinics. (Author)

  16. Neutron dosimetry. Environmental monitoring in a BWR type reactor; Dosimetria de neutrones. Monitoreo ambiental en un reactor del tipo BWR

    Energy Technology Data Exchange (ETDEWEB)

    Tavera D, L; Camacho L, M E

    1991-01-15

    The measurements carried out on reactor dosimetry are applied mainly to the study on the effects of the radiation in 108 materials of the reactor; little is on the environmental dosimetry outside of the primary container of BWR reactors. In this work the application of a neutron spectrometer formed by plastic detectors of nuclear traces manufactured in the ININ, for the environmental monitoring in penetrations around the primary container of the unit I of the Laguna Verde central is presented. The neutron monitoring carries out with purposes of radiological protection, during the operational tests of the reactor. (Author)

  17. Dosimetry on the radiological risks prevention in radiotherapy; La dosimetria en la prevencion de riesgos radiologicos en radioterapia

    Energy Technology Data Exchange (ETDEWEB)

    Fornet R, O. M.; Perez G, F., E-mail: nuclear2@citmahlg.holguin.inf.cu [Delegacion Territorial del CITMA, Peralta 16 esq. P. Feria, Rpto. Peralta, 80400 Holguin (Cuba)

    2014-08-15

    Dosimetry in its various forms plays a determining role on the radiological risks prevention in radiotherapy. To prove this in this paper is shown an analysis based on the risk matrix method, how the dosimetry can influence in each stages of a radiotherapy service; installation and acceptance, operation, maintenance and calibration. For each one of these stages the role that can play is analyzed as either the initiating event of a radiological accident or limiting barrier of these events of the dosimetric processes used for the individual dosimetry, the area monitoring, fixed or portable, for radiation beam dosimetry and of the patients for a radiotherapy service with cobalt-therapy equipment. The result of the study shows that the application of a prospective approach in the role evaluation of dosimetry in the prevention and mitigation of the consequences of a radiological accident in radiotherapy is crucial and should be subject to permanent evaluation at each development stage of these services. (author)

  18. Statistical analysis of personal dosimetry of exposed workers; Analisis estadistico de la dosimetria personal de trabajadores expuestos

    Energy Technology Data Exchange (ETDEWEB)

    Sanchez Munoz, F. J.; Alejo Luque, L.; Mas Munoz, I.; Serrada Hierro, A.

    2013-07-01

    The dosimetry centers accredited by the Nuclear Safety Council (CSN) normally report overcoming legal limits, or some fraction thereof, but do not provide comparative dosimetric criteria indicating if assigned to a given dose is large TPE or small relative to that of their peers. In order to help to resolve the difficulties mentioned ds, it has developed an application that statistically processes the dosimetric data provided by the National Dosimetry Center. (Author)

  19. Teflon pastille use in high dose dosimetry; Utilizacao de pastilhas de teflon em dosimetria de doses altas

    Energy Technology Data Exchange (ETDEWEB)

    Teixeira, Maria Ines [Associacao Educacional Nove de Julho (UNINOVE), Sao Paulo, SP (Brazil); Caldas, Linda V.E., E-mail: miteixeira@ipen.b, E-mail: lcaldas@ipen.b [Instituto de Pesquisas Energeticas e Nucleares (IPEN/CNEN-SP), Sao Paulo, SP (Brazil)

    2011-10-26

    This paper study the Teflon, which is used as aglomerant in the confection of dosimetric pastilles, for the viabilization of this material as high dose dosimeter. This paper used the OSL technique for the characterization of dosimetric properties of Teflon. The doses-response curve has been obtained for {sup 60}Co radiation between 100 Gy and 50 kGy, and the OSL answer reproducibility. The preliminary results shown that the Teflon is a material which can be used for high dose dosimetry

  20. Thermoluminescent dosimetry in the radiodiagnostic area of the INNSZ; Dosimetria termoluminiscente en el area de radiodiagnostico del INNSZ

    Energy Technology Data Exchange (ETDEWEB)

    Azorin V, J C; Azorin N, J; Rivera M, T [Universidad Autonoma Metropolitana-Iztapalapa, 09340 Mexico D.F. (Mexico)

    1999-12-31

    During the year 1997 the Secretaria de Salud through the Direccion de Riesgos Radiologicos published the Mexican Official Standard about the medical diagnostic using X-rays in the Diario Oficial de la Federacion. They are of obligatory observance for all hospitals and radiological rooms which have medical diagnostic with X-ray equipment in the country. These standards were emitted with the purpose improve the conditions as for safety and radiological protection it is referred employing this type of ionizing radiation emitter equipment. Also it is presented the evaluation results about conditions existing about in thirteen X-ray medical diagnostic rooms in the Instituto Nacional de la Nutricion with the purpose of providing the radiological protection means toward the occupationally exposure personnel. It was realized measurements of each one of the blinding barriers for the X-ray equipment and it was suggested the appointments arrangement. (Author)

  1. Status of food and raw milk supply and problem just after the reactor accident

    International Nuclear Information System (INIS)

    Hirakawa, Sachiko; Murakami, Kana; Yoshizawa, Nobuaki; Takizawa, Mari; Kawai, Masaki; Sato, Osamu; Takagi, Syunji; Nakamura, Takashi

    2014-01-01

    Iodine 131 was detected in the environment and the food such as vegetables, raw milk and tap water just after the reactor accident following the East Japan Great Earthquake occurred in March 11, 2011. This article investigated status of refuge of Fukushima residents, their dietary life and food distribution from March 11 to 31 just after the accident so as to reevaluate internal exposure dose with Iodine 131. Investigation results showed most of food taken by refugees was confirmed food stock or relief supplies outside from the disaster area and suggested food contaminated with Iodine 131 was not widely consumed and distributed due to limit to send designated vegetables, restriction of tap water intake, damaged distribution facilities and closing down of retail stores. Restriction of tap water intake was only applied partly, so this might cause internal exposure dose due to tap water. (T. Tanaka)

  2. Production of 131 Iodine in research reactors from elementary tellurium

    International Nuclear Information System (INIS)

    Silva, Constancia Pagano Goncalves da

    1970-01-01

    Presents the history of the production of iodine-131 in the Institute of Atomic Energy (IEA), SP, Brazil), the preliminary works for the development of the method, which were done in small scale and it was not necessary protection for the operators, the evolution of these operations until the final assembling of the equipment in shielded cells, the efficiency of operations and product purity. The problems linked to the presence of iodate in the preparations and the changes made for elimination of that ion, harmful to many types and use of iodine-131 are examined. The quality of the product delivered today, an average of 140 departures per month, and the number of departures, per year since the beginning of iodine-131 production were indicated

  3. Release of fission products from a fuel rod with an artificial hole through cladding irradiated in an in-pile water loop, (2)

    International Nuclear Information System (INIS)

    Ishiwatari, Nasumi

    1978-11-01

    To make clear the iodine spiking phenomenon from a defective fuel rod into the primary coolant, the fuel rod (UO 2 pellets, with stainless steel sheath) with an artificial pin hole was irradiated in the inpile test section of water loop JMTR.OWL-1. Experimental conditions were depressurization and temperature drop of the primary loop coolant and diameter and position of the pin hole. Iodine 131 and cesium 137 in loop coolant were measured under various coolant conditions. The inventory and translation rate of iodine 131 in fuel rod related to irradiation histories were calculated. The levels of I-131 and Cs-137 released to loop coolant from fuel rod were compared. Compa